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Abstract 
 
Over the past few years one of the major concerns in the Atlantic salmon (Salmo 
salar) farming industry has been the increasing incidence and severity of 
inflammatory viral diseases. Heart and skeletal muscle inflammation (HSMI) and 
cardiomyopathy syndrome (CMS) are currently two of the most prevalent viral 
diseases in commercial Atlantic salmon farms in Norway. Mortality levels in both 
diseases are generally low but morbidity can be very high with the associated chronic 
inflammatory response lasting for several months. The consequent reduced growth 
performance is causing considerable financial impact as HSMI has become 
increasingly widespread in recent years. The impact of CMS is further exacerbated as 
it generally affects large fish close to harvest. HSMI lesions occur in the atrium and 
ventricle in the heart including inflammation and necrosis in epi- endo- and 
myocardium along with myositis of red skeletal muscle. CMS lesions are commonly 
observed in the spongy myocardium in the atrium and ventricle of the heart with 
severe mononuclear inflammation and necrosis. Furthermore, circulatory 
disturbances associated with reduced cardiac function cause multifocal liver steatosis 
and necrosis in both diseases. Currently there are no vaccines or any other effective 
treatments for these diseases and so alternative therapies that could potentially 
modulate the intensity of the inflammatory response could be crucial to improve the 
clinical manifestation of the diseases. Therefore, the overall aim of the present study 
was to evaluate the concept of “clinical nutrition” to improve the clinical symptoms 
of both viral diseases, HSMI and CMS, through the use of functional feeds 
formulated with reduced lipid content and increased proportions of anti-
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inflammatory fatty acids to moderate the apparently uncontrolled inflammatory 
response in the heart tissue associated with both diseases and also alleviate the 
secondary hepatic lesions. The experimental work consisted of three major dietary 
trials in Atlantic salmon in seawater.  Two large trials investigated the effects of 
functional feeds in Atlantic salmon challenged with Atlantic salmon piscine reovirus 
(ASRV) and piscine myocarditis virus (PMCV), the causal agents of HSMI and 
CMS, respectively. In both trials, heart transcriptome, heart and liver histopathology 
and tissue lipid and fatty acid compositions and metabolism were determined post-
infection in fish fed with the functional feeds in comparison with fish fed with a 
standard commercial feed formulation considered as a reference diet. All the 
functional feeds were formulated to have reduced digestible energy through lower 
dietary lipid and higher protein contents, and increased levels and proportions of 
anti-inflammatory long-chain polyunsaturated fatty acids (LC-PUFA), particularly 
eicosapentaenoic acid (EPA) compared with the reference diets. Histopathology, 
fatty acid composition and gene expression of heart were assessed over a long time-
period of 16 weeks and 14 weeks post-challenge with ASRV and PMCV, 
respectively. Viral load in heart tissue, hepatic histopathology and fatty acid 
composition of liver and head kidney along with expression of the genes involved in 
the eicosanoid and LC-PUFA and eicosanoid biosynthesis pathways were also 
determined in the HSMI trial. The third trial was a nutritional trial evaluating the 
effects of dietary digestible energy content on lipid and fatty acid metabolism in 
salmon fed diets containing graded amounts of lipid. Fatty acid composition of liver 
and heart were assessed over 12 weeks, along with the hepatic expression of genes of 
lipid and fatty acid metabolism. The results of this research are presented in four 
chapters (Chapters 2-5) as four paper manuscripts. The manuscripts/Papers are either 
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published (Chapter 2), in review (Chapter 3 and 4) or drafted for submission 
(Chapter 5) in appropriate peer-reviewed international journals. Chapter 2 and 3 
correspond to the HSMI trial, Chapter 4 to the nutritional trial, and Chapter 5 to the 
CMS trial. 
Chapter 2 showed that viral load and histopathology scores were lower in fish fed the 
functional feeds, especially diet FF1, which displayed better performance. Diet 
strongly influenced the expression of genes related with the immune and 
inflammatory responses, with delayed expression in fish fed the functional feeds. Up-
regulation of pro-inflammatory genes was correlated with the higher viral load 
observed at early-mid stages of the disease in fish fed the reference diet (ST). 
Expression of genes related with the immune response at 16-weeks post challenge 
reflected the differences in immunomodulation between the functional feeds, with 
fish fed diet FF1 showing lower expression. Therefore, severity of the heart lesions 
was correlated with the intensity of the immune response and could be associated 
with tissue anti-inflammatory LC-PUFA levels. Chapter 3 was focused on liver 
histopathology, fatty acid composition and LC-PUFA biosynthesis, along with 
phospholipid fatty acid composition and eicosanoid production in head kidney and 
heart tissue at early and late stages of ASRV infection. Liver was severely affected 
by the virus at the beginning of the infection in fish fed the reference ST diet, but the 
level of lesions were similar in all dietary groups at the end of the trial. Hepatic 
expression of fatty acyl desaturases was significantly depressed in fish fed the ST 
diet compare with fish fed the functional feeds despite the lower levels of dietary 
LC-PUFA in that feed. Thus endogenous production and bioavailability of anti-
inflammatory LC-PUFA was potentially enhanced in fish fed the functional feeds. 
Changes in tissue lipid content, mobilization of fatty acids involved in inflammatory 
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responses and changes in expression of transcription factors and genes involved in 
eicosanoid biosynthesis were more prominent in head kidney, confirming the 
important role of this organ in dietary immunomodulation after viral infection. To a 
lesser extent similar changes were observed in heart tissue, suggesting in situ 
production of eicosanoids could also be important. The unexpected effects of diet on 
expression of genes of LC-PUFA biosynthesis were specifically investigated in the 
trial described in Chapter 4. One aim of this study was to clarify whether dietary 
lipid content or viral infection was the cause of altered expression of desaturase 
genes between the different diets. Hepatic expression of other genes of lipid and fatty 
acid metabolism were also determined to evaluate metabolic changes associated with 
dietary lipid/energy level. In general, reduction of dietary energy and lipid contents 
while maintaining similar proportions of dietary fatty acids, led to a general up-
regulation of genes involved in lipid biosynthetic pathways. Thus salmon fed lower 
energy diet showed increased liver expression of fatty acyl desaturases in comparison 
with fish fed higher energy levels. Heart transcriptomic data in Chapter 5 showed a 
similar delay in the inflammatory response in fish fed the functional feeds after 
PCMV infection as observed in the HSMI study. Modulation of inflammatory 
responses, similar to that previously described after ASRV infection, was also 
observed in fish fed the functional feeds. However, the differences in the expression 
of immune related genes and the level of heart lesions were not as prominent at mid-
late stages of the disease as in fish fed FF1 in the HSMI trial. The present study 
demonstrated the beneficial effects of a clinical nutrition approach via functional 
feeds in two viral inflammatory diseases, HSMI and CMS, currently affecting farmed 
Atlantic salmon. Dietary immunomodulation increased the availability of anti-
inflammatory LC-PUFA and significantly influenced the expression of the genes 
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related with the immune/inflammatory response reducing the level and severity of 
cardiac and liver lesions and therefore improving the performance of fish suffering 
the diseases. 
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Chapter 1 
General Introduction 
 
Global production of farmed fish has been growing rapidly over the past decade 
reaching 60 million tonnes in 2010 (FAO/NACA, 2012).  The estimated data for 2012 
indicates that more than 50% of global food fish production and consumption will be 
from aquaculture (Figure 1.1). 
 
 
 
 
 
 
 
Figure 1.1. World capture fisheries and aquaculture production (FAO, 2012) 
Even with an increase in production of Atlantic salmon (Salmo salar) of more than 
600% (1.25 million tons) between 1990 and 2008, total global supply of salmonids is 
still marginal compared to most other seafood categories. However, Atlantic salmon is 
still at the top of the list of major cultured species with production of 1.43 million 
tonnes in 2010 (FAO 2010). Salmon is also the most important farmed finfish species in 
 2 
terms of value with a production valued at USD 7.8 billion (FAO, 2010). The leading 
producers of farmed salmon are Norway with 33 % of global production, followed by 
Chile with 31 % and the United Kingdom, specifically Scotland, with 19% of global 
production. 
The salmon farming production cycle can be largely divided into two phases. During 
the first phase, which occurs over 12 to 18 months, the salmon are hatched from eggs 
and the parr raised in freshwater (tanks or freshwater lakes/lochs) up to smoltification. 
The second phase starts with the transfer of the salmon smolts to seawater net pens or 
cages where they will be on grown over a period ranging from 12 to 24 months until 
they reach market size (2.5 - 4+ kg). The seawater stage takes place in a more or less 
uncontrolled environment in which infectious diseases are one of the major concerns. 
Indeed, the incidence of various diseases has increased in the past decades and these 
lead to economic losses that can dramatically impact the salmon farming industry. The 
recent drastic reduction in Chilean production was the most dramatic example of the 
impacts of a generally uncontrolled disease outbreak, albeit this has now been reversed. 
Viral infections remain the most significant diseases in Salmon aquaculture, as 
highlighted by the most recent Fish Health Report from the Norwegian Veterinary 
Institute (Alarcon et al., 2012). In addition to direct mortality losses due to viral disease, 
reduced growth and secondary infections in fish showing lower disease resistance are 
major problems associated with these viral infections (Alarcon et al., 2012). The 
diseases showing the highest incidence of outbreaks in the past year in Norway were 
infectious pancreatic necrosis (IPN), pancreas disease (PD), heart and skeletal muscle 
inflammation (HSMI) and cardiomyopathy syndrome (CMS). Infectious salmon 
anaemia (ISA) was previously the disease with very high incidence in the last decade, 
not only in Norway, but also in other salmon farming countries and was primarily 
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responsible for the recent problems in Chile. However, ISA is now under control after 
successful vaccination programs and biosecurity counter-measures against this virus. 
Similarly, since IPN and PD were first diagnosed in 1979 and 1981, respectively, the 
incidences of both diseases have had important impacts in the European salmon farming 
industry (see McCoy et al., 1994; Roberts and Pearson, 2005). However, several studies 
and management strategies, including vaccination and selective breeding programs 
appear to be working successfully to reduce the number of outbreaks and the 
consequential impact of these diseases (McLoughlin et al., 2007; Gomez-Casado et al., 
2011). In contrast, the situation with HSMI and CMS is currently a more pressing 
concern as the number and severity of outbreaks are increasing.  Therefore, incidence of 
HSMI in the Norwegian sector increased 20 % from 2010 to 2011 alone (Alarcon et al., 
2012).  The severity of these inflammatory diseases is also appearing to increase with 
higher morbidity and, importantly, the fish suffering from these diseases, especially 
CMS, are those close to commercial size just prior to harvest. Thus, the impact of both 
these cardiac inflammatory diseases, leading to financial losses, combined with the lack 
of effective treatments is currently one of the major concerns for both farmers and 
authorities involved in salmon production industries in Europe. 
Heart and Skeletal Muscle Inflammation was first reported in the mid-coast of 
Norway in 1999 and generally affects salmon after 5-9 months following seawater 
transfer (Kongtorp et al., 2004a). In recent years, however, it has become widespread 
along the entire Norwegian coast, affecting 162 sites in 2011 (Alarcon et al., 2012). 
However, although the incidence of the disease has been mainly focused in Norway, 
outbreaks in Scotland have also been reported (Ferguson et al., 2005). The mortality 
associated with HSMI varies from 0 to 20 % at affected sites although morbidity in 
most cases is close to 100 %. Fish affected by the disease do not present obvious 
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external signs, although they can be anorexic and display abnormal swimming 
behaviour (Kongtorp et al., 2004b). Autopsy reveals pale heart, yellowish liver, ascites, 
swollen spleen and petechiae in perivisceral fat, along with general circulatory 
disturbance caused by the inflammation of the heart tissue (Figure 1.2).  
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.2 by Kongtorp et al., 2004b Salmo salar. Macroscopical findings in heart and skeletal muscle 
inflammation (HSMI). (A) In this salmon, the heart is pale and there is haemopericardium. The spleen 
appears swollen. (B) Closer picture of a pale heart. (C) Fibrinous layer on the liver. a: haemopericardium, 
b: spleen, c: heart, d: fibrinous layer 
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Histopathologically, major changes occur in the myocardium and red skeletal 
muscle, where extensive inflammation by infiltration of lymphocytic cells and 
degeneration in spongy and compact layers of the ventricle are evident (Figure 1.3) 
(Kongtorp et al., 2004b). Atlantic salmon Reovirus (ASRV), a double-stranded RNA 
virus, has been described recently as the causal agent of HSMI (Mikalsen et al., 2012). 
In this study, cytotoxic CD8 T-cells were identified as the main cells infiltrating in the 
heart tissue playing a major role in the immune and inflammatory responses against this 
virus, although the presence of CD3 markers on those T-cells in the heart tissue during 
the inflammatory process has also been reported recently (Yousaf et al., 2012). 
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Figure. 1.3 by Kongtorp et al., 2004b. Salmo salar. Micrographs of sections from affected fish 
(H&E). (A) Ventricle showing severe epicarditis and myocarditis in the underlying compact 
myocardium. (B) Focal cellular infiltration in the compact myocardium. (C) Severe, diffuse myocarditis 
in the compact myocardium. (D) Cross section of red skeletal muscle, featuring severe myositis. (E) 
Vacuolisation and degeneration of red skeletal muscle fibres. Infiltration of mononuclear cells. (F) 
Longitudinal section of red skeletal muscle. The muscle fibres show signs of degeneration. a: epicardium, 
b: compact myocardium, c: focal cellular infiltration. Scale bars = 20 μm 
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Cardiomyopathy syndrome is also a cardiac disease with a viral aetiology, with a 
double-stranded RNA virus of the totiviridae family named piscine myocarditis virus 
(PCMV) recently reported as the causal agent (Haugland et al., 2011). This disease 
primarily affects adult Atlantic salmon during the second year after seawater transfer, 
when it is close to being harvested. CMS was firstly described in Norwegian farmed 
salmon in 1985 (Ferguson et al., 1990) and has since been diagnosed in Scotland 
(Rodger and Turnbull, 2000), the Faroe Islands, Denmark and Canada (Bruno and 
Noguera, 2009). In 2011, the Norwegian Veterinary Institute diagnosed the presence of 
CMS at 74 salmon farming sites mainly located in the mid-coast of Norway (Alarcon et 
al., 2012).  Although the number of fish affected by CMS and hence the sites in where  
CMS outbreaks were reported, are generally lower compared with HSMI or PD, as the 
fish are large fish close to harvest, the economic impact can be considerable (Brun et 
al., 2003). Indeed, Brun et al. (2003) estimated the direct annual economic losses to the 
industry due to CMS were between €4.5 to 8.8 million. Similar to HSMI, fish suffering 
CMS do not show any specific obvious symptoms apart from abnormal swimming 
behaviour and anorexia. However, sudden deaths may also occur due to rupture of the 
atrium or sinus venosus resulting in cardiac tamponade (Bruno and Noguera, 2009). At 
autopsy, fish with CMS can show skin haemorrhages, ascites, blood in the pericardial 
cavity, and the atrium and sinus venosus are usually enlarged (Bruno and Pope, 1996). 
Histopathologically, the diagnosis of CMS is characterized by severe inflammation, 
degeneration and necrosis of the spongious part of the myocardium of the atrium and 
ventricle. Inflammatory infiltrates consist of mononuclear cells, probably lymphocytes 
and macrophages (Ferguson et al., 1990). As CMS can last several months, it is also 
regarded as a chronic disease, and circulatory disturbances with multifocal liver 
necrosis may also occur. 
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Figure. 1.4 as in Alarcon et al., 2012. Salmon with cardiomyopathy syndrome (CMS). The atrium is 
distended to the point of rupture and there is a layer of fibrin on the liver. Photo: Trygve T. Poppe, 
Norwegian School of Veterinary Science. 
 
 
 
 
 
 
 
 
 
 
Figure. 1.5 as in Wiik-Nielsen et al., 2012. (a) Micrograph of a heart section with typical, focal 
cardiomyopathy syndrome (CMS) lesions in the spongy layers of the ventricle (H&E). (b) Micrograph of 
a myocardial lesion with mononuclear cell infiltration (H&E). (c) Micrograph of the spongy layers of a 
ventricle with typical myocardial lesions obtained for laser capture microdissection (Hx) showing the two 
lesions to be captured (brown line, vertical arrows). (d) Following removal of the lesion (arrowheads), an 
adjacent apparently normal area is outlined to serve as normal control tissue (light brown line, horizontal 
arrows; Hx). 
Thus, both viral diseases, HSMI and CMS, have in common lower mortality but high 
morbidity, and both show chronic, severe inflammation of the heart tissue, Therefore in 
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both diseases, external factors related to the inflammatory process could be highly 
relevant in potential therapies to moderate the impact of the diseases. For example, 
environment and stressor factors like temperature and vaccination or handling of 
farmed fish, respectively, could affect the general health status of the fish. However, in 
addition, the unavoidable changes in the formulation of aquafeeds, with the increasing 
necessary use of terrestrial plant-derived ingredients could potentially be detrimental to 
the control and consequences of the inflammatory responses to these infectious 
diseases. 
As a carnivorous fish, the nutritional requirements of salmon have traditionally been 
effectively covered by the use of fishmeal (FM) and fish oil (FO) from wild capture 
fisheries as the primary diet ingredients (Tacon and Metian, 2008). FM had been chosen 
as the main protein source in those aquafeeds for several scientifically sound nutritional 
reasons, which were mainly based on its high protein content, excellent amino acid 
profile, high digestibility and the general lack of antinutrients (Gatlin et al., 2007). The 
fat/lipid content of the diet is the main source of metabolic energy in feeds for 
carnivorous fish in addition to being the source of essential lipids, specifically the 
supply of essential polyunsaturated fatty acids (PUFA) (Sargent et al., 2002). In 
vertebrates, essential PUFA are, theoretically, the short chain PUFA 18:3n-3 (-
linolenic acid; LNA) and 18:2n-6 (linoleic acid; LA), precursors for the biosynthesis of 
the biologically active long-chain polyunsaturated fatty acids (LC-PUFA) of 20:5n-3 
(eicosapentaenoic acid; EPA) and 22:6n-3 (docosahexaenoic acid; DHA), and 20:4n-6 
(arachidonic acid; ARA), the main members of the n-3 and n-6 PUFA series, 
respectively. 
Synthesis of ARA is achieved by Δ6 desaturation of LA to produce 18:3n-6, which 
is then elongated to 20:3n-6 followed by Δ5 desaturation (Cook, 1996).  The pathway 
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for EPA synthesis from LNA is essentially similar, but DHA synthesis requires two 
further elongation steps, a second Δ6 desaturation and a chain shortening step 
(Sprecher, 2000) (Figure 1.6). 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6. The LC-PUFA biosynthesis pathways for n-3 and n-6 fatty acids. 5, 6, fatty acyl 
desaturases. Elovl,  elongases of very long-chain fatty acids.  
Apart from being the precursors of LC-PUFA, LNA and LA have no physiological 
role themselves in fish. However, LC-PUFA are major components of biological 
membranes, with particularly important specific roles in neural tissues and immune 
cells, regulating a multitude of metabolic and immune pathways through their roles as 
secondary messengers and transcription factor ligands, and being precursors of the 
immune modulators signaling molecules termed eicosanoids that can have both pro- or 
anti-inflammatory properties (Tocher, 2003). Although, Atlantic salmon are able to 
biosynthesise LC-PUFA from their C18 PUFA precursors, it is now well accepted that 
the conversion is not particularly efficient and may also decline when the fish are older 
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and in seawater (Sargent et al., 1999). Thus, LC-PUFA, especially those of the n-3 
PUFA series and ARA, are considered essential for salmon.  
The aforementioned global expansion of the aquaculture industry, with an average 
growth rate of 12.6 percent in the 1990s and 7.5 percent in the 2000s (FAO, 2012) 
coupled with the static or even diminishing global fisheries, including those utilised for 
the production of FM and FO, has led to the search for alternatives to these marine 
ingredients in aquafeeds. Therefore, in the last decade or so, aquafeed manufacturers 
have been increasingly replacing marine ingredients with cheaper and more sustainable 
sources of protein and lipid (Figure 1.7), (Tacon and Metian, 2008).  
 
 
 
 
 
 
 
 
Figure 1.7. Actual and predicted fishmeal use relative to the global production of compound aquafeed 
Among the alternative sources available, plant-derived raw materials have been 
widely studied as they are produced in large volumes, are renewable and can be less 
expensive than marine-sourced ingredients (Gatlin et al., 2007; Turchini et al., 2009; 
Miller et al., 2008) (Figure 1.8).  
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Figure 1.8. Global production of major oilseed plants (FAO/NACA 2012) 
In general, high levels of FO and FM substitution with plant-derived ingredients 
does not affect growth of salmonids (Bell et al., 1993, 2001, 2002), including Atlantic 
salmon, but detrimental effects on fish health have been reported (Krogdahl et al., 2003, 
2010). Inclusion of soybean meal has been extensively studied as this plant meal has 
reasonably high crude protein content and a relatively well-balanced amino acid profile, 
although high inclusions can cause enteritis characterized by shortening of the primary 
and secondary mucosal folds and infiltration of inflammatory cells in the intestine 
(Krogdahl et al., 2003). Several other plant protein sources have been also studied as 
potential candidates for FM substitution including peas, wheat, rapeseed, corn, 
cottonseed and faba bean (Gatlin et al., 2007; Adamidou et al., 2009). Generally, no 
major pathological changes have been described with low levels of FM substitution. 
However, potential problems with medium to higher levels of inclusion of plant protein 
 13 
sources have been associated primarily with their relatively high contents of potential 
anti-nutritional factors (ANFs) that include proteinase inhibitors, oligosaccharides, 
saponins and lectins (Krogdahl et al., 2010). These components can also affect the 
function of the fish gastrointestinal tract and gut health by altering digestibility and the 
efficiency of the gut as a barrier to pathogens. In the past few years, improved industrial 
processing technologies for plant meals and, in particular protein concentration 
methods, have reduced the contents of ANF compounds such that the use of plant 
protein concentrates has become increasingly common. Indeed, dietary plant protein 
concentrates have been able to sustain and even improve feed conversion ratios and 
growth at relatively high inclusion levels (Carter and Hauler, 2000; Storebakken et al., 
2000). However, further investigation of these concentrates is required as some 
potential pathology associated with the use of certain protein concentrates have also 
been reported (Penn et al., 2011; Kortner et al., 2012). 
Lipids are the major part of aquafeeds constituting more than 30-35 % of Atlantic 
salmon commercial feeds (Turchini et al., 2009). The traditional use of FO, which is 
particularly rich in n-3 LC-PUFA, EPA and DHA, has until now ensured that salmon 
feeds contain sufficient essential fatty acids. As mentioned above, sustainability, wide 
production and lower price are crucial factors that make VOs currently one of the best 
alternatives for the substitution of FO in aquafeeds (Figure 1.9). Replacement of FO by 
different vegetable oils (VO) has been well documented and recently reviewed by 
Turchini et al. (2009). Most VO sources are relatively poor in n-3 LC-PUFA but instead 
contain high levels of short-chain PUFA, LA and LNA, monounsaturated (MUFA) and 
saturated (SFA) fatty acids (Table 1.1) 
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Figure 1.9. Global production of major oilseed oils (FAO/NACA 2012) 
 
Table 1.1. Fatty acid composition (% total fatty acids) of fish oils, vegetable oils used in fish feed 
formulations (Adapted from Turchini et al., 2009) 
 
AA, arachidonic acid, 20:4 n-6; ALA, α-linolenic acid, 18:3 n-3; DHA, docosahexaenoic acid, 22:6 n-
3; EPA, eicosapentaenoic acid, 20:5 n-3; LA, linoleic acid, 18:2 n-6; MUFA, monounsaturated fatty 
acids; n-3 PUFA, polyunsaturated fatty acids with the first double bond at the 3
rd
 carbon atom; n-6 
PUFA, polyunsaturated fatty acids with the first double bond at the 6th carbon atom; SFA, saturated fatty 
acids. 
Oils ⁄ fats SFA MUFA LA ARA LNA EPA DHA 
n-6 
PUFA 
n-3 
PUFA n-3 ⁄ n-6 
Fish oils           
Anchovy oil 28.8 24.9 1.2 0.1 0.8 17.0 8.8 1.3 31.2 24.0 
Capelin oil 20.0 61.7 1.7 0.1 0.4 4.6 3.0 1.8 12.2 6.8 
Menhaden oil 30.5 24.8 1.3 0.2 0.3 11.0 9.1 1.5 25.1 16.7 
Herring oil 20.0 56.4 1.1 0.3 0.6 8.4 4.9 1.4 17.8 12.7 
Cod liver oil 19.4 46.0 1.4 1.6 0.6 11.2 12.6 3.0 27.0 9.0 
Vegetable oils           
Crude palm oil 48.8 37.0 9.1 -- 0.2 - - 9.1 0.2 0.0 
Soybean oil 14.2 23.2 51.0 - 6.8 - - 51.0 6.8 0.1 
Canola ⁄ rapeseed oil 4.6 62.3 20.2 - 12.0 - - 20.2 12.0 0.6 
Sunflower oil 10.4 19.5 65.7 - - - - 65.7 0.0 0.0 
Cottonseed oil 45.3 17.8 51.5 - 0.2 - - 51.5 0.2 0.0 
Groundnut oil 11.8 46.2 32.0 - - - - 32.0 0.0 0.0 
Corn oil 12.7 24.2 58.0 - 0.7 - - 58.0 0.7 0.0 
Linseed oil 9.4 20.2 12.7 - 53.3 - - 12.7 53.3 4.2 
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Although digestion and absorption of SFA and MUFA are known to be inferior to 
PUFA in fish (Torstensen et al., 2000), the VO best suited as a substitute for FO should 
contain high SFA and MUFA as energy sources and low amounts of LA because this 
fatty acid may be relatively poorly oxidized (Turchini et al., 2009). Furthermore, as it 
will be mentioned further in this text n-3 LC-PUFA are involved in several pathways of 
the immune response mostly displaying anti-inflammatory roles, in contrast n-6 LC-
PUFA, ARA, stimulate the inflammatory response. Therefore, even with an inefficient 
LC-PUFA biosynthesis in carnivorous fish, VOs containing the precursor of n-3 LC-
PUFA, LNA could be potentially more desirable for FO substitution. 
Partial level of substitutions with different VOs such as sunflower oil (Bell et al., 
1993; Tocher et al., 1997), rapeseed oil (Bell et al., 2001), soybean oil (Rosenlund et 
al., 2001) and palm oil (Bell et al., 2002) did not compromise the growth of different 
species of farmed fish, although morphology of the gastrointestinal tract and, hence, 
digestion and nutrient uptake (Caballero et al., 2002, 2003; Jutfel et al., 2007) as well as 
liver morphology (Figuereido-Silva et al., 2005; Ruyter et al., 2006) have been reported 
to be negatively affected by high levels of VO inclusion. Nevertheless, the major 
concern with the inclusion of dietary VO is the influence of specific PUFA (EPA, 
DHA, and ARA) on the different pathways of the fish immune response, recently 
reviewed by Montero and Izquierdo (2010). According to this publication, studies over 
the last few years have yielded contradictory results that have shown the effects of VO 
substitution on fish health are dependent upon species, VO used, levels of substitution, 
other dietary ingredients, antioxidants and dietary lipid levels, although some general 
trends can be observed. As described in mammals (Calder, 2007) changes in fatty acid 
profiles of the membranes of fish immune cells are highly dependent on the fatty acid 
composition of the diet. Therefore inclusion of VO in aquafeeds results in a reduction 
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of n-3 LC-PUFA, especially EPA and DHA, and increased incorporation of LNA and 
especially LA, and lower n-3/n-6 PUFA ratios in the phospholipids of immune cells 
such as peripheral blood leukocytes (Thompson et al., 1996; Petropoulos et al., 2009) 
and macrophages (Waagbø et al., 1995; Montero et al., 2003), compared with diets 
containing FO. 
LC-PUFA are involved in many physiological processes that provide several 
mechanisms whereby they may affect different pathways of the immune response 
(Stulnig and Zeyda, 2004).  Thus, changing the fatty acid composition of the 
membranes of human immune cells affected phagocytosis, production of eicosanoids, 
T-cell signalling pathways, antigen presentation capability and expression of 
transcription factors (Shaik and Edidin, 2006; Calder, 2008). Phagocytosis is the first 
stage of the elimination of many invading pathogens.  The influence of n-3 PUFA on 
phagocytic activity in human studies appears to be controversial and highly dependant 
on the methodology used to assess that activity, although it has been reported that 
phagocytosis was negatively correlated with the n-3/n-6 PUFA ratio (Calder, 2007). 
However, macrophage phagocytic activity against bacterial infections and respiratory 
burst activity was reduced in fish fed dietary VO, which increased the levels of dietary 
n-6 PUFA (Sheldon and Blazer, 1991; Montero et al., 2003). 
Eicosanoids, highly metabolically active derivatives of LC-PUFA, are a direct link 
between the fatty acid compositions of phospholipids of the immune cell membrane and 
the inflammatory response (Calder, 2001). Eicosanoids are synthesised mainly from 
ARA and EPA, those fatty acids being released from the membranes by the action of 
phospholipases A2 that is activated in response to particular stimuli. Once released from 
the membrane phospholipids, the LC-PUFA are converted through the action of the 
enzymes cyclooxygenase 2 (COX2) and lipooxygenase 5 (ALOX5), to give rise to 
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prostaglandins (PG) and leukotrienes (LT). Specifically, metabolism of ARA gives rise 
to the 2-series PG, including PGE2, and the 4-series LT including LTB4. In comparison, 
EPA gives rise to 3-series PG, including PGE3, and the 5-series LT, including LTB5 
(Figure 1.6). The ARA-derived eicosanoids have a largely pro-inflammatory action, 
whereas the EPA derivatives are generally less or anti-inflammatory (Calder, 2001). As 
the enzymes related with the eicosanoid pathway have higher affinity for ARA, this n-6 
LC-PUFA is the primary substrate for the eicosanoid forming pathways, even in fish 
(Bell et al., 1996; Tocher et al., 1997). The actions of the eicosanoids derived from 
ARA have been well documented in humans. PGE2 increases vascular permeability and 
vasodilatation contributing to the mobilization of the immune cells to the sites of the 
infection and thus enhancing the inflammatory process (Calder, 2001). However, PGE2 
can also suppress pro-inflammatory cytokines like tumour necrosis factor (TNF) - α and 
interleukin (IL) -1 during the recovery process after an inflammatory episode (Calder, 
2009a). LTB4 is a potent chemotactic agent for leukocytes and enhances the production 
of pro-inflammatory cytokines such as TNF- α, IL-1, IL-6, IL-2, Interferon (IFN) -γ and 
Natural killer activity. In contrast, eicosanoids produced from EPA are less potent and 
pro-inflammatory than those derived from ARA, although it is believed that the 
competition between these two fatty acids for the eicosanoid biosynthetic enzymes is 
also a key factor in regulating and controlling the release of the pro-inflammatory 
eicosanoids (Figure 1.6). Thus, incorporation of increasing levels of EPA in the 
membrane phospholipids through dietary supplementation has been reported to 
decrease the production of ARA-derived eicosanoids in humans (Calder, 2008). 
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Figure 1.10. Biosynthesis of eicosanoids. LT, leukotriene; PG, prostaglandin; TX, thromboxane;ARA 
arachidonic acid; EPA eicosapentaenoic acid 
Studies in fish are in agreement with those in humans described above albeit that the 
dietary interventions are in the opposite direction. That is, the normal situation in fish is 
high dietary EPA and the “intervention” is increased dietary n-6 PUFA. Therefore, the 
inclusion of VO rich in n-6 PUFA such as LA in aquafeeds increased the production of 
PGE2 (Bell et al., 1993; Gjøen et al., 2004) and LTB4 (Bell et al., 1996) and decreased 
the release of eicosanoids derived from EPA. As most of these were in vitro cell 
studies, further investigation would be required to fully elucidate the function, 
relevance and importance of the eicosanoids in fish after an infection. However, the 
positive correlation between heart lesions and the production of PGE2 reported in 
Atlantic salmon fed VO (Bell et al., 1993) and the higher expression of LTB4 described 
after a viral hemmorrhagic septicemia virus (VHSV) infection in leukocyte-derived 
supernatants of turbot (Scophthalmus maximus) (Tafalla et al., 2002) suggests similar 
roles of fish eicosanoids to those reported in humans. 
ARA EPA 
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Resolvins are a new family of n-3 LC-PUFA-derived mediators that have been 
recently identified in humans (Levy, 2010). These eicosanoid-like compounds are 
produced from EPA and DHA during the resolution phase of acute inflammation by a 
series of reactions involving COX2 and ALOX 15.  The resolvins have potent anti-
inflammatory actions by reducing natural killer cells migration, and decreasing 
production of TNF-α, LTB4 and IL-1 and other inflammatory cytokines (Ji et al., 2011). 
This new pathway provides evidence of the important role of DHA in the control of the 
inflammatory process, as well as reinforcing the anti-inflammatory role of EPA. The 
roles of resolvins in fish have not been fully characterized (Montero and Izquierdo, 
2010), probably due to the complexity of accurate identification and quantification, 
based on the fact that these mediators, like eicosanoids, have a short half-life in vivo. 
In recent years, the potential immunomodulatory roles of LC-PUFA have been 
reported to go beyond the aforementioned production of eicosanoids and resolvins. As 
LC-PUFA constitute an important fraction of the phospholipids of the immune cell 
membranes, their roles controlling signalling pathways related to T-cell activation 
through antigen presentation and the production of cytosolic calcium (Ca
2+
) are 
becoming of increasing interest in human clinical studies. One of the key events in the 
activation of T-cells is the production of cytosolic Ca
2+
 through the phosphorylation of 
the phospholipase C, which liberates inositol-1, 4, 5-triphosphate from 
phosphatidylinositol (the PI-cycle), which in turn, stimulates the increase of 
intracellular calcium (Stulning and Zeyda, 2004). That event is mediated by the 
signalling molecule linker of activated T cells (LAT) present on specific regions of the 
membranes called lipid rafts. The incorporation of n-3 LC-PUFA in T cell membranes 
has been reported to displace LAT from the lipid rafts inhibiting the membrane 
proximal signalling of those cells (Calder, 2007).  
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Antigen presentation through major histocompatibility complex (MHC) class I and 
MHC II is an additional crucial event for the activation of cytotoxic T cells and helper T 
cells after infection by intra- or extracellular pathogens (Manning & Nakanishi, 1997). 
Considerable data are available on LC-PUFA modulation of the expression of both 
MHC I and MHC II and it seems that incorporation of DHA and EPA may alter the 
conformation of both antigen presentation molecules (Shaikh and Edidin, 2006). Thus, 
FO supplementation in rats and addition of DHA and EPA in different in vitro studies 
has been reported to decrease the production of both MHC-I and MHC-II. The T cells 
have an important role in viral clearance in emerging virus diseases in Atlantic salmon 
such as CMS (Timmerhaus et al., 2011) and HSMI (Mikalsen et al., 2012). However, it 
appears that there are no published studies evaluating the interaction of LC-PUFA in 
the activation of T-cells in fish. 
The recent appreciation of the ligand-activated transcription factors, peroxisome 
proliferator-activated receptors (PPARs), in modulation of the immune response has 
implicated a new inmmunomodulatory role to LC-PUFA (Varga et al., 2011). As 
transcription factors, PPARs bind to DNA recognition sites and regulate gene 
expression. The role of PPARs in lipid and fatty acid metabolism has been extensively 
reported in humans (Xiao-Feng and Hui, 2006) and fish (Kennedy et al., 2006; Kjaer et 
al., 2008). In addition, PPARs are important regulators of the development of adipose 
tissue, fatty acid synthesis and peroxisomal and mitochondrial β-oxidation of fatty 
acids.  PPARs are activated by wide range of ligands of which LC-PUFA and 
eicosanoids are among the most important. Recent studies of the expression of PPARs, 
especially PPARγ and PPARα, have reported that they are, in general, involved in the 
suppression of the inflammatory response (Varga et al., 2011), specifically controlling 
the production of inflammatory cytokines through the inhibition of NF-κB and activator 
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protein 1 (AP-1) family members, which are critical transcription factors involved in 
pro-inflammatory responses (Choi and Bothwell, 2012).  PPARs are expressed not only 
on the adipose tissue but also in macrophages, dendritic cells and T cells. PPAR 
expression changes with T cell activation and proliferation following T-cell receptor 
(TCR) stimulation controlling T-cell survival and differentiation (Choi and Bothwell, 
2012). 
Whether the recently appreciated immune modulatory role of PPARs in mammals 
has a similar role in the fish immune response is something that requires further 
investigation.  The recent study by Sundvol et al. (2010), reporting higher expression of 
PPARγ in fish resistant to Aeromonas salmonicida, has contributed to this area and has 
pointing to a similar relationship between PPARs and inflammatory response in fish. 
Despite the potential detrimental consequences for fish health described above and 
the associated implications for the incidence of emerging inflammatory diseases 
following the inclusion of plant-derived meals and VO in aquafeeds, the aquaculture 
industry still has to rely on these substitutes to FM and FO given the lack of suitable 
alternative products.  
Recently, based on quite widely documented experiments investigating “clinical 
nutrition” in humans (Olson, 1978; Roberfroid, 2000), the concept of functional feeds 
has emerged as a potential solution to counteract the harmful effects of plant-derived 
ingredients on fish health (Kiron, 2012). In general, functional feeds are defined as food 
that, beyond simple nutritional (nutrient) effects, can provide additional benefits for 
health and well-being (Tacchi et al., 2011). There are different strategies regarding the 
formulation of functional feeds in aquaculture. They can contain additives from 
synthetic or natural sources that could potentially be used, in some cases, on a regular 
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basis as, in general, only the increase in price would limit step their use. Alternatively, a 
functional feed could have a high quality macronutrient composition derived from 
marine sources which in this case, due to the aforementioned sustainability problems, 
would limit their use to certain specific periods of stress and to prevent/mitigate the 
inflammatory episodes associated with disease outbreaks. However, vitamin and 
mineral supplementation also seems to be important as, even though the raw materials 
used in the aquafeeds generally meet the nutrient requirements for fish, antagonistic 
interactions with other dietary ingredients could lower their natural bioavailability, 
leading to immune status suppression that could further affect disease resistance (Lim et 
al., 2001). 
Many recent studies taking a functional feeding approach in aquaculture have used 
additives or micronutrients in the feeds, particularly focusing on probiotics, prebiotics, 
nucleotides and immunomodulatory polysaccharides (Kiron, 2012). Probiotics and 
prebiotics have, in general, been used to improve growth, feed conversion and health 
status of the gastrointestinal tract of fish while also conferring resistance to certain 
diseases. Probiotics are live microorganisms that can compete with pathogenic bacteria 
for attachment to the gut wall and improving the digestion, while prebiotics are 
fermented ingredients with a low molecular weight that cannot be digested by the fish, 
but influence the composition and activity of the endogenous gastrointestinal microflora 
(Tacchi et al., 2012). Immunomodulation of phagocytic activity, respiratory burst, 
lysozyme and complement activity with the inclusion of both these types of additives in 
fish feeds have been reviewed previously (Merrifield et al. 2010). However, their 
effects on immune responses vary between species and different studies and thus future 
research is required to plan feeding strategies on a practical industrial scale using pre- 
and probiotics for improved preventive health care. Even so, these dietary components 
 23 
may offer potential strategies for mitigating certain possibly detrimental effects on the 
gastrointestinal tract when plant proteins are included in aquaculture feeds. 
Immunomodulatory polysaccharides and nucleotides have also been included in 
aquafeeds (Kiron, 2012). These are specific factors that, when added to the diet, can 
modulate the immune system of fish increasing disease resistance by enhancing the host 
immune response. 
Dietary nucleotides would support their physiologically required levels in tissues 
with limited capacity of their novo synthesis like lymphoid tissues, preventing an 
inadequate energetic expenditure and modulating gene expression patterns and 
immunoendocrine interactions. (Li and Gatlin, 2006). Immunomodulatory 
polysaccharides act directly on pathogenic recognition receptors (PRR) stimulating 
them to release and produce pro-inflammatory cytokines that could potentially lead to 
more rapid development of the immune response after an infection (Tacchi et al., 2011). 
Both components have been reported to increase disease resistant towards various 
bacterial infections. However, immunomodulatory polysaccharides are not particularly 
effective against intracellular pathogens like viruses, although nucleotide 
supplementation was reported to increase resistance to IPN in juvenile rainbow trout 
(Leonardi et al., 2003). Even though the use of both additives in functional feeds has 
been intensively studied in the past few years, further investigations are required to 
fully understand all the possible interactions of these components on different 
physiological responses and expression of immunogenes, as well as appropriate doses 
and timing of administration (Li and Gatlin, 2006; Kiron, 2012). 
As the main source of lipid for aquafeeds was traditionally n-3 LC-PUFA-rich FO, 
the concept of using sources of anti-inflammatory fatty acids such as EPA and DHA in 
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functional feeds is very new for the aquaculture industry. The use of increasing levels 
of n-6 PUFA-rich VO as replacement for traditional FO has meant that the concept of 
n-3 LC-PUFA as an ingredient in functional feeds is now completely logical. In 
humans, n-3 LC-PUFA have been widely documented as an alternative therapy in 
chronic inflammatory diseases such as rheumatoid arthritis, inflammatory bowel 
diseases and asthma (Calder and Yaqoob, 2009; Miles and Calder, 2012). Among these 
chronic inflammatory diseases, the effects of FO supplementation in patients suffering 
rheumatoid arthritis has shown the most consistently positive effects, with most trials 
reported significant clinical benefits (Stamp et al., 2005). As one of the primary 
symptoms of some of the aforementioned emerging diseases in farmed salmon such as 
HSMI and CMS is a chronic inflammatory process, it is expected that novel 
formulations of functional feeds including sources of n-3 LC-PUFA including 
alternative marine sources such as unicellular algae, pelagic organisms or benthic 
invertebrates containing high amounts of n-3 LC-PUFA could also mitigate the 
incidence of these inflammatory diseases in fish. 
In addition to traditional measures of the effects of dietary formulations on fish 
performance such as growth and feed efficiency, tissue composition, nutritional quality 
and histopathology, recent advances in functional genomics, essentially the study of 
gene expression, has opened up new possibilities for understanding the mechanisms 
involved in the use of functional feeds. Determining patterns of gene expression 
through study of tissue transcriptomes (mRNA expression) can provide large amounts 
of information on individual molecular responses that, with detailed bioinformatic 
analyses, can provide great insights into the physiological and immunological responses 
being studied (Taggart et al., 2008; Panserat et al., 2009). The use of transcriptomic 
analyses to provide a global overview of cellular and molecular events has become 
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increasingly popular in salmonid studies including the description of metabolic changes 
associated with different sources and levels of dietary lipids (Kolditz et al., 2008a; 
Morais et al., 2011). In addition, characterization of the immune response after viral 
infections such as infectious hematopoietic necrosis (IHN) virus (Miller et al., 2007), 
ISA (Jørgensen et al., 2008) and CMS (Timmerhaus et al., 2011) has helped to achieve 
a better understanding of antiviral and disease resistance mechanisms and to indicate 
possible new ways of treatment. 
Aim and outline of the thesis 
The current situation regarding the increased incidence of chronic inflammatory 
disease outbreaks associated with a viral aetiology, such as HSMI and CMS, in Atlantic 
salmon aquaculture, is resulting in severe financial losses for producers. Although this 
problem is currently particularly manifest in the Norwegian salmon aquaculture sector, 
it is highly likely that it has the potential to also severely affect the UK sector. The lack 
of vaccines to date requires a review of the use of alternative therapies that are crucial 
to mitigate the detrimental impacts of both diseases on growth and health of farmed 
salmon. In both diseases, although mortality rates are generally relatively low, 
morbidity can be very significant. Lesions are mainly focussed in the heart tissue and 
are characterized by severe inflammation and necrosis while lesions in the liver are also 
a commonly found, partly as a consequence of circulatory disturbances. Hence, any 
dietary factor modulating or attenuating chronic inflammatory processes would be a 
prime candidate for improving the performance, and subsequent recovery, of fish 
suffering from these two cardiac diseases. 
The concept of clinical nutrition, widely studied and applied in humans, is becoming 
increasingly popular in salmonid aquaculture. This concept is based on the use of 
functional feeds enriched with active components, in this case anti-inflammatory 
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agents, to improve disease resistant and restore the health status of the fish through 
dietary immunomodulation. 
Dietary lipid composition has been extensively studied in fish regarding multiple 
implications of effects of n-3 LC-PUFA in the inflammatory responses. In addition, 
reduction of dietary lipid content has also been used in commercial scale trials as a 
strategy/therapy to treat fish infected with pancreas disease (PD) having promising 
results with decreased mortality (EWOS internal communication). Although the precise 
mechanism is unclear, reduction in dietary lipid has been previously used to treat dogs 
with different pancreas pathologies related with lipid digestion (Westermack et al., 
1995, Suzuki et al., 1999). Apart from pancreas, liver is one of the main organs in 
charge of the lipid digestion (Bogevik et al., 2009) and as aforementioned, is affected 
by both HSMI and CMS viral infections. Therefore reduction on the dietary lipid 
content could potentially reduce the digestive pressure in this organ alleviating the level 
of pathology associated with both viral diseases. Thus, both increasing the level of anti-
inflammatory agents and reducing total lipid load could potentially contribute to the 
control of chronic inflammatory processes related to emerging viral diseases in Atlantic 
salmon. 
Within the context of the above, the overall aim of the present thesis was to 
investigate the application of a clinical nutrition-based strategy in the therapy for two 
viral diseases, heart and skeletal muscle inflammation (HSMI) and cardiomyopathy 
syndrome (CMS), currently causing a significant financial impact in salmonid 
aquaculture. Functional feeds were specifically formulated to attenuate the chronic 
inflammatory processes in affected fish and thereby reduce the level of lesions in heart 
tissue.  Thus, the functional feeds contained reduced dietary lipid content and elevated 
levels of n-3 LC-PUFA, specifically eicosapentaenoic acid (EPA; 20:5n-3). 
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To this end, three dietary trials were performed in Atlantic salmon.  The first trial 
investigated the effects of two functional feed formulations in comparison to a standard, 
commercial reference feed on Atlantic salmon experimentally infected with ASRV, the 
causal agent of HSMI. The effects on tissue lipid and fatty acid compositions, heart 
inflammation, and heart tissue transcriptome were determined. As the mechanism of 
reduced dietary lipid in functional feeds was unclear, a second trial specifically 
investigated the effects of decreased dietary digestible energy through reduced dietary 
lipid on fish performance, tissue lipid and fatty acid metabolism and gene expression. 
Based on the results of trials one and two, a third and final trial investigated the effects 
of two revised functional feed formulations, again in comparison to a standard, 
commercial reference feed, on Atlantic salmon experimentally infected with piscine 
myocarditis virus (PMCV), the causal agent of CMS. The effects on tissue lipid and 
fatty acid compositions, heart and liver inflammation, and heart tissue transcriptome 
were determined. 
The specific objectives of the four primary manuscripts produced from the dietary trials 
were: 
1. To evaluate transcriptomic responses of fish fed with functional feeds having 
reduced lipid content and increased levels of EPA, by the inclusion of krill-
based products following an infection with ASRV. 
2. To investigate the correlation of the moderate immune response observed after 
the use of functional feeding in fish suffering HSMI with the eicosanoid and 
LC-PUFA biosynthesis pathways. 
3. To assess the effects of dietary energy on the hepatic expression of genes related 
to lipid and fatty acid metabolism in Atlantic salmon fed diets containing graded 
amounts of lipid. 
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4. To evaluate the dietary immunomodulation of functional feeds with reduced 
lipid content increased levels of EPA and histidine supplementation after 
infection with PCMV through the use of oligomicroarray technology. 
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Abstract 
Heart and Skeletal Muscle Inflammation (HSMI), recently associated with a novel Atlantic 
salmon reovirus (ASRV), is currently one of the most prevalent inflammatory diseases in 
commercial Atlantic salmon farms in Norway. Mortality varies from low to 20%, but 
morbidity can be very high, reducing growth performance and causing considerable 
financial impact. Clinical symptoms, including myocarditis, myocardial and red skeletal 
muscle necrosis, correlate with the intensity of the inflammatory response. In the present 
study, the effects of two functional feeds (FF1 and FF2) were compared to a standard 
commercial reference feed (ST) in Atlantic salmon subjected to an ASRV challenge. The 
functional feeds had reduced levels of total lipid and digestible energy, and different levels 
and proportions of long-chain polyunsaturated fatty acids (LC-PUFA). The objective was 
to determine whether these feeds could provide effective protection by decreasing the 
inflammatory response associated with HSMI. Histopathology, viral load, fatty acid 
composition and gene expression of heart tissue were assessed over a period of 16 weeks 
post-infection with ASRV. The viral load and histopathology scores in heart tissue in 
response to ASRV infection were reduced in fish fed both functional feeds, with FF1 
showing the greatest effect. Microarray hierarchical cluster analysis showed that the 
functional feeds greatly affected expression of inflammation/immune related genes over 
the course of the ASRV infection. Viral load correlated with up-regulation of pro-
inflammatory genes at the early-mid stages of infection in fish fed the ST diet. Expression 
of inflammatory genes 16-weeks after ASRV challenge reflected the difference in efficacy 
between the functional feeds, with fish fed FF1 showing lower expression. Thus, severity 
of the lesions in heart tissue correlated with the intensity of the innate immune response 
and was associated with tissue fatty acid compositions. The present study demonstrated 
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that dietary modulation through clinical nutrition had major influences on the development 
and severity of the response to ASRV infection in salmon. Thus, HSMI was reduced in fish 
fed the functional feeds, particularly FF1. The modulation of gene expression between fish 
fed the different feeds provided further insight into the molecular mechanisms and 
progression of the inflammatory and immune responses to ASRV infection in salmon. 
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2.1 Introduction 
Heart and Skeletal Muscle Inflammation (HSMI) was first diagnosed in 1999 (Kongtorp 
et al., 2004a) and has been associated with a novel piscine reovirus (Palacios et al., 2010) 
recently defined as Atlantic salmon reovirus (ASRV) (Mikalsen et al., 2012). It is currently 
one of the most prevalent inflammatory diseases in commercial Atlantic salmon farms in 
Norway, with over 600 sites affected since 2003. Isolated cases have also been detected in 
the United Kingdom (Ferguson et al., 2005). Mortality associated with HSMI varies 
between outbreaks; from insignificant to 20% of stock (Kongtorp et al., 2004a), but 
morbidity can be very high, significantly reducing growth performance, increasing feed 
conversion ratio, and causing considerable financial impact. Clinical symptoms include 
aberrant swimming behaviour (lethargic fish) believed to be associated with reduced heart 
function and poor circulation. Histopathologically, heart and red skeletal muscle appear to 
be the main organs affected showing severe inflammation. Epi-, endo-, and myocarditis 
and myocardial necrosis, as well as necrosis of red skeletal muscle are characteristic of the 
disease, although liver damage is also found (Kongtorp et al., 2004b). These clinical 
symptoms are believed to correlate with the intensity of the inflammatory response, so 
factors modulating inflammation might influence the clinical manifestation of this disease.  
       One strategy to potentially control outbreaks of HSMI, or reduce the severity of the 
disease, is through the application of clinical nutrition and functional feeds. The concept of 
clinical nutrition and functional foods is well known in human nutrition. Functional foods 
are defined as foods that contain a component (whether a nutrient or not) that could be 
beneficial for the state of well-being and health, or reduce the risk of a disease, beyond the 
basic nutritional requirement (Bellisle et al., 1980). Therefore, dietary supplementation is 
now a common complementary therapy, not only to improve the general health status of 
the population, but also for the management of common inflammatory diseases such as 
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rheumatoid arthritis (Stamp et al., 2005) or coronary diseases (Erkkilä et al., 2008). This 
type of approach is also becoming increasingly popular in aquaculture as it could 
potentially result in great economical savings in terms of increased productivity and lower 
costs of disease treatment/management (Raynard et al., 1991; McCoy et al., 1994; Tacchi 
et al., 2011). At the current time HSMI vaccines are still under development and efficacy 
of other commercially available viral vaccines may be variable (Sommerset et al., 2005).  
Clinical nutrition offers a valuable additional tool to reduce the impact of viral diseases. 
       There are many additives used in aquaculture diets including probiotics, prebiotics, 
immunostimulants, vitamins and nucleotides, which are included in commercial feeds to 
increase growth and feed conversion efficiency, as well as having positive effects on the 
fish immune system (Tacchi et al., 2011). The replacement of fishmeal with plant-derived 
protein sources can lead to changes in gut flora and physiology, probably due to higher 
contents of non-digestible fibrous components, and increased levels of anti-nutritional 
factors, whose negative effects can be ameliorated by the additives mentioned above 
(Dimitroglou et al., 2010). Another concern in recent years has been the replacement of 
dietary fish oil (FO) by vegetable oils (VO). This is a consequence of generally decreasing 
wild fisheries worldwide that, not only supply a declining proportion of fish for direct 
human consumption, but also, paradoxically, could constrain the growth of aquaculture 
due to reduced availability of fishmeal and FO, required for the manufacture of aqua feeds 
(Tacon and Metian, 2008; FAO, 2010).  
It is well known that dietary polyunsaturated fatty acids (PUFA) can influence the 
immune response. Arachidonic acid (ARA, 20:4n-6), eicosapentaenoic acid (EPA, 20:5n-
3) and docosahexaenoic acid (DHA, 22:6n-3), derived from cell membrane phospholipids, 
are precursors of eicosanoids, resolvins and protectins, which modulate leukocyte function 
and thereby influence production of inflammatory cytokines and adhesion molecules 
(Calder, 2007). The eicosanoids derived from ARA promote pro-inflammatory responses, 
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whereas those derived from EPA and DHA either produce a reduced inflammatory 
response or actually resolve (terminate) the inflammatory response (Calder et al., 2009b). 
Dietary supplementation with n-3 long-chain (LC) PUFA, EPA and DHA, protects against 
cardiovascular diseases, and may also be beneficial for some common inflammatory 
disorders in humans (Calder and Yaqoob, 2009a). Studies have demonstrated that these 
LC-PUFA have the same role in immunomodulation in fish, and this has been an important 
concern particularly in recent years with increased energy (lipid) content of commercial 
diets and the aforementioned replacement of dietary FO by VO, which are devoid of LC-
PUFA, but rich in n-6 PUFA (Balfry and Higgs, 2001; Ganga et al., 2005). Such dietary 
replacement decreases the n-3/n-6 LC-PUFA ratio in tissues, potentially promoting the 
synthesis of pro-inflammatory eicosanoids, and several studies have examined whether this 
might affect disease resistance in farmed animals (Bell et al., 1996; Montero et al., 2008a). 
In general, fish fed diets with a high level of VO inclusion may be less resistant to 
infection and prone to increased severity of inflammatory responses due to the reduced n-
3/n-6 PUFA ratio. Influence of dietary lipid content has also been investigated. It was 
reported that diets with higher lipid content may be associated with increased mortality and 
muscle lesions in Atlantic salmon suffering from pancreas disease, a common viral 
infection in salmon farming (McCoy et al., 1994).  
         Oligonucleotide microarray analysis of tissue transcriptomes has become an 
increasingly popular tool in fish nutritional studies but, in addition, has also provided a 
global overview of the cellular and molecular events activated upon viral infections, and 
genome-wide changes after vaccination (Zhu et al., 2010) or infection (Kawada et al., 
2006). Host genes and immune responses induced after infection with different viral 
diseases of salmon such as infectious salmon anaemia (ISA) (Jørgensen et al., 2008; 
Workenhe et al., 2009) and infectious hematopoietic necrosis (IHN) virus (Miller et al., 
2007) have been characterized using transcriptomic analysis. Krasnov et al. (2011) 
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identified virus responsive genes (VRG) in different viral diseases including HSMI, but 
there are no further descriptions of the immune response specifically related with this 
disease, such as the expression of host genes after infection with ASRV. 
          The aim of the present study was to investigate the application of a clinical nutrition 
strategy in Atlantic salmon subjected to experimental ASRV challenge, through the use of 
two potential functional feed formulations in comparison to a standard commercial feed. 
The standard reference diet (ST diet) contained 31% lipid derived from marine (FO and 
fishmeal) and terrestrial (rapeseed oil) sources. The functional feeds had reduced energy 
levels through lower lipid (18%), and increased levels of EPA, and increased n-3/n-6 
PUFA and EPA/ARA ratios, which were achieved by increased protein (fishmeal and krill 
meal) (FF1 diet), or krill meal plus krill oil (FF2 diet). Krill products, especially krill oil, 
are good sources of EPA and DHA in a phospholipid form (Storebakken, 1988). Dietary 
krill oil increased incorporation of EPA and DHA into heart phospholipids in rats (Reeves 
et al., 1993), and decreased the inflammatory process associated with chronic diseases such 
as rheumatoid arthritis in humans (Ierna et al., 2010). The incorporation of anti-
inflammatory LC-PUFA into heart, the main organ affected by the disease, and head 
kidney (the main immune organ) was assessed. In addition to histological evaluation, the 
inflammatory profile in heart tissue was monitored by microarray analysis of gene 
expression over a period of 16 weeks after infection with ASRV, and viral load assessed 
over the later collections times (˃10 weeks post challenge). Therefore, this was a 
nutritional study specifically designed to determine whether functional feeds could 
ameliorate the pathological effects of the ASRV infection, and to identify 
pathways/mechanisms underpinning the dietary effects in order to improve feed 
formulations. 
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2.2 Materials and Methods 
2.2.1 Fish and experimental feeds 
     Three fishmeal-based diets were formulated and manufactured by EWOS Innovation 
(Dirdal, Norway) (Table 2.1). The reference diet (ST) was essentially a standard, 
commercial formulation with 31 % lipid with the added oil being a blend of FO and 
rapeseed oil. The two functional feeds (FF) both contained a lower level of lipid that was 
balanced by increased protein, provided by fishmeal and krill meal. Both also contained 
increased proportions of EPA, but with different levels of n-6 PUFA and DHA, resulting in 
the n-3/n-6 PUFA ratio in the feeds varying from 1.5 to 3.6, through the inclusion of krill 
oil in one of the feeds replacing rapeseed oil (Table 2.2). The precise formulations were 
based on small-scale commercial screening trials (unpublished). Therefore, as one major 
factor being investigated was dietary lipid level, the diets were not isolipidic or isoproteic. 
The diets were termed ST (standard reference diet), FF1 and FF2.  
        A total of 450 Atlantic salmon (Salmo salar L.), unvaccinated AquaGen strain, were 
distributed into three tanks at the EWOS facility, Lønningdal, Norway and fed one of the 
three feeds for a period of 8 weeks. After this pre-challenge feeding phase, 390 (130 fish 
per treatment) fish (non-vaccinated) with an initial average weight 220g (±3.2g, standard 
error), were transferred to the challenge facility at the Industrial and Aquatic Laboratory 
(ILAB), Bergen, Norway. Fish were distributed into two independent experimental rooms 
supplied with filtered sea water (of approximately 30‰) each containing 9 tanks (3 tanks 
per dietary treatment in each system). Water delivery was flow-through, with a supply to 
maintain oxygen concentration in outlet water ˃ 8 mg/L. Water temperature was 
maintained at 10 ± 1°C, water flow rate was 0.8 L / kg fish / min, and a 12:12 h light/dark 
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regime was followed. The fish were acclimated for 2 weeks prior to challenge and were 
fed with the same diets during the acclimation period and throughout the period of the 
challenge (16 weeks) that they were fed prior to transfer. No previous diseases were 
described. Ten fish from each feeding group (n = 30 in total) were sampled prior to 
challenge (0 time-point controls) for histological examination to confirm they were 
disease-free.  
Table 2. 1 Formulation of the experimental diets. 
Component %
1
 STD FF1 FF2 
Fish meal and hydrolysates 42.1 53 53 
Fish oil 13.7 7 5.2 
Vegetable protein 
concentrates
2
 21 18 18 
Vegetable oil 11.2 3 0 
Carbohydrate-based binders
3
 11.2 12.1 12.1 
Micro premixes
4
 0.8 1.9 1.7 
Krill meal
5
 0 5 5 
Krill oil
5
 0 0 5 
Total 100 100 100 
Proximate composition    
Moisture 6.5 6.5 6.5 
Fat 31 18 18 
Protein 42.2 53.4 53.4 
 
1) All ingredients sourced from EWOS stocks unless otherwise stated. 
2) Includes soy protein concentrate, pea protein concentrate, wheat gluten and sunflower 
meal 
3) Includes wheat grain 
4) Includes vitamins, minerals, crystalline amino acids, ammonium phosphate 
5) Aker Biomarine A 
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Table 2.2 Total lipid fatty acid composition (percentage of total fatty acids) and lipid class composition 
(percentage of total lipid) of the experimental diets 
 
 
 
 
 
 
 
 
 
 
 
ARA, Arachidonic acid; EPA, eicosapentaenoic acid; PUFA, polyunsaturated fatty acids. 
 
2.2.2 Virus isolation and preparation of inoculum 
       Heart tissue, collected from a clinical outbreak of HSMI, was homogenized and 
centrifuged 3500 x g for 20 min 4ºC to remove cellular debris and then filtered (0.45 μm). 
The homogenate was inoculated onto GF-1 cells derived from fin tissue of orange-spotted 
grouper, Epinephelus coioides. This was done in collaboration with PHARMAQ AS, Oslo, 
Norway who supplied the cell line. The cells were grown at 15°C in Leibovitz L-15 
medium (Invitrogen AS, Oslo, Norway) supplemented with 1 % L-glutamine, 0.1 % 
gentamicin sulphate (Sigma Aldrich Norway AS, Oslo, Norway) and 10 % fetal bovine 
serum (Invitrogen). At 2 weeks after inoculation the supernatant and cell lysate were 
harvested and cleared by centrifugation at 3500 x g for 20 min at 4ºC. 
 
Fatty acid ST FF1 FF2 
Saturated 23.97 36.48 31.86 
18:1n-9 32.30 18.65 16.31 
Monounsaturated 45.73 33.10 37.05 
18:2n-6 10.73 7.11 5.30 
20:3n-6 0.06 0.11 0.10 
20:4n-6 0.36 0.48 0.54 
n-6 PUFA 11.63 8.09 6.50 
18:3n-3 4.62 2.35 1.55 
20:5n-3 4.85 8.76 9.53 
22:6n-3 6.09 5.98 9.03 
n-3 PUFA 17.83 19.83 23.32 
PUFA 30.31 30.42 31.09 
EPA/ARA 13.67 18.16 17.75 
N-3/N-6 1.53 2.45 3.59 
Phospholipids 8.94 10.77 17.30 
Triacylglycerols 65.39 53.47 52.45 
% Lipid 24.52 13.71 13.35 
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2.2.3 ASRV Challenge 
       As this was a nutritional trial designed to test the effects of different feeds, all 360 
remaining fish were challenged with pathogen. The fish were sedated using Aqui-S at final 
concentration of 5 mg/L of isoeugenol, followed by anaesthesia in Benzoak using a final 
concentration of 30 ml/L of water. Fish were challenged by intramuscular injection (0.1 ml 
on each side close to the lateral line) of ASRV collected from cell culture supernatant of 
piscine reovirus (as above). There were no mortalities during the trial, which was 
consistent with previous experimental studies of HSMI (Kongtorp et al., 2004a; Kongtorp 
et al., 2004b). 
2.2.4 Sampling  
       Ten fish, chosen at random, from each dietary treatment group (5 fish from each of 
the two independent systems) were sampled at 8-, 10-, 12-, and 16-weeks post-challenge 
for histology, lipid and biomolecular analysis (data presented). However, in addition a 
further 10 fish per treatment were sampled at 14 weeks post-challenge for histology (data 
not shown) and all remaining fish were culled at week 16 post-challenge for possible 
further histological analysis.  Fish were anaesthetized and killed by a blow to the head, and 
heart and head kidney collected for analyses. Part of each heart sample was transferred to 
10% buffered formalin for histological analyses and another part was immediately frozen 
in liquid N2 and stored at -80 
o
C prior to lipid and molecular analyses. Head kidney was 
immediately frozen in liquid N2 and stored at -80 
o
C.  
 
2.2.5 Histological examinations 
       Inflammatory response in ASRV challenged fish was assessed by histological changes 
in heart tissue (epicardium and myocardium) as assessed by light microscopy. The scoring 
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system marked samples on a visual analog scale on the basis of the criteria given in 
Supplementary Table 2.3 (Mikalsen et al., 2012). A maximum score of 6 can be achieved 
for combined epicardial and myocardial changes. All evaluations were carried out blind. 
Further, details of the different feeds were not revealed to the histological examiner (ØE), 
i.e. the histological examination was carried out as a double‐blind study. 
Micrographs showing examples of the correspondence between different levels of heart 
lesions and histoscores assigned are shown in Figure 2.1 
 
2.2.6 Lipid analyses 
       Lipid and fatty acid analyses were performed on heart and head kidney tissue samples 
from five fish per treatment at 8- and 16-weeks post-challenge. Total lipid from 
approximately 1g of heart and head kidney tissue was extracted by homogenization in 
chloroform/methanol (2:1, by volume) according to Folch et al. (1957), and determined 
gravimetrically. Fatty acid methyl esters (FAME) of total lipid were prepared by acid-
catalyzed transmethylation (Christie, 2003), and FAME separated and quantified by gas 
chromatography as described in detail previously (Bell et al., 1993). Tissue and diet lipid 
class compositions were determined by single-dimension double-development high-
performance thin-layer chromatography (HPTLC) and densitometry as described 
previously (Bell et al., 1993). Significance of differences due to diet and time were 
determined by two-way ANOVA (p<0.05) using the SPSS 19.0 statistical package (SPSS 
Inc., Chicago IL, USA). 
 
 
 
 
 41 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 Micrographs showing different levels of pathology on the heart tissue. A, epicarditis (score 1); B, epicarditis (score 2); C, epicarditis with inflammation in 
compactum of the ventricle (score 1.5 epicard and 2 of compactum); D, Spongious part of ventricle, Infiltration of inflammatory cells and degeneration/necrosis of 
myocytes. (score 2). 
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2.2.7 RNA extraction and purification 
       Heart tissue from six individuals per dietary treatment was rapidly homogenized in 
TRI Reagent (Ambion, Applied Biosystems, Warrington, U.K.) using an Ultra-Turrax 
homogenizer (Fisher Scientific, Loughborough, U.K.). Total RNA was isolated following 
manufacturer’s instructions, and RNA quality and quantity assessed by gel electrophoresis 
and spectrophotometry (NanoDrop ND-1000, Thermo Scientific, Wilmington, U.S.A.), 
respectively. One hundred micrograms of total RNA from each individual sample was 
further purified by mini spin-column purification (RNeasy Mini Kit, Qiagen, Crawly, UK), 
and quantified and quality assessed as above. 
2.2.8 Microarray hybridizations and analysis 
       The transcriptomic experiment used an Atlantic salmon custom-made oligoarray with 
44k features per array on a four-array-per-slide format, with each feature printed singly 
(Agilent Technologies UK Ltd., Wokingham, UK). The probes were co-designed by 
researchers at the Institute of Aquaculture, University of Stirling, U.K. and The Norwegian 
Institute of Food, Fisheries and Aquaculture Research (Nofima, Tromsø, Norway), and 
array design is available on request. A dual-labelled experimental design was employed for 
the microarray hybridizations. Each experimental sample was competitively hybridized 
against a common pooled-reference sample, which comprised equal amounts of each of the 
replicates used in the study. This design permits valid statistical comparisons across all 
treatments to be made. The entire experiment comprised 72 hybridizations; 4 time points 
(8, 10, 12 and 16 weeks) × 3 diets (ST, FF1 and FF2) × 6 biological replicates. 
        Indirect labelling methodology was employed in preparing the microarray targets.  
Amplified antisense RNA (aRNA) was produced from each RNA sample using the Amino 
Allyl MessageAmpTM II aRNA Amplification Kit (Ambion, Applied Biosystems, 
Warrington, UK), following the manufacturer’s methodology, followed by Cy3 or Cy5 
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fluor incorporation through a dye-coupling reaction. Briefly, 500 ng of total RNA per 
sample were amplified and column-purified according to manufacturer’s instructions 
including a 17 h transcription step. Resultant aRNA was quantified and quality assessed as 
above. Subsequently, Cy dye suspensions (Cy3 & Cy5) in sufficient quantity for all 
labelling reactions were prepared by adding 36 µL high purity dimethyl sulphoxide 
(Stratagene, Agilent Technologies UK Ltd.) to each tube of Cy dye (PA23001 or 
PA25001, GE HealthCare, Chalfont St. Giles, UK). To attach the Cy dyes, 3 µg each 
aRNA sample was suspended in 10 µL nuclease-free H2O and heated to 70 ºC for 2 min. 
When cooled to room temperature, 3 µL of coupling buffer (0.5 M NaHCO3; pH 9.2) and 
2µL of Cy3 dye suspension stock was added and then incubated for 1 h at 25 ºC in the 
dark.  To label the common pooled reference sample with Cy5, a scaled-up batch reaction 
was similarly performed. Unincorporated dye was removed by column purification 
(Illustra AutoSeq G-50 spin columns; GE Healthcare). Dye incorporation and aRNA yield 
were quantified by spectrophotometry (NanoDrop) and further quality controlled by 
separating 0.4 μL of the sample on a thin mini-agarose gel and visualising products on a 
fluorescence scanner (Typhoon Trio, GE Healthcare). 
       Hybridization of a total of 6 slides (24 arrays) was performed in a single day, with 
sample order semi-randomized, using SureHyb hybridization chambers in a DNA 
Microarray Hybridization Oven (Agilent Technologies). For each hybridization, 825 ng of 
Cy3-labelled experimental biological replicate and Cy5-labelled reference pool were 
combined and total volume made up to 38 μl with nuclease-free water. A fragmentation 
master mix was prepared containing, per reaction, 11 μl 10× blocking agent, 2.2 μl 25× 
fragmentation buffer and 6.8 μl nuclease-free water, and 20 μl was dispensed into the Cy-
dyes mix. After incubating in the dark at 60 ºC for 30 min, 57 μl 2×GE Hybridization 
buffer (pre-heated to 37 ºC) was added, contents gently mixed, spun at 16,000 g for 1 min 
and kept on ice until loaded onto the microarray slides as per the manufacturers protocol. 
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Hybridization was carried out in the oven rotator (Agilent Technologies) at 65 ºC and 10 
rpm for 17 h. Post-hybridization washes were carried out in EasyDip
TM
 Slide staining 
containers (Canemco Inc., Quebec, Canada). After disassembling the array-gasket 
sandwiches submersed in wash buffer 1 at room temperature, the microarray slides were 
transferred to an EasyDip
TM
 container and incubated in wash buffer 1 for 1 min at 31 ºC in 
an orbital incubator rotating at 150 rpm, and then a further 1 min at 31 ºC at 150 rpm in 
wash buffer 2. A final dip in wash buffer 2 at room temperature was performed, after 
which the slides were dried by centrifugation (500 x g for 6 min) and kept in a desiccator 
in the dark until scanned the same day. Unless otherwise stated, all reagents were from 
Agilent Technologies. 
       Scanning was performed at 5 μm resolution using an Axon GenePix 4200AL Scanner 
(MDS Analytical Technologies, Wokingham, Berkshire, U.K.). Laser power was kept 
constant (80 %) and the “auto PMT” function within the acquisition software (v.4) was 
enabled to adjust PMT for each channel such that less than 0.1% of features were saturated 
and that the mean intensity ratio of the Cy3 and Cy5 signals was close to one. Agilent 
Feature Extraction Software (v 9.5) was used to identify features and extract fluorescence 
intensity values from the resultant TIF images. The remaining analysis was then performed 
in the GeneSpring GX version 10.0.2 analysis platform (Agilent Technologies). All 
intensity values < 0.1 were set to 0.1 followed by a block Lowess normalisation. After 
removing control features, a series of four quality filtering steps was carried out 
sequentially using a range of quality control metrics produced by the Agilent Feature 
Extraction software to remove features that were saturated, non-uniform, population out 
layers and spots non-significantly different from background. 
       Hybridization data were analyzed by two-way ANOVA, which examined the 
explanatory power of the variables ‘diet’ and ‘time’ and the interaction between the two, at 
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a significance level of 0.05. In the present study we focussed on immune-related genes 
whose expression was differentially affected by diet at 16 weeks post-challenge and thus 
only data from the significant interaction list was analyzed. That list contained 2584 genes, 
including repeated probes. Due to the large size of the list, hierarchical cluster analysis and 
5x5 Self-Organizing Maps cluster analysis (SOM) were used to map the common temporal 
expression profiles of the genes from the list using the GeneSpring GX version 10.0.2 
analysis platform (Agilent Technologies). 
2.2.9 RT-qPCR 
Expression of 12 selected genes showing a significant diet × time interaction in the 
microarray analysis and related to relevant immune-related pathways was studied by 
reverse transcription quantitative real-time PCR (qPCR). The qPCR primer sequences, 
annealing temperature (Tm) and size of amplicon are given in Supplementary Table 2.1 
(end of the chapter). The sequences were obtained either by literature searches or designed 
from EST sequences corresponding to microarray clones or candidate genes of interest 
using Primer3 software (http://biotools.umassmed.edu/bioapps/primer3_www.cgi). In 
addition, amplification of three potential reference genes, cofilin-2, elongation factor-1α 
(elf-1α) and -actin, was performed but only cofilin-2 and elf-1α expression was 
sufficiently stable across treatments for normalization. Cofilin-2 and elf-1α had been 
identified in previous salmon cDNA microarray and qPCR studies as suitable reference 
genes on the basis of constant expression between different feeds and time points 
(Jørgensen et al., 2006; Morais et al., 2011).  
Samples used for the microarrays hybridizations from 12 and 16 weeks post challenge, 
were selected for the qPCR validation (6 samples x 3 treatments x 2 time points). For 
qPCR, 2 µg of column-purified total RNA per sample was reverse transcribed into cDNA 
using the High-Capacity cDNA RT kit (Applied Biosystems, Paisley, U.K.), following 
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manufacturer’s instructions, but using a mixture of the random primers (1.5µl as supplied) 
and anchored oligo-dT (0.5 µl at 400 ng/ µl, Eurofins MWG Operon, Ebersberg, 
Germany). Negative controls (containing no enzyme) were performed to check for 
genomic DNA contamination. cDNA was then diluted 20-fold with water, after a similar 
amount of cDNA was pooled from all samples. qPCR analysis used relative quantification 
with the amplification efficiency of the primer pairs being assessed by serial dilutions of 
the cDNA pool. qPCR amplifications were carried out in duplicate (Quantica, Techne, 
Cambridge, U.K.) in a final volume of 20 µL containing either 5 µL (for most genes) or 
2µL (for the reference genes and other highly expressed genes) diluted (1/20) cDNA, 
0.5µM of each primer and 10 µL AbsoluteTM QPCR SYBR® Green mix (ABgene). 
Amplifications were carried out with a systematic negative control (NTC-non template 
control, containing no cDNA). The qPCR profiles contained an initial activation step at 
95°C for 15 min, followed by 30 to 40 cycles: 15 s at 95 °C, 15 s at the specific primer pair 
annealing Tm and 15 s at 72 °C. After the amplification phase, a melt curve of 0.5 °C 
increments from 75 ºC to 90 °C was performed, enabling confirmation of amplification of 
single products, and sizes were checked by agarose gel electrophoresis and identities 
confirmed by sequencing. Non-occurrence of primer-dimer formation in the NTC was also 
verified. Data were analyzed using the relative expression software tool (REST 2009, 
http://www.gene-quantification.info/), which employs a pair wise fixed reallocation 
randomization test (10,000 randomizations) with efficiency correction, to determine the 
statistical significance of expression ratios (or gene expression fold-changes) between two 
treatments (Pfaffl et al., 2002) 
2.2.20 Assessment of viral load  
Relative quantification of ASRV by qPCR was used to determine differences in the viral 
load between the different dietary treatments at the two critical points in the time-course of 
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the infection (12- and 16- weeks post-challenge) when differential expression of genes 
related with the inflammatory process was greatest between fish fed the ST diet and fish 
fed the functional feeds. The qPCR primer sequences (Supplementary Table 2.4) 
previously described by Mikalsen et al. (2012) were employed following the same 
procedure and from the same RNA samples used for the validation of the microarray (as 
described above). 
2.2.11 Statistical analysis 
Histological changes in epicardium and myocardium were ranked according to a non-
continuous score grade from 0 to 4 (0 indicates no pathology, normal tissue; 4 intense 
inflammation). A description of each of the scores is included in Supplementary Table 2.3. 
All data preparation and simulation output analysis was conducted with the R language
 
(R:Languaje). The model was a mixed-effects linear model estimated with the lmer 
function in the lme4 package. The treatment estimates were based on posterior simulation 
(n = 2500) with 95 % credible intervals as absolute and proportional to the reference level 
(control diet). 
Histopathological scores were analysed by using a multilevel ordered categorical logistic 
regression because the data are multinomial. The model was written in BUGS (Lunn et al., 
2000) language and fitted with JAGS (Plummer, 2009). Vague non-informative uniform 
priors [0,100] were given for the variance parameters and vague non-informative normal 
priors N (0, 1.0E + 4) for all other parameters. 25000 “burn-in" simulation runs were used 
to adapt the Markov Chain Monte Carlo (MCMC) before subsequent 2500 runs that were 
used for inference. Three chains were run in parallel, i.e. there were a total of 7500 
simulations for inference. These were thinned so that only every 10th simulation was saved 
to reduce the size of saved objects and to reduce the effects of autocorrelation. In effect, 
the posterior density is based on 750 draws from the posterior probability distribution. 
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Convergence of the MCMC simulation was judged by the so-called Gelman-Rubin 
convergence diagnostic (Gelman and Rubin, 1992). 
 
2.3 Results 
2.3.1 The viral load and histopathology scores in the heart tissue in response 
to ASRV infection were reduced in fish fed both functional feeds, with the 
FF1 feed showing the significantly greatest effect. 
We first used RT-qPCR to compare the heart virus load between the different dietary 
groups at later stages of the infection, when the inflammatory response typical of HSMI 
appeared in heart tissue in challenged fish, i.e. 12- to 16-weeks post-challenge (Kongtorp 
et al., 2004a; Kongtorp et al., 2004b). We found there was considerably higher viral load at 
12-weeks post-challenge in fish consuming the ST diet compared with fish fed the two 
functional feeds (Figure 2.2). Fish fed the ST diet showed 260-fold greater viral load 
(p<0.05) than fish fed the FF1 diet. Compared to the FF2 diet, relative levels were 25-fold 
higher in ST fish but, due to the high variability between individuals, this difference was 
not significant. The pathophysiological response to the infection characterised 
histologically by infiltration of lymphocytes and macrophages in heart tissue, reflected the 
pattern of virus load as had been shown earlier (Mikalsen et al., 2012). There was no 
infiltration of inflammatory or immune cells in heart tissue in any dietary group at 8-weeks 
post-challenge (Figure 2.3). However, from 10-weeks onwards, the histopathology scores 
showed that the levels of cardiac inflammation were much higher at all-time points in fish 
consuming the ST diet compared to fish fed the functional feeds (FF1 and FF2 groups). In 
addition, the fish fed diet FF1 showed the significantly lowest level of cardiac 
inflammation when the data were combined across all time points (Figure 2.3).  
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Figure 2.2 Viral load in heart tissue of the different dietary groups at 12- and 16-weeks post-challenge. Viral 
load was determined by quantitative real-time PCR analysis of Atlantic salmon reovirus OH-2010 strain 
ALV726 inner capsid protein lambda-1/VP3 gene (HM453201). Results are presented as normalised 
expression data (n=6) relative to β-actin on a log scale (log10) with statistical analysis by Kruskal-Wallis 
test (non-parametric). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3. Average histoscores (± SEM) in the different dietary treatment groups at 8-, 10-, 12-, 14- and 16-
weeks post-challenge. Significant differences between feed groups are indicated. N = 10 to 20 per group. 
Samples were scored by marking on a visual analog scale on the basis of criteria described previously by 
Mikalsen et al. (3) (see Supplementary Table 2.3). A maximum score of 6 can be achieved for combined 
epicardial and myocardial changes. Scoring was carried out with a double‐blind format. 
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2.3.2 Fatty acid compositions of heart and head kidney tissues were 
associated with the severity of the inflammatory response/disease 
    The fact that diets modulated the viral load and inflammatory scores to the extent 
observed was surprising and, based on the difference in fatty acid composition between 
diets, we first examined the fatty acid profiles of heart and head kidney tissues (Tables 2.2 
and 2.3). Generally, the composition of these organs reflected the diets fed to the fish 
(Table 2.4) in a similar manner to that observed in previous studies that investigated effects 
of diet on fatty acid profiles of heart (Bell et al., 1992) and head kidney (Gjoen et al., 
2007). The proportion of EPA and the EPA/ARA ratio were significantly higher in heart 
tissue of fish consuming the functional feeds (Table 2.3). In general, the overall fatty acid 
profile of heart tissue changed relatively little during the course of the infection. In 
contrast, we found that the fatty acid profile of head kidney tissue showed more significant 
differences between the three dietary groups, and the proportions of most of the LC-PUFA 
related with the immune response changed during the course of the infection (Table 2.4). 
For instance, the proportions of total n-3PUFA and DHA increased, and those of ARA and 
monoenes decreased, over the course of the infection. The proportion of EPA also 
decreased in fish fed the ST diet over the course of the infection but, in contrast, EPA 
increased in fish fed the functional feeds between weeks 8 and 16 (Table 2.4). Previous 
studies have shown that levels of EPA, ARA and DHA could determine the intensity of 
inflammatory response, with EPA and DHA being anti-inflammatory fatty acids and ARA 
pro-inflammatory (Calder, 2005). In concert with this finding, our results showed that 
tissue levels of EPA and DHA and the EPA/ARA ratios were significantly higher in fish 
fed the functional feeds than in fish fed the ST diet, which was consistent with the reduced 
inflammatory response in heart tissue in these groups (Figure 2.3). 
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Table 2.3 Total lipid fatty acid composition (percentage of total fatty acids) of heart from Atlantic salmon fed the different diets at 8- and 16- weeks post-infection with 
ASRV   
 
Results are means ± SD (n = 5). P-values of two-way ANOVA are presented for factors ‘diet’, ‘time’ and interaction between both factors. 
ARA, arachidonic acid; EPA, eicosapentaenoic acid; ns, not significant (p > 0.05); PUFA, polyunsaturated fatty acids. 
 
  
 
 
 
 
 
 
 
 
 
 8 weeks 16 weeks TWO WAY ANOVA P-value 
Fatty acid ST FF1 FF2 ST FF1 FF2 Diet Week Diet*Week 
Saturated 25.48 ± 4.17 27.22 ± 1.92 28.45 ± 1.45 22.33 ± 0.90 25.16 ± 1.05 27.07 ± 1.01 0.001 0.008 ns 
Mono 26.48 ± 8.25 21.69 ± 4.19 26.74 ± 9.68 35.32 ± 7.35 26.58 ± 7.44 24.97 ± 6.90 ns ns ns 
20:3n-6 0.32 ± 0.07 0.38 ± 0.06 0.27 ± 0.06 0.28 ± 0.02 0.35 ± 0.05 0.30 ± 0.03 0.005 ns ns 
20:4n-6 1.87 ± 0.76 1.95 ± 0.44 1.40 ± 0.56 1.10 ± 0.37 1.45 ± 0.42 1.53 ± 0.39 ns ns ns 
N-6 PUFA 8.36 ± 1.11 6.82 ± 0.31 6.00 ± 0.43 9.34 ± 0.88 7.30 ± 0.65 5.66 ± 0.38 0.000 ns ns 
20:5n-3 6.21 ± 1.96 8.67 ± 1.31 6.98 ± 2.19 4.53 ± 1.27 7.86 ± 1.39 7.19 ± 1.21 0.002 ns ns 
22:6n-3 27.69 ± 7.03 30.08 ± 3.40 26.67 ± 9.10 22.19 ± 6.52 27.23 ± 7.34 30.26 ± 7.29 ns ns ns 
N-3 PUFA 38.64 ± 8.39 43.44 ± 4.54 38.30 ± 11.09 32.45 ± 7.20 40.28 ± 8.20 41.62 ± 8.08 ns ns ns 
PUFA 48.04 ± 8.05 51.08 ± 4.22 44.81 ± 11.12 42.35 ± 6.48 48.22 ± 7.19 47.95 ± 7.70 ns ns ns 
EPA/ARA 3.49 ± 0.65 4.57 ± 0.77 5.21 ± 0.86 4.19 ± 0.40 5.62 ± 0.98 4.83 ± 0.76 0.000 ns ns 
N-3/N-6 4.73 ± 1.36 6.40 ± 0.89 6.38 ± 1.83 3.56 ± 1.13 5.62 ± 1.54 7.46 ± 1.84 0.000 ns ns 
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Table 2.4 Total lipid fatty acid composition (percentage of total fatty acids) of head kidney of Atlantic salmon 8- and 16-weeks post-infection with ASRV   
 
  8 weeks 16 weeks TWO WAY ANOVA P-value 
Fatty acid ST FF1 FF2 ST FF1 FF2 Diet Week Diet*Week 
Saturated 22.01 ± 0.72 25.13 ± 1.26 27.41 ± 0.58 21.84 ± 0.50 25.03 ± 0.41 28.15 ± 0.67 0.000 ns ns 
Monounsaturated 41.76 ± 2.01 40.24 ± 4.18 38.85 ± 3.44 40.44 ± 3.63 35.15 ± 1.97 30.38 ± 3.19 0.000 0.000 ns 
20:3n-6 0.24 ± 0.02 0.25 ± 0.03 0.22 ± 0.03 0.26 ± 0.03 0.30 ± 0.01 0.24 ± 0.03 0.002 0.002 ns 
20:4n-6 1.31 ± 0.21 1.22 ± 0.44 1.25 ± 0.35 0.66 ± 0.14 0.82 ± 0.08 0.88 ± 0.12 ns 0.000 ns 
N-6 PUFA 9.88 ± 0.56 7.91 ± 0.33 6.56 ± 0.26 9.82 ± 0.60 7.83 ± 0.46 5.51 ± 0.21 0.000 0.000 0.007 
20:5n-3 4.73 ± 0.57 5.78 ± 1.33 5.81 ± 1.18 3.72 ± 0.67 6.63 ± 0.44 6.71 ± 0.80 0.000 ns 0.027 
22:6n-3 15.02 ± 1.53 14.39 ± 2.68 15.77 ± 2.26 17.47 ± 3.46 18.26 ± 2.68 23.69 ± 2.75 0.014 0.000 ns 
N-3 PUFA 25.79 ± 1.81 25.79 ± 3.93 26.52 ± 3.30 27.42 ± 3.76 30.87 ± 2.60 35.37 ± 3.06 0.022 0.000 ns 
PUFA 36.23 ± 1.78 34.63 ± 4.04 33.74 ± 3.44 37.72 ± 3.15 39.82 ± 2.07 41.47 ± 2.88 ns 0.000 ns 
EPA/ARA 3.65 ± 0.44 4.91 ± 0.67 4.75 ± 0.46 5.69 ± 0.78 8.12 ± 0.91 7.69 ± 0.40 0.000 0.000 ns 
N-3/N-6 2.62 ± 0.26 3.25 ± 0.41 4.03 ± 0.38 2.82 ± 0.52 3.97 ± 0.56 6.44 ± 0.76 0.000 0.000 0.001 
 
Results are means ± SD (n = 5). P-values of two-way ANOVA are presented for factors ‘diet’, ‘time’ and interaction between both factors. 
ARA, arachidonic acid; EPA, eicosapentaenoic acid; ns, not significant (p > 0.05); PUFA, polyunsaturated fatty acids. 
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2.3.3 Microarray hierarchical cluster analysis showed that the functional feeds 
greatly affected expression of immune related genes over the course of the 
ASRV infection 
   We then went on to profile the transcriptomes of the heart tissue over time post challenge 
in an effort to fingerprint the contrasting inflammatory responses observed in the different 
diet groups. A hierarchical cluster analysis of heart tissue transcriptomes was performed 
and the results indicated clearly contrasting patterns of gene expression over the course of 
the infection between different dietary treatments (Figure 2.4). There was a strong up-
regulation (shown in red colour) of a group of genes at 12-weeks post-challenge in fish 
consuming the ST diet. The same group of genes was similarly strongly up-regulated at 16-
weeks post-challenge in fish consuming the FF2 diet (Figure 2.4, outmost lane to the 
right). In both cases there was concomitant down-regulation of another distinct group of 
genes. On this basis we prepared two lists containing all up- and down-regulated genes 
from the cluster groups (identified by Self-Organizing Maps cluster analysis) showing 
these patterns of expression. The list of down-regulated features contained a set of 378 
genes related with various cellular, biological and metabolic pathways including cell 
survival processes, regulation of apoptosis, regulation of transcription and general lipid 
metabolic processes (Supplementary Table 2.1). In contrast, the list of up-regulated 
features contained a set of 732 genes primarily related to various aspects and stages of the 
immune response, including both innate and adaptive immune system responses 
(Supplementary Table 2.2). To assist the interpretation of these data, the genes of the up-
regulated list were sorted by fold-change comparing 8 weeks versus 16 weeks in fish fed 
the FF2 diet. All the genes showing an increase in expression from 8 to 12 weeks greater 
than or equal to 5-fold, along with a small number of other highly relevant genes with a 
fold-change lower than 5, were considered for more detailed discussion of the data. The 
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179 genes in this list (Supplementary Table 2.2) were categorized according to the specific 
pathways/processes to which they are commonly associated. The effects of the dietary 
treatments on these pathways were analyzed to provide both an overview of the major 
impacts of the functional feeds and, in particular, to discriminate differences in gene 
expression between the two functional feeds underpinning their differential effects on 
HSMI. The major findings are outlined in the ensuing paragraphs. 
  
2.3.4 Virus load correlated with up-regulation of pro-inflammatory genes at 
the early-mid stages of the infection in fish fed the ST diet 
     The heat map in Figure 2.4 clearly indicated that timing of the immune response was 
affected by the functional feeds and that the ST diet at 12 weeks stands out compared to 
the other groups/time points. As mentioned above, viral load was highest in heart tissue of 
the ST diet (256x higher than FF1) at 12-weeks post-challenge (Figure 2.2), which was 
reflected in the strong up-regulation of genes associated with viral entry and infection in 
ST-fed fish at that time, (shown as down-regulated in functional diets relative to ST diet in 
Table 2.5, Figure 2.5A). As would be expected, the expression of genes associated with the 
different pathways of the innate immune response (see below) was considerably up-
regulated at 12-weeks post-challenge in fish fed the ST diet (Table 2.6 and 2.7; Figure 
2.5B and C), particularly those involved in the interferon-inducible response (Table 2.7; 
Figure 2.5C), the natural killer cells response and apoptosis (Table 2.8). Responses that 
fingerprint the cellular adaptive immune response, were in general of lower magnitude, but 
also markedly up regulated in the ST compared to the FF1 diet group, while lesser so 
compared to the FF2 diet group (Table 2.9). Fish in the ST diet group mount a strong, early 
response biased towards pro-inflammatory and early adaptive responses. 
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Figure 2.4. Hierarchical clustering of expression profiles for 2581 genes from the significant interaction list 
of the 2-way ANOVA analysis across the different dietary treatments over the time course of the 
infection. Individual gene expression profiles are plotted horizontally against vertical columns of each 
dietary group over the different time-points. Up- and down-regulation of gene expression with respect to 
a common reference (a pool of all the samples) are represented in red and green, respectively. Colour 
intensity depends on the value of the expression ratio. 
 56 
Table 2.5 Viral infection-related genes differentially expressed in heart of fish fed the functional feeds (FF1 and FF2) relative to the standard diet during the course of the 
infection with ASRV  
 
 
 
 
 
 
 
 
 
 
 
 
Transcripts, with probe names or accession number (when possible), are arranged by functional categories and the data are presented as the expression ratio between the 
functional diet group and the standard group (ST/FF1 and ST/FF2), for each time point. 
 Accession or 8 weeks 10 weeks 12 weeks 16 weeks 
BlastxHit probe number FF1 FF2 FF1 FF2 FF1 FF2 FF1 FF2 
Viral entry and Cellular transport                  
CD209 antigen-like protein d Ssa#STIR16806 - 1,4 - 1,6 - 1,2 + 1,0 - 3,3 - 2,7 + 1,3 + 3,3 
C-type lectin domain family 4 member e Ssa#STIR09786 - 1,4 - 1,2 - 1,4 + 1,2 - 4,1 - 3,2 + 1,5 + 4,0 
Kelch-like protein 6 DW579982 + 1,2 + 1,3 + 1,3 + 1,2 - 2,6 - 1,6 - 1,1 + 3,1 
CD209 antigen-like protein A Ssa#KSSb2272 - 1,4 - 1,5 + 1,0 + 1,3 - 3,3 - 2,7 + 1,1 + 2,7 
Ecotropic viral integration site 2a Ssa#STIR14026 - 1,0 - 1,1 + 1,2 + 1,1 - 3,3 - 2,1 - 1,0 + 2,4 
Macrosialin precursor Ssa#KSS4521 - 1,3 - 1,5 + 1,2 + 1,2 - 4,8 - 3,0 + 1,1 + 1,1 
General viral induced proteins          
Proteasome subunit beta type-6 precursor Ssa#STIR04422 - 1,4 - 1,4 + 1,0 + 1,1 - 3,3 - 2,4 + 1,1 + 2,3 
Proteasome subunit beta type-6 precursor Ssa#STIR02309 - 1,3 - 1,4 + 1,0 + 1,0 - 3,2 - 2,4 + 1,2 + 2,5 
14 kda transmembrane protein Ssa#STIR00068_4 - 1,5 - 1,4 + 1,2 + 1,8 - 3,1 - 1,6 + 1,3 + 3,1 
Proteasome subunit beta type-6 precursor Ssa#STIR09223 - 1,4 - 1,4 + 1,0 + 1,1 - 3,2 - 2,4 + 1,1 + 2,4 
Anti-viral protein          
Ferritin, lower subunit putative mRNA Ssa#STIR07882 + 1,3 + 1,1 + 1,2 + 1,5 - 5,0 - 2,9 - 1,1 + 4,1 
Retroviral DNA integration          
Barrier-to-autointegration factor Ssa#CL95Contig1 - 1,4 - 2,6 + 1,6 + 3,1 - 12,4 - 11,0 + 1,9 + 3,5 
Prob. ATP-dependent RNA helicase DHX58 DW582483 - 1,2 - 2,9 + 1,9 + 1,6 - 4,3 - 5,3 + 4,1 + 5,5 
Prob. ATP-dependent RNA helicase DHX58 DW567942 - 1,5 - 2,2 + 1,1 + 1,6 - 6,3 - 6,1 + 1,7 + 2,5 
 57 
Table 2.6 Innate immune system-related genes differentially expressed in heart of fish fed the functional feeds (FF1 and FF2) relative to the standard diet during the 
course of the infection with ASRV 
 Accession or 8 weeks 10 weeks 12 weeks 16 weeks 
BlastxHit probe number FF1 FF2 FF1 FF2 FF1 FF2 FF1 FF2 
Innate Immune system                  
Platelet basic protein precursor EG823365 - 2,5 - 5,0 + 1,1 - 1,3 - 17,3 - 7,0 - 1,2 + 3,9 
Platelet basic protein EG761718 - 1,9 - 3,0 - 1,5 - 1,2 - 14,7 - 7,0 + 1,2 + 4,0 
c-c motif chemokine 19 precursor Ssa#STIR10724 - 1,7 - 1,5 - 1,1 + 1,0 - 5,2 - 2,7 - 1,3 + 6,2 
Ubiquitin-like protein BG936428 - 1,2 - 2,0 + 1,7 + 1,8 - 11,1 - 5,3 + 1,3 + 4,1 
Skin mucus antibact. l-amino acid oxidase Omy#CA377250 - 4,1 - 1,8 + 1,1 + 1,3 - 27,8 - 23,4 + 2,1 + 3,1 
C-C motif chemokine 19 precursor DW571080 - 3,3 - 4,0 + 1,1 + 1,2 - 12,3 - 7,2 + 1,2 + 3,5 
Skin mucus antibact. l-amino acid oxidase DY698830 - 2,1 - 2,0 + 1,2 + 1,4 - 15,1 - 9,1 + 1,9 + 2,7 
Chemokine (c-c motif) ligand 19 Ssa#STIR04367 - 2,5 - 2,6 + 1,3 + 1,4 - 5,9 - 3,5 + 1,5 + 3,7 
Chemokine (c-c motif) ligand 19 Ssa#STIR21382 - 2,1 - 1,9 + 1,2 + 1,3 - 6,2 - 3,4 + 1,5 + 3,6 
Interferon regulatory factor 7 BX307182 - 1,5 - 1,7 + 1,1 + 1,2 - 5,0 - 3,7 + 1,7 + 3,3 
Neutrophil cytosolic factor 2 Ssa#KSS461 - 1,1 - 2,8 + 1,4 + 2,0 - 2,6 - 2,0 - 1,2 + 1,9 
Grn protein Ssa#STIR07488 - 1,3 - 1,4 + 1,2 + 1,4 - 3,7 - 2,4 + 1,2 + 2,6 
Engulfment adaptor ptb domain contain. 1 Ssa#STIR11362 + 1,7 - 1,9 - 4,9 - 5,2 - 2,5 + 1,3 + 1,3 + 4,4 
Granulocyte colony-stimulating factor R prec Ssa#STIR20316 + 1,2 + 1,3 - 1,0 - 1,6 - 1,4 - 1,2 - 1,2 + 4,7 
Interferon regulatory factor 7 DY725939 - 1,5 - 2,0 + 1,0 + 1,1 - 5,2 - 4,0 + 1,5 + 2,2 
Interferon regulatory factor 7 Ssa#STIR00062_4 - 1,8 - 2,3 + 1,2 + 1,4 - 5,0 - 4,0 + 1,4 + 2,2 
Interferon regulatory factor 7 Ssa#TC107831 - 1,6 - 1,6 + 1,1 + 1,3 - 5,9 - 4,1 + 1,4 + 2,3 
Interferon regulatory factor 7 Ssa#STIR00062_3 - 1,6 - 1,9 + 1,1 + 1,3 - 5,1 - 3,8 + 1,4 + 2,1 
Bloodthirsty Ssa#DY699301 - 2,0 + 1,1 - 1,2 + 1,0 - 13,4 - 5,7 + 1,5 + 2,4 
Interferon regulatory factor 7 Ssa#STIR00062_2 - 1,4 - 1,7 + 1,1 + 1,4 - 4,6 - 3,8 + 1,4 + 2,2 
Immune-related, lectin-like receptor 4 CB511660 + 1,1 + 1,0 + 1,3 + 1,2 - 2,8 - 1,7 - 1,1 + 3,0 
Cysteine dioxygenase Ssa#STIR21327 + 1,1 - 1,0 - 1,2 + 1,0 - 3,1 - 2,3 - 1,3 + 2,7 
Sub-fam. B ATP-binding cassette transport 2 DW563628 - 1,2 - 1,2 - 1,1 - 1,2 - 4,2 - 2,9 + 1,5 + 1,9 
Tripartite motif-containing protein 35 EG878686 - 1,4 - 1,3 - 1,1 + 1,2 - 3,6 - 2,8 + 1,4 + 2,0 
Rho-related GTP-binding protein RhoG Ssa#KSS4662 - 1,2 - 1,4 + 1,1 + 1,2 - 2,9 - 1,9 - 1,1 + 1,9 
RAB26, member RAS oncogene family Omy#BX082318 - 1,9 - 2,3 + 1,3 + 1,5 - 2,7 - 1,7 - 1,0 + 2,0 
fMet-Leu-Phe receptor Ssa#STIR17576 - 1,2 - 1,2 - 1,1 + 1,1 - 2,6 - 1,7 + 1,1 + 2,8 
Bactericidal permeability-increasing protein DW540097 - 1,2 - 1,6 + 1,2 + 1,6 - 3,2 - 2,2 - 1,0 + 2,0 
TNFα-induced protein 8-like protein 2 Ssa#STIR00030_4 + 1,1 - 1,1 + 1,1 + 1,2 - 2,3 - 1,5 - 1,1 + 2,0 
Transcripts, with probe names or accession number (when 
possible), are arranged by functional categories and the data 
are presented as the expression ratio between the functional 
diet group and the standard group (ST/FF1 and ST/FF2), for 
each time point.  
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Table 2.7 IFN I related-genes differentially expressed in heart of fish fed the functional feeds (FF1 and FF2) relative to the standard diet during the course of the infection 
with ASRV 
 Accession or 8 weeks 10 weeks 12 weeks 16 weeks 
BlastxHit probe number FF1 FF2 FF1 FF2 FF1 FF2 FF1 FF2 
JAK-STAT signal transduction pathway                  
Suppressor of cytokine signaling 1 Ssa#STIR25114 - 2,1 - 2,1 - 1,1 + 1,4 - 7,0 - 5,1 + 1,6 + 2,5 
IFN-inducible protein Gig2-like Ssa#EG876062 - 1,3 - 1,6 - 1,1 + 1,4 - 5,4 - 3,3 + 1,9 + 2,3 
Suppressor of cytokine signaling 1 DW563373 - 1,6 - 1,4 - 1,1 + 1,2 - 6,8 - 3,8 + 1,5 + 2,6 
N-myc (and stat) interactor Ssa#STIR09454 - 1,3 - 1,5 + 1,1 + 1,1 - 3,1 - 2,3 + 1,2 + 2,1 
IFN-inducible protein Gig2-like Ssa#EG871163 - 1,3 - 1,4 - 1,1 + 1,1 - 3,2 - 2,5 + 1,4 + 2,1 
JAK3 tyrosine kinase Ssa#DY728848 + 1,3 + 1,1 + 1,1 - 1,2 - 2,7 - 1,7 - 1,1 + 2,0 
STAT 1 Ssa#STIR06397 - 1,3 - 1,4 + 1,0 + 1,0 - 3,3 - 2,5 + 1,4 + 1,6 
STAT 1α EU016199 - 1,2 - 1,3 + 1,1 + 1,1 - 3,0 - 2,4 + 1,5 + 2,0 
JAK1 Ssa#DW006200 - 1,2 - 1,3 + 1,5 + 1,3 - 3,0 - 2,4 + 1,2 + 2,0 
Interferon inducible          
IFN inducible mx protein U66475 - 1,8 - 2,3 + 1,0 + 1,2 - 13,9 - 8,9 + 2,1 + 3,7 
IFN inducible mx protein Ssa#STIR00154_2 - 1,8 - 2,2 + 1,0 + 1,2 - 14,0 - 8,3 + 2,1 + 3,7 
Vig-2 protein Ssa#STIR08402 - 1,4 - 2,5 + 1,1 + 1,7 - 15,2 - 9,2 + 1,7 + 2,6 
Mx2 protein mRNA complete cds Con_CANDS_07 - 1,7 - 1,9 + 1,0 + 1,1 - 11,8 - 7,6 + 2,4 + 4,0 
14 kda transmembrane protein Ssa#STIR17386 - 1,7 - 3,1 + 4,9 + 4,3 - 1,2 + 1,5 - 1,2 + 4,1 
Myxovirus resistance 2 U66476 - 1,5 - 1,7 + 1,1 + 1,2 - 11,3 - 7,4 + 2,3 + 3,7 
IFN inducible mx protein Ssa#STIR00154_3 - 1,6 - 1,8 + 1,0 + 1,2 - 8,3 - 5,9 + 1,7 + 2,9 
Mx1 protein mRNA complete cds Con_CANDS_06 - 1,5 - 1,8 + 1,0 + 1,1 - 8,6 - 5,9 + 1,7 + 2,8 
IFN inducible mx protein Ssa#STIR00154_4 - 1,8 - 1,9 + 1,0 + 1,2 - 8,3 - 6,0 + 1,8 + 2,7 
IFN-induced GTP-binding protein Mx Ssa#STIR21272 - 1,9 - 2,5 + 1,1 + 1,3 - 8,6 - 6,9 + 1,6 + 2,1 
vig-2 protein Ssa#STIR10385 - 1,3 - 1,7 + 1,1 - 1,0 - 7,1 - 4,5 + 1,4 + 2,4 
Mx3 protein U66477 - 1,5 - 1,7 + 1,0 + 1,1 - 7,6 - 5,0 + 1,8 + 2,5 
IFN inducible mx protein Ssa#STIR00067_3 - 1,5 - 1,6 + 1,0 + 1,1 - 7,6 - 5,0 + 1,8 + 2,3 
Cholesterol 25-hydroxylase-like protein A DW536322 - 2,1 + 1,0 + 2,1 + 2,4 - 6,5 - 1,7 + 1,3 + 2,4 
IFN-induced protein with tetratricopeptide  Ssa#STIR00073_2 - 2,3 - 1,8 - 1,0 + 1,1 - 4,5 - 3,9 + 1,4 + 1,6 
IFN-induced guanylate-binding protein 1  Ssa#STIR18623 - 1,0 - 1,1 + 1,2 + 1,2 - 4,6 - 3,0 + 1,0 + 2,9 
IFN-induced guanylate-binding protein 1 DY713986 - 1,0 - 1,4 + 1,3 + 1,3 - 4,2 - 3,6 + 1,3 + 2,4 
14 kda transmembrane protein Ssa#STIR22465 - 1,4 - 1,4 + 1,2 + 1,6 - 2,9 - 1,6 + 1,2 + 2,7 
IFNγ induc. lysosomal thiol reductase precur Ssa#STIR04691 - 1,1 - 1,3 - 1,1 + 1,0 - 2,1 - 1,5 - 1,3 + 2,1 
IFN-induced transmembrane protein 3 CA387902 - 1,4 - 1,5 + 1,2 + 1,5 - 2,4 - 1,3 + 1,3 + 2,7 
Guanylate binding protein 3 Ssa#STIR19322 - 1,2 - 1,2 + 1,3 + 1,7 - 3,8 - 3,3 + 1,3 + 2,3 
Transcripts, with probe names or accession number (when 
possible), are arranged by functional categories and the data 
are presented as the expression ratio between the functional 
diet group and the standard group (ST/FF1 and ST/FF2), for 
each time point.  
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Table 2.8 Antiviral host responses related-genes differentially expressed in heart of fish fed the functional feeds (FF1 and FF2) relative to the standard diet during the 
course of the infection with ASRV 
 Accession or 8 weeks 10 weeks 12 weeks 16 weeks 
BlastxHit probe number FF1 FF2 FF1 FF2 FF1 FF2 FF1 FF2 
Acute phase                  
Serum amyloid A-5 protein Ssa#KSS3451 - 1,7 - 2,2 + 1,3 - 1,3 - 5,3 - 3,0 + 2,1 + 4,3 
Serum amyloid a-5 protein Ssa#CK882427 - 1,7 - 2,3 + 1,4 - 1,3 - 5,1 - 2,9 + 2,2 + 4,0 
CCAAT/enhancer-binding protein beta Ssa#CL285Ctg1 - 1,2 - 1,2 + 1,5 + 2,0 - 2,1 + 1,0 + 1,4 + 2,4 
LBP (LPS binding protein)/BPI like-2 Ssa#KSS5230 - 1,2 - 1,1 + 1,1 + 1,3 - 3,3 - 2,1 + 1,0 + 2,8 
Cathelicidin EG840650 + 1,2 + 1,3 - 1,4 + 1,1 - 3,7 - 2,0 + 1,9 + 5,4 
Natural killer cells          
Granzyme A precursor EG853597 + 1,1 + 1,7 + 1,2 + 1,6 - 26,6 - 9,1 - 3,2 + 5,5 
Interleukin 18 form a, IL-18A AJ556990 - 1,0 + 1,1 + 1,2 + 1,1 - 1,2 + 1,1 - 1,3 + 2,1 
Immune-lectin-like receptor 3 Ssa#STIR08687 + 1,0 - 1,0 + 1,2 + 1,0 - 1,8 - 1,2 - 1,0 + 1,9 
Interleukin 12b Ssa#STIR00077_3 - 1,2 - 1,6 + 1,3 + 1,2 - 1,4 - 1,2 + 1,3 + 1,6 
Perforin-1 precursor CB515603 - 1,2 - 1,1 + 1,1 - 1,2 - 1,4 - 1,3 + 1,3 + 1,9 
Apoptosis          
Mgc81823 transcript variant 2 Omy#TC159807 - 1,0 - 1,2 + 1,1 + 1,1 - 7,8 - 4,1 - 1,2 + 4,1 
Cathepsin l precursor Omy#CX262263 - 1,3 - 1,2 + 1,1 + 1,0 - 8,2 - 4,1 - 1,1 + 4,0 
Cathepsin l Ssa#STIR23260 + 1,0 - 1,0 + 1,2 + 1,1 - 7,9 - 4,5 - 1,2 + 3,8 
E3 ubiquitin-protein ligase LINCR DY697357 + 2,2 - 1,0 - 2,0 + 1,2 - 10,9 - 2,1 - 1,4 + 4,5 
Caspase-14 precursor EG868944 - 1,3 - 1,5 + 1,0 + 1,4 - 6,2 - 4,5 - 1,2 + 2,4 
Caspase 14 Ssa#STIR02208 - 1,4 + 2,1 + 1,4 - 3,6 - 2,0 + 1,2 - 4,5 + 1,8 
E3 ubiquitin-protein ligase RNF144A-A EG829820 - 1,7 - 1,5 + 1,1 + 1,4 - 6,0 - 4,2 + 1,0 + 2,0 
E3 ubiquitin-protein ligase RNF144A-A EG841469 - 1,3 - 1,7 + 1,2 + 1,2 - 5,9 - 3,3 + 1,0 + 2,5 
AN1, ubiquitin-like, homolog Omy#CU065924 - 1,2 - 3,4 + 1,1 - 1,5 - 1,9 + 1,5 - 1,4 - 1,3 
Ubiquitin carboxyl-terminal hydrolase iso L5 Ssa#S35587724_S - 1,9 - 2,1 + 1,0 + 1,4 - 1,5 - 1,1 - 1,8 + 2,7 
Ubiquitin specific protease 18 EG868088 - 1,3 - 2,1 - 1,1 + 1,1 - 4,2 - 3,5 + 1,5 + 1,9 
Tripartite motif-containing protein 39 DW545632 - 1,5 - 1,8 + 1,3 + 1,4 - 4,1 - 4,0 + 1,1 + 2,1 
Tyrosine-protein kinase Lyn Omy#CX255862 - 1,1 - 1,5 + 1,2 + 1,2 - 2,4 - 1,8 - 1,1 + 2,0 
 
 Transcripts, with probe names or accession number 
(when possible), are arranged by functional 
categories and the data are presented as the 
expression ratio between the functional diet group 
and the standard group (ST/FF1 and ST/FF2), for 
each time point.  
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 Transcripts, with probe names or accession number 
(when possible), are arranged by functional 
categories and the data are presented as the 
expression ratio between the functional diet group 
and the standard group (ST/FF1 and ST/FF2), for 
each time point.  
 
 
Table 2.9 IFN II-related genes differentially expressed in heart of fish fed the functional feeds (FF1 and FF2) relative to the standard diet during the course of the infection  
 
 
 
 Accession or 8 weeks 10 weeks 12 weeks 16 weeks 
BlastxHit probe number FF1 FF2 FF1 FF2 FF1 FF2 FF1 FF2 
Induction proliferation/maduration of T-cells          
T-cell receptor α chain V region 2B4 precur. EG773958 - 1,3 - 5,2 - 3,9 - 2,0 - 2,7 - 1,4 - 2,4 + 3,1 
T-cell receptor β chain AJ517930 - 1,1 - 2,0 + 2,1 + 1,5 - 4,8 - 1,8 - 1,2 + 3,9 
Differentially expressed in FDCP 6 homolog Ssa#S48397573 - 1,7 - 1,8 - 1,1 + 1,1 - 6,2 - 3,2 + 1,9 + 2,2 
Immediate early response gene 2 protein DW562838 - 1,5 - 1,6 + 3,6 + 5,8 + 1,1 + 2,3 + 1,2 - 1,0 
CD9 antigen CB515563 - 1,4 - 1,2 - 1,1 + 1,2 - 4,2 - 3,1 + 1,4 + 2,5 
T-cell receptor α chain V region 2B4 precur. EG890703 - 2,2 - 1,6 - 1,7 - 1,4 - 1,7 - 1,4 + 1,5 + 3,2 
Core-binding factor beta subunit Ssa#TC107774 - 1,5 - 2,2 - 1,2 + 1,1 - 2,9 - 1,6 + 1,0 + 3,1 
CD97 antigen EG935955 - 1,3 - 1,3 + 1,3 + 1,2 - 3,1 - 2,3 - 1,0 + 2,4 
Rho-related GTP-binding protein RhoG Ssa#KSS4662 - 1,2 - 1,4 + 1,1 + 1,2 - 2,9 - 1,9 - 1,1 + 1,9 
Ras homolog genemember g Ssa#STIR25495 - 1,3 - 1,5 + 1,1 + 1,2 - 2,4 - 1,7 - 1,0 + 1,9 
Ras homolog genemember g Ssa#STIR05697 + 1,1 - 1,2 - 1,6 + 1,2 - 2,9 - 1,5 + 1,3 + 2,2 
Hemopoietic cell kinase partial cds AF321110 - 1,0 - 1,1 + 1,2 + 1,2 - 2,6 - 1,7 + 1,1 + 2,2 
Tyrosine-protein kinase SRK2 Ssa#STIR23204 - 1,8 - 1,8 + 1,2 + 1,4 - 3,9 - 4,0 + 1,3 + 2,0 
Galectin-9 putative mRNA Ssa#STIR13309 - 1,2 - 1,3 - 1,1 + 1,1 - 4,3 - 2,5 + 1,1 + 1,9 
Galectin like protein Ssa#STIR12085 - 1,2 - 1,3 - 1,1 + 1,1 - 4,3 - 2,6 + 1,1 + 1,8 
CD80-like protein EG933501 + 1,2 + 1,1 + 1,1 + 1,2 - 1,7 - 1,3 + 1,0 + 2,3 
C-C motif chemokine 28 precursor Ssa#STIR03768 - 1,5 - 2,0 - 1,7 + 9,3 + 2,1 - 3,7 + 1,5 + 2,7 
Cellular immunity          
Interferon gamma AJ841811 - 1,8 - 2,1 + 1,0 - 1,2 - 10,1 - 4,4 - 1,1 + 6,4 
Interferon gamma Ssa#STIR00056_4 - 1,7 - 1,6 - 1,4 - 1,2 - 11,1 - 4,7 - 1,0 + 4,5 
Interferon gamma 2 Omy#gi238231582 - 1,3 - 2,4 + 1,2 + 1,4 - 5,8 - 4,1 - 1,0 + 4,6 
Interferon gamma Ssa#STIR00056_3 + 1,0 - 1,1 + 1,0 - 2,0 - 9,4 - 5,7 - 1,3 + 3,0 
Tripartite motif-containing protein 47 Ssa#DY714453 - 1,1 - 1,1 - 1,4 - 1,2 - 5,4 - 1,9 + 2,2 + 5,6 
TRIM 16  protein EG875618 - 1,6 - 1,7 - 1,0 + 1,3 - 3,7 - 3,3 + 1,6 + 2,4 
Beta-2 microglobulin AF180490 - 1,3 - 1,3 + 1,0 + 1,0 - 2,6 - 2,1 + 1,1 + 1,8 
Tapasin-related protein DW567893 - 1,2 - 1,1 - 1,1 - 1,1 - 2,4 - 1,9 + 1,1 + 1,4 
CD83 antigen precursor Ssa#KSS3110 - 1,1 - 1,0 + 1,6 + 1,6 - 1,9 - 1,6 - 1,2 + 1,4 
CD80-like protein EG933501 + 1,2 + 1,1 + 1,1 + 1,2 - 1,7 - 1,3 + 1,0 + 2,3 
Tapasin DQ451008 - 1,3 - 1,5 + 1,1 + 1,1 - 2,6 - 2,1 - 1,0 + 1,4 
TAP2 protein DW580644 - 1,4 - 1,6 + 2,2 + 2,7 - 1,7 - 2,3 - 1,4 - 1,1 
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 Transcripts, with probe names or accession number 
(when possible), are arranged by functional 
categories and the data are presented as the 
expression ratio between the functional diet group 
and the standard group (ST/FF1 and ST/FF2), for 
each time point.  
 
 
Table 2.10 Adaptive immune system related-genes differentially expressed in heart of fish fed the functional feeds (FF1 and FF2) relative to the standard diet during the 
course of the infection with ASRV 
 
   Accession or 8 weeks 10 weeks 12 weeks 16 weeks 
BlastxHit probe number FF1 FF2 FF1 FF2 FF1 FF2 FF1 FF2 
Innate to adaptive          
MHC class II antigen beta chain Ssa#STIR00007_3 - 1,2 - 4,5 - 16,5 - 4,2 - 3,1 + 1,2 + 41,0 + 15,0 
MHC class II antigen beta chain Ssa#STIR00007_4 + 1,3 - 2,4 - 36,5 - 7,4 - 2,1 - 1,2 + 70,6 + 27,4 
IFNγ-inducible lysosomal thiolreductase prec. Ssa#STIR09719 - 1,1 - 1,3 - 1,0 + 1,0 - 2,1 - 1,5 - 1,3 + 2,1 
IFNγ-inducible lysosomal thiolreductase prec. Ssa#STIR04691 - 1,1 - 1,3 - 1,1 + 1,0 - 2,1 - 1,5 - 1,3 + 2,1 
Chemokine (c-x-c motif) ligand 13 Ssa#STIR03818 - 2,7 - 1,6 - 1,1 + 1,0 - 4,8 - 2,3 + 3,8 + 13,1 
CC chemokine Ssa#STIR23541 - 1,5 - 1,4 + 1,5 - 1,4 - 5,0 - 3,4 + 1,6 + 5,2 
CD226 antigen DW553192 - 2,2 - 2,2 + 1,6 + 1,2 - 3,5 - 1,4 + 1,9 + 6,5 
TNF superfamily member 14 Ssa#S31975856_S - 5,9 - 3,2 + 1,4 - 1,0 - 5,2 - 1,5 - 1,2 + 4,4 
Chemokine cxcl-c1c Ssa#STIR11364 - 1,6 - 1,6 + 1,1 + 1,2 - 5,1 - 3,0 + 1,7 + 3,5 
High affinity IgG fc receptor i precursor Ssa#STIR11789 - 2,6 - 1,1 - 1,9 + 1,4 - 2,4 - 3,0 + 1,3 + 3,2 
High affinity IgE receptor subunit  γ precur. Ssa#STIR03935 - 1,1 - 1,2 + 1,0 + 1,2 - 2,8 - 2,0 - 1,0 + 2,4 
High affinity IgG fc receptor i precursor Ssa#STIR24788 - 1,3 - 1,5 + 1,1 + 1,2 - 2,8 - 1,8 + 1,0 + 2,2 
High affinity IgE receptor subunit  γ precur. Ssa#STIR08428 - 1,1 - 1,3 + 1,0 + 1,2 - 2,8 - 2,0 - 1,0 + 2,4 
High affinity IgE receptor subunit  γ precur. Ssa#STIR09946 - 1,1 - 1,3 + 1,0 + 1,2 - 2,7 - 2,0 + 1,0 + 2,4 
High affinity IgE receptor subunit  γ precur. Ssa#STIR05473 - 1,1 - 1,2 + 1,1 + 1,2 - 2,7 - 1,9 - 1,0 + 2,3 
Chemokine (c-x-c motif) receptor 3 Ssa#STIR10673 - 1,1 - 1,2 + 1,5 + 1,2 - 2,7 - 2,0 + 1,1 + 2,3 
Chemokine (c-x-c motif) ligand 10 Ssa#STIR02663 - 1,1 - 1,1 + 1,1 + 1,1 - 2,6 - 2,3 + 1,2 + 2,2 
C-X-C chemokine receptor type 3A, variant 1 AJ888878 + 1,1 + 1,0 + 1,1 + 1,2 - 2,3 - 1,7 - 1,0 + 2,4 
Humoral immunity          
Interleukin 20alpha Ssa#STIR13743 + 1,0 - 1,7 + 1,3 + 2,2 - 10,6 - 10,6 - 2,2 + 1,9 
PREDICTED: similar to CD22 molecule CU073328 + 2,2 - 1,2 + 1,3 - 1,8 - 5,2 - 1,4 - 4,0 + 1,3 
Interleukin 20alpha Ssa#STIR18005 + 1,0 - 1,2 + 1,2 + 1,1 - 3,0 - 2,0 - 1,0 + 2,2 
Interleukin 10beta Ssa#STIR00087_3 - 1,7 - 1,7 + 1,1 + 1,3 - 4,1 - 3,2 + 1,5 + 1,9 
Leukocyte surface antigen CD53 EG836748 - 1,0 - 1,1 + 1,2 + 1,3 - 2,3 - 1,6 - 1,1 + 2,2 
TNFR superfamily member 5 Ssa#CL366Ctg1 - 1,1 - 1,1 + 1,2 + 1,4 - 2,1 - 1,6 + 1,2 + 2,2 
B-cell linker protein Ssa#KSS4516 + 1,2 + 1,3 - 1,0 + 1,2 - 1,9 - 1,2 + 1,4 + 2,5 
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Figure 2.5A-F Normalized gene expression levels in heart for different gene groups. The genes 
listed in Tables 2.5-2.10 are included in Figures A-F, showing the average gene expression 
levels (as whiskers), with maximum and minimum range for each gene group. Outliers are 
depicted as black dots. A) Viral infection-related genes; B) Innate immune system-related 
genes; C) IFN I related-genes; D) Antiviral host responses related-genes; E) IFN II-related 
genes; and F) Adaptive immune system related-genes. P values are depicted (One-way 
ANOVA) and n is the same as in corresponding Tables 2.5-2.10. 
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2.3.5 Contrasting inflammatory gene expression in fish fed the two functional 
feeds at 16-weeks after ASRV challenge 
     Sixteen weeks after challenge, the replication of the viral load had increased in fish 
consuming both functional feeds (Figure 2.2). At this time they also had a similar pattern 
of expression of immune response genes2. (Tables 2.6-2.10), although the up-regulation 
was greater in fish fed the FF2 diet compared with those fed the FF1 diet (Figure 2.5B-F). 
Genes related with both the innate (Table 2.6; Figure 2.5B) and adaptive immune 
responses (Tables 2.9 and 10; Figures 2.5E and F) were particularly highly expressed in 
fish fed the FF2 diet compared with fish fed the FF1 diet. The expression of the MHC class 
II gene was, however, higher in fish fed the FF1 diet than in fish fed the FF2 diet and, in 
both groups, the expression of this gene was much higher than in the fish fed the ST diet 
(Table 2.10). Leukotriene B4 receptor and arachidonate 5-lipoxygenase (ALOX) are 
directly related with the eicosanoid pathway and therefore the expression of their genes is 
likely related to levels of ARA and EPA. We found that both were up-regulated at 16-
weeks in fish fed both functional feeds and interestingly the fold-changes comparing the 
expression of both genes between 8- and 16-weeks were twice as high in fish fed the FF2 
diet compared to fish fed the FF1 diet (Table 2.11), which again concurs with the observed 
difference in the inflammatory profile between the two diets.   
2.3.6 Severity of the lesions observed in heart tissue correlated with the 
intensity of the innate immune response 
     The microarray data showed that increased expression of genes related to the innate 
immune response correlated with higher histopathology scores. In general, this correlation 
was most obvious in fish fed the ST diet at 12 weeks post-challenge, with higher 
expression of genes involved in pathways of the virus-induced innate immune response. 
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These included platelet basic protein, IRF7 and barrier to auto integration factor 
(Table2.6), interferon-inducible Mx proteins, Vig-2, gig-2 and cholesterol 25-hydrolase 
(Table 2.7), granzyme A, serum amyloid A5, interleukins 12 and 18 and genes related with 
apoptosis (Table 2.8), and chemokines (Table 2.6 and 2.10) among others. Again, there 
was a lower intensity of this immune response in fish fed both the functional feeds, 
particularly FF1, which correlated with the lower histopathology scores in this group. 
2.3.7 Innate and adaptive immune responses  
    Activation of the innate immune response in fish leads to the stimulation of different 
components of the adaptive immune response (Dixon and Stet, 2001; Magnadottir, 2006). 
Consistent with this, the data obtained in the present study show that differential 
upregulation of innate responses in the ST diet group at 12 weeks (Table 2.6,  Figure 2.5B) 
coincide with high expression of adaptive immune response genes at 12 weeks in the ST 
group (Table 2.10;  Figure 2.5F). Similarly FF1 and particularly FF2 have higher up 
regulation of innate and adaptive immune genes by 16 weeks (Table 2.6 and 2.10; Figure 
2.5B and F).  
2.3.8 The microarray analyses data were fully validated by RT-qPCR of 
selected genes 
       Validation of the microarray data was performed by comparing the expression of 12 
key genes showing both up- and down-regulation with a range of fold-changes from 1.1 to 
13.9, across all three feed comparisons, and at two time points (12- and 16-weeks), 
providing a matrix of 72 comparisons. There was extremely good agreement between the 
microarray results and the RT-qPCR quantification with 93 % of comparisons (67 out of 
72) showing identical regulation with very similar fold differences (Table 2.12). This 
analysis indicates that the gene expression data obtained using the oligoarray were reliable 
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and robust, which enabled interpretations to be made with some confidence, at least with 
regards to immune response-related genes. 
 
Table 2.11 Lipid-related inflammatory pathway genes differentially expressed in heart of fish fed the 
functional feeds (FF1 and FF2) relative to the standard diet during the course of the infection with ASRV 
 
Transcripts, with probe names or accession number (when possible), are arranged by functional categories 
and the data are presented as the expression ratio between the functional diet group and the standard group 
(ST/FF1 and ST/FF2), for each time point.  
 
Table 2.12 RT-qPCR validation of microarray results 
 
 
Values represent the expression ratios for the selected genes between the functional diet group and the 
standard group at 12- and 16-weeks post-infection with ASRV obtained by microarray analysis or RTqPCR.  
 
 
 
 Accession or 8 weeks 10 weeks 12 weeks 16 weeks 
BlastxHit probe number FF1 FF2 FF1 FF2 FF1 FF2 FF1 FF2 
Inflamatory pathways                  
Leukotriene B4 receptor 1 (LTB4-R 1)  DW558098 - 1,0 + 1,1 + 1,2 + 1,1 - 2,6 - 1,5 + 1,4 + 3,4 
Arachidonate 5-lipoxygenase Ssa#DW575444 + 1,2 + 1,2 + 1,0 + 1,1 - 1,6 - 1,2 - 1,1 + 1,9 
  12 weeks 16 weeks 
 FF1 FF2 FF1 FF2 
  Microarray qPCR Microarray qPCR Microarray qPCR Microarray qPCR 
IL10 - 3.89 - 3.73 - 3.31 - 2.87 + 1.50 + 1.32 + 1.85 + 1.13 
Casp14 - 6.19 - 4.82 - 4.50 - 2.47 - 1.15 - 1.33 + 2.39 + 1.57 
TCRa - 2.70 - 2.34 - 1.39 - 1.32 - 2.37 - 1.58 + 3.07 + 1.26 
IRF1 - 2.45 - 2.56 - 1.90 - 1.57 - 1.10 - 1.10 + 1.82 + 1.40 
MX1 - 13.88 - 13.57 - 8.87 - 8.44 + 2.08 + 2.06 + 3.66 + 2.48 
INFII - 9.36 - 8.48 - 5.74 - 4.58 - 1.28 - 1.91 + 3.01 + 1.25 
GIG2 - 5.41 - 5.59 - 3.34 - 4.41 + 1.95 + 2.06 + 2.34 + 1.69 
SAA - 5.07 - 3.95 - 2.90 - 2.43 + 2.20 + 1.74 + 4.01 + 2.00 
FLAP - 1.50 - 1.26 - 1.23 + 1.34 + 1.12 + 1.01 + 2.04 + 1.42 
BAF - 12.38 - 11.99 - 11.02 - 11.78 + 1.88 + 1.82 + 3.47 + 2.03 
B2M - 2.59 - 1.83 - 2.11 - 1.68 + 1.11 - 1.54 + 1.79 - 1.49 
IgER - 2.23 - 2.18 - 1.68 - 1.35 - 1.04 - 1.22 + 2.03 + 1.22 
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2.4 Discussion 
This study demonstrated that a clinical nutrition approach through the use of functional 
feeds significantly reduced viral load in the heart tissue at early stages of the infection and 
resulted in significantly lower heart pathology over the course of the experiment. There 
was also a corresponding lower expression of inflammatory and immune markers in heart 
tissue of fish fed the functional feeds.  
    There are several studies evaluating the modulation of inflammatory responses to 
bacterial or viral infections in fish fed diets formulated with different lipid sources (Bell et 
al., 1993; Thompson et al., 1997; Montero et al., 2003; Alne et al., 2009). In general, diets 
containing high inclusion of VO, particularly n-6 PUFA-rich oils such as soybean 
(Montero et al., 2003) or sunflower (Bell et al., 1993), have lower n-3/n-6 PUFA and 
EPA/ARA ratios, which can lead to increased pro-inflammatory responses in fish. This 
could be a consequence of the production of pro-inflammatory eicosanoids (e.g. LTB4, 
TXA2 and PGE2) derived from ARA released from cell membrane phospholipids of, 
especially, immune-related cells (Bell et al., 1992). In the present study, a high quality feed 
with a commercial formulation served as a standard reference diet (ST), with protein 
supplied by a mixture of fishmeal and plant meals, and FO and rapeseed oil as the main 
lipid sources. Functional feeds were designed with reduced lipid content and relatively 
small changes in fatty acid composition focussed on increasing supply of EPA in the form 
of phospholipid. The hypothesis was that these changes in dietary formulation would 
increase the potential bioavailability of EPA by increasing its relative proportion in tissue 
phospholipids, and thus mitigate the inflammatory response to ASRV infection in fish fed 
the functional feeds. One analytical tool was the oligoarray, and the present trial clearly 
demonstrated the utility of the Atlantic salmon 44k microarray for transcriptomic analysis 
and the evaluation of a large number of genes involved in many metabolic pathways. The 
 67 
oligoarray results provided an overview of when and how the immune response developed 
after an infection with ASRV and, especially, how changes in diet (feed formulation) 
influenced the magnitude and progression of these processes.  
     In addition, a further hypothesis was that the mechanism whereby increased EPA 
availability in fish fed the functional feeds could affect immune response would involve 
eicosanoid pathways. Although heart is the main organ affected in fish suffering HSMI, 
head kidney is an important immune-related tissue in fish producing macrophages, 
monocytes, B cells and other immune-related cells (Balfry and Higgs, 2001). Thus, as 
macrophages are a major source of eicosanoids, the fatty acid profiles of both organs were 
determined to define the precise effects of the different feeds on key tissue compositions. 
Although the fatty acid profile of the heart tissue was more conserved during the course of 
the infection, the higher levels of EPA in the functional feeds was reflected in this organ, 
with the proportion of EPA and the EPA/ARA ratio being significantly higher in both 
groups of fish fed the FF diets. However, head kidney fatty acid profile showed more 
extensive differences in fatty acid composition, not only between fish fed the ST diet and 
fish fed the FF feeds, but also during the time course of the infection, including decreased 
ARA. These data confirm that salmon consuming the functional feeds did indeed display 
higher absolute and relative levels of EPA, which could increase its potential 
bioavailability for eicosanoid synthesis. The data also suggested that head kidney showed 
signs of a mobilization of key fatty acids, especially ARA, during the course of the 
infection. 
       The results from the histological examinations showed that fish fed the ST diet had 
relatively high scores 12-weeks after ASRV inoculation, as reported in previous studies 
describing the aetiology of HSMI (Kongtorp et al., 2004a; Kongtorp et al., 2004b). 
Histopathology scores from the ST-fed group showed that half of the fish sampled had 
major inflammation of the heart tissue at 12-weeks, and that the inflammatory changes 
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were even greater at the end of the experiment. In contrast, fish fed the functional feeds 
were relatively unaffected by the disease at 12-weeks. Furthermore, at later time points, 
when inflammation was observed, it was less severe than in fish fed the ST diet. These 
data are consistent with our overall hypothesis that increasing dietary EPA and reducing 
dietary energy content would be beneficial in reducing the severity of the disease through 
the salmon experiencing a milder inflammatory response. However, the results also 
showed that the fish fed the FF1 diet showed the lowest inflammatory scores and, 
therefore, supplementation of EPA in the form of krill oil, as in the FF2 diet, was not more 
effective than simply supplying it as FO. Although the EPA/ARA ratio was higher in the 
FF1 diet than in the FF2 diet, the similarity in lipid content and fatty acid profiles of the 
two functional feeds, and the tissues of salmon fed the diets, suggests that another dietary 
factor could underlie the differences in immune response (Lee et al., 2008). Therefore, the 
precise reason for the difference between the two functional feeds is not clear at present. 
       Transcriptomic analyses have been used recently to assess changes in the expression 
of immune-related genes in viral infections (Miller et al., 2007; Jørgensen et al., 2008; 
Schiøtz et al., 2008), but these studies have focussed on the early stages of the infection as, 
in some cases, the high virulence of the virus caused mortalities early in the infection. In 
the present study, the slow replication of ASRV and the low mortality previously recorded 
during HSMI outbreaks (Kongtorp et al., 2004a; Kongtorp et al., 2004b) enabled us to 
evaluate the immune response over a much longer term. In most microarray studies, 
clustering methods are commonly used where a wide range of genes require organization 
(Miller et al., 2007; Lin and Chien 2009). The graphical display of the gene categories, and 
their pattern of expression during the course of the infection, enabled clear discrimination 
of when, and in which dietary treatment, the major responses occurred. The cluster 
analysis showed that, at early stages of the infection, 8- to 10-weeks post-challenge, there 
were only relatively minor differences in gene expression between fish fed the different 
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dietary treatments, whereas there was strong up-regulation of immune-related genes 12-
weeks post-challenge in fish fed the ST diet compared to fish fed the FF1 and FF2 diets. 
Similar up-regulation of the same gene set was observed 16-weeks post-infection in fish 
fed the FF2 diet whereas fish fed the FF1 diet did not show a similar up-regulation of this 
gene set during the time-course of the experiment. Although the modification of expression 
of some immune related genes by functional feeds has been reported previously (Tacchi et 
al., 2011), clear differential effects of feeds on gene expression patterns, as displayed in the 
cluster analysis in the present study, are largely unprecedented and not previously reported 
in fish. The markedly different modulation of gene expression confirms that changes in 
dietary composition, including lipid content and source, and relatively small changes in 
fatty acid profiles, may influence the severity of the immune response. 
        The transcriptome analysis revealed a clear correlation between the severity of 
histopathological lesions and activation of the innate immune response in heart tissue. A 
similar correlation was described in previous studies on viral infections in salmon, 
specifically ISAV (Jørgensen et al., 2008) and PMCV (Timmerhaus et al., 2011), the latter 
being the causal agent of cardiomyopathy syndrome (CMS). Furthermore, the 
transcriptome analysis uncovered important players in the immune response, aiding its 
characterization. Up-regulation of genes related to antiviral host responses was observed 
when the heart lesions were higher, and this also correlated with the higher viral load (12-
weeks post-challenge for fish fed ST diet and 16-weeks post-challenge for fish fed the 
other diets, particularly FF2). Therefore, genes like barrier-to-autointegration factor, 
chemokine 19, platelet basic protein, gig-2, galectin-9 among others, and those genes 
related with apoptosis, were strongly up-regulated. Although up-regulation of similar 
suites of genes was reported in earlier studies on common salmon viral diseases (Miller et 
al., 2007; Krasnov et al., 2011; Timmerhaus et al., 2011), fold-changes as high as those 
obtained in the present study have not been reported previously. This could be related to 
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improvements in oligomicroarray technology but, most likely, also to the longer duration 
of the present experimental design. 
       When virus loads are high, interferon regulatory factors (IRF) are induced to activate 
the transcription of type I interferon (IFN) (Børre, 2006). In the present study, the 
expression of IRF7 was up-regulated. Although type I IFNs were not present in the up-
regulated list, the activation of genes for proteins of the JAK-STAT signalling pathway, 
which may result in increased expression of Mx proteins, and of Vig-2 and cholesterol 25-
hydroxylase, the latter being an enzyme of steroid biosynthesis activated with type I IFNs 
in mammalian macrophages (Park and Scott, 2010), indicate molecular mechanisms 
inducing immune pathways in ASRV infection. Consequences of activation of this 
pathway could include stimulation of natural killer cells (NK), confirmed in our list by 
strong up-regulation of granzyme A, and receptors found in NK cells such as CD229, and 
T cell receptor α. Activation of IFN I could lead to increased expression of major 
histocompatibility complex (MHC) class I to promote antigen presentation activation. 
However, although genes related to MHC I such as beta-2 microglobulin and TAP proteins 
were up-regulated (see Table 2.7), it appears that activation of this pathway may not be as 
important in ASRV infection as it is in other viral infections such as ISAV (Jørgensen et 
al., 2007). The previous ISAV study was performed at early stages of the infection in 
comparison to the much longer time scale of the present study, and so this may indicate 
that the importance or role of different pathways varies during the progression of the 
infection, as would be expected. The activation of NK cells, the prominent up-regulation of 
genes associated with cytotoxic T cells (T-cell receptor α and  chains, CD97 and CD9), 
and up-regulation of interleukins 12 and 18 will likely result in increased IFN II (IFN-γ), 
which was also shown to be up-regulated. This up-regulation is in agreement with the 
induction of the IFN II responses reported previously in viral infections of salmon, 
specifically ISAV (Jørgensen et al., 2007), IPNV (Skjesol et al., 2011) and PMCV 
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(Timmerhaus et al., 2011). As was reported previously, the activation of the cytotoxic T 
cells after infection with PMCV seems to be a prominent feature of the immune system for 
clearance of the viral infection (Timmerhaus et al., 2011). As LC-PUFA have been shown 
to modulate the production of IFN-γ, (Hara et al., 2003), the differences in the levels of 
EPA and in the EPA/ARA ratio between the diets may contribute to the differential 
immune responses observed although, as described above, the differences in LC-PUFA 
between the two functional feeds were relatively small. 
  The present study also showed up-regulation of MHC class II that may indicate an 
important humoral immune response to ASRV. In contrast, up-regulation of this gene was 
not observed in salmon in response ISAV at early stage infection (Jørgensen et al., 2007). 
The 70-fold higher expression of MHC class II in fish fed the FF1 diet at 16-weeks post-
infection, when viral load was high, compared with those fed the ST diet, could be 
indicative of a more efficient response against ASRV at that time in fish fed FF1. 
       In general, the expression of all genes characteristic of the immune response was 
different between the dietary treatments, not only in terms of the time-courses of ASRV 
infection and response, but also when comparing gene expression in fish presenting high 
viral load, with consistently lower expression in fish fed the FF1 diet. The less extreme 
effects on immune gene expression, especially those of the innate immune response, may 
be indicative of a milder/controlled response in fish fed the FF1 diet, and the reason why 
fish on this treatment presented fewer and less severe heart lesions. This is consistent with 
previous data on salmon challenged with ISAV that showed fish with the highest 
expression of genes involved in the innate immune response were those with low 
resistance to the disease (Jørgensen et al., 2008). Therefore, it appears that in viral diseases 
like HSMI, with lower mortality but high morbidity, the control of over-expression of 
genes involved in antiviral host responses could be key to better performance of the fish. 
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       Leukotriene LTB4 plays important roles in the immune response, enhancing NK cell 
activity, stimulating lymphocyte production of IFN-γ, and modulating immune cell 
function promoting the proliferation of T cells and stimulating the release of cytokines 
from those cells (Chang et al., 1991¸Montero et al., 2008a). As LTB4 is synthesized from 
ARA derived from cell membrane phospholipids, it represents a link between tissue LC-
PUFA profiles and the expression of the immune related genes mentioned above. Two 
genes in the up-regulated list related with LTB4 metabolism, arachidonate 5-lipoxygenase 
(LTB4 biosynthesis) and leukotriene B4 receptor, were up-regulated two-fold when the 
viral load was high in fish fed the ST and FF2 diets compared with fish fed the FF1 diet. 
This is one example of how, early in the cascade of events of the inflammatory response, 
differences can be found between fish fed the FF1 diet and fish fed the other diets. 
Differential expression of both these genes was also reported after infection with ISAV 
(Jørgensen et al., 2008), thus the eicosanoid pathways appear to be important in salmon 
viral diseases, determining the magnitude of the inflammatory response. 
The present study has clearly demonstrated that application of clinical nutrition and the use 
of functional feeds can have a major influence on the development and severity of the 
response to ASRV infection in salmon. Furthermore, the differences in gene expression 
between fish fed the different diets have provided further insight into the molecular 
mechanisms and progression of the immune responses to ASRV infection in salmon. 
However, the precise mechanisms underpinning both the delayed replication of the virus in 
fish fed the functional feeds and the differential effects of these two formulations require 
further investigation. 
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2.5 Conclusion 
The present study is the first to describe the effects of functional feeds on the expression of 
genes related with the immune response after infection with ASRV. The long duration of 
the experiment allowed us to evaluate the host-pathogen interaction, increasing knowledge 
of HSMI, an important emerging disease in Atlantic salmon aquaculture. Clear differences 
on viral load and the immune response were found in fish fed the different dietary 
treatments, highlighting the immune modulatory role of dietary lipid content and 
composition in viral infections. Reduction in dietary lipid along with increased EPA can 
lead to a milder inflammatory response and consequently less severity of the heart lesions 
caused by ASRV infection indicating that dietary immunomodulation could reduce the 
morbidity of the disease improving the performance of fish suffering HSMI. 
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Supplementary Table 2.1. Primers used for the RT-qPCR 
Transcript 
Primer name 
Primer sequence Fragment  Tm Accession No. Source 
IL10 IL10-F1 5’- AAGGCAGTGTTCGAGAGCAT -3’ 162 bp 60º BT047745 1 New design  
 IL10-R1 5’- CTTCCCCATCCACTTCAAGA -3’     
Casp14 CASP14-F1 5’- TGGAGAGATCACAGGAGAGGA -3’ 166 bp 60º BT048360 1 New design 
 CASP14-R1 5’- GGAAGCAAAATGGAACGAAA -3’     
TCRa TCRa-F1 5’- GCCTGGCTACAGATTTCAGC -3’ 220 bp 60ºC BT050114 1 New design 
 TCRa-R1 5’- CCAGAATGGTCAGGGATAGG -3’     
IRF1 IRF1-F2 5’- CGGTCACCAAGAAACCCTTA -3’ 386 bp 60ºC EF067841 1 New design 
 IRF1-R2 5’- CGCAGCTCTATTTCCGTTTC -3’     
MX1 MX1-F2 5’- CTGCAGAACAAGCTCAAACG -3’ 171 bp 60ºC U66475 2  New design 
 MX1-R2 5’- TCCTCTGGGTCCACATTGTA -3’     
INFII INFII-F2 5’- TTCAGGAGACCCAGAAACACTAC -3’ 125 bp 60ºC AJ841811 1 S.M. Jørgensen et al. 2007 
 INFII-R2 5’- TAATGAACTCGGACAGAGCCTTC-3’     
GIG2 GIG2-F 5’- CCCCTGAGGACAGCCACGTCT -3’ 114 bp 60ºC        EG8151231 New design 
 GIG2-R 5’- CACCGGCACCAAGCATGCCA -3’     
SAA SAA-F 5’- GGGAGATGATTCAGGGTTCCA -3’ 79 bp 60ºC X99387 2 M.K. Raida, K. Buchmann 2009 
 SAA-R 5’- TTACGTCCCCAGTGGTTAGC -3’     
FLAP FLAP-F 5’- TCTGAGTCATGCTGTCCGTAGTGGT -3’ 111 bp 60ºC CA369467 1 Jørgensen et al. (2008) 
 FLAP-R 5’- CCTCCCTCTCTACCTTCGTTGCAAA -3’     
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Supplementary Table 2.1 (Continuation). Primers used for the RT-qPCR 
Transcript 
Primer name 
Primer sequence Fragment  Tm Accession No. Source 
BAF BAF-F2 5’- GCAGACAGTCACCTTCTCTCC -3’ 187 bp 60ºC BT049316 1 New design 
 BAF-R2 5’- GGGTACAAGCAGGGGTCTTA -3’     
B2M B2M-F 5’- TCCCAGACGCCAAGCAG -3’ 138 bp 55ºC AF180487 1 N.D. Young et al. (2008) 
 B2M-R 5’- TGTAGGTCTTCAGATTCTTCAGG -3’     
IgER IgER-F1 5’- GGGAAGTTGAGCTGTGGGTA -3’ 201 bp 60ºC BT048133 1 New design 
 IgER-R1 5’- AGCGCCATAGAAGCTTTGAA -3’     
ASRV ASRV-F1 5’- CGTACCGCTTCTAACCAAGC -3’ 215 bp 58ºC HM453201 1 Mikalsen et al.(2012) 
 ASRV-R1 5’- ACATGACGACGGACTCCAAT -3’     
Reference genes:      
elf-1 ELF-1A jbt2 5’-CTGCCCCTCCAGGACGTTTACAA-3’ 175 bp 60ºC AF321836 
1 Morais et al. (2011) 
 ELF-1A jbt2 5’-CACCGGGCATAGCCGATTCC-3’     
-actin BACT-F 5’-ACATCAAGGAGAAGCTGTGC-3’ 141 bp 56ºC AF012125 
1 Morais et al. (2011) 
 BACT-R 5’-GACAACGGAACCTCTCGTTA-3’     
Cofilin-2 B2F 5’-AGCCTATGACCAACCCACTG-3’ 224 bp 60ºC TC63899 2  Morais et al. (2011) 
 B2R 5’-TGTTCACAGCTCGTTTACCG-3’     
1
 GenBank (http://www.ncbi.nlm.nih.gov/) 
2 
Atlantic salmon Gene Index (http://compbio.dfci.harvard.edu/tgi/) 
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Supplementary Table 2.3 Criteria used to score the histological changes in the heart (epicard, ventricle and 
atrium). Max score within each category is given in the left-most column. Scoring was done on a visual 
analogue scale.  
 
 
 
 
 
Inflammation 
score for HSMI 
infected fish 
Pathological description - epicard Pathological description - myocard 
0 No pathological changes observed. No pathological changes observed. 
 
0-1.8 Score 0.1-0.9: Focal / multifocal (2-4 
foci) of inflammatory cells lifting the 
epicardial layer from the surface of the 
heart, typically 2-3 cell layers thick. 
Limited number (countable) of 
mononuclear inflammatory cells 
infiltrating the epicardium.  
 
If there is only involvement of epicard 
with minor or very little compact layer 
involvement; max 1.5 score (diffuse 
and >5 cell layer thick for most of the 
inflamed area). 
 
Score 0.1-0.9. Vascular changes in the small 
vessels of the compact layer characterized by 
enlarged endothelial cells, typically stretching 
out. Minor inflammatory changes of the 
compact layer without significant involvement 
of the spongious layer. 
2-3.8 Score 1-1.9: Diffuse infiltration of 
inflammatory cells (mononuclear) >5 
cell layers thick in most of the epicard 
present. The infiltration of cells is 
multifocal to diffuse and can involve 
parts of or the entire epicardium 
available for assessment. 
 
 
Score 1-1.9: Focal to multifocal inflammatory 
foci (2-5 foci) of the compact layer and/or in 
the spongious part (2-5 foci). Extension 
typically seen along small vessels and 
perivascular infiltration. 
 
4-5.8 Score 2.0-2.9: Diffuse infiltration of 
inflammatory cells (mononuclear) >10 
cell layers thick in most of the epicard 
present. Moderate pathological changes 
consisting of high number 
(uncountable) of inflammatory cells in 
the epicardium 
 
Score 2.0-2.9: The changes in the compact 
layer are multifocal or diffuse in areas and 
typically concentrate along small blood 
vessels. Combined with focal or multifocal 
changes in the spongious layer. 
 
6 Score 3: Diffusely thickened (>15 cell 
layers) epicard in more than ¾ of the 
layer present. Severe pathological 
changes characterized by intense 
infiltration of inflammatory cells in the 
epicardium,. 
Score 3: Widespread to diffuse infiltration of 
inflammatory cells in the compact layer and 
involving the spongius layer in a multifocal 
pattern. Degeneration and or necrosis of 
muscle fibers may be/are seen. Atrium can 
also be involved with inflammatory changes 
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Abstract 
Heart and Skeletal Muscle Inflammation (HSMI) is an emerging viral disease caused by a 
novel Atlantic salmon reovirus (ASRV) affecting farmed fish. Primary symptoms associated 
with HSMI include myocardial and skeletal muscle necrosis indicating a severe inflammatory 
process. Recently, we applied the concept of clinical nutrition to moderate the long-term 
inflammatory process associated with HSMI in salmon subjected to experimental ASRV 
challenge. The use of functional feeds with lower energy through reduced lipid content 
reduced inflammatory responses to ASRV infection and severity of associated heart lesions. 
The aim of the present study was to elucidate possible mechanisms underpinning the observed 
effects of the functional feeds, focussing on liver and head kidney lipid and fatty acid 
metabolism. Here, we confirmed that liver was also a site for histopathological lesions in 
HSMI showing steatosis reflecting impaired lipid metabolism. This study is also the first to 
evaluate the expression of a suite of key genes involved in pathways relating diet and 
membrane phospholipid fatty acid compositions, and the inflammatory response after ASRV 
infection. The expression of hepatic Δ6 and Δ5 desaturases was higher in fish fed the 
functional feeds, potentially increasing their capacity for endogenous production and 
availability of anti-inflammatory EPA. Effects on mobilisation of lipids and changes in the 
LC-PUFA composition of membrane phospholipids, along with the changes in the expression 
of the genes related to eicosanoid pathways, showed the important role of the head kidney in 
inflammatory diseases caused by viral infections. The effects on gene expression suggests that 
clinical nutrition through functional feeding could be an effective complementary therapy for 
emerging salmon viral diseases associated with long-term inflammation. 
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3.1 Introduction 
 
      Heart and Skeletal Muscle Inflammation (HSMI) is an emerging viral disease caused by a 
novel Atlantic salmon reovirus (ASRV) (Palacios et al., 2010) affecting farmed salmon in 
Norway (Rimstad, 2011). Mortality varies between outbreaks from 0 to 20% (Kongtorp et al., 
2004b), and the morbidity of the lesions can reach 100%, affecting almost all the fish in a 
farm, leading to significant growth reduction and great financial impact. The main symptoms 
associated with HSMI are epi-, endo-, and myocarditis, myocardial and red skeletal muscle 
necrosis indicating these tissues experience a severe inflammatory process. Early stages of the 
disease have been reported around five months after transfer to sea water (Kongtorp et al., 
2006) and the cardiac lesions persist for several months until the fish are able to control the 
infection and reduce tissue damage. Thus, factors modulating and dampening the 
inflammatory process might be key to mitigating the clinical symptoms and improving 
performance, including growth, of affected fish. 
Polyunsaturated fatty acids (PUFA), in particular long-chain PUFA (LC-PUFA), are well 
known to have essential roles in the development and control of the inflammatory response. 
They are important components of the plasma membrane that are integral in controlling 
membrane signalling pathways. A key link between fatty acid composition of immune cell 
membranes and the inflammatory process are the eicosanoids, lipid mediators including 
prostaglandins (PG), leukotrienes (LTB) and thromboxanes (TX), which modulate the 
intensity and duration of inflammatory responses in humans (Calder, 2007) and fish (Rowley 
et al., 1995). In mammals, arachidonic acid (ARA, 20:4n-6) is the major LC-PUFA precursor 
of eicosanoids including leukotriene B4 (LTB4) and prostaglandin E2 (PGE2), which are two of 
the main eicosanoids studied in relation to several immune-related pathways (Calder, 2005; 
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Yedgar et al., 2006). LTB4 is an important chemotactic agent for leukocytes, enhancing the 
proliferation of T and B cells, increasing the production of tumour necrosis factor α (TNFα) 
and interleukins, IL-1 and IL-6, and inducing NK cell activity and thus being highly relevant 
in viral infections (Tafalla et al., 2002). PGE2 is generally related with pro-inflammatory, 
although it has also been associated with anti-inflammatory actions at the resolution of the 
inflammatory process (Calder et al., 2009c). In contrast, the n-3 LC-PUFA, eicosapentaenoic 
acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3), are considered as anti-
inflammatory fatty acids, with EPA particularly relevant as an antagonist of ARA, acting as a 
competitive substrate for the main enzymes of the eicosanoid pathways, cyclooxygenase 
(COX) and lipoxygenase (LOX), giving rise to anti-inflammatory eicosanoids and 
inflammation-resolving E-series resolvins (Calder, 2009; Calder et al., 2009). Although fish 
cell membranes have higher levels of EPA than ARA, previous studies indicated that ARA 
was the preferred substrate for the enzymes involved in the eicosanoid pathway in fish, as in 
mammals (Bell et al., 1994). Similarly, altering the ratio of ARA and EPA in cell membranes 
alters the production of eicosanoids and modulates the inflammatory response in fish as it does 
in mammals (Bell et al., 1995). In the Western-style diet, prevalent in many human societies, 
the intake of n-3 LC-PUFA is very low compared to the habitual high intake of n-6 PUFA, and 
so there has been a strong focus on clinical nutrition involving dietary supplementation with 
EPA, particularly in a range of pathologies and diseases involving acute or chronic 
inflammation, such as rheumatoid arthritis, acute cardiovascular events or inflammatory bowel 
diseases (Calder, 2009). 
The aquaculture industry has traditionally relied on the use of the marine resources, fish 
meal (FM) and fish oil (FO), as major feed ingredients and also to provide n-3 LC-PUFA and 
so maintain the high levels of these fatty acids in the farmed fish and seafood products. There 
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is a finite source of fish meal (6 million tonnes) and fish oil (1 million tonnes), which has been 
generally stable since 1975. However aquaculture output has increased at around 9% per 
annum. To sustain this continued increase in aquaculture production, from a fixed supply of 
marine raw materials, alternative sources of protein and oil have been successfully developed. 
Although VO are generally rich in n-6 PUFA and do not contain n-3 LC-PUFA, the 
replacement of high levels of FO by VO does not appear to negatively affect growth 
performance in salmonids (Turchini et al., 2010). However, the reduced dietary n-3 LC-PUFA 
and increased n-6 PUFA are directly reflected in the fish tissue fatty acid compositions, not 
only potentially impacting on the nutritional quality for the human consumer, but also raising 
concerns regarding the health of the fish themselves (Tocher, 2009c; Montero and Izquierdo, 
2010a). Thus, the fatty profile of aquaculture diets, especially total n-3 LC-PUFA levels as 
well as the n-3/n-6 PUFA ratio are becoming of increasing interest in the modulation of 
disease resistance in fish (Thompson et al., 1996; Montero et al., 2003). Dietary modulation 
for the treatment of pancreas disease has been used in human and animal medicine for many 
years (Westermarck et al., 1996; Suzuki et al., 1999). These diets have now been adapted for 
salmon operations, with a focus on reducing overall digestible energy, adapting the lipid and 
fatty acid profile and increasing digestibility of nutrients.  
In this context, we recently applied the concept of clinical nutrition to moderate the long-
term inflammatory process associated with HSMI in salmon (Martinez-Rubio et al., 2012). In 
this study we investigated the effects of functional feed formulations, in comparison to a 
standard commercial feed, on inflammatory responses in the heart of Atlantic salmon 
subjected to experimental ASRV challenge. The standard reference diet (ST diet) contained 
31% lipid and a digestible energy content of 22 MJ/Kg. The functional feeds had reduced DE 
levels (18 MJ/Kg) through lower lipid (18%), and increased levels of EPA, and increased      
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n-3/n-6 PUFA and EPA/ARA ratios (FF1 and FF2 diets). A milder (dampened) inflammatory 
response to ASRV infection, and reduced severity of heart lesions was found in fish fed the 
functional feeds, particularly FF1 and transcriptome (microarray) analysis of heart showed that 
expression of inflammation/immune related genes was greatly affected by the functional feeds. 
This study demonstrated that dietary modulation through clinical nutrition had major 
influences on the development and severity of the response to ASRV infection in salmon and 
the modulation of gene expression between fish fed the different feeds provided insight into 
the molecular mechanisms and progression of the inflammatory and immune responses to 
ASRV infection in salmon.  
The primary objective of the present study was to elucidate possible mechanisms 
underpinning the observed effects of the functional feeds, particularly focussing on lipid 
metabolism, membrane fatty acid compositions and the fatty acid metabolic pathways 
involved in LC-PUFA biochemistry and inflammatory processes, and that would be affected 
by changes in dietary fatty acid composition. Thus, head kidney, heart and liver from the same 
fish sampled in the previous study were analysed and fatty acid compositions of the cell 
membrane phospholipids determined. In addition, as one of the tissues affected in HSMI, liver 
inflammation was measured and the expression of genes, including transcription factors 
controlling aspects of lipid metabolism, and those involved of LC-PUFA biosynthesis and 
eicosanoid metabolism, were determined in liver and head kidney. 
3.2 Material and methods 
3.2.1 Fish and feeds 
     Three fishmeal-based diets were formulated and manufactured by EWOS Innovation 
(Dirdal, Norway).  Details of the formulation and proximate composition of the feeds were 
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reported previously (Martinez-Rubio et al. 2012) (Table 3.1). In short, the reference diet (ST) 
was essentially a standard, commercial formulation with 31% lipid with the added oil being a 
blend of FO and rapeseed oil. Both functional feeds had lower lipid content (18%) and 
increased proportions of EPA, but differed in n-3/n-6 PUFA ratio, which varied from 1.5 (ST) 
to 2.5 (FF1) and 3.6 (FF2) (Table 3.2). A total of 450 Atlantic salmon (Salmo salar L.), 
AquaGen strain, were distributed into three tanks at the EWOS facility, Lønningdal, Norway 
and fed one of the experimental feeds for a period of 8 weeks prior to being transferred to the 
challenge facility.  
Table 3.1 Formulation and proximate compositions of the feeds. 
Component %
1
 ST FF1 FF2 
Fish meal and hydrolysates 42.1 53 53 
Fish oil 13.7 7 5.2 
Vegetable protein concentrates
2
 21 18 18 
Vegetable oil 11.2 3 0 
Carbohydrate-based binders
3
 11.2 12.1 12.1 
Micro premixes
4
 0.8 1.9 1.7 
Krill meal
5
 0 5 5 
Krill oil
5
 0 0 5 
Total 100 100 100 
Proximate composition    
Moisture 6.5 6.5 6.5 
Fat 31 18 18 
Protein 42.2 53.4 53.4 
 
1) All ingredients sourced from EWOS stocks unless otherwise stated. 
2) Includes soy protein concentrate, pea protein concentrate, wheat gluten and sunflower meal 
3) Includes wheat grain 
4) Includes vitamins, minerals, crystalline amino acids, ammonium phosphate 
5) Aker Biomarine A 
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Table 3.2 Total lipid fatty acid composition (percentage of total fatty acids) and lipid class composition 
(percentage of total lipid) of the experimental diets. ARA, Arachidonic acid; EPA, eicosapentaenoic acid; PUFA, 
polyunsaturated fatty acids. 
Fatty acid ST FF1 FF2 
Saturated 23.97 36.48 31.86 
18:1n-9 32.30 18.65 16.31 
Monounsaturated 45.73 33.10 37.05 
18:2n-6 10.73 7.11 5.30 
20:3n-6 0.06 0.11 0.10 
20:4n-6 0.36 0.48 0.54 
n-6 PUFA 11.63 8.09 6.50 
18:3n-3 4.62 2.35 1.55 
20:5n-3 4.85 8.76 9.53 
22:6n-3 6.09 5.98 9.03 
n-3 PUFA 17.83 19.83 23.32 
PUFA 30.31 30.42 31.09 
EPA/ARA 13.67 18.16 17.75 
N-3/N-6 1.53 2.45 3.59 
Total PL 8.94 10.77 17.30 
TAG 65.39 53.47 52.45 
% Lipid 24.52 13.71 13.35 
 
3.2.2 ASRV Challenge 
After the pre-feeding period, the fish (non-vaccinated) were transferred to the challenge 
facility at the Industrial and Aquatic Laboratory (ILAB), Bergen, Norway. A total of 390 fish 
(130 fish per treatment), initial average weight 220g (±3.2g, standard error), were distributed 
into two independent experimental rooms each containing 9 flow-through tanks (3 tanks per 
dietary treatment in each system). Filtered seawater (approximately 30‰) with a constant 
temperature of 10 ± 1°C was supplied with a flow sufficient to maintain oxygen concentration 
in the outlet water at ˃ 8 mg/L (48 L / kg fish / h). The light regime was set at 12h:12h 
light/dark. The fish were acclimated for 2 weeks prior to challenge. Fish were fed with the 
same diets during the acclimation period, pre-challenge (8 weeks) and post-challenge periods 
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(16 weeks) No previous diseases were described. The fish were sedated using Aqui-S (at final 
concentration of 5 mg/L of isoeugenol) followed by anaesthesia in benzocaine (Benzoak) 
using a final concentration of 30 ml/L of water. After an initial sampling of 10 fish per dietary 
treatment, a total of 360 fish (20 per tank; 60 fish per diet per treatment room) were challenged 
by intramuscular injection (0.1 ml on each side close to the lateral line) of inoculum collected 
from cell culture supernatant of ASRV (Martinez-Rubio et al. 2012). 
3.2.3 Sampling 
Ten fish from each dietary treatment group (5 fish from each of the two independent 
systems) were sampled randomly at 8- and 16-weeks post-challenge.  Fish were anaesthetised 
as above, killed by a blow to the head, and heart, liver and head kidney collected for analyses. 
Part of each liver sample was transferred to 10% buffered formalin for histological analyses 
and another part was immediately frozen in liquid N2 and stored at -80
o
C prior to lipid and 
molecular analyses. Heart and head kidney were immediately frozen in liquid N2 and stored at 
-80
o
C. 
3.2.4 Liver histology 
Liver histology was assessed for micro- and macrovesicular steatosis by light microscopy 
of hematoxylin and eosin-stained sections. At least five different fields at 20x original 
magnification where examined and scored for presence of formation of vesicles of individual 
hepatocytes. A subjective assessment of the proportion of hepatocytes that showed these 
changes was also made. The changes were scored based a pre-determined system (see below) 
and all sections were scored double-blinded. A selected proportion of liver samples were 
stained with Periodic-Acid Schiff stain (PAS) according to standard methods with the purpose 
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to rule out vacuole formation as a cause of glycogen storage. Positive samples were included 
and also treated pre-treated with diastase/amylase (Bancroft and Stevens, 1980). 
     Liver steatosis scores were ranked according to a non-continuous score grade from 0 to 5 
(Table 3.3).  
Table 3.3 Scoring of liver steatosis in individual sections was based on the following system.  
0 formation of vacuoles in the cytoplasm, involving less than 10% of the hepatocytes and 
including less than 25% of the area of the individual hepatocytes 
1 formation of vacuoles in the cytoplasm, involving less than 25% of the hepatocytes and 
including less than 25% of the area of the individual hepatocytes 
2 formation of vacuoles in the cytoplasm, involving less than 50% of the hepatocytes and 
including less than 50% of the area of the individual hepatocytes 
3 formation of vacuoles in the cytoplasm, involving less than 75% of the hepatocytes and 
including less than 75% of the area of the individual hepatocytes 
4 formation of vacuoles in the cytoplasm, involving less than 90% of the hepatocytes and 
including less than 80% of the area of the individual hepatocytes 
5 formation of vacuoles in the cytoplasm, involving more than 90% of the hepatocytes and 
including more than 80% of the area of the individual hepatocytes 
 
Briefly, a score of 0 indicated the formation of vacuoles in the cytoplasm, involving less 
than 10% of the hepatocytes and including less than 25% of the area of the individual 
hepatocytes. A score of 5 indicated formation of vacuoles in the cytoplasm, involving more 
than 90% of the hepatocytes and including more than 80% of the area of the individual 
hepatocytes. All data preparation and simulation output analysis was conducted with the R 
language (R Development Core Team, 2009). The model was a mixed-effects linear model 
estimated with the lmer function in the lme4 package. The treatment estimates were based on 
posterior simulation (n=2500) with 95% credible intervals as absolute and proportional to the 
reference level (control diet). Histopathological scores were analysed by using a multilevel 
ordered categorical logistic regression because the data are multinomial. The model was 
written in BUGS (Lunn et al., 2000) language and fitted with JAGS (Plummer, 2009). Vague 
non-informative uniform priors (0,100) were given for the variance parameters and vague non-
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informative normal priors N (0, 1.0E + 4) for all other parameters. 25000 “burn-in" simulation 
runs were used to adapt the Markov Chain Monte Carlo (MCMC) before subsequent 2500 
runs that were used for inference. Three chains were run in parallel, i.e. there were a total of 
7500 simulations for inference. These were thinned so that only every 10th simulation was 
saved to reduce the size of saved objects and to reduce the effects of autocorrelation. In effect, 
the posterior density is based on 750 draws from the posterior probability distribution. 
Convergence of the MCMC simulation was judged by the Gelman-Rubin convergence 
diagnostic. 
3.2.5 Lipid analyses 
Total lipid from approximately 1g of liver, 0.5 g of head kidney and 0.2g of heart was 
extracted by homogenisation in chloroform/methanol (2:1, by volume) according to Folch et 
al. (1957), and determined gravimetrically. Total lipid from head kidney and heart samples 
was separated by one-dimensional thin-layer chromatography (TLC) and the major 
phospholipid classes, phosphatidylcholine (PC) and phosphatidylethanolamine (PE), were 
isolated as described previously (Bell et al., 1991). Fatty acid methyl esters (FAME) of heart 
and head kidney phospholipid classes and liver total lipid were prepared by acid-catalysed 
transmethylation (Christie, 2003). FAME were separated and quantified by gas 
chromatography (Tocher and Harvie, 1988). Tissue and diet lipid class compositions were 
determined by single-dimension double-development high-performance thin-layer 
chromatography (HPTLC) and densitometry (Henderson and Tocher, 1992). Significance of 
differences due to diet and time were determined by two-way ANOVA (p<0.05) using the 
SPSS 19.0 statistical package (SPSS Inc., Chicago IL, USA) of arcsin-transformed data. 
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3.2.6 Real-time quantitative PCR  
Expression of 13 selected genes were studied by reverse transcription real time quantitative 
PCR (qPCR). Six genes are related to the eicosanoid biosynthesis pathway, secretory 
phospholipase A2 or sPLA2 (PLA2G1), cytosolic calcium-dependent phospholipase A2 or 
cPLA2 (PLA2G4), cytosolic calcium-independent phospholipase A2 or iPLA2 (PLA2G6), 
cyclooxygenase 2 (COX2), 5-lipoxygenase-activating protein (FLAP) and arachidonate 5-
lipoxygenase (ALOX5). Four genes are involved in the LC-PUFA biosynthesis pathway, Δ5 
and Δ6 fatty acyl desaturases (D5FAD, D6FAD) and elongases 5 and 2 (ELOVL5, ELOVL2). 
The remaining genes are transcription factors related to regulation of storage and catabolism 
of dietary fats, and recently associated with the immune response, peroxisome proliferator-
activated receptors α, β and γ (PPAR-A, PPAR-B and PPAR-G). The qPCR primer sequences, 
including the annealing temperature (Tm) and size of amplicon, are shown in Table 3.4. The 
primer sequences were obtained either by literature searches or designed from EST sequences 
corresponding to candidate genes of interest using Primer3 software 
(http://biotools.umassmed.edu/bioapps/primer3_www.cgi). In addition, amplification of two 
reference genes, cofilin-2 and elongation factor-1α (elf-1α) was performed as their expression 
was stable across treatments, and they had been identified in previous salmon qPCR studies as 
suitable reference genes on the basis of constant expression between different feeds and time 
points (Morais et al. 2011; Martinez-Rubio et al., 2012(Chapter 2)).  
Six samples per treatment per time point (6 x 3 x 2) were randomly selected for  qPCR 
analysis in each one of the 3 tissues collected. 
For qPCR, 2 µg of column-purified total RNA per sample was reverse transcribed into 
cDNA using the High-Capacity cDNA RT kit (Applied Biosystems, Paisley, U.K.), following 
manufacturer’s instructions, but using a mixture of the random primers (1.5µl as supplied) and 
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anchored oligo-dT (0.5 µl at 400 ng/ µl, Eurofins MWG Operon, Ebersberg, Germany). 
Negative controls (containing no enzyme) were performed to check for genomic DNA 
contamination. cDNA was then diluted 20-fold with water, after a similar amount of cDNA 
was pooled from all samples. RT-qPCR analysis used relative quantification with the 
amplification efficiency of the primer pairs being assessed by serial dilutions of the cDNA 
pool. qPCR amplifications were carried out in duplicate (Quantica, Techne, Cambridge, U.K.) 
in a final volume of 20 µL containing either 5 µL (for most genes) or 2 µL (for the reference  
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Table 3.4 Primers used for RT-qPCR. 
Transcript 
Primer name 
Primer sequence Fragment  Tm Accession No. Source 
Δ5fad D5DES-F 5’-GTGAATGGGGATCCATAGCA-3’ 192 bp 56º AF478472 1 Morais et al. (2009) 
 D5DES-R 5’-AAACGAACGGACAACCAGA-3’     
Δ6fad_a D6DES-F 5’-CCCCAGACGTTTGTGTCAG-3’ 181 bp 56º AY458652 1 Morais et al. (2009) 
 D6DES-R 5’-CCTGGATTGTTGCTTTGGAT-3’     
elovl5a Elo1UTR-SM-1F 5’-ACAAGACAGGAATCTCTTTCAGATTAA-3’ 137 bp 60ºC AY170327 1 Morais et al. (2009) 
 Elo1UTR-SM-1R 5’-TCTGGGGTTACTGTGCTATAGTGTAC-3’     
elovl2 Elo2-SM-1F 5’-CGGGTACAAAATGTGCTGGT-3’ 145 bp 60ºC TC91192 2  Morais et al. (2009) 
 Elo2-SM-1R 5’-TCTGTTTGCCGATAGCCATT-3’     
COX2 COX2-F3 5’- TGTCCTGACATCTCGCTCAC -3’ 217 bp 60ºC AY848944 1 (New design) 
 COX2-R3 5’- AAACCGCTTCCTCAACAAAA -3’     
PLA2G1 PLA2G1-F7 5’- AGGCCCTGTGGCAGTTCAGA -3’ 97 bp 66ºC DY716300 1 (New design) 
 PLA2G1-R7 5’- CCCTTGCCACAGTAGCAGCCG -3’     
PLA2G4 PLA2G4-F2 5’- GTCGCTGGCTGGAGCTGTGG -3’ 138 bp 65ºC NM_001141333 2 (New design) 
 PLA2G4-R2 5’- AGCCCTATGGGCCCTGGTCA -3’     
PLA2G6 PLA2G6-F4 5- AGGCCCATCAAGGAACTCTT -3’ 72 bp 64ºC DQ294237 1 (New design) 
 PLA2G6-R4 5’- GATGATAGCCAGGGCCAGTA -3’     
FLAP FLAP-F 5’- TCTGAGTCATGCTGTCCGTAGTGGT -3’  bp 60ºC CA369467 1 Jørgensen et al. (2008) 
 FLAP-R 5’- CCTCCCTCTCTACCTTCGTTGCAAA -3’     
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Table 3.4 (Continuation) 
Transcript 
Primer name 
Primer sequence Fragment  Tm Accession No. Source 
ALOX5 ALOX5-F1 5’- TATCTCCCTCTCCCTCAGTCC-3’ 155 bp 56ºC CX727592 1 Ø. Haugland et al. 2005 
 ALOX5-R1 5’- GGTCAGCAGTGCCATCA-3’     
PPARα SsPPAR-A-F1 5- TCCTGGTGGCCTACGGATC-3’ 111 bp 60ºC DQ294237 1 Kleveland et al. (2006) 
 SsPPAR-A-R1 5’-CGTTGAATTTCATGGCGAACT-3’     
PPAR SsPPAR-B-F1 5’-GAGACGGTCAGGGAGCTCAC-3’ 151 bp 60ºC AJ416953 1 Kleveland et al. (2006) 
 SsPPAR-B-R1 5’-CCAGCAACCCGTCCTTGTT-3’     
PPARγ SsPPAR-G-F1 5’-CATTGTCAGCCTGTCCAGAC-3’ 144 bp 60ºC AJ416951 1 Kleveland et al. (2006) 
 SsPPAR-G-R1 5’-TTGCAGCCCTCACAGACATG-3’      
       
Reference genes:       
elf-1 ELF-1A jbt2 5’-CTGCCCCTCCAGGACGTTTACAA-3’ 175 bp 60ºC AF321836 1 Morais et al. (2009) 
 ELF-1A jbt2 5’-CACCGGGCATAGCCGATTCC-3’     
-actin BACT-F 5’-ACATCAAGGAGAAGCTGTGC-3’ 141 bp 56ºC AF012125 1 Morais et al. (2009) 
 BACT-R 5’-GACAACGGAACCTCTCGTTA-3’     
Cofilin-2 B2F 5’-AGCCTATGACCAACCCACTG-3’ 224 bp 60ºC TC63899 2  Morais et al. (2009) 
 B2R 5’-TGTTCACAGCTCGTTTACCG-3’     
       
1
 GenBank (http://www.ncbi.nlm.nih.gov/) 
2 
Atlantic salmon Gene Index (http://compbio.dfci.harvard.edu/tgi/)  
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genes and other highly expressed genes) diluted (1/20) cDNA, 0.5 µM of each primer and 
10µL AbsoluteTM QPCR SYBR® Green mix (ABgene). Amplifications were carried out with 
a systematic negative control (NTC-non template control, containing no cDNA). The qPCR 
profiles contained an initial activation step at 95°C for 15 min, followed by 30 to 40 cycles: 
15s at 95°C, 15 s at the specific primer pair annealing Tm (Table 3.4) and 15 s at 72°C. After 
the amplification phase, a melt curve of 0.5°C increments from 75ºC to 90°C was performed, 
enabling confirmation of the amplification of a single product in each reaction. qPCR product 
sizes were checked by agarose gel electrophoresis and identities confirmed by sequencing. 
Non-occurrence of primer-dimer formation in the NTC was also verified. Results were 
analysed using the relative expression software tool (REST 2009, http://www.gene-
quantification.info/), which employs a pair wise fixed reallocation randomisation test (10,000 
randomisations) with efficiency correction to determine the statistical significance of 
expression ratios (or gene expression fold-changes) between two treatments (Pfaffl et al., 
2002). 
 
3.3 Results 
 
3.3.1 Liver histology  
The liver histology scores, based on the degree of steatosis was read as vacuole-formation 
in hepatocyte cytoplasm characterised by both micro- and macro-vesicular lesions (Figure 
3.1). There were clear differences between the fish fed the functional feeds and fish fed the ST 
diet 8-weeks post-challenge, with the latter group presenting higher micro- and macro-
vesicular steatosis. Quantification of the liver histopathology thus showed that both the 
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incidence (percentage of fish sampled) and severity (based on the scoring system in Table 3.3) 
of steatosis at 8-weeks post challenge was clearly greater in salmon fed the ST diet compared 
to fish fed the two functional feeds (Figure 3.2). At 16 weeks post-challenge, there were no 
differences in liver histology between the three dietary treatments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Liver histology. Micrographs showing the degrees of steatosis. A, Microvesicular steatosis, 0.5 score; 
B, Moderate steatosis with a mix of microvesicular and some macrovesicular, 2.0 score; C, Pronounced 
steatosis dominated by macrovesicular, 3.5 score. 
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Figure 3.2 Incidence (percentage of fish sampled) and severity of histopathology (based on the steatosis scoring 
system in Table 3.3) in liver at 8-weeks and 16-weeks post challenge with Atlantic salmon reovirus in fish fed 
the Standard (ST) reference feed and the two functional feeds (FF1 and FF2). 
 
3.3.2 Lipid content and composition of tissues  
The total lipid and triacylglycerol (TAG) contents of the liver were lower in fish fed the 
functional feeds compared to fish fed the ST diet with higher lipid (Table 3.5).  
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Table 3.5 Lipid content, total Phospholipids (TPL) and Triacylglycerol (TAG) of liver, head kidney and heart 
from Atlantic salmon fed the different diets at 8- and 16- weeks post-infection with PRV.  Results are means ± 
SD (n = 5).P-values of two-way ANOVA are presented for factors ‘diet’, ‘time’ and interaction between factors 
 ST FF1 FF2 TWO WAY ANOVA P-value 
Liver 8w 16w 8w 16w 8w 16w Diet Week Diet*Week 
Lipid 
content 5.7 ± 0.8 4.3 ± 0.5 4.5 ± 0.4 4.0 ± 0.3 4.3 ± 0.3 3.5 ± 0.2 0.000 0.000 ns 
TPL 37.7 ± 2.4 44.7 ± 2.7 54.0 ± 4.6 50.3 ± 6.4 54.9 ± 3.9 53.5 ± 0.9 0.000 ns 0.007 
TAG 32.4 ± 3.8 14.8 ± 4.0 13.8 ± 6.3 14.9 ± 7.8 12.0 ± 5.1 11.7 ± 2.6 0.000 0.025 0.001 
Head kidney          
Lipid 
content      6.4 ± 0.5 2.9 ± 1.4 8.1 ± 4.4 2.1 ± 0.3 7.1 ± 2.4 1.6 ± 0.4 ns 0.000 ns 
TPL 34.9 ± 4.1 25.2 ± 4.0 32.4 ± 5.2 37.3 ± 5.0 36.5 ± 5.2 38.1 ± 6.8 0.012 ns 0.009 
TAG 42.8 ± 4.2 49.1 ± 8.8 49.6 ± 7.9 35.0 ± 7.0 44.6 ± 7.6 35.8 ± 9.0 ns 0.047 0.016 
Heart          
Lipid 
content 6.5 ± 1.4 5.9 ± 1.8 5.7 ± 1.4 4.0 ± 1.4 7.6 ± 1.4 4.2 ± 2.1 ns 0.003 ns 
TPL 48.7 ± 8.4 30.8 ± 7.1 48.8 ± 7.1 41.5 ± 9.6 45.1 ± 6.6 45.7 ± 7.5 ns 0.008 0.043 
TAG 25.0 ± 14.3 46.5 ± 11.3 25.9 ± 11.7 34.7 ± 13.1 32.1 ± 13.0 26.1 ± 6.1 ns ns ns 
 
 
In contrast, diet had no effect on the total lipid or TAG contents of heart and head kidney. 
Total lipid levels in all three tissues decreased during the time course of the infection 
irrespective of diet.  In liver, this decrease was greatest in fish fed diet ST, which also showed 
a large decline in TAG. In contrast, the decline in liver lipid was associated with lower 
proportions of polar lipids in fish fed the functional feeds. The decline in tissue lipid content 
over the course of the infection was greatest in head kidney.  This was associated with 
decreased percentages of TAG in fish fed the functional feeds but, conversely, with reduced 
proportions of polar lipids in fish fed diet ST (Table 3.5). In heart, the lower lipid content at 
16-weeks post-challenge was associated with lower proportions of polar lipids in fish fed diet 
ST but lower TAG in fish fed FF2. 
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3.3.3 Fatty acid compositions of tissues 
The fatty acid compositions of the functional feeds were characterised by increased 
proportions of saturated and n-3 PUFA, decreased proportions of monoenes and n-6 PUFA, 
and increased n-3/n-6 PUFA and EPA/ARA ratios (Table 3.1). The differences in saturated 
and monounsaturated fatty acid levels were greatest between diets ST and FF1, whereas the 
differences in PUFA levels were greatest between diet ST and FF2. The two functional feeds 
also varied in the relative proportions of ARA, EPA and DHA. The fatty acid profile of total 
lipid of liver generally reflected the composition of the diets, and so showed the same 
differences between the ST diet and functional feeds, and between the two functional feeds 
(Table 3.6). The overall liver profile changed relatively little during the course of the 
infection, especially in the groups of fish eating both functional diets, however there was 
increased proportions of DHA and n-3 PUFA, a decreased proportions of monoenes in fish fed 
the ST diet. 
Table 3.6 Total lipid fatty acid composition (percentage of total fatty acids) of liver from Atlantic salmon fed the 
different diets at 8- and 16- weeks post-infection with PRV.  Results are means ± SD (n = 5).P-values of two-way 
ANOVA are presented for factors ‘diet’, ‘time’ and interaction between factors.ARA, arachidonic acid; EPA, 
eicosapentaenoic acid; ns, not significant (p > 0.05); PUFA, polyunsaturated fatty acids. 
  8 weeks   16 weeks TWO WAY ANOVA P-value 
Fatty acid ST FF1 FF2   ST FF1 FF2 Diet Week Diet*Week 
Saturated 19.1 ± 1.2 26.8 ± 1.4 27.3 ± 1.0  22.5 ± 0.9 25.4 ± 2.0 25.6 ± 0.9 0.000 ns 0.000 
Monounsaturated 42.9 ± 4.2 27.5 ± 5.0 25.7 ± 3.3  31.5 ± 6.2 28.0 ± 3.5 26.6 ± 3.3 0.000 ns 0.008 
18:2n-6 6.5 ± 0.3 3.0 ± 0.2 2.2 ± 0.2  5.5 ± 0.5 3.0 ± 0.5 2.1 ± 0.22 0.000 0.028 0.038 
20:3n-6 0.5 ± 0.1 0.8 ± 0.0 0.6 ± 0.2  0.6 ± 0.1 1.0 ± 0.1 0.8 ± 0.2 0.000 0.009 ns 
20:4n-6 1.8 ± 0.4 2.5 ± 0.5 2.5 ± 0.5  2.3 ± 0.6 2.6 ± 0.4 2.6 ± 0.3 0.020 ns ns 
N-6 PUFA 11.0 ± 0.6 7.4 ± 0.6 6.3 ± 0.7  10.0 ± 0.4 7.7 ± 0.4 6.5 ± 0.5 0.000 ns 0.035 
18:3n-3 2.0 ± 0.1 0.5 ± 0.1 0.3 ± 0.1  1.6 ± 0.2 0.5 ± 0.2 0.3 ± 0.1 0.000 0.031 ns 
20:5n-3 3.8 ± 0.5 7.0 ± 1.1 7.5 ± 1.4  4.9 ± 0.8 7.0 ± 0.6 7.2 ± 0.4 0.000 ns ns 
22:6n-3 18.2 ± 3.6 27.3 ± 4.4 30.0 ± 2.5  26.6 ± 4.5 27.9 ± 2.8 30.2 ± 2.2 0.000 0.018 0.017 
N-3 PUFA 26.7 ± 3.4 37.9 ± 5.4 40.3 ± 2.7  35.6 ± 5.2 38.5 ± 3.1 40.7 ± 2.7 0.000 0.026 0.029 
PUFA 38.0 ± 3.7 45.7 ± 6.0 47.0 ± 3.5  46.0 ± 5.4 46.6 ± 2.8 47.8 ± 3.0 0.022 0.049 ns 
EPA/ARA 2.1 ± 0.4 2.9 ± 0.5 3.1 ± 0.5  2.2 ± 0.3 2.7 ± 0.4 2.8 ± 0.2 0.000 ns ns 
n-3/n-6 2.4 ± 0.3 5.1 ± 0.4 6.5 ± 0.3   3.6 ± 0.5 5.0 ± 0.6 6.2 ± 0.5 0.000 0.027 0.001 
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      The focus in head kidney and heart was on eicosanoid metabolism, and so fatty acid 
compositions were determined in the lipid sources of precursor LC-PUFA, the major 
membrane phospholipid classes phosphatidylcholine (PC) and phosphatidylethanolamine 
(PE). The phospholipid fatty acid profiles of head kidney showed some significant effects of 
diet, including increased proportions of saturated fatty acids and decreased proportions of n-6 
PUFA, but the differences were not as pronounced as in the diet of liver total lipid (Table 3.7). 
Irrespective of diet, the proportions of the major eicosanoid precursors, ARA and EPA and the 
EPA/ARA ratio, declined in head kidney phospholipids, especially PE, over the course of the 
infection, being significantly reduced in fish at 16-weeks compared to 8-weeks post-challenge 
(Table 3.7). The percentage of DHA in both phospholipid classes was similar in all dietary 
groups and decreased in PC, but not PE, over the time-course of the infection.  
As with head kidney, the phospholipid fatty acid composition of heart also showed effects 
of diet but they were not so pronounced and the profiles only changed slightly, and mainly in 
PC, over the course of the infection (Table 3.8). The changes in the proportions of the 
eicosanoid precursor LC-PUFA showed a different pattern in heart compared to head kidney. 
Whereas, the proportions of ARA decreased in PC, they increased in PE, during the course of 
the infection. It was noteworthy that, although EPA declined in both PC and PE of heart over 
the course of the infection, the decline was much lower in fish fed the functional feeds (Table 
3.8). Similarly, although the EPA/ARA ratio in heart phospholipids decreased over the course 
of the infection, this was much less pronounced in fish fed the functional feeds. In contrast the 
n-3/n-6 PUFA ratio did not change over the course of the infection. 
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Table 3.7 Phospholipid fatty acid composition (percentage of total fatty acids) of head kidney from Atlantic 
salmon fed the different diets at 8- and 16- weeks post-infection with PRV.  Results are means ± SD (n = 5).P-
values of two-way ANOVA are presented for factors ‘diet’, ‘time’ and interaction between factors. ARA, 
arachidonic acid; EPA, eicosapentaenoic acid; ns, not significant  (p > 0.05); PUFA, polyunsaturated fatty acids.  
 PE       
 ST FF1 FF2 TWO WAY ANOVA P-value 
 8w 16w 8w 16w 8w 16w Diet Week Diet*Week 
Saturated 14.5 ± 0.6 14.7 ± 0.6 15.6 ± 0.9 18.2 ± 3.1 16.1 ± 0.6 17.4 ± 1.9 0.007 0.030 ns 
Monounsaturated 17.5 ± 0.6 17.2 ± 1.3 19.9 ± 4.7 18.6 ± 2.9 17.6 ± 2.0 17.5 ± 1.6 ns ns ns  
18:2n-6    4.3 ± 0.1 3.4 ± 0.2 3.6 ± 0.6 2.7 ± 0.3 2.5 ± 0.3 2.0 ± 0.3 0.000 0.000 ns 
20:3n-6    0.3 ± 0.0 0.4 ± 0.1 0.4 ± 0.0 0.4 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.000 0.000 0.019 
20:4n-6    3.5 ± 0.3 2.5 ± 0.4 2.8 ± 0.4 2.1 ± 0.2 2.8 ± 0.3 1.6 ± 0.4 0.000 0.000 ns 
Total n-6 PUFA    9.5 ± 0.4 7.6 ± 0.5 7.9 ± 0.3 6.4 ± 0.3 6.5 ± 0.1 4.7 ± 0.7 0.000 0.000 ns 
18:3n-3    0.8 ± 0.2 0.6 ± 0.1 0.6 ± 0.2 0.4 ± 0.1 0.4 ± 0.1 0.3 ± 0.1 0.000 0.000 ns 
20:5n-3  11.3 ± 1.0 5.8 ± 0.8 10.4 ± 1.8 6.2 ± 0.7 12.1 ± 0.8 5.8 ± 0.3 ns 0.000 ns 
22:6n-3  35.8 ± 0.6 38.8 ± 1.5 33.9 ± 4.1 35.8 ± 4.1 36.3 ± 1.6 38.9 ± 2.7 ns 0.030 ns 
Total n-3 PUFA  50.0 ± 1.3 47.1 ± 1.1 47.3 ± 5.6 45.0 ± 5.0 51.0 ± 1.9 47.1 ± 2.7 ns 0.027 ns 
Total PUFA 59.5 ± 1.0 54.7 ± 1.2 55.2 ± 5.4 51.3 ± 5.0 57.5 ± 1.9 51.8 ± 2.4 ns 0.001 ns 
EPA/ARA    3.3 ± 0.6 2.3 ± 0.5 3.7 ± 0.4 3.0 ± 0.5 4.3 ± 0.4 3.8 ± 0.7 0.000 0.001 ns 
n-3/n-6    5.3 ± 0.3 6.2 ± 0.4 6.0 ± 0.9 7.1 ± 0.8 7.8 ± 0.4 10.2 ± 1.7 0.000 0.000 ns 
          
  PC       
 ST FF1 FF2 TWO WAY ANOVA P-value 
 8w 16w 8w 16w 8w 16w Diet Week Diet*Week 
Saturated 30.6 ± 2.0 38.1 ± 0.7 35.0 ± 1.2 38.8 ± 1.0 35.1 ± 0.2 38.4 ± 1.2 0.000 0.000 0.001 
Monounsaturated 23.2 ± 2.7 26.2 ± 1.6 19.5 ± 0.5 25.0 ± 1.0 17.7 ± 0.8 23.9 ± 0.5 0.000 0.000 0.023 
18:2n-6 3.1 ± 1.0 2.8 ± 0.0 1.9 ± 0.1 2.1 ± 0.1 1.3 ± 0.1 1.6 ± 0.3 0.000 ns ns 
20:3n-6 0.3 ± 0.1 0.4 ± 0.1 0.4 ± 0.1 0.5 ± 0.1 0.3 ± 0.1 0.4 ± 0.0 0.010 0.017 ns 
20:4n-6 1.7 ± 0.2 1.5 ± 0.1 1.7 ± 0.1 1.5 ± 0.2 1.6 ± 0.1 1.3 ± 0.3 ns 0.002 ns 
Total n-6 PUFA 6.0 ± 1.1 5.6 ± 0.2 4.8 ± 0.3 4.9 ± 0.1 3.8 ± 0.1 3.9 ± 0.5 0.000 ns ns 
18:3n-3 1.0 ± 0.2 0.4 ± 0.3 0.5 ± 0.0 0.3 ± 0.2 0.3 ± 0.0 0.2 ± 0.1 0.000 0.000 ns 
20:5n-3 9.5 ± 0.7 6.5 ± 0.5 11.2 ± 1.1 8.7 ± 1.0 12.7 ± 1.6 9.6 ± 0.5 0.000 0.000 ns 
22:6n-3 24.4 ± 2.9 17.8 ± 1.9 23.6 ± 1.8 16.5 ± 0.9 25.2 ± 1.6 18.2 ± 0.9 ns 0.000 ns 
Total n-3 PUFA 37.0 ± 2.4 26.2 ± 2.0 37.3 ± 2.2 27.3 ± 1.3 40.2 ± 0.8 29.7 ± 1.0 0.000 0.000 ns 
Total PUFA 43.0 ± 1.7 31.8 ± 2.1 42.1 ± 2.1 32.2 ± 1.2 44.1 ± 0.8 33.7 ± 1.1 0.049 0.000 ns 
EPA/ARA 5.6 ± 0.9 4.3 ± 0.7 6.8 ± 1.1 5.9 ± 1.2 8.0 ± 1.3 7.8 ± 1.3 0.000 0.040 ns 
n-3/n-6 6.3 ± 1.3 4.6 ± 0.3 7.9 ± 0.8 5.6 ± 0.4 10.6 ± 0.4 7.6 ± 0.9 0.000 0.000 ns 
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Table 3.8 Phospholipid fatty acid composition (percentage of total fatty acids) of heart from Atlantic salmon fed 
the different diets at 8- and 16- weeks post-infection with PRV.  Results are means ± SD (n = 5).P-values of two-
way ANOVA are presented for factors ‘diet’, ‘time’ and interaction between factors. ARA, arachidonic acid; 
EPA, eicosapentaenoic acid; ns, not significant (p > 0.05); PUFA, polyunsaturated fatty acids.  
 PE       
 ST FF1 FF2 TWO WAY ANOVA P-value 
 8w 16w 8w 16w 8w 16w Diet Week Diet*Week 
Saturated 16.7 ± 0.8 20.3 ± 0.5 16.8 ± 1.0 17.9 ± 0.8 18.6 ± 0.6 17.4 ± 1.1 0.049 0.003 0.000 
Monounsaturated 11.3 ± 0.8 11.6 ± 0.8 10.7 ± 0.5 11.1 ± 2.0 15.0 ± 1.1 11.7 ± 2.2 0.019 ns ns 
18:2n-6 2.5 ± 0.2 2.3 ± 0.3 1.9 ± 0.2 2.4 ± 0.6 1.7 ± 0.3 1.7 ± 0.5 0.016 ns ns 
20:3n-6 0.2 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.2 ± 0.0 0.3 ± 0.2 ns ns ns 
20:4n-6 1.5 ± 0.0 1.6 ± 0.1 1.4 ± 0.1 1.4 ± 0.1 1.2 ± 0.0 1.4 ± 0.1 0.001 0.028 ns 
Total n-6 PUFA 5.8 ± 0.4 5.5 ± 0.3 5.0 ± 0.3 5.3 ± 0.5 4.1 ± 0.4 4.5 ± 0.7 0.000 ns ns 
18:3n-3 0.7 ± 0.0 0.7 ± 0.1 0.4 ± 0.1 0.7 ± 0.3 0.3 ± 0.1 0.4 ± 0.2 0.002 ns ns 
20:5n-3 4.6 ± 0.5 4.0 ± 0.3 6.0 ± 0.4 5.6 ± 0.6 4.8 ± 0.4 5.5 ± 0.1 0.000 ns 0.010 
22:6n-3 49.1 ± 1.1 47.1 ± 1.9 48.4 ± 0.4 48.2 ± 3.0 45.5 ± 1.8 49.5 ± 2.3 ns ns 0.039 
Total n-3 PUFA 58.4 ± 0.7 54.8 ± 2.0 60.4 ± 0.8 59.1 ± 3.3 54.5 ± 2.5 59.3 ± 2.5 0.032 ns 0.008 
PUFA 64.2 ± 1.0 60.3 ± 2.0 65.4 ± 0.9 64.5 ± 3.0 58.6 ± 2.8 63.8 ± 2.0 0.011 ns 0.003 
EPA/ARA 3.2 ± 0.3 2.6 ± 0.3 4.3 ± 0.5 4.0 ± 0.3 3.9 ± 0.3 4.0 ± 0.3 0.000 0.044 ns 
N-3/N6 10.1 ± 0.6 10.1 ± 0.6 12.1 ± 0.8 11.2 ± 1.6 13.5 ± 0.8 13.5 ± 2.5 0.001 ns ns 
          
          
  PC       
 ST FF1 FF2 TWO WAY ANOVA P-value 
 8w 16w 8w 16w 8w 16w Diet Week Diet*Week 
Saturated 33.0 ± 0.8 37.5 ± 2.0 35.1 ± 0.5 37.4 ± 0.7 35.6 ± 2.4 36.4 ± 1.4 ns 0.000 ns 
Monounsaturated 16.2 ± 1.9 17.9 ± 2.2 13.7 ± 0.7 13.4 ± 0.7 14.3 ± 2.6 13.1 ± 1.8 0.001 ns ns 
18:2n-6 1.8 ± 0.3 1.7 ± 0.4 1.2 ± 0.1 1.1 ± 0.1 1.1 ± 0.1 0.8 ± 0.1 0.000 0.048 ns 
20:3n-6 0.2 ± 0.0 0.2 ± 0.1 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.2 ± 0.0 ns ns ns 
20:4n-6 1.9 ± 0.1 1.4 ± 0.1 1.7 ± 0.1 1.6 ± 0.1 1.6 ± 0.1 1.5 ± 0.0 ns 0.000 0.003 
Total n-6 PUFA 4.8 ± 0.4 4.2 ± 0.4 4.0 ± 0.3 3.7 ± 0.2 3.8 ± 0.1 3.3 ± 0.2 0.000 0.001 ns 
18:3n-3 0.7 ± 0.1 0.6 ± 0.1 0.4 ± 0.0 0.3 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.000 0.007 ns 
20:5n-3 9.5 ± 1.4 6.0 ± 1.0 12.7 ± 1.2 11.0 ± 0.4 12.8 ± 2.6 11.1 ± 0.4 0.000 0.000 0.067 
22:6n-3 31.2 ± 3.8 29.2 ± 1.4 29.1 ± 1.0 29.8 ± 1.1 29.3 ± 2.9 32.1 ± 2.2 ns ns ns 
Total n-3 PUFA 42.9 ± 2.8 37.1 ± 1.8 44.3 ± 0.9 43.0 ± 0.9 44.2 ± 0.3 45.2 ± 2.5 0.000 0.016 0.007 
PUFA 47.8 ± 2.6 41.4 ± 1.5 48.3 ± 0.8 46.7 ± 0.9 48.0 ± 0.4 48.4 ± 2.4 0.001 0.002 0.003 
EPA/ARA 5.1 ± 0.5 4.2 ± 0.6 7.4 ± 0.6 6.9 ± 0.5 7.9 ± 2.0 7.2 ± 0.4 0.000 0.023 ns 
N-3/N6 8.9 ± 1.2 8.8 ± 1.2 11.1 ± 0.9 11.7 ± 0.6 11.7 ± 0.1 13.9 ± 1.4 0.000 ns ns 
 
3.3.3 Expression of genes of LC- PUFA biosynthesis pathway in liver 
      The expression of both Δ6 and Δ5 fatty acyl desaturases in liver was significantly up-
regulated at both 8- and 16-weeks post-challenge in fish fed the functional feeds compared to 
fish fed the ST diet (Figure 3.3). 
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Figure 3.3 Expression of genes of LC-PUFA biosynthesis in liver. Expression of genes involved in long-chain polyunsaturated fatty acid (LC-PUFA) 
biosynthesis in liver was determined by real-time quantitative PCR. Values were normalised by dividing the number of copies of the target genes by the 
number of copies of reference genes (an average value for the expression of cofilin-2 and elf-1α). Different letters represent significant differences 
between diets within time points and symbols represents differences between time-points within diets (two way ANOVA, p<0.05). 
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There was no difference in expression of these genes between fish fed diets FF1 and FF2, 
or between 8- and 16-weeks. In contrast, diet had no significant effects on the expression of 
fatty acyl elongases in the liver other than ELOVL5 expression was higher in fish fed diet FF1 
compared to fish fed diet FF2 at 8-weeks post-challenge (Figure 3.3). There appeared to be a 
trend for elongase expression to be lower at 16-weeks compared to 8-weeks post-challenge, 
but this was only significant for ELOVL5 in fish fed diet FF1. 
3.3.4 Expression of PPARs 
     There were no significant effects of diet on the expression of PPARs in liver (Figure 3.4). 
There was a trend for the expression of all PPAR subtypes to be lower at 16-weeks compared 
to 8-weeks post-infection in fish fed the ST diet, but this was not statistically significant. 
Similarly, the expression of PPARγ was lower at 16-weeks compared to 8-weeks post-
challenge in all fish, although it was only significant in fish fed FF1 (Figure 3.4).  
The expression of PPARs in head kidney was also investigated due to the considerable 
decrease in lipid content observed in this tissue during the course of the infection, and the 
recently reported potential immune modulatory role of these transcription factors (Varga et al. 
2011). All three PPAR subtypes showed higher expression at 8-weeks compared to 16-weeks 
post-challenge, with this being significant in fish being fed the functional feeds (Figure 3.5). 
The only other significant effect of diet was increased expression of PPARβ in fish fed the ST 
diet compared to fish fed diet FF2 at16-weeks post-challenge. 
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Figure 3.4. Expression of PPAR genes in liver. Expression of peroxisome proliferator-activated receptor (PPAR) genes in liver was determined by real-time 
quantitative PCR. Values were normalised by dividing the number of copies of the target genes by the number of copies of reference genes (an average 
value for the expression of cofilin-2 and elf-1α). Different letters represent significant differences between diets within time points and symbols represents 
differences between time-points within diets(two-way ANOVA, p<0.05). 
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Figure 3.5 Expression of PPAR genes in head kidney. Expression of peroxisome proliferator-activated receptor (PPAR) genes in head kidney was determined 
by real-time quantitative PCR. Values were normalised by dividing the number of copies of the target genes by the number of copies of reference genes (an 
average value for the expression of cofilin-2 and elf-1α). Different letters represent significant differences between diets within time points and symbols 
represents differences between time-points within diets (two-way ANOVA, p<0.05). 
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3.5. Expression of genes related to eicosanoid biosynthesis 
 In head kidney, the expression of three phospholipases reported to be involved in the 
release of inflammatory fatty acids from cell membranes (Yedgar et al. 2006) was higher at 8-
weeks compared to 16-weeks post-challenge in fish fed all diets, significantly so in fish fed the 
functional feeds (Figure 3.6). At 8-weeks, the expression of sPLA2 (PLA2G1) was higher in 
fish fed the functional feeds compared to fish fed the ST diet, albeit only significant with fish 
fed diet FF2. The expression of COX2 (prostaglandin synthesis), ALOX5 and FLAP, both 
involved in the biosynthesis of LTs, showed generally few differences between dietary 
treatments or over the course of the infection.  However, the expression of ALOX5 was lower 
in fish fed diet FF1 compared to fish fed diet FF2, and expression of COX2 was significantly 
higher at 16-weeks compared to 8-weeks post-challenge in fish fed diet FF1 (Figure 3.6).  
      In heart, phospholipases showed a different pattern of expression compared to head 
kidney. Thus, expression of sPLA2 (PLA2G1) was negligible in heart (Figure 3.7). There 
were no major differences in expression of phospholipases over the course of the infection, 
other than higher expression of cPLA2 (PLA2G4) at 8- compared to 16-weeks post-challenge 
in fish fed diet FF2. Expression of cPLA2 at 16-weeks and iPLA2 (PLA2G6) at 8-weeks was 
significantly lower in fish fed diet FF2 compared to fish fed the other diets. Expression of 
ALOX5 and FLAP was not different between the three dietary groups but there was a trend for 
FLAP expression to be higher at 16- compared to 8-weeks post-challenge, although this was 
only significant in fish fed diet FF2 (Figure 3.7). In general, the expression pattern of COX2 in 
heart was similar to that observed in head kidney, with the expression significantly lower at   
8-weeks post-challenge in fish fed the FF1 diet compared to fish fed the other diets, and with a 
general up-regulation of this gene in all dietary groups, significant in diet FF1, at 16- 
compared to 8-weeks post-challenge (Figure 3.7). 
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Figure 3.6 Expression of genes related to eicosanoid pathways in head kidney. Expression of genes involved in eicosanoid metabolism pathways was 
determined in head kidney by real-time quantitative PCR. Values were normalised by dividing the number of copies of the target genes by the number of 
copies of reference genes (an average value for the expression of cofilin-2 and elf-1 α). Different letters represent significant differences between diets 
within time points and symbols represents differences between time-points within diets (two-way ANOVA, p<0.05). 
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Figure 3.7.Expression of genes related to eicosanoid pathways in heart. Expression of genes involved in eicosanoid metabolism pathways was determined in 
heart by real-time quantitative PCR. Values were normalised by dividing the number of copies of the target genes by the number of copies of reference genes 
(an average value for the expression of cofilin-2 and elf-1α). Different letters represent significant differences between diets within time points and symbols 
represents differences between time-points within diets (two-way ANOVA, p<0.05). 
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4. Discussion 
 
As previously described, reduced dietary lipid along with increased dietary EPA and 
EPA/ARA ratio can modulate the inflammatory response and consequently reduce the severity 
of the heart lesions caused by ASRV infection (Martinez-Rubio et al., 2012). The present 
study investigated the metabolic pathways that closely relate lipids and fatty acids, especially 
LC-PUFA, with the inflammatory response, correlating the previous findings on dietary 
immuno-modulation during ASRV infection, with availability of the LC-PUFA and 
eicosanoid metabolism in the main organs involved in those processes.  
     Fatty acids can impact the immune response in a variety of ways apart from simply being 
an energy source for the immune cells, including being integral components of cell membrane 
phospholipids, influencing the physical and functional properties of those membranes, 
affecting signalling pathways and regulating the activation of different transcription factors 
and, thus, gene expression (Calder, 2007; Yaqoob, 2003). It is well-known that different levels 
and proportions of the key LC-PUFA, ARA, EPA and DHA, can determine the intensity of the 
inflammatory response (Calder, 2005), with a major link between LC-PUFA and inflammation 
being their role as precursors of eicosanoids, critical inflammatory mediators. The levels of 
LC-PUFA in immune cell membrane phospholipids in both mammals and fish are determined 
by both dietary input and hepatic fatty acyl desaturase and elongase activities, and delivery via 
plasma lipoproteins (Calder, 2001; Tocher, 2003). In addition to liver being a major organ 
involved in LC-PUFA biosynthesis, liver lesions were reported in fish affected by HSMI, and 
so liver was also investigated in the present study to determine how the different dietary levels 
of lipid and EPA (and C18 PUFA), as well as how the disease progression, could affect the 
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expression of the genes involved in the LC-PUFA biosynthesis pathway. Eight weeks post-
challenge there was higher micro- and macro-vesicular steatosis in the fish fed the ST diet 
compared with fish fed the functional feeds, which is consistent with the higher levels of TAG 
and monounsaturated fatty acids, and lower levels of n-3 PUFA, especially DHA, observed at 
this time point in ST-fed fish. Although the primary cause of the increased steatosis index in 
the ST-fed fish was not identified in detail, the observed differences could possibly relate to 
this fact. There is however a potential interaction with the ongoing viral infection although 
previous studies have found no correlation between the severity of heart and liver lesions 
during different stages of HSMI disease (Kongtorp et al., 2006). However, in the current 
study, liver steatosis was usually more frequent when the severity of the heart lesions was 
high, and this was found in fish from all three dietary groups at the end of the present trial.  
    The most notable effect of diet upon the expression of genes of LC-PUFA biosynthesis was 
the higher expression of both fatty acyl desaturases in fish fed with the functional feeds 
compared with fish fed the standard diet. As this effect largely correlates with viral load it is 
possible that this effect on desaturase expression could be related to the viral infection and, 
indeed, it could be seen as an effective strategy for a virus to block the production of LC-
PUFA key to the inflammatory response (Martinez-Rubio et al., 2012). Supporting this, in 
vitro studies with human cells have reported inhibition of Δ6 fatty acyl desaturase activity 
after infection with several different viruses (Horrobin, 1990). However, if the effect on the 
expression of fatty acyl desaturase genes was related to the viral infection it is more likely to 
be due to a more general down-regulation of host cell metabolism rather than a specific effect 
on desaturase genes per se. Furthermore, the differences in the feed formulations also offer a 
possible explanation for the observed effect on desaturase expression; with the higher lipid 
(and energy) content of the ST diet being the reason for lower expression of desaturases in 
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salmon fed this diet. Previously, it was shown that fatty acyl desaturase activity was lower in 
rainbow trout (Oncorhynchus mykiss) consuming high-energy diets (Kolditz et al., 2008a). In 
addition, the levels of hepatic mRNA for both Δ6 and Δ5 desaturases were 4-fold higher in 
rats fed a fat-free diet in comparison to animals fed diets containing vegetable or fish oils (Cho 
et al., 1999a,b). The precise mechanism underpinning the increased desaturase expression in 
animals fed diets of lower energy (fat/oil) content is unknown. However, the higher expression 
of Δ6 and Δ5 fatty acyl desaturases in fish fed the FF diets would increase their capacity for 
the endogenous production and, possibly availability, of EPA. The general lack of major 
effects, whether related to nutrition and feed composition or to the course of the viral 
infection, on the expression of elongases was perhaps not unexpected as they do not appear to 
be under the same level of transcriptional control as desaturases (Zheng et al., 2005a; Leaver 
et al., 2008b; Torstensen and Tocher, 2010). Further investigation of the relationship between 
dietary lipid and energy contents and the expression of genes of the LC-PUFA biosynthesis 
pathway in Atlantic salmon without a viral infection is required. However, the data indicate 
that, irrespective of the precise molecular mechanism, the LC-PUFA biosynthesis activity in 
fish fed the ST diet was low further limiting the availability of anti-inflammatory n-3 LC-
PUFA in these fish in comparison to fish fed the functional feeds with higher proportions of 
these fatty acids, highlighting, therefore, the crucial role of diet to maintain the availability of 
n-3 LC-PUFA in membrane phospholipids. 
       PPARs are a group of nuclear transcription factors activated by dietary fatty acids and 
their metabolic derivatives that have been associated traditionally with lipid metabolism 
regulation in mammals and fish (Feige et al., 2006; Leaver et al., 2008b). Therefore, as 
differences in lipid and energy contents of the feeds were expected to affect the pathways of 
lipid metabolism, the expression of PPARs were investigated. However, few effects of diet 
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were observed, with only PPARβ in head kidney showing a dietary effect with reduced 
expression in fish fed the functional feeds. In contrast there were substantial effects of the 
progression of the viral infection or HSMI with the expression of all PPARs, particularly 
PPARα and γ. This was a trend in liver but was highly significant in head kidney. This was 
noteworthy as, recently, there has been interest in the involvement of PPARs in the 
inflammatory process as they are expressed in the immune cells and activated by different 
components of the eicosanoid pathways (Varga et al., 2011). Although, all three isoforms of 
PPAR, PPARα, PPARβ and PPARγ, appear to be involved in the immune response, most of 
the studies in humans focus on the immunomodulatory role of PPARα (Becker et al., 2007) 
and PPARγ (Varga and Nagy, 2008). The expression of PPAR genes was reported to decrease 
during acute inflammatory process in lung (Becker et al., 2007), adipose tissue (Khovidhunkit 
et al., 2004) and activated lymphocytes (Jones et al., 2002). In mammals, in vitro studies 
generally suggest that PPARs play roles in the resolution of inflammation, modulating the 
expression of inflammatory genes such as iNOS2, p38mitogen activated protein (MAP) kinase 
and STAT1 in the case of PPARγ and inflammatory mediators such as LTB4 in the case of 
PPARα (Varga et al., 2011). The results from the present study on ASRV/HSMI are in general 
agreement with those studies suggesting that PPARs may have similar roles in regulating or 
modulating inflammatory processes in Atlantic salmon. The considerable reduction in lipid 
content observed in head kidney between 8- and 16-weeks post-challenge has not previously 
been reported in fish studies and may be related to the differences in PPAR expression in head 
kidney discussed above. However, it is possible that it may also reflect mobilisation of 
immune cells from this organ towards the tissue sites of infection and inflammation. 
The fatty acid compositions of the major membrane phospholipids in head kidney and heart 
gave some insight into the availability of LC-PUFA for the production of the inflammatory 
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mediators, eicosanoids (Rowley et al., 1995). The tissue phospholipid fatty acid compositions 
at 8-weeks post-challenge, when no signs of tissue damage were found in hearts irrespective 
of diet (Martinez-Rubio et al., 2012) and therefore before the major inflammatory response to 
ASRV, showed that the proportions of the main LC-PUFA involved in inflammatory response 
generally reflected the characteristic compositions of PC (higher saturated fatty acid and EPA) 
and PE (higher DHA and total PUFA), as reported in previous studies in salmon (Bell et al., 
1993; 1996). The effects of dietary fatty acid composition affected the phospholipid 
compositions although this varied between the different LC-PUFA. Thus the proportions of 
ARA in PE of the head kidney was not correlated with the levels of ARA in the feeds, but 
reflected the levels of precursor 18:2n-6 in the feeds suggesting in vivo biosynthesis of ARA 
as previously reported (Bell et al., 1993).  In contrast, the levels of EPA in PC, but not PE, 
reflected the dietary EPA intakes at 8-weeks. These results are in general agreement with 
previous studies in humans and salmon where increased dietary EPA lead to increased 
proportions of this fatty acid in immune cells and heart (Calder, 2001; Bell et al., 1993). 
However, the levels of LC-PUFA in PC and PE were significantly impacted by the course of 
the infection with ARA and EPA both being considerably reduced at 16-weeks compared to 8-
weeks post-challenge. Importantly, these losses of ARA and, especially, EPA were somewhat 
mitigated by the functional feeds possibly contributing to the better outcome in fish fed these 
diets. In contrast, the levels of DHA were relatively unaffected by diet. It is difficult to predict 
whether these changes in LC-PUFA composition are cause or effect, or if they would lead to 
pro- or anti-inflammatory responses, but it appears clear that EPA and ARA are released from 
the membrane to a greater extent than DHA. Further investigation is therefore required to 
elucidate if the production of resolvins from DHA are as relevant to the resolution of the 
inflammatory process in fish as they are in humans (Calder, 2009).   
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The initial step in eicosanoid metabolism (biosynthesis) is the release of LC-PUFA 
precursors from phospholipids, mediated by phospholipase A2 (PLA2) that hydrolyse fatty 
acids from the sn-2 position of phospholipids. The above phospholipid fatty acid composition 
data suggested that there had been mobilisation of ARA and EPA during the course of the 
infection. The generally higher expression, particularly in head kidney, of phospholipases at 8-
weeks post-challenge is consistent with the important role of these enzymes in the initiation of 
inflammatory processes at early stages of infection. PLA2 is a family of enzymes with at least 
15 isoforms described in mammals with the most accepted classification system based on 
cellular disposition and calcium dependence, including calcium-dependent (cPLA2) and 
calcium-independent (iPLA2), both cytosolic, and secretory PLA2 (sPLA2) (Gilroy et al., 
2004). To date, most studies in fish have investigated cPLA2 to evaluate a possible activation 
of the eicosanoid pathway (Bell et al., 1993; Zhou et al., 2008), but all three classes of PLA2 
could be potentially involved in the inflammatory response. However, research in this field 
has usually focussed on the immunomodulatory role of cPLA2 and sPLA2, as iPLA2 is 
considered more important for the remodelling of cell membrane phospholipids (Yedgar et al., 
2006). 
       The present study is the first to report the effects of viral infection on the expression of 
PLA2 genes in fish. All three main classes of PLA2 were expressed in head kidney, although 
expression of sPLA2 was negligible in heart. The higher expression of the three PLA2 at the 
early (8-week) stage of the disease in head kidney could indicate an activation of the 
eicosanoid pathway in macrophages and other immune related cells present in this tissue 
highlighting the importance of the fatty acid composition of the cell membrane of those cells 
for the synthesis of either pro- or anti-inflammatory eicosanoids. In heart, this pattern of 
expression was only observed for cPLA2 in fish the FF2 diet. Diet also affected PLA2 
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expression with sPLA2 being up-regulated in head kidney of fish fed the functional feeds, and 
iPLA2 down-regulated in fish fed diet FF2, but the mechanism or significance of these effects 
are not clear. Obviously, the present results only represent snapshots of gene expression and so 
can similarly only provide an indication of the possible inflammatory processes at specific 
time-points particularly in a largely non-fatal disease such as HSMI that presents as a long on-
going infection. The choice of time points in the present study was informed by histological 
data on the progression of inflammatory disease in heart and liver (Martinez-Rubio et al., 
2012), and may not represent ideal times for assessing all parts of the inflammatory response.  
      Therefore, in order to broaden scope of the study, the expression of enzymes further 
downstream in the production of eicosanoids was assessed. FLAP and ALOX5 are both 
enzymes involved in the biosynthesis of leukotrienes, with ARA-derived leukotriene B4 
(LTB4) being one of the most critical in the inflammatory response. LTB4 has an important 
role during the inflammatory process stimulating aggregation of neutrophils and promoting 
leukocyte adherence to the endothelium (Bates, 1995). Regarding viral immunity, LTB4 
enhances the activity of NK cells and IFNγ (Calder, 2001) both elements of the immune 
system that play important roles in the immune response following ASRV infection (Martinez-
Rubio et al., 2012). Expression of ALOX5 and FLAP were reported after infection with 
infectious salmon anaemia virus (ISAV) and infectious pancreatic necrosis virus (IPNV) and, 
in both cases, fold changes of expression were not very high when the inflammatory process 
was more evident, suggesting that either the expression of these genes occurs in short periods 
(pulses) or small changes in expression are functionally effective (Jørgensen et al., 2008; 
Skjesol et al., 2011). In the present study, there was a clear trend for lower expression, 
significant at 8-weeks, of ALOX5 and FLAP in head kidney of fish fed the FF1 diet, which 
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may indicate lower production of LTB4 that would correlate with the milder inflammatory 
response in this dietary group (Martinez-Rubio et al., 2012).  
In general, viral infections stimulate the production of COX2 in humans and there is 
evidence that PGE2 plays important roles in controlling viral replication and modulating the 
inflammatory responses to virus (Steer and Corbett, 2003). This prostanoid has also been 
recently related to anti-inflammatory responses, inhibiting the production of LTB4 and some 
other inflammatory cytokines during resolution of the inflammatory process (Calder, 2009). 
However, PGE2 has generally been regarded as pro-inflammatory and, in the present study, 
there was a clear trend of higher expression of COX2 at 16-weeks post-challenge in both head 
kidney and heart and in all diets, significant in fish fed the FF1 diet. This was in agreement 
with previous studies in both humans (Steer and Corbett, 2003) and fish (Chettri et al., 2011) 
in which an enhanced expression of COX2 was reported along with cytokines involved in the 
inflammatory response. Furthermore, the present study also showed a trend of lower 
expression of COX2 in fish fed the functional feeds and that could indicate lower production 
of PGE2 in these fish, consistent with results from in vitro studies in which increased levels of 
n-3 PUFA decreased production of PGE2 (Calder, 2001).  
As aforementioned EPA-derived eicosanoids are also produced through the action of 
ALOX5 and COX2 (Calder, 2007) so biosynthesis of anti-inflammatory eicosanoids, LTB5 
and PGE3 could be also happening during the time-course of ASRV infection. However, 
changes on the expression of both enzymes in this study were correlated with the enhancement 
of the inflammatory response and therefore production of pro-inflammatory eicosanoids 
derived from ARA, was more likely to be happening at those later stages of the viral infection. 
In line with this, no changes on the EPA-derived eicosanoids were reported in turbot despite 
different levels of this FA on the phospholipids of the cell membranes of different tissues (Bell 
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et al.,1998a) however production of LTB4 and PGE2 was inversely correlated with the levels 
of EPA/ARA on that polar fraction of the cell membranes. Furthermore, based on the results 
obtained on the latter study and the findings of a previous study using primary cultures of 
turbot astrocytes where supplementing EPA suppressed the production of PGE2 (Bell et al., 
1994) they concluded that the role of EPA in attenuating the effects of AA-derived 
eicosanoids largely involves interfering with the production of the latter rather than forming 
eicosanoids in its own right. 
In conclusion, this study on HSMI (ASRV infection) in salmon is the first to evaluate the 
expression of a suite of important genes involved in several pathways relating diet and 
membrane phospholipid LC-PUFA compositions, and the inflammatory response after a viral 
infection. Previously, we showed the potential benefits of using diets with reduced dietary 
lipid and increased EPA on disease outcomes (Martinez-Rubio et al., 2012), and the present 
study has supported the earlier results with data on the LC-PUFA status of membrane 
phospholipids during the course of the infection. In addition, however, the present study has 
demonstrated that liver was also a site for histopathological lesions in HSMI. The observed 
steatosis in liver likely reflects a general impairment of lipid metabolism. However, the higher 
expression of hepatic Δ6 and Δ5 desaturases in fish fed the FF diets would increase their 
capacity for the endogenous production and availability of anti-inflammatory EPA. Thus, 
mobilisation of lipids, changes in the LC-PUFA composition of membrane PC and PE, along 
with the changes in the expression of the genes related to eicosanoid pathways, showed the 
important role of the head kidney in inflammatory diseases caused by viral infections. Further 
studies will be required to elucidate the crucial role of the production of eicosanoids at 
different stages of the inflammatory process, especially at the resolution of inflammation. 
However, the effects on gene expression reported in the present study further suggests that, as 
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in humans, clinical nutrition through functional feeding could be an effective complementary 
therapy for emerging salmon viral diseases associated with long-term inflammation.  
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Abstract 
The relationship between lipid and digestible energy content of the feed and growth 
performance has been exploited with great effect in Atlantic salmon (Salmo salar). The 
precise metabolic consequences of so-called “high-energy” feeds have not been fully 
defined, but increased and altered tissue lipid deposition patterns impacting on carcass 
and product quality have been reported. Recent studies on global gene expression have 
shown that dietary lipid and digestible energy content can have significant effects on 
gene expression in salmonids. In addition, we recently showed that functional feeds 
with reduced digestible energy significantly improved outcomes in response to 
inflammatory disease in salmon. The present study aimed to elucidate and clarify the 
effects of dietary digestible energy content (22, 20 and 18 MJ/Kg; HE, ME and LE 
diets, respectively) on lipid and fatty acid metabolism in salmon fed diets containing 
graded amounts of lipid. Specifically the effects on tissue lipid and fatty acid 
composition and on the hepatic expression of genes of lipid and fatty acid metabolism 
were determined. Final weight and weight gain were significantly higher, and FCR 
lower, in fish fed the HE diet. Crude lipid content was significantly lower in fish fed the 
LE diet compared to fish fed the two higher energy contents. Significantly lower total 
lipid and triacylglycerol levels were recorded in liver and heart of fish fed the LE diet 
compared to fish fed the higher energy diets. Tissue lipids in salmon fed the LE diet had 
generally significantly higher proportions of saturated fatty acids and long-chain 
polyunsaturated fatty acids (LC-PUFA), and lower monounsaturated fatty acids, C18 
and n-6 PUFA. Consistent with this, salmon fed the LE diet showed increased liver 
expression of both 6 and 5 fatty acyl desaturases in comparison to fish fed the diets 
with higher energy levels. Fatty acid synthase expression showed a clear upward trend 
as dietary energy decreased, and sterol regulatory element binding protein 2 and liver X 
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receptor showed reciprocal trends that were consistent with the level of dietary 
cholesterol that reflects digestible energy content. Although not statistically significant, 
these trends were biologically logical, significant and relevant. Expression of genes of 
fatty acid oxidation was less consistent. Overall, reduced dietary digestible energy/lipid 
content alone, without major changes in dietary fatty acid composition, altered the 
expression of key genes of lipid and fatty acid metabolism resulting in general up-
regulation of biosynthetic pathways. The results suggest that the beneficial effects of a 
clinical nutrition approach to improving inflammatory disease outcomes, through the 
use of functional feeds with reduced digestible energy, include alterations in lipid and 
fatty acid metabolism that may underpin effects on inflammatory responses. 
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4.1 Introduction 
Lipid is required in the diet of fish to supply both metabolic energy and some 
essential nutrients such as specific (essential) fatty acids (EFA) and, in early life stages, 
possibly cholesterol and intact phospholipid (Sargent et al., 2002). Consequently, it is 
not possible to define a single dietary lipid requirement for any species as this will vary 
depending upon the other dietary components supplying energy, such as protein and 
carbohydrate (NRC, 2011). Although an optimum level of dietary lipid cannot be 
defined, there are lower and upper limits within which dietary lipid should be supplied. 
The lower limit is the level required to supply the requirements for essential 
components like EFA, and will depend upon the precise lipid class and fatty acid 
compositions of the dietary lipid sources. Increasing dietary lipid above this minimum 
level will support higher growth rates due to the simple fact that lipid supplies twice as 
much energy per unit mass compared to other dietary energy sources, and so more 
energy can be supplied in the feed per unit mass, a phenomenon often referred to as 
“protein sparing” (Hemre et al., 1995; Bendiksen et al., 2003). However, an upper limit 
will be reached where the biochemical and physiological capacities of the animal to 
digest and/or metabolise dietary lipid is exceeded leading to reduced digestibility 
(undigested lipid in faeces) and/or unwanted deposition of lipid in the peritoneal cavity, 
liver, or other tissues (Company et al., 1999; Craig et al., 1999; Gaylord and Gatlin, 
2000). 
    This relationship between lipid and digestible energy (DE) content of the feed and 
growth performance has been particularly exploited in species such as Atlantic salmon 
(Salmo salar), which deposit significant amounts of lipid in the flesh and thus are able 
to tolerate and utilize high lipid, such that the dietary levels have increased steadily over 
the years (Sargent et al., 2002). Although excess deposition and altered tissue lipid 
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deposition patterns are known to cause various problems in terms of carcass and 
product quality in farmed fish like salmon (Sargent et al., 2002), the precise metabolic 
consequences of so-called “high-energy” feeds have not been fully defined. However, 
recent studies looking at global gene expression using transcriptomic (microarray) and 
proteomic approaches have shown that dietary lipid and DE content can have significant 
effects on gene expression in salmonids (Kolditz et al., 2008a,b; Panserat et al., 2008; 
Higgs et al., 2009). 
     Recently, we investigated the effects of functional feeds, which included alteration 
of dietary lipid and DE content, in the control of Heart and Skeletal Muscle 
Inflammatory (HSMI) disease in Atlantic salmon experimentally infected with the 
causative agent, Atlantic salmon reovirus (ASRV) (Martinez-Rubio et al., 2012). The 
concept of clinical nutrition and functional foods is well known in human nutrition. 
These are defined as foods that contain a component (whether a nutrient or not) that 
could be beneficial for the state of well-being and health, or reduce the risk of a disease, 
beyond the basic nutritional requirement (Bellisle et al., 1980). This approach is also 
becoming increasingly used in aquaculture, as it could potentially lead to economic 
savings in terms of increased productivity and lower costs of disease 
treatment/management (Raynard et al., 1991; McCoy et al., 1994; Tacchi et al., 2011). 
In the HSMI study, we investigated the effects of functional feed formulations that 
contained reduced energy levels through lower lipid contents (18%) and altered levels 
of long-chain polyunsaturated fatty acids (LC-PUFA), including increased 
eicosapentaenoic acid (EPA, 20:5n-3) in comparison to a standard commercial feed that 
contained 31% lipid. A much reduced inflammatory response to ASRV infection, and 
reduced severity of heart lesions were found in fish fed the functional feeds, and 
transcriptome (microarray) analysis of heart showed that expression of 
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inflammation/immune related genes was greatly affected. However, in addition to 
effects on immune genes, it was clear that the feeds were also having significant effects 
on the expression of metabolic genes in the heart, including those of lipid and fatty acid 
metabolism (Martinez-Rubio et al., 2012). However, it was not clear whether dietary 
DE and lipid content or fatty acid composition were primarily responsible for the 
alterations in metabolic gene expression.  
The primary objective of the present study was to elucidate and clarify the effects of 
dietary DE on lipid and fatty acid metabolism in Atlantic salmon fed diets containing 
graded amounts of lipid. Specifically the effects on tissue lipid and fatty acid 
composition, and on the hepatic expression of genes of lipid and fatty acid metabolism 
were determined. Lipid compositions of liver, heart and flesh, representing the main 
tissue of intermediary metabolism, a lipid-utilising tissue, and the farmed product, were 
determined.  The expression of key genes involved in the major lipid metabolic 
pathways including lipogenesis (fatty acid synthase, FAS), fatty acid -oxidation 
(carnitine palmitoyl transferase-1, CPT1; acyl CoA oxidase, ACO), and LC-PUFA 
biosyntheis (fatty acyl desaturases, 6fad_a and 5fad; fatty acid elongases, elovl2, 
elovl5a and elovl5b), and the major transcription factors (liver X receptor, LXR; 
peroxisome proliferator-activated receptors, PPAR) and nuclear receptors (sterol-
responsive element-binding protein, SREBP) controlling and regulating their 
expression, were investigated by quantitative real-time PCR (qPCR).  
4.2 Materials and Methods 
4.2.1 Fish and feeds 
Three hundred and sixty pit-tagged Atlantic salmon (Salmo salar L.) post-smolts were 
distributed equally into 9 tanks of 1.5m diameter, 1.5m
3
 volume (40 fish /tank) at the 
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University of Stirling, Marine Environmental Research Laboratory, (Machrihanish, 
Argyll, Scotland, U.K.).  The tanks were supplied with flow-through seawater at 
ambient temperature, average 12 
o
C (± 1 
o
C). After a 3-week acclimatisation period, the 
fish in triplicate tanks were fed in excess (i.e. feed was not limiting) for 12 weeks with 
one of three feeds supplied by automatic feeders every 30 min 23 h per day. The three 
fishmeal-based diets were manufactured by EWOS Innovation (Dirdal, Norway), and 
were formulated to be isoproteic (40 % crude protein), but deliver three levels of DE 
being 22 (high, HE), 20 (medium, ME) and 18 (low, LE) MJ/Kg by replacing dietary oil 
(a 50:50 mix of fish and rapeseed oils) with starch (Table 4.1). The fatty acid 
compositions of the feeds reflected the formulations with trends of increased saturated 
fatty acids, 20:1n-9, 22:1n-11 and n-3 LC-PUFA, and decreased 18:1n-9, as DE 
decreased, reflecting the lower level of rapeseed oil and increased proportion of lipid 
derived from marine sources (Table 4.2). All the fish in each tank were individually 
weighed at the initiation of the experiment (415g average weight) and the mid-point and 
the feed ration adjusted to 0.9%. Lights and feeders were on 24h/day and waste feed 
was collected using an airlift system. Feed fed, waste feed, fish behaviour, and general 
health and mortalities were monitored daily as were water temperature and quality 
measurements.  
4.2.2 Sampling 
Fish were sampled at the end of the feeding period (12 weeks) with body weight and 
length, and liver and viscera weights recorded for all fish culled. A total of 15 fish/tank 
were anaesthetised (MS222) and killed by a blow to the head with three whole fish 
frozen immediately for analysis of proximate composition. Tissues for lipid and 
biomolecular analysis were collected from the remaining 12 fish. Thus, samples of flesh 
(Norwegian Quality Cut) were collected and frozen immediately on dry ice before 
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storage at –20 oC prior to lipid and fatty acid analyses. Similarly, samples of liver (for 
fatty acid and molecular analyses) and heart (lipid and fatty acid analyses) were 
collected and frozen immediately in liquid nitrogen and stored at -80 
o
C prior to 
analysis. Further samples of liver, specifically for lipid class analysis, were collected in 
5ml glass vials containing 4 ml of chloroform/methanol (2:1, by volume).  
 
Table 4.1. Formulation (g/Kg) proximate composition (percentage of wet weight) and digestible energy 
(MJ/Kg) of experimental feeds with high (HE), medium (ME) and low (LE) levels of digestible energy 
   
 
  HE ME LE 
Fish meal 350.0 350.0 350.0 
Wheat grain 93.1 93.1 93.1 
Wheat gluten 80.0 80.0 80.0 
Soy protein conc. 80.0 80.0 80.0 
Pea protein conc. 70.0 70.0 70.0 
EWOS premix
1
 26.9 26.9 26.9 
Soy lecithin 15.0 15.0 15.0 
Starch (tapioca) 10.0 80.0 150.0 
Fish oil 137.5 102.5 67.5 
Rapeseed oil 137.5 102.5 67.5 
    
Proximate composition 
  
Moisture 4.9 5.7 6.5 
Dry matter 95.1 94.3 93.5 
Crude protein 40.4 40.5 40.6 
Crude lipid 33.9 27.0 20.0 
Digestible energy 21.9 20.1 18.2 
  
  
1
EWOS premix including minerals, vitamins, inorganic phosphorus, lysine, methionine and astaxanthin to 
satisfy nutritional requirements (NRC, 2011)  
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Table 4.2 Fatty acid composition (percentage of total fatty acids) of total lipids of feeds containing high 
(HE), medium (ME) and low (LE) levels of digestible energy 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data are means of duplicate analyses. 
1
Totals include 15:0, 20:0 and 22:0 at up to 0.3%; 
2
Totals include 
20:1n-7, 22:1n-9 and 24:1n-9 at up to 0.8%; 
3
Totals include 18:3n-6, 20:2n-6, 20:3n-6, 22:4n-6 and 
22:5n-6 at up to 0.2%; 
4
Totals include 20:3n-3, 20:4n-3 and 22.5n-3 at up to 0.6%. PUFA, 
polyunsaturated fatty acid.  
 
4.2.3 Growth performance and feed utilization  
The effects of feeds on growth performance, biometry and feed utilization efficiency 
were calculated according to the following formulae. Weight gain (g/fish) = final 
weight – initial weight. Specific growth rate (SGR, % day) = 100 × [ln (final mean 
  HE ME LE 
14:0 3.3 3.5 3.7 
16:0 10.0 10.2 11.4 
18:0 1.9 1.8 1.9 
Total saturated
1
 16.0 16.3 17.7 
    16:1n-7 3.2 3.5 3.8 
18:1n-9 32.1 30.1 24.0 
20:1n-9 7.0 7.3 7.8 
22:1n-11 8.0 8.3 9.0 
Total 
monoenes
2
 52.0 51.0 48.2 
    18:2n-6 12.3 12.1 12.6 
20:4n-6 0.2 0.2 0.2 
Total n-6 
PUFA
3
 13.0 12.6 13.2 
    18:3n-3 5.0 4.8 4.2 
18:4n-3 2.4 2.6 2.7 
20:5n-3 4.4 4.8 5.2 
22:6n-3 5.4 5.9 6.6 
Total n-3 
PUFA
4
 18.0 19.0 19.8 
Total PUFA 32.0 32.7 34.1 
        
 127 
weight) − ln (initial mean weight)] × days− 1. Feed consumption (g/day) = feed intake 
(g) × [number of fish × days]
− 1
, and  Feed conversion ratio (FCR) = feed intake 
(g) × [final biomass − initial biomass + dead fish]− 1. Hepato-somatic index (HSI, 
%) = 100 × [weight of liver (g)] × [weight of fish (g)]
− 1
. Viscero-somatic index (VSI, 
%) = 100 × [weight of viscera (g)] × [weight of fish (g)]
− 1
 
4.2.4 Proximate composition of feeds and fish 
The proximate compositions of feeds and whole fish at the end of the trial were 
determined by standard procedures (AOAC, 2000). For fish, the three fish per tank were 
pooled and minced prior to analysis (n = 3 per dietary treatment). Moisture content was 
determined after drying to constant weight in an oven at 105 °C for 24 h. The samples 
were then rigorously blended into a homogeneous crumb and used for determination of 
feed or whole body lipid, protein and ash contents. Lipid content of dried crumb was 
determined using the Soxhlet method with extraction using petroleum ether at 120 °C 
(Avanti Soxtec 2050 Auto Extraction apparatus; Foss, Warrington, UK). Crude protein 
content (N × 6.25) was determined using the automated Kjeldahl method (Tecator 
Kjeltec Auto 1030 Analyser; Foss, Warrington, UK). Ash contents were determined 
after heating at 600 °C for 24 h. The gross energy content of the feeds was determined 
by Bomb Calorimetry (Gallenkamp Autobomb System).  
 
4.2.5 Lipid content, lipid class and fatty acid compositions 
Lipid content, lipid class and fatty acid compositions of total lipid were determined 
in liver, heart, and flesh.  Tissue samples were pooled according to tank (n = 3). Total 
lipid from approximately 1g of pooled heart, liver and muscle (flesh) tissue was 
extracted by homogenization in chloroform/methanol (2:1, by volume) according to 
Folch et al. (1957), and determined gravimetrically. Tissue lipid class compositions 
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were determined by single-dimension double-development high-performance thin-layer 
chromatography (HPTLC) and densitometry (Henderson and Tocher, 1992). Fatty acid 
methyl esters (FAME) of total lipid were prepared by acid-catalyzed transmethylation 
(Christie, 2003), and separated and quantified by gas-liquid chromatography (Carlo 
Erba Vega 8160, Milan, Italy) using a 30m x 0.32 mm i.d. capillary column (CP Wax 
52CB, Chrompak, London, U.K.) and on-column injection at 50
o
C. Hydrogen was used 
as carrier gas and temperature programming was from 50 
o
C to 150 
o
C at 40 
o
C min
-1
 
and then to 230 
o
C at 2.0 
o
C min
-1
. Individual methyl esters were identified by 
comparison with known standards and by reference to published data (Ackman, 1980; 
Tocher and Harvie, 1988). Data were collected and processed using Chromcard for 
Windows (version 1.19).  
4.2.6 Determination of gene expression by quantitative real-time PCR  
     Reverse transcription quantitative real-time PCR (qPCR) analysis was performed to 
evaluate the relative expression of genes involved in major lipid metabolism pathways 
including fatty acid synthesis (fatty acid synthase, FAS), LC-PUFA biosynthesis (fatty 
acyl desaturases, 6fad_a and 5fad; fatty acid elongases, elovl2, elovl5a and elovl5b), 
and β-oxidation (carnitine palmitoyl transferase-1, CPT1; acyl CoA oxidase, ACO), and 
their control and regulation (sterol-responsive element-binding protein 2, SREBP2; liver 
X receptor, LXR; peroxisome proliferator-activated receptors, PPARα, PPARβ and 
PPARγ). The qPCR primer sequences (obtained by literature searches), annealing 
temperature (Tm) and size of amplicon are given in Table 4.3. In addition, amplification 
of cofilin-2 and elongation factor-1α Elf-1α) was performed and their expression was 
confirmed as sufficiently stable across treatments for normalization. These genes had 
been identified as suitable reference genes in previous qPCR studies in salmon (Morais 
et al., 2011).  
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Table 4.3 Sequences, annealing temperatures (Tm) and fragment sizes produced by the primer pairs used for real-time quantitative PCR (qPCR) 
Transcript Primer name Primer sequence FFragment (bp)  Tm (
o
C) Accession No. Source 
Δ5fad D5DES-F 5’-GTGAATGGGGATCCATAGCA-3’ 192 56 AF478472 1 Hastings et al. (2005) 
 
D5DES-R 5’-AAACGAACGGACAACCAGA-3’ 
    
Δ6fad_a D6DES-F 5’-CCCCAGACGTTTGTGTCAG-3’ 181 56 AY458652 1 Zheng et al. (2005a) 
 
D6DES-R 5’-CCTGGATTGTTGCTTTGGAT-3’ 
    
elovl5a Elo1UTR-SM-1F 5’-ACAAGACAGGAATCTCTTTCAGATTAA-3’ 137 60 AY170327 1 Morais et al. (2009) 
 
Elo1UTR-SM-1R 5’-TCTGGGGTTACTGTGCTATAGTGTAC-3’ 
    
elovl5b Elo2UTR-5F 5’-ACAAAAAGCCATGTTTATCTGAAAGA-3’ 141 60 DW546112 1 Morais et al. (2009) 
 
Elo2UTR-5R 5’-AAGTGGGTCTCTGGGGCTGTG-3’ 
    
elovl2 Elo2-SM-1F 5’-CGGGTACAAAATGTGCTGGT-3’ 145 60 TC91192 2  Morais et al. (2009) 
 
Elo2-SM-1R 5’-TCTGTTTGCCGATAGCCATT-3’ 
    
SREBP2 SREBP2-1F 5’-GACAGGCACAACACAAGGTG-3’ 215 60 DY733476 1 Leaver et al. (2008b) 
 
SREBP2-1R 5’-CAGCAGGGGTAAGGGTAGGT-3’ 
    
cpt1 CPT1-1F 5’-CCTGTACCGTGGAGACCTGT-3’ 212 60 AM230810 1 Leaver et al. (2008b) 
 
CPT1-1R 5’-CAGCACCTCTTTGAGGAAGG-3’ 
    
aco ACO-2F 5’-AAAGCCTTCACCACATGGAC-3’ 230 60 TC49531 2 Leaver et al. (2008b) 
 
ACO-2R 5’-TAGGACACGATGCCACTCAG-3’ 
    
PPARα SsPPAR-A-F1 5- TCCTGGTGGCCTACGGATC-3’ 111 60 DQ294237 1 Kleveland et al. (2006) 
 
SsPPAR-A-R1 5’-CGTTGAATTTCATGGCGAACT-3’ 
    
PPARβ SsPPAR-B-F1 5’-GAGACGGTCAGGGAGCTCAC-3’ 151 60 AJ416953 1 Kleveland et al. (2006) 
 
SsPPAR-B-R1 5’-CCAGCAACCCGTCCTTGTT-3’ 
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Table 4.3 (Continuation) 
1
 GenBank (http://www.ncbi.nlm.nih.gov/) 
2 
Atlantic salmon Gene Index (http://compbio.dfci.harvard.edu/tgi/) 
Transcript Primer name Primer sequence Fragment (bp)  Tm (
o
C) Accession No. Source 
PPARγ SsPPAR-G-F1 5’-CATTGTCAGCCTGTCCAGAC-3’ 144 60 AJ416951 1 Kleveland et al. (2006) 
 
SsPPAR-G-R1 5’-TTGCAGCCCTCACAGACATG-3’ 
    
FAS SsFAS-F4 5’-GTGCCCACTGAATACCATCC-3’ 212 60 CK876943 1 Morais et al.(2011) 
 
SsFAS-R4 5’-ATGAACCATTAGGCGGACAG-3’ 
    
LXR SsLXR-F 5’-GCCGCTGCTATCTGAAATCTG-3’ 210 58 FJ470290 Cruz-Garcia et al. (2009) 
 
SsLXR-R 5’-CCATCCGGCAACCAATCTGTAGG-3’ 
    
Reference genes: 
     
elf-1α ELF-1A jbt2 5’-CTGCCCCTCCAGGACGTTTACAA-3’ 175 60 AF321836 1 Morais et al. (2009) 
 
ELF-1A jbt2 5’-CACCGGGCATAGCCGATTCC-3’ 
    
β-actin BACT-F 5’-ACATCAAGGAGAAGCTGTGC-3’ 141 56 AF012125 1 Morais et al. (2009) 
 
BACT-R 5’-GACAACGGAACCTCTCGTTA-3’ 
    
Cofilin-2 B2F 5’-AGCCTATGACCAACCCACTG-3’ 224 60 TC63899 2  Morais et al. (2009) 
  B2R 5’-TGTTCACAGCTCGTTTACCG-3’         
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For qPCR, 2 µg of column-purified total RNA per sample was reverse transcribed 
into cDNA using the High-Capacity cDNA RT kit (Applied Biosystems, Paisley, U.K.), 
following manufacturer’s instructions, but using a mixture of the random primers (1.5µl 
as supplied) and anchored oligo-dT (0.5 µl at 400 ng/ µl, Eurofins MWG Operon, 
Ebersberg, Germany). Negative controls (containing no enzyme) were performed to 
check for genomic DNA contamination. cDNA was then diluted 20-fold with water, 
after a similar amount of cDNA was pooled from all samples. qPCR analysis used 
relative quantification with the amplification efficiency of the primer pairs being 
assessed by serial dilutions of the cDNA pool. qPCR amplifications were carried out in 
duplicate (Quantica, Techne, Cambridge, U.K.) in a final volume of 20 µL containing 
either 5 µL (for most genes) or 2 µL (for the reference genes and other highly expressed 
genes) diluted (1/20) cDNA, 0.5 µM of each primer and 10 µL AbsoluteTM QPCR 
SYBR® Green mix (ABgene). Amplifications were carried out with a systematic 
negative control (NTC-non template control, containing no cDNA). The qPCR profiles 
contained an initial activation step at 95 °C for 15 min, followed by 30 to 40 cycles: 15s 
at 95 °C, 15 s at the specific primer pair annealing Tm and 15 s at 72 °C. After the 
amplification phase, a melt curve of 0.5 °C increments from 75 ºC to 90 °C was 
performed, enabling confirmation of amplification of single products, and sizes were 
checked by agarose gel electrophoresis and identities confirmed by sequencing. Non-
occurrence of primer-dimer formation in the NTC was also verified. Data were analyzed 
using the relative expression software tool (REST 2009, http://www.gene-
quantification.info/), which employs a pair wise fixed reallocation randomization test 
(10,000 randomizations) with efficiency correction, to determine the statistical 
significance of expression ratios (or gene expression fold-changes) between two 
treatments (Pfaffl et al., 2002). 
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4.2.7 Statistical analyses 
The effects of dietary treatments on fish growth performance, feed efficiency, 
biometry, tissue lipid contents, class and fatty acid compositions were analysed by 
Analysis of Covariance (ANCOVA) with fish weight (or pooled fish weights) as the 
covariate. Briefly, the weight gain based on repeated weights on individual fish was 
modelled by fitting individual growth trajectories with the help of a multilevel model 
using the fish tag ID, tank and treatments (DE levels) as the levels of variation. Time 
dimension was added to the model by the day of weighing since the start of the trial and 
its effect was modelled with the help of cubic splines. FCR was calculated by dividing 
the observed feed intake by the observed weight gain and log-transformed before 
conducting stats. Differences in body length, liver and visceral weights between diets 
were analysed including fish body weight as a covariate to account for fish size 
differences at the end of the trial. Afterwards the condition factor, hepatosomatic and 
visceral indices were calculated based on the model estimates. Differences in proximal 
composition analyses of the fish, fatty acid profiles and lipid class composition in the 
flesh, heart and liver were also analysed statistically including a covariate. Since these 
analyses were conducted on pool samples the average weight of each fish pool was used 
as a covariate in order to account for size differences. Multilevel models were fitted 
with the lme4 package of the R language (R Development Core Team 2008). All 
treatment effects were based on posterior simulation (n = 2,500) with 95 % credible 
intervals. Ninety-five per cent credible intervals were interpreted as statistical 
significant at p = 0.05 % level when the interval did not overlap the reference value in 
question. 
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4.3 Results 
4.3.1 Growth performance and body composition 
The salmon more than doubled their weight over the period of the trial with final 
weights and weight gain showing clear effects of DE content and so both were 
significantly higher in fish fed the HE diet compared to fish fed the diets with lower DE 
(Table 4.4). Similarly, FCR showed an increasing trend as DE decreased and so was 
significantly lower in fish fed the HE diet compared to fish fed the diets with lower DE. 
Both HSI and VSI tended to be lower in fish fed the LE diet with the lowest DE, but the 
differences were not statistically significant (Table 4.4). Crude lipid of whole fish 
showed a clear trend with DE content with the content being significantly lower in fish 
fed diet LE compared to fish fed the ME and HE diets (Table 4.4). 
4.3.2 Tissue lipid and fatty acid compositions 
The lipid contents of liver and heart showed clear relationships with dietary DE 
content, increasing as DE increased, with tissue of fish fed HE having significantly 
higher lipid contents (Tables 4.5 & 4.6). Although this association between dietary DE 
content and tissue lipid content was not observed in muscle (flesh), there was a clear 
significant increase in storage lipid, triacylglycerol (TAG), in muscle tissue as dietary 
DE increased (Table 4.7). Similarly, the lower lipid contents in liver and heart of fish 
fed the diets with lower DE were reflected in lower levels of TAG, with significantly 
lower levels in fish fed diet LE (Tables 4.5 & 4.6). Consistent with this, tissue polar 
lipids (phospholipids) and cholesterol, reflecting membrane lipids, were generally 
significantly higher in salmon fed the LE diet (Tables 4.5-4.7). The effects of the 
different feeds on fatty acid compositions were similar in all three tissues investigated 
with salmon fed diet LE showing generally increased saturated fatty acids and LC-
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PUFA, and decreased monounsaturated fatty acids, C18 PUFA and n-6 PUFA (Tables 
4.8-4.10).  Thus, 16:0, 18:0, EPA and DHA were all generally increased, whereas, 
18:1n-9, 18:2n-6 and 18:3n-3 were generally decreased in liver, heart and muscle of 
salmon fed diet LE compared to the tissues in fish fed the HE diet. Due to the variation 
observed in the data not all of these effects were statistically significant in each case, 
but the clear consistent pattern observed in all tissues supported the overall conclusion.  
4.3.3 Liver gene expression 
Salmon fed the LE diet showed significantly increased liver expression of both 6 
and 5 fatty acyl desaturases (Fad) in comparison to fish fed the diets with higher 
energy levels (Figure 4.1). In contrast, there were no significant effects of diet on the 
expression of fatty acyl elongases (Elovl2 or Elovl5 transcripts) (Figure 4.2). There was 
a clear effect of dietary energy upon fatty acid synthase (FAS) expression, which 
increased with reducing DE albeit that the relatively large standard deviations rendered 
the effect non-significant statistically (Figure 4.3A). There was no effect of dietary 
energy on carnitine palmitoyl transferase 1 (CPT-1), a marker of mitochondrial fatty 
acid -oxidation, and although it appeared as though the expression of acyl-CoA 
oxidase (ACO), a marker of peroxisomal fatty acid oxidation, was higher in fish fed the 
LE diet, this was not significant (Figure 4.3B & C). Although statistically non-
significant, reciprocal trends in the expression of sterol regulatory element binding 
protein 2 (SREBP2) and liver X receptor (LXR) with DE were observed (Figure 4.4). 
Similarly, the liver expression of all three peroxisome proliferator-activated receptor 
subtypes (,  and ) tended to show increasing expression as dietary DE decreased, but 
none of the differences were statistically significant (Figure 4.5). 
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Table 4.4 Growth performance, feed efficiency, biometry and proximate composition of salmon fed diets 
containing high (HE), medium (ME) or low (LE) levels of digestible energy. Values between brackets 
indicate 95%CI.  
  HE ME LE 
Initial weight (g) 420.3 420.1 407.3 
 
(405.9, 435.0) (405.8, 435.3) (392.9, 421.7) 
Final weight (g) 952.5 900.4 877.4 
 
(910.2, 993.4) (860.4, 945.1) (835.5, 921.0) 
Weight gain (g) 532.3 480.3 470.2 
 
(492.6, 569.6) (443.9, 520.3) (431.2, 511.4) 
FCR 0.67 0.71 0.82 
 
(0.63, 0.70) (0.68, 0.74) (0.78, 0.86) 
HSI 1.27 1.30 1.25 
 
(1.13, 1.41) (1.19, 1.40) (1.12, 1.39) 
VSI 10.89 11.22 10.60 
 
(10.50, 11.31) (10.91, 11.54) (10.21, 10.98) 
Condition factor 1.43 1.34 1.35 
 
(1.53, 1.33) (1.42, 1.26) (1.45, 1.26) 
Proximate composition (percentage of wet weight) 
1
 
Moisture 65.4 66.4 66.8 
 
(64.2, 66.6) (65.2, 67.5) (65.7, 67.9) 
Dry matter 34.6 33.6 33.2 
 
(33.4, 35.8) (32.5, 34.7) (32.0, 34.4) 
Crude protein 17.1 17.2 17.3 
 
(16.4, 17.7) (16.5, 17.8) (16.7, 18.0) 
Crude lipid 14.2 12.7 10.9 
 
(12.3, 16.0) (10.9, 14.5) (9.0, 12.6) 
Ash 1.9 1.7 2.0 
 
Data are means (n=3). Upper and lower limits for 95% credible intervals (CI) are in parenthesis. Ninety-
five percent CI were interpreted as statistically significant at P=0.05% level when the interval did not 
overlap the reference value in question. 
1
Proximate compositions adjusted for fish weight at the end of the 
trial.  
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Table 4.5 Lipids content (percentage of wet weight) and lipid class composition (percentage of total 
lipid) of liver of salmon fed diets containing high (HE), medium (ME) or low (LE) levels of digestible 
energy. Values between brackets indicate 95%CI.   
 
Diet 
  HE ME LE 
Lipid content 7.0 6.3 5.5 
 
(5.6, 8.4) (5.7, 6.9) (4.7, 6.3) 
Lipid class 
   
PC 18.8 19.5 21.4 
 
(17.8, 19.9) (18.6, 20.3) (20.5, 22.4) 
PE 10.2 10.9 12.0 
 
(9.7, 10.6) (10.5, 11.3) (11.6, 12.5) 
PI 3.4 3.2 3.6 
 
(2.9, 3.9) (2.8, 3.6) (3.2, 4.0) 
PS 2.1 1.9 2.5 
 
(1.9, 2.4) (1.7, 2.1) (2.28, 2.7) 
CL/PG 2.1 2.0 2.4 
 
(1.8, 2.4) (1.7, 2.3) (2.1, 2.8) 
Sphingomyelin 1.6 1.8 2.1 
 
(1.3, 1.9) (1.5, 2.1) (1.8, 2.4) 
LPC 0.1 0.1 0.2 
 
(0.0, 0.4) (0.0, 0.3) (0.0, 0.5) 
    Total polar lipid 38.3 39.4 44.3 
 
(36.3, 40.3) (37.7, 41.1) (42.6, 46.2) 
Total neutral 
lipid 
61.7 60.7 55.7 
 
(59.6, 63.7) (59.0, 62.4) (54.0, 57.5) 
    Triacylglycerol 42.7 42.6 35.4 
 
(39.8, 45.5) (40.1, 45.2) (32.8, 38.1) 
Cholesterol 11.8 11.6 12.5 
 
(11.0, 12.5) (11.0, 12.3) (11.8, 13.2) 
Free fatty acid 0.4 0.3 0.6 
 
(0.0, 0.7) (0.0, 0.6) (0.4, 1.0) 
Steryl ester 6.8 6.1 7.0 
 
(5.1, 8.4) (4.6, 7.6) (5.4, 8.6) 
 
Data are means (n=3). Upper and lower limits for 95% credible intervals (CI) are in parenthesis. Ninety-
five percent CI were interpreted as statistically significant at P=0.05% level when the interval did not 
overlap the reference value in question. All effects adjusted for fish weight at the end of the trial. CL, 
cardiolipin; LPC, lyso-PC; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PG, 
phosphatidylglycerol; PI, phosphatidylinositol; PS, phosphatidylserine.  
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Table 4.6 Lipids content (percentage of wet weight) and lipid class composition (percentage of total 
lipid) of heart of salmon fed diets containing high (HE), medium (ME) or low (LE) levels of digestible 
energy. Values between brackets indicate 95%CI.   
 
Diet 
  HE ME LE 
Lipid content 4.7 3.9 3.3 
 
(3.7, 5.6) (3.4, 4.3) (2.7, 3.9) 
Lipid class 
   
PC 13.5 12.3 13.5 
 
(12.6, 14.4) (11.4, 13.1) (12.7, 14.3) 
PE 13.8 12.9 14.7 
 
(13.0, 14.7) (12.2, 13.4) (14.0, 15.4) 
PI 3.4 3.3 3.8 
 
(3.0, 3.9) (2.9, 3.8) (3.3, 4.2) 
PS 2.1 2.0 2.3 
 
(2.0, .2.2) (2.0, 2.3) (2.0, 2.4) 
CL/PG 5.8 6.3 6.6 
 
(4.6, 7.5) (5.1, 7.8) (5.4, 8.2) 
Sphingomyelin 1.5 1.6 1.7 
 
(1.3, 1.8) (1.4, 1.8) (1.5, 1.9) 
LPC 0.1 0.1 0.1 
 
(0.0, 0.3) (0.0, 0.3) (0.0, 0.3) 
    Total polar lipid 40.6 38.6 42.9 
 
(37.6, 43.6) (35.7, 41.4) (40.0, 45.8) 
Total neutral 
lipid 
59.4 61.4 57.1 
 
(56.3, 62.3) (58.6, 64.1) (54.3, 60.0) 
    Triacylglycerol 39.2 41.5 37.3 
 
(35.8, 42.5) (38.5, 44.4) (34.4, 40.2) 
Cholesterol 12.4 11.8 12.6 
 
(12.0, 12.8) (11.5, 12.1) (12.2, 12.9) 
Free fatty acid 5.8 5.8 5.8 
 
(3.9, 7.8) (3.9, 7.7) (3.9, 7.6) 
Steryl ester 2.2 2.2 1.5 
 
(0.2, 4.2) (0.4, 4.0) (0.0, 3.3) 
 
Data are means (n=3). Upper and lower limits for 95% credible intervals (CI) are in parenthesis. Ninety-
five percent CI were interpreted as statistically significant at P=0.05% level when the interval did not 
overlap the reference value in question. All effects adjusted for fish weight at the end of the trial. CL, 
cardiolipin; LPC, lyso-PC; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PG, 
phosphatidylglycerol; PI, phosphatidylinositol; PS, phosphatidylserine.  
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Table 4.7 Lipids content (percentage of wet weight) and lipid class composition (percentage of total 
lipid) of flesh of salmon fed diets containing high (HE), medium (ME) or low (LE) levels of digestible 
energy. Values between brackets indicate 95%CI.   
 
Diet 
  HE ME LE 
Lipid content 3.7 5.5 5.3 
 
(0.8, 6.6) (4.1, 6.8) (3.4, 7.1) 
Lipid class 
   PC 6.8 7.5 8.0 
 
(6.0, 7.6) (6.8, 8.1) (7.3, 8.7) 
PE 5.3 5.9 6.4 
 
(4.7, 5.9) (5.3, 6.4) (5.9, 7.0) 
PI 1.7 1.8 2.2 
 
(1.5, 2.0) (1.6, 2.1) (1.9, 2.4) 
PS 0.9 1.1 1.1 
 
(0.4, 1.3) (0.7, 1.5) (0.7, 1.5) 
CL/PG 1.1 1.2 1.4 
 
(0.9, 1.4) (1.0, 1.5) (1.2, 1.7) 
Sphingomyelin 0.7 0.8 0.6 
 
(0.6, 0.8) (0.7, 0.9) (0.5, 0.7) 
LPC 0.3 0.4 1.0 
 
(0.0, 0.7) (0.1, 0.8) (0.6, 1.4) 
    Total polar lipid 16.9 18.7 20.8 
 
(15.0, 18.9) (17.0, 20.4) (19.1, 22.5) 
Total neutral 
lipid 83.1 81.3 79.2 
 
(81.3, 85.0) (79.7, 83.1) (77.6, 81.0) 
    Triacylglycerol 69.1 66.0 62.8 
 
(67.0, 71.1) (64.2, 67.7) (61.1, 64.5) 
Cholesterol 7.5 8.4 8.7 
 
(6.6, 8.4) (7.5, 9.3) (7.8, 9.6) 
Free fatty acid 6.7 7.0 7.8 
 
(5.6, 7.8) (6.0, 7.9) (6.8, 8.8) 
Steryl ester 0.0 0.0 0.0 
 
(0, 0) (0, 0) (0, 0) 
 
Data are means (n=3). Upper and lower limits for 95% credible intervals (CI) are in parenthesis. Ninety-
five percent CI were interpreted as statistically significant at P=0.05% level when the interval did not 
overlap the reference value in question. All effects adjusted for fish weight at the end of the trial. CL, 
cardiolipin; LPC, lyso-PC; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PG, 
phosphatidylglycerol; PI, phosphatidylinositol; PS, phosphatidylserine.  
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Table 4.8 Fatty acid composition (percentage of total fatty acids) of total lipid of liver of salmon fed diets 
with high (HE), medium (ME) and low (LE) levels of digestible energy. Values between brackets indicate 
95%CI. 
 
Diet 
  HE ME LE 
14:0 1.5 1.7 1.5 
 
(1.1, 1.9) (1.6, 1.9) (1.2, 1.7) 
16:0 9.9 11.2 13.6 
 
(8.2, 11.5) (10.5, 11.9) (12.6, 14.6) 
18:0 3.7 4.2 5.3 
 
(3.2, 4.3) (4.0, 4.5) (5.0, 5.6) 
Total saturated
1
 15.5 17.5 20.6 
 
(13.6, 17.4) (16.7, 18.4) (19.5, 21.8) 
16:1n-7 2.9 3.2 4.0 
 
(2.1, 3.5) (2.8, 3.5) (3.5, 4.4) 
18:1n-9 32.1 30.7 30.2 
 
(27.5, 36.7) (28.6, 32.7) (27.4, 32.9) 
18:1n-7 2.6 2.7 2.4 
 
(1.9, 3.4) (2.36, 3.0) (1.9, 2.8) 
20:1n-9 6.7 6.4 4.8 
 
(5.9, 7.6) (6.0, 6.8) (4.2, 5.3) 
22:1n-11 1.9 2.0 1.5 
 
(1.6, 2.3) (1.9, 2.2) (1.3, 1.7) 
Total monounsaturated
2
 47.8 46.6 44.5 
 
(42.0, 53.5) (44.1, 49.2) (40.9, 48.0) 
18:2n-6 7.7 6.6 5.0 
 
(6.9, 8.6) (6.2, 7.0) (4.5, 5.5) 
20:2n-6 1.7 1.5 1.1 
 
(1.5, 1.9) (1.4, 1.6) (1.0, 1.2) 
20:3n-6 0.4 0.5 0.7 
 
(0.0, 0.7) (0.4, 0.6) (0.5, 0.8) 
20:4n-6 0.7 0.7 0.8 
 
(0.5, 0.9) (0.7, 0.8) (0.7, 0.9) 
Total n-6 PUFA
3
 10.9 9.7 7.8 
 
(9.8, 12.1) (9.2, 10.2) (7.0, 8.4) 
18:3n-3 2.4 1.9 1.1 
 
(2.1, 2.7) (1.8, 2.0) (0.9, 1.2) 
20:4n-3 1.6 1.5 1.0 
 
(1.4, 1.8) (1.4, 1.6) (0.9, 1.1) 
20:5n-3 4.8 5.0 5.0 
 
(3.7, 5.9) (4.5, 5.5) (4.4, 5.7) 
22:5n-3 1.2 1.5 1.6 
 
(1.0, 1.5) (1.4, 1.6) (1.4, 1.8) 
22:6n-3 14.6 15.2 17.6 
 
(10.5, 18.8) (13.4, 16.8) (15.2, 20.1) 
Total n-3 PUFA
4
 25.4 25.8 26.8 
 
(20.5, 30.4) (23.6, 28.1) (23.9, 29.8) 
Total PUFA 36.9 35.9 34.9 
 
(32.2, 41.6) (33.9, 38.0) (32.0, 37.6) 
n-3/n-6 2.3 2.7 3.4 
 
(1.8, 3.0) (2.4, 3.0) (3.0, 4.0) 
Data are means (n=3). Upper and lower limits for 95% credible intervals (CI) are in parenthesis. Ninety-
five percent CI were interpreted as statistically significant at P=0.05% level when the interval did not 
overlap the reference value in question. effects adjusted for fish weight at the end of the trial. 
1
Totals 
include 15:0, 20:0 and 22:0 at up to 0.2%; 
2
Totals include 16:1n-9, 20-1n-7, 22:1n-9 and 24:1n-9 at up to 
0.8%; 3Totals include 18:3n-6, 22:4n-6 and 22:5n-6 at up to 0.2%; 4Totals include 18:4n-3 and 20:3n-3 
at up to 0.5%. PUFA, polyunsaturated fatty acid.  
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Table 4.9 Fatty acid composition (percentage of total fatty acids) of total lipid of heart of salmon fed 
diets with high (HE), medium (ME) and low (LE) levels of digestible energy. Values between brackets 
indicate 95%CI. 
 
Diet 
 HE ME LE 
14:0 2.4 2.2 2.2 
 
(1.9, 3.0) (2.0, 2.5) (1.9, 2.5) 
16:0 15.4 16.1 17.6 
 
(14.1, 16.7) (15.6, 16.7) (16.8, 18.4) 
18:0 3.5 3.8 4.0 
 
(3.2, 4.0) (3.6, 3.9) (3.7, 4.2) 
Total saturated
1
 21.9 22.6 24.3 
 
(20.3, 23.5) (21.9, 23.3) (23.3, 25.2) 
16:1n-7 2.7 2.5 2.7 
 
(2.0, 3.5) (2.2, 2.9) (2.3, 3.2) 
18:1n-9 20.6 17.8 15.1 
 
(18.1, 23.0) (16.7, 18.9) (13.7, 16.6) 
18:1n-7 2.6 2.5 2.5 
 
(2.4, 2.8) (2.42, 2.6) (2.4, 2.64) 
20:1n-9 4.7 4.3 3.7 
 
(4.1, 5.3) (4.0, 4.6) (3.3, 4.1) 
22:1n-11 3.6 3.3 2.8 
 
(3.0, 4.3) (3.0, 3.6) (2.4, 3.1) 
Total monounsaturated
2
 35.8 32.0 28.2 
 
(31.4, 40.2) (30.1, 34.0) (25.5, 30.7) 
18:2n-6 7.2 6.5 5.5 
 
(6.5, 7.9) (6.2, 6.8) (5.1, 5.9) 
20:2n-6 0.6 0.6 0.7 
 
(0.5, 0.8) (0.6, 0.7) (0.6, 0.8) 
20:3n-6 0.3 0.3 0.4 
 
(0.2, 0.3) (0.3, 0.3) (0.4, 0.4) 
20:4n-6 0.7 0.8 0.9 
 
(0.5, 0.8) (0.8, 0.9) (0.8, 1.0) 
Total n-6 PUFA
3
 9.2 8.7 8.0 
 
(8.5, 9.8) (8.4, 9.0) (7.6, 8.4) 
18:3n-3 2.6 2.3 1.8 
 
(2.3, 2.8) (2.2, 2.4) (1.6, 1.9) 
18:4n-3 0.9 0.8 0.7 
 
(0.6, 1.1) (0.7, 0.9) (0.5, 0.8) 
20:4n-3 1.0 1.1 1.1 
 
(0.9, 1.1) (1.1, 1.1) (1.0, 1.1) 
20:5n-3 5.8 6.9 7.6 
 
(4.9, 6.8) (6.5, 7.3) (7.0, 8.1) 
22:5n-3 1.7 2.0 2.3 
 
(1.4, 1.9) (1.9, 2.1) (2.2, 2.5) 
22:6n-3 20.5 22.9 25.5 
 
(15.5, 25.3) (20.8, 25.0) (22.5, 28.5) 
Total n-3 PUFA
4
 32.7 36.2 39.1 
 
(26.9, 38.5) (33.7, 38.7) (35.8, 42.5) 
Total PUFA 42.3 45.4 47.5 
 
(37.3, 47.5) (43.2, 47.7) (44.4, 50.6) 
n-3/n-6 3.6 4.2 4.9 
 
(2.7, 4.5) (3.8, 4.6) (4.3, 5.4) 
Data are means (n=3). Upper and lower limits for 95% credible intervals (CI) are in parenthesis. Ninety-five percent 
CI were interpreted as statistically significant at P=0.05% level when the interval did not overlap the reference value 
in question. effects adjusted for fish weight at the end of the trial. 1Totals include 15:0, 20:0 and 22:0 at up to 0.2%; 
2Totals include 16:1n-9, 20-1n-7, 22:1n-9 and 24:1n-9 at up to 0.8%; 3Totals include 18:3n-6, 22:4n-6 and 22:5n-6 at 
up to 0.2%; 4Totals include 18:4n-3 and 20:3n-3 at up to 0.5%. PUFA, polyunsaturated fatty acid.  
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Table 4.10 Fatty acid composition (percentage of total fatty acids) of total lipid of flesh of salmon fed 
diets with high (HE), medium (ME) and low (LE) levels of digestible energy. Values between brackets 
indicate 95%CI. 
 
Diet 
 HE ME LE 
14:0 3.1 3.4 3.7 
 
(2.3, 3.9) (3.1, 3.8) (3.2, 4.2) 
16:0 12.2 13.0 14.9 
 
(11.4, 12.9) (12.7, 13.4) (14.4, 15.3) 
18:0 2.6 2.8 3.3 
 
(2.4, 2.8) (2.8, 2.9) (3.2, 3.4) 
Total saturated
1
 18.4 19.8 22.6 
 
(17.0, 19.6) (19.2, 20.3) (21.8, 23.4) 
16:1n-7 3.7 4.3 5.1 
 
(3.2, 4.3) (4.0, 4.5) (4.8, 5.4) 
18:1n-9 27.5 26.2 24.2 
 
(25.8, 29.2) (25.5, 26.9) (23.2, 25.1) 
18:1n-7 2.7 2.3 2.9 
 
(1.9, 3.5) (2.0, 2.7) (2.7, 3.0) 
20:1n-9 6.1 6.1 5.7 
 
(5.7, 6.6) (5.9, 6.3) (5.5, 6.0) 
22:1n-11 5.3 5.0 4.8 
 
(3.7, 6.9) (4.3, 5.7) (3.9, 5.8) 
Total monounsaturated
2
 46.6 46.0 44.1 
 
(44.1, 48.8) (45.0, 47.0) (42.8, 45.4) 
18:2n-6 9.8 9.1 8.1 
 
(9.3, 10.3) (8.9, 9.3) (7.8, 8.4) 
20:2n-6 0.8 0.8 0.8 
 
(0.8, 0.9) (0.7, 0.8) (0.8, 0.8) 
20:3n-6 0.2 0.2 0.3 
 
(0.1, 0.4) (0.1, 0.3) (0.2, 0.4) 
20:4n-6 0.4 0.4 0.4 
 
(0.3, 0.4) (0.4, 0.4) (0.4, 0.5) 
Total n-6 PUFA
3
 11.6 10.7 10.0 
 
(11.1, 12.1) (10.5, 11.0) (9.6, 10.3) 
18:3n-3 3.6 3.2 2.4 
 
(3.4, 3.8) (3.1, 3.3) (2.3, 2.5) 
18:4n-3 1.4 1.5 1.4 
 
(1.3, 1.5) (1.4, 1.5) (1.3, 1.4) 
20:4n-3 1.2 1.3 1.2 
 
(1.1, 1.3) (1.21, 1.3) (1.1, 1.2) 
20:5n-3 4.4 4.9 5.3 
 
(3.8, 5.1) (4.6, 5.2) (5.0, 5.6) 
22:5n-3 1.6 1.8 2.1 
 
(1.1, 2.2) (1.6, 2.1) (1.8, 2.4) 
22:6n-3 10.0 9.5 9.9 
 
(7.8, 12.1) (8.6, 10.5) (8.6, 11.2) 
Total n-3 PUFA
4
 22.7 22.5 22.2 
 
(20.1, 25.2) (21.5, 23.6) (20.8, 23.6) 
Total PUFA 35.0 34.3 33.2 
 
(32.3, 37.6) (33.1, 35.4) (31.8, 34.7) 
n-3/n-6 2.0 2.1 2.2 
 
(1.7, 2.2) (2.0, 2.2) (2.1, 2.4) 
Data are means (n=3). Upper and lower limits for 95% credible intervals (CI) are in parenthesis. Ninety-
five percent CI were interpreted as statistically significant at P=0.05% level when the interval did not 
overlap the reference value in question. Effects adjusted for fish weight at the end of the trial. 
1
Totals 
include 15:0, 20:0 and 22:0 at up to 0.2%; 
2
Totals include 16:1n-9, 20-1n-7, 22:1n-9 and 24:1n-9 at up to 
0.8%; 3Totals include 18:3n-6, 22:4n-6 and 22:5n-6 at up to 0.2%; 4Totals include 18:4n-3 and 20:3n-3 
at up to 0.5%. PUFA, polyunsaturated fatty acid.  
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Figure 4.1 Expression of fatty acyl desaturase (Fad) genes involved in long-chain polyunsaturated fatty 
acid (LC-PUFA) biosynthesis. Expression of Δ6 Fad (A) and Δ5 Fad (B) genes in liver was 
determined by real-time quantitative PCR. Values were normalized by dividing the number of copies 
of the target genes by the number of copies of reference genes (an average value for the expression of 
cofilin-2 and elf-1α). Different letters represent significant differences between diets (ANOVA, 
p<0.05) 
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Figure 4.2 Expression of fatty acid elongase (Elovl) genes involved in long-chain polyunsaturated fatty 
acid (LC-PUFA) biosynthesis. Expression of Elovl2 (A), Elovl5a (B) and Elovl5b (C) genes in liver 
was determined by real-time quantitative PCR. Values were normalized by dividing the number of 
copies of the target genes by the number of copies of reference genes (an average value for the 
expression of cofilin-2 and elf-1). Different letters represent significant differences between diets 
(ANOVA, p<0.05). 
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Figure 4.3 Expression of genes involved in fatty acid biosynthesis (lipogenesis) and oxidation. 
Expression of fatty acid synthase (A), carnitine palmitoyl tranferase-1 (B) and acyl coA oxidase (C) 
genes in liver was determined by real-time quantitative PCR. Values were normalized by dividing the 
number of copies of the target genes by the number of copies of reference genes (an average value for 
the expression of cofilin-2 and elf-1α). Different letters represent significant differences between diets 
(ANOVA, p<0.05). 
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Figure 4.4 Expression of genes involved in the regulation of cholesterol biosynthesis and catabolism. 
Expression of sterol regulatory element binding protein 2 (A) and liver X receptor (B) genes in liver 
was determined by real-time quantitative PCR. Values were normalized by dividing the number of 
copies of the target genes by the number of copies of reference genes (an average value for the 
expression of cofilin-2 and elf-1). Different letters represent significant differences between diets 
(ANOVA, p<0.05). 
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Figure 4.5 Expression of genes involved in the regulation of fatty acid metabolism. Expression of 
peroxisome proliferator –activated receptors (PPAR), PPARα (A), PPARβ (B) and PPARγ (C), genes 
in liver was determined by real-time quantitative PCR. Values were normalized by dividing the 
number of copies of the target genes by the number of copies of reference genes (an average value for 
the expression of cofilin-2 and elf-1α). Different letters represent significant differences between diets 
(ANOVA, p<0.05). 
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Discussion 
Although the present study was designed to investigate effects of dietary DE content, 
the differences in DE were achieved by varying the level of dietary lipid such that the 
LE diet was formulated with half the amount of added oil compared to the HE diet, and 
so it is not possible to distinguish effects of energy content per se from effects of lipid 
content. Therefore, as lipid content is used here as a proxy for energy content, we 
focussed on lipid metabolism and so the results are discussed in these terms.  
The use of high energy feeds in aquaculture is based on their ability to promote 
growth and feed efficiency and this was observed in the present study with increased 
final weights and weight gain, and lower FCR, in fish fed diet HE. It is important to 
note that this was observed despite the fish not being limited by ration.  That is, the fish 
were fed in excess so that fish had the opportunity to vary feed intake to compensate for 
the different dietary DE. Increased weight gain in response to increased dietary lipid 
content has been consistently shown in salmonids including brown (Salmo trutta) and 
rainbow (Oncorhynchus mykiss) trout, and Atlantic salmon (Arzel et al., 1993; Luzzana 
et al., 1994; Hemre and Sandnes, 1999). As a result, dietary lipid in commercial feeds 
for salmon doubled in a twenty-year period reaching around 35% of total diet by the 
mid-1990s (Einen and Roem, 1997).  
However, in addition to increasing growth, increased dietary DE through higher 
dietary lipid can also have negative impacts on other aspects of fish performance. Chief 
among these is based on the well-known positive correlation between dietary lipid 
levels and tissue/body lipid levels of fish (Sargent et al., 2002). Although the lipid data 
in the present study showed quite large variation, due to the use of an essentially 
ungraded stock, chosen to eliminate bias towards fast or slow growers, tissue lipid 
contents were generally reduced, significantly in liver and heart, with decreasing dietary 
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DE content. This was confirmed by the significantly lower total neutral (storage) lipid 
and/or TAG in all tissues in fish fed diet LE compared to fish fed HE. These consistent 
effects in all tissues supported the assertion that the differences are biologically 
significant. In this respect it is noteworthy that previous studies have reported that the 
level of lipid in flesh of salmon can vary considerably within a population, but the 
extent to which the observed biological variation is determined by environmental or 
genetic factors is not known (Bell et al., 1998b). Notwithstanding the above, previous 
studies support the present data, as high dietary lipid increased flesh lipid levels in 
salmonids including rainbow trout and Atlantic salmon (Bell et al., 1998b; Dias et al., 
1999; Hemre and Sandnes, 1999). Increased tissue lipid in response to increased dietary 
lipid was also shown in marine fish including sea bass (Dicentrarchus labrax) and 
turbot (Psetta maximus) (Catacutan and Coloso, 1995; Saether and Jobling, 2001). 
Increased tissue lipid deposition may have unwanted physiological effects such as 
promoting early sexual maturation in male salmon (Shearer and Swanson, 2000), or the 
development of fatty liver pathology in marine fish (Caballero et al., 1999), possibly 
through mechanisms involving altered gene expression, and hence the focus on this 
aspect in the present study.  
In relation to the above, a highly significant effect of dietary DE content in terms of 
altered gene expression was the higher expression of both 6- and 5-Fads in liver of 
salmon consuming the LE diet compared with fish consuming the higher energy diets. 
Liver transcript expression in fish fed LE was around 3-fold higher than that in fish fed 
HE, and was highly significant (p-value = 0.002). In contrast, dietary DE did not appear 
to affect the expression of fatty acid elongases, consistent with the fact that these 
enzymes do not show the same level of nutritional regulation as desaturases (Leaver et 
al., 2008a; Morais et al., 2009; Tocher, 2010). In addition to being the clearest effect of 
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DE on gene expression, this was also an important result as the effects of DE and/or 
lipid content on the expression of genes of LC-PUFA biosynthesis had not been 
reported previously in salmon. Previously, microarray analysis had shown that           
6-desaturase transcript expression was down-regulated in trout fed a high energy feed 
compared to fish fed a lower energy feed (Kolditz et al., 2008b). Nutritional regulation 
of fatty acid desaturase gene expression was first reported in mammals. The levels of 
liver mRNA for both Δ6- and Δ5-desaturases were approximately 3-fold higher in rats 
fed a fat-free diet compared to animals fed either safflower oil (18:2n-6) or fish oil (n-
3LC-PUFA) (Cho et al., 1999a). However, rats fed a diet containing triolein (a 
symmetrical triglyceride derived from glycerol and three units of the unsaturated fatty 
acid oleic acid) showed a similar high expression of both desaturases as observed in rats 
fed the fat-free diet (Cho et al., 1999a). Therefore, this suggested that it was the fatty 
acid composition of the diet, specifically a lack of PUFA that was responsible for the 
higher expression rather than the lipid content of the diets. Consistent with this, hepatic 
expression of Δ6-desaturase in mice fed an essential fatty acid (EFA)-deficient diet 
(triolein) was double that in mice fed a corn oil diet rich in 18:2n-6 (Cho et al., 1999b).   
Previous work investigating the nutritional regulation of LC-PUFA biosynthesis in 
fish has focussed on dietary fatty acid composition (Leaver et al., 2008a; Tocher, 2010). 
The activity of the LC-PUFA biosynthesis pathway in freshwater carp cells was 
increased by EFA-deficiency (Tocher and Dick, 1999). In vivo dietary trials showed that 
the activity of the LC-PUFA biosynthetic pathway was increased in freshwater and 
salmonid fish fed vegetable oils rich in C18 PUFA compared to fish fed fish oil, rich in 
the n-3 LC-PUFA, EPA and DHA (Tocher et al., 1997, 2002, 2003a,b). Consistent with 
this, expression of Δ6 Fad mRNA was increased in salmon fed diets lacking LC-PUFA 
(vegetable oil), compared to fish fed diets containing EPA and DHA (fish oil) (Zheng et 
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al., 2004b, 2005a,b; Leaver et al., 2008b; Taggart et al., 2008). Therefore, Fad 
expression was increased when diets contain lower levels of the pathway end-products 
such as EPA and DHA. In the present study, the fatty acid compositions of the feeds 
were similar and, indeed the levels of the LC-PUFA, EPA and DHA were slightly 
higher in the LE diet, which resulted in generally higher levels of these fatty acids in 
fish fed LE.  Therefore, the higher expression of the Fad genes in liver of fish fed the 
LE diet is not consistent with the previous data, supporting the view that dietary lipid 
content itself underpins the differences in expression observed in the present study. The 
only previous study in salmon that reported LC-PUFA biosynthesis in fish fed different 
levels of dietary lipid gave inconclusive results. Consistent with the data in the present 
study, LC-PUFA synthesis in liver was higher in fish fed a low lipid diet compared to a 
high lipid diet when supplied as fish oil (Tocher et al., 2003a, b). However, when the 
dietary lipid was supplied as vegetable oil, hepatic LC-PUFA synthesis was higher than 
both low and high fish oil, but there was no difference between low and high vegetable 
oil. This perhaps suggests a more complex interaction between lipid content and fatty 
acid composition, but LC-PUFA biosynthesis could be generally increased by low 
dietary lipid, perhaps associated with increased lipid biosynthesis in general (see 
below).  The finding that dietary lipid content can affect the expression of the genes of 
LC-PUFA biosynthesis may be related to early work that suggested that the quantitative 
requirement for EFA may vary with dietary lipid level. Thus, the dietary requirement 
for n-3 LC-PUFA appeared to increase with increased dietary lipid in fingerlings of red 
sea bream (Pagrus major) and yellowtail (Seriola quinqueradiata) (Takeuchi et al., 
1992a,b), although this was not apparent in larval gilthead sea bream (Salhi et al., 
1994). 
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Other than the above effect on Fad genes, there were few statistically significant 
effects of dietary DE (lipid content) on the expression of the other genes of lipid 
metabolism investigated. However, several showed clear trends with the DE regression 
that were scientifically logical and, as argued above, in combination with each other and 
the growth and lipid compositional data discussed above, support the contention that 
some have biological significance. For instance, the effect of DE on FAS, although not 
statistically significant, was highly likely biologically significant as it is well established 
that lipogenesis and FAS, as the rate-limiting step of lipid biosynthesis pathway, is 
regulated by dietary lipid and is up-regulated by diets with lower lipid (DE) contents 
(Sargent et al., 2002). Consistent with this, early studies showed increased dietary lipid 
depressed lipogenesis in common carp (Shimeno et al., 1995), and high lipid diets 
decreased the activities of lipogenic enzymes in juvenile yellowtail (Shimeno et al., 
1996).  Furthermore FAS activity and gene expression was lower in trout fed a high 
energy diet compared to fish fed a low energy diet (Kolditz et al., 2008a). 
A further example of data reinforcing each other was observed in the reciprocal 
responses observed in the liver expression of LXR and SREBP2, which are key 
regulators controlling cholesterol homeostasis.  The transcription factor, LXR, regulates 
cholesterol catabolism, storage, absorption and transport through the transcriptional 
regulation of key target genes involved in these processes (Aranda and Pascual, 2001). 
A single LXR cDNA was recently isolated and characterised from Atlantic salmon and 
shown to be similar to mammalian LXRα (Cruz-Garcia et al., 2009). The nuclear 
receptor, SREBP2, is activated by reduced cholesterol and is a key regulator in the 
biosynthesis of cholesterol (Horton et al., 2002) and, recently, SREBP2 was isolated 
and characterised from Atlantic salmon (Minghetti et al., 2011). In the present study, 
although relatively small, there seems to be an effect of DE on these factors with LXR 
 152 
showing a trend of decreased expression, and SREBP2 showing a trend of increased 
expression, in fish fed feeds with lower DE. This is consistent with the level of dietary 
cholesterol supplied by the feeds, which reflects level of dietary fish oil (Leaver et al., 
2008b; Taggart et al., 2008; Tocher et al., 2008).  Thus, even not significant, it seems 
that the lower level of dietary cholesterol in the LE feed compared to the HE feed, 
resulted in a slightly increased expression of SREBP2, promoting cholesterol 
biosynthesis, and lower expression of LXR, reducing cholesterol catabolism. 
Previously, lower expression of LXR was observed in liver of Atlantic salmon fed 
vegetable oil (lower cholesterol) compared to fish fed fish oil (Cruz-Garcia et al., 2009). 
Peroxisome proliferator-activated receptors are ligand-activated transcription factors 
that have key roles in regulating lipid and fatty acid metabolism including fatty acid 
oxidation (esp. PPAR) and tissue lipid deposition (esp. PPAR) in mammals 
(Desvergne et al., 2006). Their natural ligands include unsaturated fatty acids and their 
derivatives, which has led to the view that PPARs are general fatty acid sensors 
responding to changes in nutritional status and energy metabolism (Michalik et al., 
2006). Although, compared to mammals, there is considerably less known, but available 
data suggests that PPARs have similar roles in the control of metabolism in fish as in 
mammals (Leaver et al., 2005, 2008a). It is therefore likely that PPARs would be 
involved in the metabolic response to dietary DE content. In the present study, although 
not significant, there was a clear trend for the hepatic expression of all PPAR subtypes, 
but especially PPAR, to increase with decreasing DE, and this was accompanied by 
increased expression of liver ACO, but CPT-1 expression was unaffected. Similarly, 
possible association of PPAR and ACO expression was observed in sea bream (Sparus 
aurata), with expression of all PPAR subtypes and ACO reduced in liver of fish fed 
conjugated linoleic acid (CLA) (Diez et al., 2007). In contrast, feeding Atlantic salmon 
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with CLA increased PPAR expression in liver and this was associated with increased 
CPT-1 expression and -oxidation (Leaver et al., 2006). In salmon fed the thia fatty 
acid, tetradecylthioacetic acid (TTA), PPAR expression in liver was decreased, but 
expression of ACO was unaffected (Kleveland et al., 2006). In trout fed a high energy 
diet, CPT-1 and ACO expression, and -oxidation activity in liver were all increased in 
comparison to fish fed a low energy diet, but PPAR expression was unaffected 
(Kolditz et al., 2008a). All of these data highlight the inconsistency of results obtained 
on expression of PPARs and genes of fatty acid oxidation. Clearly, as PPAR function is 
dependent upon activation by ligands, the relationship between PPAR expression, its 
functionality, and thus its role in controlling expression of target genes, is complicated 
and unclear at present (Leaver et al., 2008a,b).  
In conclusion, the present study determined the effects of dietary DE on the hepatic 
expression of key genes of lipid and fatty acid metabolism in Atlantic salmon fed diets 
containing graded amounts of lipid. Dietary DE and/or lipid content had important 
effects on the expression of genes involved in LC-PUFA biosynthesis pathway (Δ6 Fad, 
Δ5 Fad) and could possibly play a role on major lipid pathways including lipogenesis 
(FAS), and cholesterol metabolism (LXR and SREBP2) as the trend of the expression 
of the genes involved in those pathways was biologically significant and consistent with 
current understanding. In contrast, the effects on fatty acid β-oxidation (CPT1, ACO 
and PPARs) were more inconclusive. Overall though, it was clear that changes in 
dietary DE alone, without major changes in dietary fatty acid composition, could result 
in altered expression of key genes of lipid and fatty acid metabolism. Combined, these 
changes resulted in an overall up-regulation of lipid biosynthetic pathways.  
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Abstract 
 
Cardiomyopathy syndrome (CMS) is a severe cardiac disease of farmed Atlantic 
salmon (Salmo salar) recently associated with a double-stranded RNA virus, Piscine 
Myocarditis Virus (PMCV).  CMS has affected 75-85 per cent of Norwegian salmon 
farms each year over the last decade resulting in annual economic losses estimated at up 
to €9 million. Recently, we showed that functional feeds lead to a milder inflammatory 
response and consequently less severity of heart lesions in salmon experimentally 
infected by Atlantic salmon reovirus (ASRV), the causal agent of heart and skeletal 
muscle inflammation (HSMI). In the present study we employed the same strategy to 
investigate the effects of similar functional feeds, with reduced lipid content and 
increased eicosapentaenoic acid (EPA) levels, in controlling CMS in salmon after 
experimental infection with PMCV. Hepatic steatosis associated with CMS was 
significantly reduced over the time course of the infection in the fish fed the functional 
feeds. Significant differences in immune and inflammatory responses and pathology in 
heart tissue were found in fish fed the different dietary treatments over the course of 
infection. Specifically, fish fed the functional feeds with reduced dietary lipid content 
and increased EPA showed a milder and delayed inflammatory response and, 
consequently, less severity of heart lesions at earlier and later stages after infection with 
PMCV. Decreasing levels of phosphatidylinositol in cell membranes combined with the 
increased expression of genes related with T-cell signalling pathways revealed new 
interactions between dietary lipid composition and the immune response in fish after a 
viral infection. Dietary histidine supplementation did not significantly affect immune 
responses or levels of heart lesions. Combined with the previous data on ASRV/HSMI, 
the present results highlight the potential role of clinical nutrition in controlling 
inflammatory diseases in Atlantic salmon. In particular, dietary lipid content and fatty 
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acid composition can have important immune-modulatory roles of potential benefit in 
Atlantic salmon viral infections. 
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5.1 Introduction 
Cardiomyopathy syndrome (CMS) is a severe cardiac disease of farmed Atlantic 
salmon (Salmo salar) recently associated with a double-stranded RNA virus termed 
piscine myocarditis virus (PMCV) (Haugland et al., 2011). The disease was first 
described and diagnosed in Norway in 1985 (Amin and Trasti, 1988), and has since also 
been diagnosed in Scotland (Rodger and Turnbull, 2000), the Faroe Islands (Poppe et 
al., 1994) and, possibly, Canada (Brocklebank and Raverty, 2002). Annual economic 
losses due to CMS have been estimated from €4.5 - 8.8 million as this disease has 
affected 75 to 85 per cent of Norwegian salmon farms each year over the last decade 
(Brun et al., 2003). Histopathologically, CMS is characterized by severe inflammation 
and necrosis of the spongy myocardium of the atrium and ventricle (Ferguson et al., 
2009), but liver may also be affected due to the circulatory disturbance associated with 
the heart lesions. Early stages of the disease have been reported in adult Atlantic salmon 
around 14 to 18 months after transfer to seawater (Fritsvold et al., 2009). Mortality is 
usually moderate although, as this is a chronic disease developing over a period of 
several months, cumulative mortality can be relevant.  
Presently, the lack of commercial vaccines to CMS makes the use of alternative 
therapies crucial. Factors that modulate the inflammatory process might be key to 
mitigate the clinical symptoms and improve the performance of affected fish. The 
concept of clinical nutrition and functional feeds is well known in humans (Roberfroid, 
2002), and is becoming of increasing interest in fish farming. Functional feeds are 
defined as high-quality feeds that, beyond their nutritional composition, are formulated 
with health promoting features that could be beneficial in supporting disease resistance 
and mitigation of clinical disease symptoms. Thus clinical nutrition enables a shift away 
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from chemotherapeutic and antibiotic treatments, lowering the costs of disease 
treatment and management (Tacchi et al., 2011). 
There are several studies in fish linking nutrition and immunology, recently 
reviewed by Kiron (2012). The inclusion in aquaculture feeds of additives such as 
probiotics, prebiotics, immunostimulants, vitamins and nucleotides, is reported to 
increase growth and feed conversion efficiency, as well as having positive effects on the 
immune system associated with the intestinal tract and protection against bacterial 
infections (Tacchi et al., 2011). Moreover, macronutrients like proteins and lipids are 
reported to play key roles in the regulation of pathways of the immune system and have 
been widely studied due to the necessity of the aquafeed industry to replace dietary 
ﬁshmeal (FM) and ﬁsh oil (FO) (Tacon and Metian, 2008). As global production of 
both FM and FO has been, at best, static over the last few years (FAO, 2010), the 
expansion of the aquaculture industry has increasingly relied on alternative sources of 
dietary protein and oil, such as plant proteins and vegetable oils (VO). There are several 
studies evaluating the consequences of FM and FO replacement in farmed fish and, 
although growth does not seem to be greatly affected by substantial levels of 
substitution, the detrimental consequences of dietary plant proteins and VO on the 
health status of fish has been an important concern in recent years (Bell et al., 1990, 
Montero et al., 2003; Bakke-McKellep et al., 2007). For instance, substitution of FM by 
some plant protein sources, particularly soybean meal, has been reported to affect the 
gastrointestinal tract and gut immune health causing enteritis and atrophy of mucosal 
folds (Kroghdal et al., 2003).  Indeed, many of the plant protein sources potentially 
suitable for aquafeeds have significant levels of a variety of antinutritional factors 
(Francis et al., 2001). However, plant protein concentrates with reduced concentrations 
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of antinutrients (Gatlin et al., 2007), and the above-mentioned dietary supplements, 
have both been used successfully to reduce the negative impacts of FM substitution. 
There are also many studies evaluating the replacement of FO by VO, recently 
reviewed by Turchini et al. (2009). A major concern of this replacement is the higher 
levels of n-6 polyunsaturated fatty acids (PUFA) contained in VO compared with FO, 
which are conversely rich in the n-3 long-chain PUFA (LC-PUFA) known to be 
essential for fish health. Dietary PUFA are involved in the regulation of the 
inflammatory response, and both innate and adaptive immune responses, through four 
potential mechanisms including gene expression, eicosanoid metabolism, cellular 
signalling and membrane organization (Raza Shaik and Eidin, 2006). Thus, specific 
transcription factors are activated by a number of PUFA, LC-PUFA and eicosanoid 
ligands (Moraes et al., 2006), and subsequently regulate the expression of genes related 
with inflammatory, B-cell and T-cell responses, which play important roles in viral 
infections. The roles of PUFA in cell membrane organization and signalling pathway 
mechanisms have been widely studied in humans (Shaik and Eidin, 2006). Inhibition of 
T-cell signalling pathways by PUFA is mainly linked to the suppression of the elevation 
of cytoplasmic calcium concentration through the phosphatidylinositol (PI) signalling 
system, which is a key event in T-cell activation (Stulnig and Zeyda, 2004). Among the 
aforementioned mechanisms, the eicosanoid pathway is the most extensively studied, 
not only in vitro but also in vivo, as eicosanoids are key mediators of inflammation and 
regulation of T and B lymphocytes. Arachidonic acid (20:4n-6; ARA) and 
eicosapentaenoic acid (20:5n-3; EPA) are released from membrane phospholipids 
through the action of phospholipases leading to the production of pro- or anti-
inflammatory eicosanoids, respectively. The enzymes of eicosanoid metabolism act on 
both the above LC-PUFA and, although they have preference for ARA, increasing 
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levels of EPA in the membranes of immune cells inhibits the production of pro-
inflammatory eicosanoids (Calder, 2008). Studies have demonstrated that LC-PUFA 
have similar roles in immune modulation in fish.  The aforementioned substitution of 
dietary FO by VO, with the consequent reduction in the ratio of n-3/n-6 LC-PUFA, has 
been reported to promote the synthesis of pro-inflammatory eicosanoids (Bell et al., 
1996), and alter humoral immunity and expression of pro-inflammatory cytokine genes 
(Montero et al., 2010b). Although most of these studies have been performed in vitro 
(Bell et al., 1993; 1995; Gjøen et al., 2007), little is known about the roles of LC-PUFA 
in viral infections. 
In a previous study, the use of functional feeds led to a milder inflammatory 
response and consequently less severity of heart lesions in salmon experimentally 
infected by Atlantic salmon reovirus (ASRV), the causal agent of heart and skeletal 
muscle inflammation (HSMI) (Martinez-Rubio et al., 2012a- Chapter 2). In the present 
study we have employed a similar strategy to investigate the effects of similar 
functional feeds in controlling CMS.  The functional feeds contained dietary lipid 
reduced from 31 % in a reference commercial feed to 18 % in the two functional feeds, 
along with dietary EPA levels increased from 3.6 % to 14 %. Supplementation of 
histidine was also assessed in one of the functional feeds as this amino acid and related 
compounds such as N-α-acetyl-histidine (NAH) have important roles in muscle pH 
buffering (Ogata, 2002; Suzuki et al., 1987) and tissue antioxidant systems (Kim et al., 
1999; Wade et al., 1998). In particular, histidine has been associated with a cardio-
protective role in human studies, being potentially beneficial in the alleviation of 
oxidative stress associated with viral diseases (Hasnain et al., 2003). Thus, we 
hypothesized that dietary supplementation of this amino acid could have a potentially 
beneficial effect in fish suffering CMS. Salmon were fed the functional feeds for         
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8-weeks prior to challenge with PMCV and throughout the 14-weeks post-infection 
period. The incorporation of LC-PUFA into membrane phospholipids of heart, the main 
organ affected by the disease, was assessed. Samples of both heart and liver tissue were 
subjected to histological evaluation. The inflammatory profile in the heart tissue was 
assessed after infection by determining gene expression by oligonucleotide microarray 
analysis.  
5.2 Materials and methods 
5.2.1 Experimental feeds and fish 
     Three fishmeal-based diets were formulated and manufactured by EWOS Innovation 
(Dirdal, Norway) (Table 5.1). The formulations were based on small-scale commercial 
screening trials (unpublished) and a previous study investigating HSMI (Martinez-
Rubio et al., 2012- Chapter 2). The reference diet (REF) was essentially a standard, 
commercial formulation with 31 % lipid with the added oil being a blend of Northern 
hemisphere FO and rapeseed oil. The two functional feeds (CMS1 and CMS2) both 
contained a lower level of lipid (18 %) that was balanced by increased protein, provided 
by fishmeal and krill meal. Therefore, as a major factor differing between the REF and 
functional feeds was dietary lipid level, the feeds were not isolipidic or isoproteic. The 
added oil in the functional feeds was provided by a Southern hemisphere FO. As a 
result the CMS1 and CMS2 feeds had a similar fatty acid profile containing higher 
proportions of EPA (almost 14 %) and an n-3/n-6 PUFA ratio around 4, in comparison 
to the REF feed (< 4 % EPA and an n-3/n-6 ratio of 1.4) (Table 5.2). The only major 
difference between the functional feeds was that CMS1 was supplemented with 
additional histidine.  
A total of 675 Atlantic salmon (Salmo salar L.), SalmonBreed IPN svak strain 
(average weight ca.150 g), were distributed into nine tanks (1 m
3
) at the VESO facility, 
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Vikan, Norway and fed one of the three feeds (3 tanks of 75 fish each per dietary 
treatment; 225 fish in total) for a period of 8 weeks prior to being transferred to the 
challenge tanks. Feeding ration was a maximum of 2 %. Seawater/ brackish water (ca. 
25 ‰-35 ‰) delivery was flow-through, being sufficient to maintain oxygen-satiation 
in effluent water ˃ 70 %. Water temperature was maintained at 12 ± 1 °C, and a 
photoperiod 24:0 h light/dark regime was followed. Stocking density of the tanks was a 
maximum of 60 Kg/m
3
. 
Table 5.1 Formulation (g/Kg) and proximate composition (percentage) of the reference (REF) and 
functional (CMS1 and CMS2) feeds 
Component
1
 REF CMS1 CMS2 
Fish meal and hydrolysates 421.0 530.0 530.0 
Plant protein concentrates
2
 215.0 180.0 180.0 
Northern fish oil 130.0 0.0 0.0 
Southern fish oil 0.0 100.0 100.0 
Rapeseed oil 107.0 0.0 0.0 
Carbohydrate-based binders
3
 119.0 119.0 121.0 
Micro premixes
4
 8.0 17.0 19.0 
Krill meal
5
 0.0 50.0 50.0 
Histidine (synthetic) 0.0 4.0 0.0 
Proximate composition    
Moisture 6.5 6.5 6.5 
Fat 31.0 18.0 18.0 
Protein 42.2 53.4 53.4 
    
1) All ingredients sourced from EWOS stocks unless 
otherwise stated. 
2) Includes soy protein concentrate, pea protein 
concentrate, wheat gluten and sunflower meal 
3) Includes wheat grain 
4) Includes vitamins, minerals, crystalline amino acids, 
ammonium phosphate 
5) Aker Biomarine AS 
 
 
164 
 
 
Table 5.2 Fatty acid compositions (percentage of total fatty acids) of the reference (REF) and functional 
(CMS1 and CMS2) feeds. 
Fatty acid REF CMS1 CMS2 
Saturated 16.5 26.6 25.8 
Mounsaturated 59.1 36.4 36.1 
18:2n-6 8.8 4.9 5.6 
20:3n-6 0.2 0.3 0.3 
20:4n-6 0.2 0.6 0.7 
n-6 PUFA 9.8 6.9 7.2 
18:3n-3 3.3 1.3 1.3 
20:5n-3 3.7 13.7 13.4 
22:6n-3 5.0 8.4 8.4 
n-3 PUFA 13.9 27.5 27.8 
PUFA 24.3 37.0 38.1 
n-3/n-6  1.4 4.0 3.9 
EPA/ARA 19.4 21.4 20.2 
 
5.2.2 PMCV Challenge 
        After the pre-feeding period, the fish (non-vaccinated and HSMI-free) were 
transferred to challenge tanks (1 m
3
) with the same rearing conditions described above. 
Of the available salmon, a total of 576 fish, pre-challenge average weight 339 ± 13g for 
the fish fed with the REF diet; 335 ± 13g for the fish fed with the CMS1 diet and 
362±14g for the fish fed with the CMS2 diet; were distributed into 12 tanks (4 tanks per 
dietary treatment with 48 fish/tank). The fish were acclimated for 2 weeks prior to 
challenge and were fed with the same diets during the acclimation period and 
throughout the period of the challenge (14 weeks) that they were fed prior to transfer. 
No previous diseases were described.  
For challenge, the fish were sedated using Aqui-S at final concentration of 5 mg/L of 
isoeugenol, followed by anaesthesia in benzocaine (20 %, Benzoak
®
) using a final 
concentration of 30 ml/L. Two fish from each pre-challenge tank, 18 in total (n = 6 per 
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dietary treatment) were collected prior to challenge (0 time-point) and then 576 fish (as 
described above) were challenged by intramuscular injection of 0.1 ml PMCV inoculum 
on each side of the fish in the lateral muscle tissue beneath the dorsal fin (total, 0.2 ml 
per fish).  
Production of the PMCV inoculum has been described previously (Haugland et al., 
2011). Briefly, the virus was originally isolated from heart tissue homogenate collected 
from a clinical outbreak of CMS and filtered through a 0.22-μm filter. Challenge of 
Atlantic salmon was performed using supernatant of GF-1 cell culture in which the 
virus was inoculated. 
 
5.2.3 Sampling  
     Ten fish from each tank (total of 40 per dietary treatment) were sampled at 6-, 8-, 
10-, 12- and 14-weeks post-challenge.  Fish were anaesthetized as above and killed by a 
blow to the head and heart tissue collected for analyses. Liver tissue and a portion of 
each heart were transferred to 10% buffered formalin for histological analyses. Of the 
remaining portions of heart tissue, half were immediately transferred to RNAlater
®
 
(following manufacturers protocol) and stored at -20
 o
C prior to molecular analyses (i.e. 
5 samples of heart tissue per tank, 20 per dietary treatment). The remaining samples of 
heart tissue were frozen in liquid N2 and stored at -80 
o
C prior to lipid analyses (five per 
tank, 20 per treatment).  
5.2.4 Growth performance 
Growth performance of fish fed the three feeds was assessed using repeated 
measurements of tank mean weights. Tank mean weights were determined at the start of 
the trial (day 0), challenge-day (day 92) and then at 6-, 8-, 10-, 12- and 14-weeks post-
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challenge. A linear mixed-effects model (multilevel model) was fitted between the 
response (weight) and predictor (diet) by allowing the intercepts and slopes of the time 
variable (day) to vary from tank to tank to account for the tank level correlations and 
variability in growth trajectories. The model was estimated with the lmer function in the 
lme4 package of the R language (R Development Core Team, 2008). All treatment 
effects were based on posterior simulation (n = 2,500) with 95 % credible intervals. 
Ninety-five percent credible intervals were interpreted as statistical significant at p = 
0.05 % level when the interval did not overlap the reference value in question. 
 
5.2.5 Histological examinations 
The histological changes in heart were assessed as described in detail previously 
(Haugland et al., 2010). In brief, the inflammatory changes were evaluated separately 
for atrium and ventricle, and to the extent present, inflammatory scores of the 
epicardium were also recorded. Histological samples were collected to include atrium 
and ventricle in the same sample. Bulbus arteriosus was also included but was not 
assessed for histopathological changes. Samples were fixed in 10 % buffered formalin, 
embedded in paraffin wax and sectioned at 3 - 4 micron and stained with hematoxylin 
and eosin according to standard methods. All sections were evaluated randomly and 
without knowledge to which feeding group they belonged (double-blind).  
Micrographs showing examples of the correspondence between different levels of heart 
lesions and histoscores assigned are shown in Figure 5.1 
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Figure 5.1 Micrographs showing different levels of pathology on the heart tissue. A, Atrium, infiltration of inflammatory cells (indicated), focal reaction (score 1); B, 
Ventricle, focal to multifocal infiltration of inflammatory cells (indicated) (score 1); C, diffuse infiltration of inflammatory cells and degeneration/necrosis (score 3)
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Liver steatosis scores were ranked according to a non-continuous score grade from 0 to 
5 (Table 5.3). Briefly, a score of 0 indicated the formation of vacuoles in the cytoplasm, 
involving less than 10 % of the hepatocytes and including less than 25 % of the area of 
the individual hepatocytes. A score of 5 indicated formation of vacuoles in the 
cytoplasm, involving more than 90 % of the hepatocytes and including more than 80 % 
of the area of the individual hepatocytes. The initial "continuous" scores were converted 
to a fewer number of discrete scores (3 - 6 classes depending on the response). Scores 
were an ordinal response and a multilevel ordinal regression was used to analyse the 
effects of feeds on the scores. This was achieved with the ordinal package Sweave le 
processed by LATEX of the R language (http://www.R-project.org) Each of the scores 
was used as the response variable in separate analyses that had feed type (REF, CMS1, 
CMS2) as the fixed effect term. Since multiple fish were examined from each replicate 
tank, a random effect of tank was added to the models. 
 
Table 5.3 Scoring system for liver steatosis in individual sections. 
0 formation of vacuoles in the cytoplasm, involving less than 10% of the hepatocytes and 
including less than 25% of the area of the individual hepatocytes 
1 formation of vacuoles in the cytoplasm, involving less than 25% of the hepatocytes and 
including less than 25% of the area of the individual hepatocytes 
2 formation of vacuoles in the cytoplasm, involving less than 50% of the hepatocytes and 
including less than 50% of the area of the individual hepatocytes 
3 formation of vacuoles in the cytoplasm, involving less than 75% of the hepatocytes and 
including less than 75% of the area of the individual hepatocytes 
4 formation of vacuoles in the cytoplasm, involving less than 90% of the hepatocytes and 
including less than 80% of the area of the individual hepatocytes 
5 formation of vacuoles in the cytoplasm, involving more than 90% of the hepatocytes 
and including more than 80% of the area of the individual hepatocytes 
 
5.2.6 Lipid analyses 
Lipid and fatty acid analyses were performed on the feeds and heart samples from all 
of the sampling points. Three pre-challenge heart samples per dietary treatment were 
randomly chosen for lipid analysis. Heart tissue samples from the post-challenge were 
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pooled per tank so that heart tissue of five fish became a pool resulting in 4 
pools/treatment/sampling point. Total lipid from each pool was extracted by 
homogenisation in chloroform/methanol (2:1, by volume) according to Folch et al. 
(1957), and lipid content determined gravimetrically. Total lipid extracts were re-
suspended in chloroform/methanol (2:1, v/v) + 0.1 % butylated hydroxytoluent (BHT), 
at a concentration of 10 mg lipid/ml and stored at -70
 o
C until analysed. 
Phospholipid (PL) fractions were prepared from 0.5 mg of total lipid by thin-layer 
chromatography. Samples were applied to a 20 x 20 cm silica gel 60 TLC plate (VWR, 
Lutterworth, Leics, UK), and developed in isohexane/diethyl ether/glacial acetic acid 
(80:20:1, by vol.). The plate was sprayed lightly with 2, 7, dichloroﬂuorescein (0.1 %, 
w/v) in 97 % methanol (v/v) and the PL band on the origin scraped from the plate. Fatty 
acid methyl esters (FAME) were prepared by acid-catalysed transesteriﬁcation directly 
on the silica by incubating in 2 ml of 1 % H2SO4 in methanol at 50
 o
C overnight 
(Christie, 2003). The samples were neutralised with 2.5 ml of 2 % KHCO3 and 
extracted twice with 5 ml isohexane/diethyl ether (1:1, v/v) + BHT and the combined 
extracts dried under a stream of oxygen-free nitrogen and resuspended in 0.3 ml 
isohexane prior to fatty acid analysis. 
FAME were separated and quantiﬁed by GLC (Fisons 8160; Carlo Erba, Milan, 
Italy) using a 60 m x 0.32 mm x 0.25 µm ﬁlm thickness capillary column (ZB-WAX; 
Phenomenex, Macclesﬁeld, Cheshire, UK). Hydrogen was used as the carrier gas at a 
ﬂow rate of 4.0 ml/min and the temperature programme was from 50 to 150 oC at 
40
o
C/min then to 195
 o
C at 2
 o
C /min and ﬁnally to 215 oC at 0.5 oC /min. Individual 
FAME were identiﬁed by comparison with well-characterised in-house standards as 
well as commercial FAME mixtures (Supelco ™ FAME mix; Sigma-Aldrich Ltd, 
Gillingham, Dorset, UK). 
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 Tissue and diet lipid class compositions were determined by single-dimension 
double-development high-performance thin-layer chromatography (HPTLC) and 
densitometry as described previously (Bell et al., 1993). Significance of differences due 
to diet and time were determined by two-way ANOVA (p<0.05) using the SPSS 19.0 
statistical package (SPSS Inc., Chicago IL, USA). 
5.2.7 Microarray experimental design 
Heart tissue, as the main organ affected during a CMS outbreak, was selected for 
transcriptomic analysis.  The choice of appropriate time-points for analysis was based 
on the description of expression of genes of the immune response after a PMCV 
infection described by Timmerhaus et al. (2011). Thus samples from fish at pre-
challenge, 6-, 8-, and 14- weeks post-challenge/infection (wpc) were analysed. The pre-
challenge sampling point was selected to evaluate the changes due to the composition 
of the diets, and 6- and 8-wpc sampling points were selected to specifically evaluate 
dietary effects on the peak of expression of the genes from various pathways of the 
immune response. As a plateau phase in the expression of the immune related genes at 
10- and 12-wpc had been described previously (Timmerhaus et al., 2011), the 14-wpc 
sampling point was selected to evaluate gene expression changes in the possible 
recovery phase of the disease. Within each of these sampling points, the available 
samples were arranged by individual histoscore and 6 samples per dietary group were 
randomly selected from the interquartile range (25 – 75 %). 
5.2.8 RNA extraction and purification 
Heart tissue of the selected samples was homogenized in TRI Reagent (Ambion, 
Applied Biosystems, Warrington, U.K.) using an Ultra-Turrax homogeniser (Fisher 
Scientific, Loughborough, U.K.). Total RNA was isolated following manufacturer’s 
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instructions, and RNA quality and quantity assessed by gel electrophoresis and 
spectrophotometry (NanoDrop ND-1000, Thermo Scientific, Wilmington, U.S.A.), 
respectively.  
5.2.9 Microarray hybridisations and analysis 
    The transcriptomic experiment used an Atlantic salmon custom-made oligoarray with 
44k features per array on a four-array-per-slide format, with each feature printed singly 
(Agilent Technologies UK Ltd., Wokingham, UK). The probes were co-designed by 
researchers at the Institute of Aquaculture, University of Stirling, U.K. and The 
Norwegian Institute of Food, Fisheries and Aquaculture Research (Nofima, Tromsø, 
Norway), and array design is available on request. A dual-labelled experimental design 
was employed for the microarray hybridisations. Each experimental sample was 
competitively hybridised against a common pooled-reference sample, which comprised 
equal amounts of each of the replicates used in the study. This design permits valid 
statistical comparisons across all treatments to be made. The entire experiment 
comprised 72 hybridisations; 4 time-points (pre-challenge, 6-, 8- and 14-wpc) × 3 diets 
(REF, CMS1 and CMS2) × 6 biological replicates. 
Indirect labelling methodology was employed in preparing the microarray targets.  
Amplified antisense RNA (aRNA) was produced from each RNA sample using the 
TargetAmp™ 1-RoundAminoallyl-aRNA Amplification Kit (Ambion, Applied 
Biosystems, Warrington, UK), following the manufacturer’s methodology, followed by 
Cy3 or Cy5 fluor incorporation through a dye-coupling reaction. Briefly, 250 ng of total 
RNA per sample were amplified and column-purified according to manufacturer’s 
instructions. Resultant aRNA was quantified and quality assessed as above. 
Subsequently, Cy dye suspensions (Cy3 & Cy5) in sufficient quantity for all labelling 
reactions were prepared by adding 38 µL high purity dimethyl sulphoxide (Stratagene, 
172 
 
Agilent Technologies UK Ltd.) to each tube of Cy dye (PA23001 or PA25001, GE 
Healthcare, Chalfont St. Giles, UK). To attach the Cy dyes, 3 µg each aRNA sample 
was suspended in 10 µL nuclease-free H2O and heated to 70 ºC for 2 min. When cooled 
to room temperature, 3 µL of coupling buffer (0.5 M NaHCO3; pH 9.2) and 2 µL of 
Cy3 dye suspension stock was added and then incubated for 1 h at 25 ºC in the dark.  
To label the common pooled reference sample with Cy5, a scaled-up batch reaction was 
similarly performed. Unincorporated dye was removed by column purification (Illustra 
AutoSeq G-50 spin columns; GE Healthcare). Dye incorporation and aRNA yield were 
quantified by spectrophotometry (NanoDrop) and further quality controlled by 
separating 0.4 μL of the sample on a thin mini-agarose gel and visualising products on a 
fluorescence scanner (Typhoon Trio, GE Healthcare). 
Hybridisation of a total of 6 slides (24 arrays) was performed in a single day, with 
sample order semi-randomised, using SureHyb hybridisation chambers in a DNA 
Microarray Hybridisation Oven (Agilent Technologies). For each hybridisation, 825 ng 
of Cy3-labelled experimental biological replicate and Cy5-labelled reference pool of all 
the samples were combined and total volume made up to 35 μl with nuclease-free 
water. A fragmentation master mix was prepared containing, per reaction, 11 μl 10× 
blocking agent, 2.2 μl 25× fragmentation buffer and 6.8 μl nuclease-free water, and 20 
μl was dispensed into the Cy-dyes mix. After incubating in the dark at 60 ºC for 30 min, 
57 μl 2×GE Hybridisation buffer (pre-heated to 37 ºC) was added, contents gently 
mixed, spun at 16,000 g for 1 min and kept on ice until loaded onto the microarray 
slides as per the manufacturers protocol. Hybridisation was carried out in the oven 
rotator (Agilent Technologies) at 65 ºC and 10 rpm for 17 h. Post-hybridisation washes 
were carried out in EasyDip
TM
 Slide staining containers (Canemco Inc., Quebec, 
Canada). After disassembling the array-gasket sandwiches were submerged in wash 
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buffer 1 at room temperature, the microarray slides were transferred to an EasyDip
TM
 
container and incubated in wash buffer 1 for 1 min at 31 ºC in an orbital incubator 
rotating at 150 rpm, and then a further 1 min at 31 ºC at 150 rpm in wash buffer 2. A 
final dip in wash buffer 2 at room temperature was performed, after which the slides 
were dried by centrifugation (500 x g for 6 min) and kept in a desiccator in the dark 
until scanned the same day. Unless otherwise stated, all reagents were from Agilent 
Technologies. 
Scanning was performed at 5 μm resolution using an Axon GenePix 4200AL 
Scanner (MDS Analytical Technologies, Wokingham, Berkshire, U.K.). Laser power 
was kept constant (80 %) and the “auto PMT” function within the acquisition software 
(v.4) was enabled to adjust PMT for each channel such that less than 0.1 % of features 
were saturated and that the mean intensity ratio of the Cy3 and Cy5 signals was close to 
one. Agilent Feature Extraction Software (v 9.5) was used to identify features and 
extract fluorescence intensity values from the resultant TIF images. The remaining 
analysis was then performed in the GeneSpring GX version 12 analysis platform 
(Agilent Technologies). After removing control features and filtration of low quality 
spots (saturated, non-uniform, population out layers and spots non-significantly 
different from background), lowess normalisation of log2-expression ratios (ER) was 
performed.  
As the primary objective of the present study was to evaluate the effects of 
functional feeding (i.e. comparison between diets), differentially expressed genes were 
selected based on expression changes between the functional feed groups (CMS1 and 
CMS2) and the fish fed the REF diet, or between the two functional feed groups at each 
sampling point (PreCh-, 6-, 8- and 14-wpc) (cutoff log2-ER = 0.8 (1.75-fold change),   
p < 0.05, one-way ANOVA. Annotation of selected genes was performed using STARS 
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software developed at the Norwegian Institute of Food, Fisheries and Aquaculture 
Research (Nofima, Tromsø, Norway) (Krasnov et al., 2011b), KEGG analysis, and 
information from literature and public databases. Selected genes from each of the one-
way ANOVA lists were submitted to Gene Expression Omnibus (Liu et al., 2007) for 
enrichment analysis. The numbers of features corresponding to GO functional classes 
and KEGG pathways were compared in the lists of differentially expressed genes and 
whole microarray. Enrichment was assessed with Yates' corrected chi-square test 
(p<0.05). 
5.3 Results 
5.3.1 Growth  
There were no significant differences overall between diets at the end of the trial (i.e. 
after 192 days) (Figure 5.2). However, separate statistical analysis at the beginning and 
the end of the trial showed a statistical different between the dietary groups before 
challenge. After 92 days of feeding (pre-challenge) fish fed diet CMS2 grew 
significantly better than those fed REF diet and CMS1.  
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Figure 5.2 Growth performances over the course of the entire trial, before and after the viral challenge. Error bars denote approximate 95 % confidence 
limits.
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5.3.2 Lipid and fatty acid composition of heart tissue 
Total lipid content of heart tissue was similar irrespective of dietary treatment and did 
not show any significant changes over the course of infection (Table 5.4). 
Table 5.4. Lipid contents (percentage of wet weight) of heart tissue of salmon fed the reference (REF) 
and functional (CMS1 and CMS2) feeds immediately prior to challenge with PMCV (PreCh) and at 
different weeks post-challenge (wpc). 
  REF CMS1 CMS 2 
PreCh 2.8 ± 0.2 3.5 ± 0.1 3.6 ± 0.2 
6-wpc 3.3 ± 0.2 3.3 ± 0.2 3.5 ± 0.2 
8-wpc 3.8 ± 0.4 3.3 ± 0.2 3.6 ± 0.6 
10-wpc 3.8 ± 0.3 3.6 ± 0.2 3.6 ± 0.3 
12-wpc 3.8 ± 0.2 3.6 ± 0.1 3.5 ± 0.1 
14-wpc 3.8 ± 0.3 3.4 ± 0.5 3.5 ± 0.4 
There were no significant differences between time-points. 
 Levels of total phospholipids (PL) and the major PL classes, phosphatidylcholine 
(PC) and phosphatidylethanolamine (PE), were significantly higher in heart tissue in 
fish fed the functional feeds (Figure 5.3) compared with heart tissue of fish fed the REF 
diet (2-way ANOVA p-value diet, < 0.05).  This was probably a consequence of the 
levels of triacylglycerols (TAG) being significantly higher in the REF group, with these 
differences being more obvious at the end of the initial feeding phase prior to infection 
with PMCV. After PMCV infection, PL levels generally decreased over the course of 
the infection with this effect being significant for phosphatidylinositol (PI) and 
phosphatidylserine (PS).  
The fatty acid compositions of total PL of heart tissue of fish fed the functional feeds 
were characterised by lower proportions of monoenes and n-6 PUFA, and higher 
proportions of saturated fatty acids, n-3 PUFA, LC-PUFA (ARA, EPA and DHA), and 
EPA/ARA ratio (Figure 5.4). The two functional feeds presented similar levels in the 
relative proportions of the important LC-PUFA, ARA, EPA and DHA. Thus, heart 
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tissue phospholipids showed proportions of the LC-PUFA relevant to eicosanoid 
pathways, and that could therefore potentially influence the immune response (Calder 
2009b), that reflected the composition of the diets. The proportions of EPA, ARA and 
the EPA/ARA ratio were significantly higher in fish fed the functional feeds compared 
to fish fed the REF diet (P value diet, <0.05). However, levels of DHA were similar 
between the different dietary groups, which is consistent with our previous study using 
similar feeds in which levels of DHA were more conserved despite differences in the 
composition of the diets (Martinez-Rubio et al., 2012b (Chapter 3). 
Changes in the proportions of the immune and inflammation-related LC-PUFA in 
heart total PL during the time course of the infection were similar between the three 
different groups (Figure 5.4). The changes in ARA post-infection were not significant, 
but the proportions of EPA and DHA were significantly higher at 6-wpc compared with 
pre-challenge.  After 6-wpc, levels of DHA progressively decreased during the time-
course of the infection but proportions of EPA were significantly higher at 10-wpc. As 
a consequence of the latter, and the changes in ARA levels, the EPA/ARA ratio in heart 
total PL was also higher in all dietary treatments at 10-wpc. There were no differences 
in the EPA/ARA ratio in heart PL between fish fed the different diets in the later stages 
of the infection. 
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Figure 5.3 Proportions of lipid classes in total lipid of heart tissue from fish fed the reference (REF) and 
functional (CMS1 and CMS2) feeds at different times before (PreCh) and after (6, 8, 10, 12 and 14 
weeks) infection with PMCV. PC, phosphatidycholine; PE, phosphatidylethanolamine; PI, 
phosphatidylinositol; PS, phosphatidylserine; TAG, triacylglycerol. Letters are showing significant 
differences during the time-course of the infection, using the p-value time of the 2-way ANOVA. P-
value diet was showing  significant differences in PC, PE, TPL and TAG. 
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Figure 5.4 Fatty acid compositions (percentage of total fatty acids) of total phospholipids of heart tissue 
from fish fed the reference (REF) and functional (CMS1 and CMS2) feeds at different times before 
(PreCh) and after (6, 8, 10, 12 and 14 weeks) infection with PMCV. ARA, arachidonic acid; DHA, 
docosahexaenoic acid (DHA); EPA, eicosapentaenoic acid; PUFA, polyunsaturated fatty acid. Letters are 
showing significant differences during the time-course of the infection, using the p-value time of the 2-
way ANOVA.P-value diet is showing significant differences between the three treatments  in EPA, ARA 
and EPA/ARA. 
180 
 
5.3.3 Heart and liver tissue histopathology 
Histological changes were first observed in the atrium at 6-wpc (Figure 5.5), 
characterised by focal infiltration of inflammatory cells dominated by lymphocytes. A 
degenerative process associated with the inflammatory changes was also observed in 
cardiomyocytes of the atrium. By 8-wpc the sum of the average scores for atrium and 
ventricle had increased to 4.1 in fish fed the REF diet, and 3.5 for fish fed both 
functional feeds. The most marked increase in histopathological changes (from 6- to 8-
wpc) was found in the ventricle with a 5.6-fold increase in the REF group, and 5.1- and 
9.1-fold for the CMS1 and CMS2 dietary groups, respectively. These changes were 
typified by multifocal infiltration of inflammatory cells, dominated by lymphocytes and 
macrophages, and concomitant degeneration and necrosis of myocytes. Another typical 
finding was hyperplasia of endothelial cells in inflamed areas. Inflammatory changes 
were greatest in the atrium from 6- to 8-wpc and significantly (p < 0.01) higher for all 
groups at both time points. Both groups of fish fed with the functional diets showed 
significantly lower histoscores in the atrium (Figure 5.6) at both 6- and 8-wpc. Lesions 
in the ventricle were also significantly lower for the group of fish fed with the 
functional feeds.  By 10-wpc, the inflammatory changes and myocyte necrosis had 
levelled off in all groups, and was not different from 8-wpc. At 12- and 14-wpc there 
was a moderate decline in inflammatory scores (Figure 5.5). There were no differences 
between dietary groups at 10- and 12-wpc in both parts of the heart. At the end of the 
trial, 14-wpc, lesions in the atrium were not significantly different between groups, 
although fish fed with the CMS2 have lower histoscores compare with the other groups. 
In ventricle, fish fed both functional feeds showed lower histoscores although they were 
not significant (Figure 5.6). 
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Figure 5.5 Average histoscores (± SEM) of atrium and ventricle in the different dietary treatment groups 
at 6-, 8-, 10-, 12- and 14-weeks post-challenge 
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Figure 5.6 Statistical analysis of the atrium and ventriculum histoscores. Estimated effects of CMS1 and 
CMS2 diets in comparison to the REF diet by sampling weeks. Negative estimates mean there are 
lower scores and positive that there are higher scores than for the REF dietary group. Error bars 
denote approximate 95 % confidence limits. 
 
The liver histology scores, based on the degree of steatosis were read as vacuole-
formation in hepatocyte cytoplasm characterised by both micro- and macro-vesicular 
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lesions. There were clear differences between the fish fed the functional feeds and fish 
fed the REF diet over all the samplings points post-challenge, with the latter group 
presenting higher micro- and macro-vesicular steatosis. Severity of the liver 
histopathology (based on the scoring system in Table 5.3) was significantly higher at 
the beginning of the infection and greater at the end of the challenge (12- and 14-wpc) 
in salmon fed the REF diet compared to fish fed the two functional feeds (Figure 5.7).  
 
 
 
 
 
 
 
 
Figure 5.7 Statistical analysis of liver histoscores. Estimated effect of CMS1 and CMS2 diets in 
comparison to the REF diet by sampling weeks. Negative estimates means there are lower scores and 
positive that there are higher scores than for the REF dietary group. Error bars denote approximate 95 
% confidence limits. 
 
5.3.4 Gene expression (microarray analysis) 
5.3.4.1 Pre-challenge.  
Immediately prior to challenge, fish were sampled to specifically evaluate the 
differences in gene expression in heart tissue between fish fed the three dietary 
treatments. The genes showing significant and relevant differential expression between 
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the three dietary groups (criteria described above) was the largest list in this study 
highlighting the great influence of diet on metabolic pathways including the 
immune/inflammatory response (Supplementary Table 5.1). The enrichment analysis 
list at this point showed the relevance of the innate immune response and especially the 
MHC class I pathway with genes related to both pathways being significantly 
represented (p-value < 0.001) (Table 5.5). The list, with annotations from Kegg 
analysis, STARS software, and literature references, shows that there was a general 
lower expression of most of the genes related with the innate immune response, MHC 
class I response, B-cell and T-cell immune response and apoptosis in fish consuming 
the functional feeds compared with fish fed the REF diet (Table 5.6). This list also 
shows there was higher expression of genes involved in transcription, translation and 
nucleotide metabolism in fish fed the functional feeds compared with fish fed the REF 
diet, possibly indicating increased protein turnover and metabolism in those groups. Of 
the genes related to lipid metabolism (Table 5.7), some genes involved in membrane 
transport showed increased expression in fish fed the functional feeds, especially 
CMS2, compared with the REF fish, but genes associated with most other lipid 
metabolic processes generally showed lower expression in fish fed the functional feeds. 
Genes related with fatty acid biosynthesis such as delta-6 fatty acyl desaturase and fatty 
acyl-CoA hydrolase precursor were differently expressed between all three dietary 
groups, with higher expression in fish fed the CMS1 diet and lower expression in fish 
fed the CMS2 diet, compared to fish fed the REF diet. 
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Table 5.5 Enrichment analysis. 
Prechallenge       
GO Biological process Category % Count % Count Yates corrected 
  in Selection in Total  Chi-square 
ErbB signaling pathway 1.73 0.72 0.0287 
focal adhesion 1.51 0.58 0.0241 
innate immune response 1.94 0.51 0.0002 
Leukocyte transendothelial migration 2.38 1.06 0.0147 
MHC class I protein complex 0.86 0.15 0.0017 
steroid hormone receptor activity 1.30 0.43 0.0159 
6-weeks post challenge       
GO Biological process Category % Count % Count Yates corrected 
  in Selection in Total  Chi-square 
basement membrane 1.45 0.32 0.0005 
cell-cell adhesion 1.69 0.57 0.0094 
ECM-receptor interaction 1.93 0.87 0.0477 
extracellular space 3.86 2.19 0.0403 
Focal adhesion 4.10 2.14 0.0142 
immune response 6.02 1.57 0 
protein serine/threonine kinase activity 4.82 2.90 0.0387 
regulation of Rab GTPase activity 2.41 0.68 0.0002 
8-weeks post challenge       
GO Biological process Category % Count % Count Yates corrected 
  in Selection in Total  Chi-square 
Cytokine-cytokine receptor interaction 1.80 0.56 0.0102 
Hematopoietic cell lineage 2.40 0.45 0 
protein serine/threonine kinase activity 5.69 2.90 0.0067 
Rab GTPase activator activity 3.29 0.70 0 
regulation of Rab GTPase activity 3.29 0.68 0 
structural constituent of cytoskeleton 2.10 0.61 0.0028 
T cell receptor signaling pathway 2.10 0.91 0.0547 
14-weeks post challenge       
GO Biological process Category % Count % Count Yates corrected 
  in Selection in Total  Chi-square 
B cell receptor signaling pathway 2.18 0.69 0.0244 
ErbB signaling pathway 2.62 0.72 0.0039 
Insulin signaling pathway 3.49 1.16 0.0042 
Jak-STAT signaling pathway 2.18 0.57 0.0066 
lipid metabolic process 2.18 0.66 0.0191 
Natural killer cell mediated cytotoxicity 2.18 0.58 0.0079 
Phosphatidylinositol signaling system 2.18 0.61 0.0114 
Purine metabolism 3.06 1.24 0.0361 
Regulation of actin cytoskeleton 3.93 1.79 0.0349 
regulation of Rab GTPase activity 2.18 0.68 0.0225 
regulation of Rho protein signal transduction 3.49 0.99 0.0008 
T cell receptor signaling pathway 3.06 0.91 0.0032 
ubiquitin-dependent protein catabolic proc. 2.62 0.96 0.03 
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Table 5.6 Gene expression pre-challenge. Immune-related genes selected by significance (one-way 
ANOVA) and expression differences between the functional feeds (CMS1 and CMS2) and reference diet 
(REF) or between CMS dietary groups. At cut-off log2-ER = 0.8 (1.75-fold). Red/orange colour intensity 
was used to indicate higher expression and green/blue colour intensity was used to indicate lower 
expression. 
BlastxHit ProbeName 
CMS1-
REF 
CMS2-
REF 
CMS1-
CMS2 
Antiviral and IFN response      
sacsin  Ssa#KSS1716 -1.90 -0.86 -1.04 
interferon induced with helicase C domain 1 Ssa#S48413574 -1.67 -1.14 -0.52 
Signal transducer and activator of transcription 3 Ssa#S32012561 -1.43 -2.07 0.64 
similar to mKIAA2005 protein  Ssa#S30296047 -1.42 -1.25 -0.17 
fish virus induced TRIM protein  Ssa#KSS4382 -1.38 -0.95 -0.43 
VHSV-inducible protein-4 Ssa#KSS4396 -1.24 -1.37 0.12 
VHSV-induced protein  Ssa#KSS1846 -1.22 -1.28 0.07 
interferon, gamma Ssa#S22497299 -1.08 -1.46 0.39 
Ubiquitin-like protein-1 Ssa#S35549782 -0.94 -0.92 -0.03 
retinoic acid-inducible gene-I  Ssa#DY714827 -0.90 -0.81 -0.09 
Gig1-2 Ssa#S30282627 -0.88 -0.99 0.11 
Interferon-induced protein 44  Ssa#S31978702 -0.87 -0.70 -0.18 
Gig1-1 Ssa#KSS1939 -0.83 -1.24 0.41 
Poly polymerase 12  Ssa#KSS366 -0.82 0.56 -1.38 
Interferon-induced protein 44-1 Ssa#S30269828 -0.80 -0.78 -0.02 
fish virus induced TRIM protein  Ssa#CL81Contig1 -0.80 -0.65 -0.15 
interferon regulatory factor 7  Ssa#KSS4495 1.74 2.15 -0.41 
Interferon regulatory factor 4  Omy#S18532156 1.49 1.40 0.09 
Interferon-induced protein with tetratricopeptide repeats 5-1 Ssa#S31971912 -0.66 -1.93 1.27 
Receptor-transporting protein 3  Ssa#KSSb2765 -0.55 -1.35 0.80 
interferon-gamma receptor 1  Ssa#KSS450 0.07 -1.08 1.15 
sacsin  Ssa#S35671378 -0.39 -0.96 0.58 
fish virus induced TRIM protein  Omy#S22915797 -0.64 -0.80 0.17 
VHSV-induced protein-10  Ssa#S35559165 -0.55 -0.64 0.09 
Interferon-induced protein 44  Ssa#EG868694 -0.74 -0.74 -0.01 
interferon regulatory factor 1  Ssa#S41489472 -0.64 -0.54 -0.10 
Tripartite motif containing TRIM 25 Ssa#DY701534 -0.77 -0.39 -0.38 
GTPase IMAP family member 7  Ssa#S35509469 0.91 0.41 0.50 
Tripartite motif-containing protein 25 Ssa#S32009123 -1.17 -0.38 -0.80 
52 kDa Ro protein Omy#S15242638 0.82 1.63 -0.81 
Toll-interacting protein Ssa#S35591296 -0.69 -1.24 0.55 
Apoptopsis     
Rho guanine exchange factor 16  Omy#S15320242 0.89 0.19 0.70 
programmed cell death 2-like  Ssa#CK879149 -2.10 -1.90 -0.20 
death associated transcription factor 1-like Omy#CA384493 -1.13 -1.04 -0.09 
caspase 7  Ssa#STIR00029 0.84 1.61 -0.77 
membrane metallo-endopeptidase  Ssa#S30275401 -2.87 -1.15 -1.72 
meprin A, beta  Ssa#CK884807 -1.63 -2.60 0.97 
endopeptidase Clp precursor Ssa#S30295980 -1.39 -1.31 -0.08 
matrix metalloproteinase  Ssa#S25807320 -1.13 -0.10 -1.02 
placental protein 11 precursor  Ssa#EG935968 -0.72 -1.01 0.30 
SUMO-activating enzyme subunit 1  Ssa#TC81961 -1.63 -0.66 -0.97 
E3 ubiquitin-protein ligase Hakai  Omy#S15282203 0.54 1.59 -1.05 
ubiquitin specific protease 32  Ssa#S18861997 -1.45 -0.45 -1.01 
E3 ubiquitin-protein ligase NRDP1  Ssa#S30262289 -0.83 -0.48 -0.35 
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Table 5.6 (continued 1) 
BlastxHit ProbeName 
CMS1-
REF 
CMS2-
REF 
CMS1-
CMS2 
B-cell     
Lymphocyte antigen 75 precursor Ssa#S48406409 1.48 1.46 0.02 
AF361437_1 interleukin 13 receptor alpha-2  Omy#EXOB3_B11 0.62 0.02 0.60 
Hematopoietic lineage cell-specific protein Ssa#KSS4990 0.22 1.80 -1.58 
Immunoglobulin light chain variable region  Ssa#S35665005 -0.94 -1.33 0.39 
IG LC Ssa#S18892313 -0.47 -1.39 0.92 
Immunoglobulin mu heavy chain Ssa#S18836426 -0.57 -1.02 0.44 
Ig kappa chain V-IV region B17 precursor Ssa#DW471462 -0.38 -0.97 0.59 
AF273017_1 immunoglobulin light chain precursor  Ssa#S18892310 -0.29 -0.83 0.54 
IG HC variable region Ssa#S18892407 -0.63 -0.77 0.14 
Complement     
complement factor H1 protein  Omy#CT568091 1.33 0.04 1.29 
Eicosanoids     
cytochrome P450, family 2, subfamily J, polypeptide 25 Ssa#S31983866 1.11 -0.17 1.28 
cytosolic phospholipase A2, group IVA  Omy#S34423720 0.90 0.37 0.53 
Innate immune response     
CD83 antigen precursor  Ssa#KSS3110 -0.55 -0.25 -0.30 
Signaling intermediate in Toll pathway  Ssa#S31970854 -0.81 -0.97 0.17 
macrophage colony-stimulating factor receptor  Ssa#S31986130 0.66 0.07 0.59 
TNF- receptor superfamily, member 19 isoform 2 prec Ssa#S30280758 -0.81 -1.34 0.53 
Ras-related and estrogen-regulated growth inhibitor  Ssa#DW542009 -0.82 -1.05 0.24 
A-kinase anchor protein 10 precursor  Ssa#S48405355 -0.63 -1.70 1.07 
kelch-like 26  Ssa#TC89603 -1.59 -1.11 -0.49 
Suppressor of G2 allele of SKP1 homolog  Ssa#S35582811 -1.01 -1.10 0.09 
Integrin, beta-like 1 (with EGF-like repeat domains) Ssa#S30292184 -0.89 -1.40 0.51 
integrin alpha 4 precursor  Ssa#CA049694 -0.74 -1.54 0.80 
neutrophil cytosolic factor 2  Ssa#S35600971 0.90 0.08 0.81 
neutrophil cytosolic factor 2 Ssa#KSS461 -0.65 -1.60 0.95 
G protein-coupled receptor 137C  Ssa#DY708003 -1.14 -0.73 -0.41 
similar to TGF-beta type II receptor  Ssa#S22709188 -1.94 -1.53 -0.41 
mitogen-activated protein kinase 7 interacting prot2 Ssa#TC110578 -1.30 -0.99 -0.31 
Mitogen-activated protein kinase 12  Ssa#S30240975 -0.88 -1.35 0.47 
akirin 1(2a)  Ssa#KSS177 -0.81 -0.76 -0.05 
MHC antigen presentation     
Cathepsin Z precursor  Ssa#AM402782 -0.66 -0.90 0.24 
MHC class I antigen  Ssa#TC108524 -2.33 -1.57 -0.76 
MHC class I antigen  Ssa#S35668662 -0.82 -0.60 -0.22 
MHC class II beta chain Omy#S15341284 1.58 0.33 1.25 
MHC class I antigen  Ssa#S29966061 -0.73 -0.57 -0.16 
AF508864_1 MHC class I  Ssa#S18892284 -0.71 -0.48 -0.24 
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Table 5.6 (continued 2) 
BlastxHit ProbeName 
CMS1-
REF 
CMS2-
REF 
CMS1-
CMS2 
Natural cell killer     
Granzyme A precursor  Ssa#DW578033 2.14 -1.33 3.47 
CD2 antigen cytoplasmic tail-binding protein 2  Omy#S15249212 -0.85 -0.33 -0.52 
protein serine/threonine kinase activity     
PREX1 protein  Omy#S15319930 2.24 2.05 0.19 
Cyclic adenosine 3, 5-monophosphate dependent prot kinase  Omy#BX913234 0.94 0.72 0.22 
protein kinase C, alpha Omy#TC170368 0.68 1.69 -1.00 
PREX1 protein Ssa#CX357733 -0.43 -1.46 1.04 
PTK2 protein tyrosine kinase 2 isoform a  Ssa#STIR25175 -0.60 -0.81 0.21 
Serine/threonine-protein kinase Sgk1 Ssa#DY693244 1.28 1.62 -0.34 
G protein-coupled receptor family C Ssa#S30281123 0.69 3.49 -2.80 
T-cell response     
T-lymphocite maturation assoc protein  Ssa#S35581943 -1.01 -0.23 -0.78 
H2.0-like homeobox protein Ssa#S35562668 0.64 0.59 0.05 
T cell receptor alpha Ssa#S37959053 -1.92 -2.10 0.18 
T cell receptor alpha Ssa#TC108495 -1.09 -1.38 0.29 
T cell receptor alpha Ssa#NP9934055 -1.05 -1.68 0.63 
T cell receptor alpha  Ssa#S37959570 -0.92 -1.46 0.54 
T-cell receptor beta chain 3 variable region Ssa#DW473052 1.91 2.35 -0.44 
T cell receptor alpha Ssa#S37959185 -0.18 -2.02 1.83 
T cell receptor alpha Ssa#NP9934310 -0.12 -1.52 1.40 
T cell receptor alpha  Ssa#S37959051 0.25 -1.46 1.71 
T-cell activation Rho GTPase-activating protein  Ssa#S32008293 0.77 0.58 0.19 
protein tyrosine phosphatase, receptor, C isoform 2 precursor  Omy#CA382452 -1.64 -0.93 -0.71 
bridging integrator 3  Ssa#S31984691 -1.59 -1.75 0.16 
proto-oncogene tyrosine-protein kinase fyn  Ssa#S35552559 -1.32 -1.30 -0.02 
crystallin, gamma B  Ssa#S19189155 1.01 1.09 -0.08 
Beta-crystallin A1-2 Ssa#S18849203 1.39 2.04 -0.66 
SH2/SH3 adaptor crk Omy#S15315949 1.77 1.22 0.55 
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Table 5.7 Gene expression pre-challenge. Metabolic genes selected by significance (one-way ANOVA) 
and expression differences between the functional feeds (CMS1 and CMS2) and reference diet (REF) or 
between CMS dietary groups. At cut-off log2-ER = 0.8 (1.75-fold). Red/orange colour intensity was used 
to indicate higher expression and green/blue colour intensity was used to indicate lower expression. 
BlastxHit ProbeName 
CMS1-
REF 
CMS2-
REF 
CMS1-
CMS2 
Lipid Metabolism transport     
diacylglycerol kinase, zeta 104kDa isoform 4  Ssa#S31987853 -1.10 -0.93 -0.17 
Ethanolamine kinase 1 Ssa#STIR44126 0.95 2.51 -1.57 
O-acyltransferase  domain containing 2  Omy#BX085588 0.34 1.52 -1.18 
Choline-phosphate cytidylyltransferase A  Omy#S34309497 0.13 1.27 -1.14 
ATP-binding cassette, sub-family A, member 2 Omy#TC156037 -1.32 0.03 -1.35 
ATP-binding cassette, sub-family A member 1  Omy#DV200496 -0.11 -1.12 1.01 
ATP-binding cassette, sub-family B, member 10  Omy#S15281990 -0.21 -0.97 0.77 
Peroxisomal 2,4-dienoyl-CoA reductase  Ssa#S48403141 -1.22 -0.70 -0.52 
carnitine O-octanoyltransferase  Ssa#DW564434 -1.83 -0.75 -1.07 
Peroxisomal 2,4-dienoyl-CoA reductase  Ssa#S48403141 -1.22 -0.70 -0.52 
delta-6 fatty acyl desaturase  Ssa#S18892244 1.00 -1.90 2.90 
protein kinase, AMP-activated, alpha 1 subunit 2 Ssa#BM414052 -0.36 0.61 -0.98 
Fatty acyl-CoA hydrolase precursor, medium chain Ssa#CA041487 0.57 -2.03 2.60 
Bile acid receptor  Ssa#S32008595 -1.10 -0.96 -0.14 
Nucleotide Metabolism     
Cullin-4B  Ssa#TC111475 -1.21 -2.28 1.06 
Uridine-cytidine kinase 2 Ssa#S32008884 -1.19 -0.94 -0.25 
hypothetical protein LOC553671  Omy#S15300468 -1.11 -0.96 -0.15 
Cytosolic 5-nucleotidase 1A  Omy#S34310160 2.63 2.55 0.07 
phosphodiesterase 7A isoform a  Ssa#DY729436 -0.47 -1.47 0.99 
Carbohydrate Metabolism     
Serine hydroxymethyltransferase, mitochondrial precursor Ssa#S30288614 -1.96 -1.79 -0.17 
Alpha-galactosidase A precursor  Ssa#S30239539 1.79 0.69 1.10 
galactosidase, beta 1 isoform a  Omy#S18164426 1.76 1.40 0.35 
hexose-6-phosphate dehydrogenase precursor Ssa#DV106122 1.09 0.63 0.46 
Glyoxylate reductase/hydroxypyruvate reductase  Ssa#CK896827 0.98 1.34 -0.36 
6-phosphofructokinase type C Ssa#DW182233 -1.46 0.70 -2.16 
alpha amylase Omy#TC139939 -0.93 -2.18 1.25 
Solute carrier family 2 Ssa#DW563694 2.01 1.24 0.77 
Triosephosphate isomerase  Ssa#EL697699 1.16 0.57 0.59 
solute carrier family 2 Ssa#TC112180 0.68 1.83 -1.16 
Amino Acid Metabolism     
cytokine-like nuclear factor n-pac Omy#TC155552 -1.64 -0.09 -1.54 
DNA cytosine methyltransferase 3 alpha isoform a  Ssa#DW561493 -1.55 -0.97 -0.58 
medium-chain acyl-CoA dehydrogenase  Ssa#S35548423 -1.33 -0.68 -0.65 
Myc protein Ssa#TC82506 -1.23 -0.66 -0.57 
similar to hCG2041215  Ssa#DW578787 0.86 1.24 -0.38 
suppressor of variegation 3-9 homolog 1  Ssa#DY732310 -0.12 -1.53 1.42 
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5.3.4.2 6 weeks post-challenge (infection) 
Six weeks after the viral infection the enrichment analysis showed that, at this point, 
differences between the three dietary groups were focussed on the immune response 
(Table 5.5). Moreover, the list of genes related with the immune response that were 
significantly differentially expressed between the three dietary groups was the largest 
over the course of the infection, highlighting the clear dietary influence on these 
responses at this point (Table 5.8). In general, genes related to the innate immune 
response, complement pathway, eicosanoids, B-cell and T-cell responses, showed lower 
expression in fish consuming the functional feeds compared with fish fed the REF diet. 
Most of the genes related to antiviral and interferon immune responses were, however, 
similarly or higher expressed in fish fed the CMS1 diet compared with the REF group, 
with fish fed the CMS2 diet showing lower expression of these genes. The expression 
of genes related with apoptosis was, in general, higher in fish fed the REF diet, although 
the expression of some important markers of the apoptotic process, such as caspase 
recruitment domain family member 11, was higher in fish consuming the functional 
feeds, which could indicate the beginning of apoptosis in these fish. 
Enrichment analysis also showed the importance of cell signalling pathways at this 
point, with genes related with basement membrane, cell-cell adhesion and the 
regulation of RAb GTPase activity generally higher expressed in the REF dietary group 
compare with the functional feed groups (Table 5.5). This result correlated with the 
broad expression of genes related with different pathways of the immune response 
observed in the REF group as cell trafficking and signal transduction are crucial for the 
development of host responses after a viral infection. 
191 
 
Differences between the groups of fish fed the two different functional feeds were 
mainly found in genes related with the Antiviral and IFN response and Apoptosis, 
which were higher expressed in fish fed the CMS1 diet compared to those fed the 
CMS2 diet. 
Table 5.8 Gene expression 6-weeks post-challenge. Immune related genes from different pathways 
selected by significance (one-way ANOVA) and expression differences between the functional feeds 
(CMS1 and CMS2) and reference diet (REF) or between CMS dietary groups. At cut-off log2-ER = 0.8 
(1.75-fold). Red/orange colour intensity was used to indicate higher expression and green/blue colour 
intensity was used to indicate lower expression. 
BlastxHit ProbeName 
CMS1-
REF 
CMS2-
REF 
CMS1-
CMS2 
Antiviral and IF response     
up-regulated gene 4 isoform 3 Omy#CA379360 -0.67 -0.98 0.31 
interferon induced with helicase C domain 1  Ssa#S48413574 -0.49 -2.39 1.90 
Very large inducible GTPase 1-3 Ssa#BQ035726 -0.38 -1.46 1.09 
Interferon regulatory factor 2  Ssa#S41489471 -0.09 -0.72 0.62 
Interferon-induced protein with tetratricopeptide repeats 5-1 Ssa#S31971912 1.00 -0.09 1.09 
GTPase IMAP family member 7  Ssa#EG764760 -0.38 -1.24 0.87 
retinoic acid induced 16  Ssa#S30239710 -0.15 -1.18 1.03 
Retinol dehydrogenase 12 Omy#CX142563 -0.14 -1.89 1.75 
ret finger protein Ssa#S32007273 -1.58 -0.41 -1.17 
v-akt murine thymoma viral oncogene 2-like protein  Ssa#DY694205 -1.70 -0.84 -0.86 
coiled-coil domain containing 55 Ssa#BM414279 -0.39 -1.09 0.69 
fish virus induced TRIM protein  Omy#S34422596 1.18 0.34 0.83 
kelch-like 3 Ssa#DY738366 1.34 0.98 0.36 
interferon-inducible double stranded RNA dependent inhibitor Ssa#KSS4526 0.66 1.33 -0.67 
dachshund homolog 1 isoform b  Ssa#S30240633 1.17 -0.01 1.18 
very large inducible GTPase 1 Ssa#CA040423 1.24 -0.51 1.75 
Apoptosis       
Regulator of G-protein signaling 1 Ssa#CL47Contig1 0.27 -1.13 1.40 
ubiquitin protein ligase E3A isoform 2 Omy#S15322642 -0.51 1.41 -1.92 
TNF receptor-associated factor 4  Ssa#S19109495 -0.98 -0.79 -0.18 
ubiquitin specific protease 47 Omy#S34315100 1.88 1.54 0.34 
apoptotic chromatin condensation inducer 1a  Ssa#S48412898 -1.41 -2.38 0.96 
death effector domain-containing protein Omy#TC135059 -0.53 -0.94 0.41 
caspase recruitment domain family, member 11  Ssa#S48433478 2.44 1.81 0.63 
calpain 5 Ssa#S31991645 -2.73 -2.46 -0.27 
placental protein 11 precursor Ssa#EG935968 -1.17 -1.12 -0.06 
Cathepsin L1  Omy#TC159807 -0.76 -0.76 0.00 
Serine protease HTRA1 Ssa#DW550176 0.01 -0.86 0.86 
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Table 5.8 (continued 1) 
BlastxHit ProbeName 
CMS1-
REF 
CMS2-
REF 
CMS1-
CMS2 
B-cell response       
SH3 protein expressed in lymphocytes Ssa#KSS3229 -0.79 -0.08 -0.72 
immunoglobulin mu heavy chain  Ssa#S35560318 -1.86 -1.80 -0.05 
immunoglobulin mu heavy chain  Omy#S15341231 -1.42 -1.09 -0.33 
IG HC variable region Ssa#S18892407 -1.34 -1.34 0.00 
IG HC variable region Ssa#S18892374 -1.34 -0.75 -0.59 
immunoglobulin mu heavy chain  Omy#S15341233 -1.29 -1.52 0.22 
immunoglobulin mu heavy chain  Omy#S15341239 -1.26 -1.61 0.35 
IG HC variable region Ssa#S30263508 -1.24 -0.95 -0.29 
immunoglobulin mu heavy chain  Omy#S15341238 -1.22 -0.86 -0.36 
immunoglobulin mu heavy chain  Ssa#S18836426 -1.20 -1.05 -0.15 
AF273426_1 immunoglobulin heavy chain variable region  Ssa#S18892363 -1.15 -0.98 -0.17 
IgM heavy chain membrane bound form Ssa#S18892409 -1.10 -0.53 -0.57 
AF273436_1 immunoglobulin heavy chain variable region Ssa#S18892353 -0.93 -1.49 0.56 
CD97 antigen precursor Ssa#S31983538 -1.63 -1.83 0.21 
Tyrosine-protein kinase Lyn  Omy#CX255862 -0.96 -1.10 0.14 
Complement pathway       
Complement factor D precursor  Ssa#S35687715 -1.90 -1.06 -0.84 
complement C4  Ssa#TC80864 -1.24 -0.95 -0.30 
Complement C1q subcomponent subunit C precursor  Ssa#S30293441 -0.18 -1.33 1.15 
Complement C1q subcomponent subunit C precursor  Ssa#S30254199 -0.07 -0.79 0.73 
Complement C1q-like protein 2 precursor  Omy#S15323007 -1.09 1.88 -2.96 
Eicosanoids        
Cytochrome P450 2U1 Ssa#DW576911 -2.43 -1.45 -0.98 
leukotriene b4 12-hydroxydehydrogenase Ssa#S35662467 -0.94 -0.59 -0.35 
Cytochrome P450 Ssa#S31996544 0.60 0.71 -0.11 
Phospholipase A1 member A precursor  Ssa#S35669014 -1.70 -2.31 0.61 
Innate immune response        
macrophage expressed gene 1  Ssa#S48415409 -1.47 -1.01 -0.46 
amyloid beta (A4) precursor-like protein 2  Ssa#CX727503 -1.09 0.43 -1.52 
integrin alpha 2b preproprotein Ssa#DW546887 0.13 -1.51 1.64 
interleukin 17 isoform D-1 Ssa#S35583279 -0.62 -0.28 -0.34 
cytokine receptor common gamma chain Ssa#KSSb2566 -0.65 -0.30 -0.35 
CD209 antigen-like protein A  Ssa#TC95863 -0.67 -1.18 0.50 
megakaryocyte-associated tyrosine kinase isoform a  Ssa#KSS3516 -1.03 -1.87 0.84 
tumor necrosis factor receptor associated factor 2 Omy#S15340564 0.04 -0.94 0.98 
Tumor necrosis factor, alpha-induced protein 2  Ssa#KSS2955 -1.81 -0.43 -1.38 
Proline-serine-threonine phosphatase-interacting protein 2  Ssa#KSS834 -1.73 -0.17 -1.55 
Integrin alpha-10 Ssa#CK891865 -0.84 -0.89 0.05 
catenin, alpha 1 Omy#S34424745 -0.18 -1.35 1.18 
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Table 5.8 (continued 2) 
BlastxHit ProbeName CMS1-REF CMS2-REF CMS1-CMS2 
T-cell response     
CD82 antigen  Ssa#S35505059 -1.10 -1.12 0.03 
L-plastin Ssa#EG803998 -0.78 -0.31 -0.47 
T cell receptor alpha  Ssa#NP9933973 -2.14 -0.63 -1.51 
T-cell receptor alpha chain V region HPB-MLT 
precursor  Ssa#S35603081 -1.96 -1.14 -0.81 
T cell receptor alpha  Ssa#S37959529 -1.41 -1.86 0.45 
T cell receptor alpha  Ssa#S37959531 -1.27 -1.16 -0.11 
T cell receptor alpha  Ssa#S37959049 -1.25 -0.66 -0.59 
T cell receptor alpha  Ssa#S37959473 -1.25 -1.05 -0.20 
T cell receptor alpha  Ssa#S37959118 -1.14 -0.56 -0.58 
T cell receptor alpha  Ssa#S37959090 -1.13 -0.74 -0.39 
T cell receptor alpha  Ssa#S37959477 -1.12 -0.84 -0.28 
T cell receptor alpha  Ssa#NP9934200 -1.11 -0.60 -0.52 
T cell receptor alpha  Ssa#NP9934238 -1.08 -0.37 -0.72 
CD8 beta  Ssa#S22938352 -1.05 -0.81 -0.24 
T cell receptor alpha  Ssa#S37959570 -0.97 -0.58 -0.38 
T cell receptor alpha  Ssa#S37959329 -0.96 -0.67 -0.29 
T cell receptor alpha  Ssa#S37959572 -0.96 -0.55 -0.40 
T cell receptor alpha  Ssa#S37959277 -0.91 -1.13 0.22 
T cell receptor alpha  Ssa#NP9934393 -0.89 -0.90 0.02 
T cell receptor alpha  Ssa#S37959654 -0.86 -0.44 -0.43 
T cell receptor alpha  Ssa#TC107916 -0.81 -0.60 -0.22 
T cell receptor alpha  Ssa#S37959481 -0.81 -0.30 -0.51 
T-cell receptor beta chain Omy#NP565024 -0.74 -0.54 -0.20 
T-cell surface glycoprotein CD3 zeta chain precursor Ssa#S37438815 -0.63 -0.47 -0.16 
T cell receptor alpha chain Ssa#S19630248 -0.61 -0.58 -0.03 
T-cell antigen receptor Ssa#S18892491 -0.60 -0.65 0.05 
Plastin-2 Omy#S15275191 -0.53 -0.84 0.31 
modified T cell receptor alpha Ssa#NP9934223 -0.90 -2.24 1.34 
Tyrosine-protein kinase SYK [Salmo salar] Ssa#S31979655 -0.97 -0.07 -0.90 
T cell receptor alpha [Salmo salar] Ssa#TC109038 -0.91 0.04 -0.94 
similar to granzyme [Danio rerio] Ssa#S18889540 -0.84 -0.26 -0.59 
T cell receptor alpha [Salmo salar] Ssa#S37959673 -0.84 0.20 -1.04 
discs, large homolog 1 isoform 1 [Homo sapiens] Ssa#TC88397 -1.39 -1.01 -0.38 
CTLA4-like protein [Oncorhynchus mykiss] Ssa#S35533507 -0.69 -1.12 0.43 
phosphoinositide-3-kinase, regulatory subunit 1 
isoform 1 Ssa#S35572038 -0.05 -1.21 1.15 
BNIP2 motif-containing molecule at the C-terminal region 1  Ssa#S31965741 -0.38 -1.56 1.18 
RAS guanyl-releasing protein 2  Ssa#DY736725 0.62 1.70 -1.08 
NOD3 protein  Ssa#S30240289 0.20 -1.06 1.25 
SH2/SH3 adaptor crk  Omy#S15315949 1.96 0.66 1.30 
Tyrosine-protein kinase SYK Ssa#DY705451 -1.39 -0.95 -0.44 
Nattectin precursor Ssa#S31963042 1.68 1.14 0.54 
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Table 5.8 (continued 3) 
 
5.3.4.3 8 weeks post-challenge  
Enrichment analysis indicated that, in the list of genes showing significant 
differences between the dietary treatments, signalling pathways such as cytokine-
cytokine receptor interaction, Rab GTPase activity and protein serine/threonine kinase 
activity were prominent at this time point (Table 5.5). However, expression of the 
annotated genes involved in those pathways was, in general, higher in fish fed the 
functional feeds compared with the fish fed the REF diet (Table 5.9). 
Overall, the expression of genes related to the immune response was generally still 
lower in the groups of fish consuming the functional feeds compared with the REF 
group. However, the magnitude of the differences was lower at this time point 
compared with the magnitude of the differences observed at 6-wpc, especially in genes 
BlastxHit ProbeName 
CMS1-
REF 
CMS2-
REF 
CMS1-
CMS2 
Innate to adaptive immune response       
AF418561_1 CC chemokine with stalk CK2  Ssa#KSS1002 0.66 0.32 0.34 
Chemokine receptor-like 1  Ssa#KSSb2250 -0.92 -0.28 -0.64 
C-X-C motif chemokine 14 precursor  Ssa#S35552426 -0.86 -0.25 -0.61 
C3a anaphylatoxin chemotactic receptor Ssa#S30270134 -1.28 -1.12 -0.15 
lymphocyte cytosolic protein 1 precursor Omy#S34314234 0.14 1.13 -0.98 
Leukocyte common antigen precursor  Ssa#KSS1719 -1.30 0.30 -1.60 
MHC antigen presentation        
MHC class II beta chain Omy#S15341284 0.24 -0.87 1.11 
Transmembrane and TPR repeat-containing protein 4 Ssa#S31973974 -0.34 -0.86 0.52 
Natural killer cells       
granzyme K precursor  Ssa#EG847002 -0.81 -0.06 -0.76 
Protein serine/threonine kinase activity     
Serine/threonine-protein kinase Nek7  Ssa#S35580453 -1.47 -0.28 -1.19 
Serine/threonine-protein phosphatase 2A 65 kDa A beta  Ssa#KSS3533 0.67 -0.94 1.61 
AKT2 kinase  Ssa#CK874283 -0.71 -1.34 0.63 
Proline-serine-threonine phosphatase-interacting protein 2 Ssa#KSS834 -1.73 -0.17 -1.55 
Serine/threonine-protein kinase tousled-like 2 Ssa#S30279923 0.50 1.14 -0.64 
inositol 1,4,5-triphosphate receptor, type 2  Omy#AB023964 -0.24 -0.84 0.60 
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related with the T-cell response that were, in some cases, even higher expressed in fish 
fed the functional feeds. Genes involved in this pathway are reported to be key to the 
host immune response after a PMCV infection (Haugland et al., 2011; Timmerhaus et 
al., 2011).  Thus, the presence of several genes related with the T-cell response in the 
lists of genes significantly differentially expressed between the dietary groups at all 
sampling points assessed after viral infection was consistent with previous data. 
Furthermore, it showed that the expression of genes in this pathway could be used to 
track the stage of the disease in fish from the different dietary groups at the different 
time points, as well as possible modulation of the host immune response by diet. 
Also interesting was the presence in the lists of genes involved in negative regulation of 
the immune response, like fetuin B, lymphocyte antigen 75 precursor or zinc finger, 
NFX1-type containing 1, which generally showed higher expression in fish consuming 
the functional feeds compared with fish fed the REF diet. Differences between the 
groups of fish fed the two different functional feeds still showed genes related to the 
antiviral and IFN response and apoptosis were higher expressed in fish fed the CMS1 
diet compared to fish fed the CMS2 diet as at 6-wpi. 
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Table 5.9 Gene expression 8-weeks post-challenge. Metabolic genes selected by significance (one-way 
ANOVA) and expression differences between the functional feeds (CMS1 and CMS2) and reference diet 
(REF) or between CMS dietary groups. At cut-off log2-ER = 0.8 (1.75-fold). Red/orange colour intensity 
indicates higher expression and green/blue colour intensity indicates lower expression. 
BlastxHit ProbeName 
CMS1-
REF 
CMS2-
REF 
CMS1-
CMS2 
Antiviral and IFN response     
GTPase IMAP family member 7 Omy#S23940134 -0.33 -1.63 1.30 
interferon induced with helicase C domain 1  Ssa#S48413574 -0.72 -1.83 1.11 
up-regulated gene 4 isoform 3  Omy#CA379360 -0.57 -1.12 0.55 
fish virus induced TRIM protein  Omy#TC148385 -0.06 -1.72 1.65 
fish virus induced TRIM protein  Omy#BX874038 -0.04 -0.71 0.67 
Very large inducible GTPase 1-3 Ssa#BQ035726 -1.82 -2.26 0.44 
52 kDa Ro protein-2 Ssa#S18855772 -1.26 -1.81 0.55 
mucin 5, subtype B, tracheobronchial  Ssa#S35597062 -0.77 -0.74 -0.03 
janus kinase 1  Ssa#DW006200 -0.70 -0.70 -0.01 
similar to LDLR dan isoform 5  Ssa#STIR19388 -0.78 -0.47 -0.31 
DEAH (Asp-Glu-Ala-His) box polypeptide 15  Ssa#S30293256 -0.82 0.79 -1.61 
Apoptosis        
TNF decoy receptor  Ssa#S35595553 -1.56 -1.67 0.10 
AF327708_1 retinoic acid receptor-gamma Ssa#S18892416 2.12 2.95 -0.83 
TNF decoy receptor  Ssa#S35595553 -1.56 -1.67 0.10 
Pleckstrin homology domain-containing family A member 1  Ssa#S31982099 -0.27 -1.84 1.58 
pleckstrin homology domain containing, family A member 7  Ssa#TC107691 0.87 0.26 0.61 
Ras-related protein Rab-31  Ssa#DW559421 -0.24 -1.90 1.66 
Programmed cell death protein 10 Ssa#S35563611 -0.03 -0.85 0.83 
death associated transcription factor 1-like Omy#CA384493 0.11 -1.14 1.25 
programmed cell death 11 Ssa#DW565559 -1.27 -2.01 0.74 
programmed cell death 2-like  Ssa#CK879149 -0.48 -0.83 0.35 
Damage-regulated autophagy modulator Ssa#DY714977 -0.48 -0.61 0.14 
death inducer-obliterator 1 isoform b  Ssa#DY702496 1.50 0.85 0.65 
ubiquitin specific protease 47  Omy#S34315100 1.35 2.41 -1.06 
Damage-regulated autophagy modulator  Ssa#DY714977 -0.48 -0.61 0.14 
endopeptidase Clp precursor  Ssa#S30295980 0.19 -0.63 0.82 
cathepsin L Omy#CX262263 -1.06 -1.16 0.09 
Cathepsin L1  Omy#TC159807 -1.02 -1.13 0.10 
Cathepsin L1  Omy#TC144585 -1.01 -1.09 0.08 
membrane alanine aminopeptidase precursor  Ssa#S31973583 -0.80 -0.78 -0.02 
matrix metalloproteinase  Ssa#S18857994 -2.31 -0.80 -1.51 
B-cell response       
B-cell CLL/lymphoma 11B isoform 1  Omy#S23946132 1.01 0.05 0.96 
B-cell receptor-associated protein 29 Ssa#S25806768 -0.27 -0.64 0.37 
Ig lambda chain V-I region BL2 precursor  Ssa#S35587819 -1.46 -1.62 0.17 
immunoglobulin tau heavy chain constant region secreted  Ssa#S35700501 -1.45 -1.50 0.05 
immunoglobulin mu heavy chain  Omy#CF752815 -1.47 0.86 -2.33 
Tyrosine-protein kinase Lyn Ssa#TC65653 -0.47 -0.81 0.34 
interleukin 4 induced 1 isoform 2 Ssa#S31970040 -0.89 -1.18 0.29 
interleukin 4 induced 1 isoform 2  Omy#CA377250 -1.12 -2.12 1.00 
Complement       
complement receptor-like  Ssa#S31993393 -0.17 -1.12 0.95 
C3a anaphylatoxin chemotactic receptor Ssa#S35585217 -1.34 -0.88 -0.46 
complement factor Bf-1  Ssa#S18849877 -2.13 -0.90 -1.23 
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Table 5.9 (continued 1) 
BlastxHit ProbeName 
CMS1-
REF 
CMS2-
REF 
CMS1-
CMS2 
Eicosanoids        
cytochrome P450  Ssa#S35596838 0.51 1.67 -1.16 
Innate immune system       
CD63 antigen  Ssa#S48427799 -0.80 1.00 -1.79 
integrin alpha 4 precursor  Ssa#CA049694 -2.07 -1.95 -0.13 
integrin alpha 4 precursor  Ssa#DY702132 -1.52 -0.77 -0.75 
C-C chemokine receptor type 3  Ssa#S30243811 -0.79 -1.32 0.53 
macrophage colony-stimulating factor receptor  Ssa#DW557277 -0.22 -1.69 1.47 
interleukin-1 receptor-like protein  Ssa#S18892319 -1.35 -0.53 -0.82 
Damage-regulated autophagy modulator  Ssa#DY714977 -0.48 -0.61 0.14 
SLAM family member 8 precursor  Ssa#S35700201 -1.06 -0.57 -0.49 
matrix metalloproteinase 13 Ssa#S35545523 -1.90 -1.97 0.07 
similar to leukocyte immune-type receptor 3  Ssa#S35683164 -0.54 -0.61 0.08 
vav 1 guanine nucleotide exchange factor Ssa#S30295362 0.24 -1.14 1.37 
Innate to adaptive       
High affinity immunoglobulin epsilon receptor gamma precursor  Ssa#KSSb2476 -1.99 -0.52 -1.47 
minor histocompatibility antigen ha-1 Ssa#KSS1884 -1.45 -1.58 0.13 
Natural cell killer       
Granzyme A precursor Ssa#S31981622 -1.60 -1.55 -0.05 
CD226 antigen  Ssa#S30266224 -2.61 -1.33 -1.29 
Regulator of the immune response       
Lymphocyte antigen 75 precursor  Ssa#S48406409 1.05 0.64 0.41 
zinc finger, NFX1-type containing 1  Ssa#S48395929 1.19 2.07 -0.88 
Cysteine-rich secretory protein LCCL domain-containing 2 
precursor Ssa#TC107297 -1.80 -0.60 -1.20 
fetuin B Ssa#S19100169 1.42 0.58 0.83 
NG,NG-dimethylarginine dimethylaminohydrolase 2  Ssa#CA048628 -0.64 -2.06 1.42 
Protein serine/threonine kinase activity       
Serine/threonine-protein kinase 38  Ssa#DW578681 2.32 2.06 0.25 
v-akt murine thymoma viral oncogene 2-like protein  Omy#CA354845 2.03 2.91 -0.88 
CHK1 checkpoint homolog  Omy#S15332619 -0.63 2.24 -2.87 
Serine/threonine-protein kinase 38  Ssa#DY695675 0.98 -0.44 1.42 
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Table 5.9 (continued 2) 
BlastxHit ProbeName 
CMS1-
REF 
CMS2-
REF 
CMS1-
CMS2 
T-cell response       
IL-6 subfamily member M17 Ssa#S48442658 -1.76 -1.70 -0.06 
Regulator of G-protein signaling 1  Ssa#S35664360 -0.51 -0.61 0.10 
Interleukin-2 receptor subunit beta Ssa#S48408611 -0.59 -0.64 0.05 
T cell receptor alpha Ssa#TC107842 -0.44 -0.98 0.54 
CD8 beta Ssa#S35494290 -0.35 -0.61 0.26 
Leukocyte common antigen precursor  Ssa#TC103193 -0.24 -0.93 0.69 
T-cell immunoglobulin and mucin domain-containing protein 4  Omy#CA368982 -2.09 -1.39 -0.70 
T cell receptor alpha  Ssa#TC109235 -1.66 -1.85 0.19 
T-cell receptor alpha chain V region HPB-MLT precursor  Ssa#S35603081 -1.24 -1.42 0.18 
T cell receptor alpha  Ssa#S37959058 -1.07 -0.92 -0.14 
T cell receptor alpha  Ssa#S37959267 -0.75 -1.08 0.33 
CD3 epsilon Ssa#S37438812 -0.70 -0.75 0.05 
CD3 gammadelta-A Ssa#S37438814 -0.65 -0.47 -0.18 
T-cell leukemia homeobox 3  Omy#TC163062 1.44 -0.15 1.59 
Nattectin precursor  Ssa#S31963042 2.41 0.33 2.08 
Differentially expressed in FDCP 6 homolog  Ssa#S35552642 -0.40 -1.33 0.93 
Fermitin family homolog 3  Ssa#KSS3812 0.62 1.10 -0.47 
NCK interacting protein with SH3 domain isoform 2  Ssa#S31979794 -0.24 0.81 -1.05 
solute carrier family 23  member 1 isoform b  Ssa#S30259049 0.74 0.86 -0.12 
hypothetical protein LOC541529  Ssa#DW178537 1.43 2.05 -0.61 
human caldesmon 1 transcript variant  Ssa#KSS4667 -0.47 -1.00 0.53 
CD40 ligand Ssa#S35485977 -0.82 -0.57 -0.24 
T-cell receptor alpha chain V region 2B4 precursor  Ssa#S35536498 0.56 -1.14 1.70 
interferon, gamma  Ssa#S22497299 -1.03 -1.03 0.00 
 
5.3.4.4 14-weeks post-challenge 
At this time point, the list of immune-related genes significantly differentially 
expressed between the dietary groups is the smallest compared with the lists reported 
above. However, the enrichment analysis showed the relevance of different immune 
related pathways in this list (Table 5.5). At 14-wpc, the main differences between the 
dietary groups were mainly in pathways related with cell signalling, but also in 
important players in the host immune response such as B-cell and T-cell immune 
response and Natural Killer cell-mediated cytotoxicity. The annotated list showed that, 
with the exception of the genes related to the innate immune response, the expression of 
genes related to the other pathways of the host immune response mentioned above was 
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similar or higher in the fish fed the functional feeds, especially the CMS1 diet (Table 
5.10). 
To better understand whether the shorter list of genes related with the immune 
response could be interpreted as remission of the immune response corresponding to a 
recovery stage of the disease, the expression of genes of the most relevant immune 
pathways that were higher expressed in fish fed the REF diet at 6-wpc, but were not 
differentially expressed at 14-wpc, was plotted (Figure 5.8). The, 6-wpc list was 
selected for this comparison as it was most representative of immune genes after PMCV 
infection (Timmerhaus et al., 2011). This showed that genes related with the immune 
response were actively transcribed 14-wpc with their expression generally being similar 
in all three dietary groups. Moreover, expression of those genes was higher in fish fed 
the functional feeds compared with their expression at 6-wpc (Figure 5.8). Therefore 
14-wpc should be considered as the beginning of a recovery phase after infection with 
PMCV in this trial. 
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Table 5.10 Gene expression 14-weeks post-challenge. Immune genes selected by significance (one-way 
ANOVA) and expression between functional feeds (CMS1 and CMS2) and reference diet (REF) or 
between CMS groups. At cut-off log2-ER = 0.8 (1.75-fold). Red/orange colour intensity indicates higher 
expression and green/blue colour intensity indicates lower expression. 
BlastxHit ProbeName 
CMS1-
REF 
CMS2-
REF 
CMS1-
CMS2 
Antiviral and IFN response     
RAP1 GTPase activating protein  Ssa#S48420291 1.65 1.35 0.30 
fish virus induced TRIM protein  Omy#BX867355 -0.25 -0.69 0.44 
dicer  Ssa#STIR40177 0.66 1.80 -1.14 
Very large inducible GTPase 1-3 Ssa#BQ035726 -0.60 -1.89 1.30 
fish virus induced TRIM protein  Omy#BX867355 -0.25 -0.69 0.44 
Apoptosis     
Pleckstrin homology domain-containing family A  Ssa#S31982099 0.56 1.28 -0.72 
cell death-inducing DFFA-like effector a isoform 1  Omy#CX043075 0.43 -1.25 1.67 
son of sevenless homolog 1 Ssa#DW548235 -1.80 -0.67 -1.13 
carboxypeptidase M precursor  Ssa#S30296241 0.75 1.32 -0.57 
membrane metallo-endopeptidase Ssa#S30275401 0.14 -0.84 0.98 
meprin A, beta Ssa#CK884807 -1.74 -1.40 -0.34 
pleckstrin homology domain interacting protein Omy#CA364148 0.15 -0.94 1.09 
triple functional domain (PTPRF interacting) Ssa#S30276444 1.45 0.34 1.11 
Amyloid beta A4 precursor protein-binding family B  Omy#CA354955 0.46 1.86 -1.40 
Inositol hexakisphosphate kinase 2 Ssa#S30279656 -0.88 0.01 -0.89 
B-cell response     
CD97 antigen precursor Ssa#DY730078 2.63 1.84 0.79 
Eicosanoid     
Cytochrome P450 2U1  Ssa#DW576911 -1.23 -0.62 -0.61 
Arachidonate-5-lipoxygenase Ssa#STIR00023_2 -0.35 0.74 -1.10 
Innate immune response     
stress protein HSP70  Ssa#KSS3301 0.12 2.31 -2.19 
ccaat enhancer-binding protein zeta  Omy#BX297669 -0.91 -1.01 0.10 
tubulin tyrosine ligase-like family member 6a Ssa#TC82460 -0.46 -0.84 0.38 
integrin, alpha 9 precursor  Ssa#TC91550 0.08 -1.03 1.11 
CC chemokine Ssa#KSSb2632 -0.61 -0.86 0.24 
CD83 antigen precursor Ssa#KSS3110 -0.45 -0.48 0.04 
megakaryoblastic leukemia 2 protein  Omy#BX913242 -1.53 -2.07 0.54 
AF345874_1 novel immune-type receptor 7  Omy#S15340598 -1.85 -1.80 -0.05 
Metalloreductase STEAP4 Ssa#TC108295 -0.04 -0.92 0.88 
TNF superfamily member 14 Ssa#S31975856 -0.96 0.14 -1.10 
Coagulation factor XIII A chain precursor  Ssa#CL28Contig1 1.05 1.91 -0.86 
talin 1  Ssa#TC81470 -1.02 0.53 -1.55 
transforming growth factor beta  Omy#S23942215 1.12 0.49 0.63 
similar to TGF-beta type II receptor Ssa#S22709188 -0.71 -1.16 0.45 
MHC antigen presentation      
beta-2 microglobulin Ssa#CL57Contig1 -0.07 -0.78 0.71 
beta-2 microglobulin type 2  Omy#S34310091 -0.04 -0.76 0.72 
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Table 5.10 (continued) 
BlastxHit ProbeName 
CMS1-
REF 
CMS2-
REF 
CMS1-
CMS2 
Immune regulator     
suppressor of cytokine signaling 5  Omy#TC163366 0.57 1.07 -0.50 
inhibitor of kappa light polypeptide enhancer in B-cells Ssa#EG816410 1.37 -0.12 1.49 
fetuin B Ssa#S19100169 1.51 -0.56 2.07 
BRCA1 associated protein-1  Ssa#CK886907 1.60 -0.31 1.91 
Phosphatidylinositol signalling system     
Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1  Ssa#DY718621 1.16 1.45 -0.29 
inositol polyphosphate-5-phosphatase A  Omy#TC156380 0.74 0.82 -0.08 
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) Ssa#DY716055 0.85 -0.30 1.15 
phosphoinositide-3-kinase, catalytic, delta polypeptide  Ssa#AM042317 0.85 -0.50 1.35 
phosphatidylinositol-4,5-bisphosphate phosphodiesterase delta-
4  Omy#S23931398 0.36 -1.45 1.81 
Phosphatidylinositol glycan anchor biosynthesis  Ssa#S30272457 0.61 0.49 0.12 
protein serine/threonine kinase activity     
ankyrin repeat domain 3  Omy#S15268006 -1.98 -1.38 -0.60 
T-cell response     
CD82 antigen  Ssa#S35505059 -0.70 -1.40 0.70 
modified T cell receptor alpha  Ssa#NP9934285 -0.73 -2.13 1.41 
CD8 alpha Ssa#S43839059 -0.33 -0.77 0.44 
T-cell leukemia homeobox 3  Ssa#DW588601 0.15 -0.74 0.89 
IL2-inducible T-cell kinase Ssa#S30292785 0.57 -0.78 1.35 
T cell receptor alpha Ssa#S37959057 -0.94 -1.23 0.29 
CD8 beta  Ssa#S22938352 -0.68 -0.80 0.12 
T cell receptor alpha  Ssa#S37959281 -0.65 -0.90 0.25 
T cell receptor alpha Ssa#S37959544 -0.44 -0.72 0.27 
Rho-related GTP-binding protein RhoE precursor  Ssa#S30264152 1.00 0.78 0.22 
Cas-Br-M (murine) ecotropic retroviral transforming sequence b  Omy#CA378941 1.08 1.82 -0.74 
discs, large homolog 1 isoform 1  Omy#S34310120 -1.17 -1.58 0.41 
phosphoinositide-3-kinase, catalytic, delta polypeptide  Ssa#AM042317 0.85 -0.50 1.35 
Tyrosine-protein kinase SYK  Omy#CA346982 0.35 1.48 -1.12 
Perforin-1 precursor  Ssa#S30280863 -1.24 -0.41 -0.84 
Plastin-2  Ssa#TC105599 0.04 1.95 -1.92 
human caldesmon 1 transcript variant Ssa#KSS4667 -0.21 -0.85 0.64 
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Figure 5.8 Box plots showing log2-ER (expression ratios) for all genes included in five gene sets comparing the expression of genes significantly different expressed 
at 6-wpc with those at14-wpc. Boxes represent 50 % of the values, while black bars mark the median log2-ER. Whiskers indicate the maximum length of 1.5 times 
the box length. Values beyond whiskers are plotted as a black circle. 
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5.4. Discussion 
 
The present study has shown the important role that dietary immunomodulation can 
have in controlling salmonid heart viral diseases. Specifically, microarray analysis of 
heart transcriptome showed how reduced dietary lipid content and increased levels of 
EPA can lead to altered expression of genes involved in the immune response after 
challenge with PMCV.  
The specific role and/or mechanism that reduced dietary lipid content has in 
mediating the effects of the functional feeds has been difficult to establish (Martinez-
Rubio et al., 2012a,b,c). Previous studies on HSMI showed that there was reduced lipid 
deposition (steatosis) in livers of fish fed the functional feeds with lower lipid content at 
initial stages of the disease and the steatosis was usually more frequent when the 
severity of the heart lesions was high (Martinez-Rubio et al., 2012b). Thus, there was 
potential correlation between liver metabolism and ongoing viral infection, although 
earlier studies had found no correlation between the severity of heart and liver lesions 
during different stages of HSMI disease, associating the lesions to the circulatory 
disturbances as a consequence of the heart lesions (Kongtorp et al. 2006). Therefore, 
even though the precise mechanism of the reduced liver steatosis index at initial stages 
in fish fed the functional feeds was not identified in detail, reduced dietary lipid was 
undoubtedly a major contributing factor (Martinez-Rubio et al., 2012b,c). Functional 
feeds used in the present study were clearly beneficial for the liver pathology associated 
with CMS. Fish fed both functional feeds showed lower histoscores over the whole 
course of the infection, with the scores being significantly lower at 12- and 14-wpc in 
fish fed both functional feeds compared to fish fed the REF diet. Hence, despite 
increased pathology in heart tissue observed in fish fed CMS1 and CMS2 at these later 
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time points of the challenge, the functional feeds clearly moderated the hepatic steatosis 
after infection with PMCV, probably due to the reduced dietary lipid content. 
As previously described in humans (Calder, 1997) and fish (Bell et al., 1991; Lin and 
Shiau, 2007; Montero et al., 2010b), the fatty acid compositions of membrane PL play a 
critical role in the regulation of the innate and adaptive immune response. Fatty acids 
such as ARA, EPA and DHA, released from membrane PL through the action of 
phospholipases, modulate the immune response not only through the production of 
eicosanoids, but also by modifying important signalling pathways and stimulating 
immune-related nuclear transcription factors (PPARs and NFkβ) and the release of 
certain cytokines (Shaik and Eidin, 2006). The n-6 LC-PUFA, ARA is associated with 
pro-inflammatory responses as the precursor of pro-inflammatory eicosanoids, and 
EPA, as well as being the precursor of anti-inflammatory eicosanoids, can also decrease 
the production of ARA-derived eicosanoids through substrate competition of the 
eicosanoid-synthesising enzymes. DHA has also an anti-inflammatory role in humans, 
particularly relevant at the recovery phase of an inflammatory process, as it is a 
precursor of immune-resolving resolvins and protectins (Calder, 2009b). 
Although macrophages, primarily produced in the head kidney of fish, are a major 
source of eicosanoids, production of eicosanoids at the site of the infection is also 
highly relevant due to the short life of these LC-PUFA derivatives (Rowley et al., 1995) 
In the present study, fatty acid composition of the PL of heart tissue, as the main site of 
infection after a challenge with PMCV, was determined before the viral challenge and 
at five time points over the course of the infection. As previously reported in 
unchallenged (Bell et al., 1991) and challenged fish (Martinez-Rubio et al., 2012a 
Chapter 1), levels of DHA in heart tissue PL did not reflect the fatty acid composition 
of the diets, as levels of this fatty acid were generally similar between the three dietary 
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groups in the present trial. This perhaps reflected the fundamental role of DHA in the 
maintenance of the structure and fluidity of cellular membranes (Stillwell and Wassall, 
2003). In our previous study investigating the effects of similar diets on HSMI in 
salmon, levels of DHA were not significantly affected during the time-course of the 
infection after challenge with ASRV (Martinez-Rubio et al. 2012a; Chapter 2). Thus, 
the precise immunomodulatory role of DHA described in humans did not appear to be 
as relevant in fish during the inflammatory response associated with HSMI (Calder, 
2007). In contrast, in the present study, the levels of DHA in heart tissue PL 
significantly changed over the time-course of the infection after PMCV challenge. 
Levels of DHA were higher when there was enhanced immune response and the levels 
of heart lesions were more prominent. Whether DHA levels were indeed directly related 
with the activation of the different immune pathways involved in the control of the 
inflammatory process is something that requires further investigation in fish. However, 
the present results suggest that changes in the levels of DHA may be correlated with 
PMCV infection and therefore this fatty acid could have a role in the immune response 
in fish as has been described previously in humans (Calder, 2009a). 
Levels of EPA and ARA, and the EPA/ARA ratio, in the PL of heart tissue were 
significantly altered by the functional feeds, and hence one of the main strategies of the 
experimental design of the present trial was achieved. Specifically, the potential 
bioavailability of EPA and its proportion relative to ARA was always higher over the 
time-course of the infection in fish fed the functional feeds compared with fish fed the 
REF diet. Interestingly, the use of Southern hemisphere FO in the functional feeds in 
the present trial also increased the level of ARA in heart tissue PL and thus the 
EPA/ARA ratio was actually lower than in heart tissue of fish in a previous trial on 
HSMI (Martinez-Rubio et al., 2012; Chapter 2). The relative proportions of ARA and 
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EPA remained generally constant during the time-course of the PMCV infection 
although, as described above for DHA, there were increased levels of both ARA and 
EPA when, according to gene expression analysis, there was activation of the immune 
response.  However, this was only significant for EPA, possibly reflecting the higher 
absolute levels of EPA generated by the functional feeds in the present trial. 
During a pathogen infection, there is considerable mobilisation to the main sites of 
infection of immune cells that are producers of eicosanoids, whose production is 
supported by release of the immune-related LC-PUFA from membrane PL (Balfry and 
Higgs, 2001). Although infiltration of inflammatory cells and their specific fatty acid 
compositions were not analysed in the present study, the correlations between levels of 
ARA, EPA and DHA in the membrane PL, the extent of heart histological lesions, and 
gene expression in the heart tissue analysed, clearly indicated that dietary effects on the 
incorporation of these fatty acids in tissues (heart, immune cells, etc.) were highly 
relevant to their immunomodulatory roles after a viral infection. 
In addition to effects on fatty acid composition, the PL class composition was also 
affected by the viral infection, with the main change being the significant decrease in 
the proportions of PI and PS as the infection progresses. Phosphorylated derivatives of 
PI such as phosphatidylinositol 4,5-bisphosphate (PIP2) are involved in the production 
of the intracellular second messengers diacylglycerol (DAG) and inositol 1,4,5-
triphosphate (IP3) through the action of the phospholipase C (Stulnig and Zeyda, 2004). 
DAG and IP3 activate calcium channels, increasing Ca
+2
 concentration in the cytosol, 
with this being an essential step for the survival of some human virus (Chami et al., 
2006). PS has also been related with this signalling pathway as it is an important 
activator of protein kinase C (Bell and Sargent, 1987; Tocher et al., 2008). As the gene 
expression data also highlight the relevance of this signalling pathway during the course 
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of the infection, the decreased proportions of PI and PS could reflect utilisation of these 
PL classes associated with an immunomodulatory role.  This relationship between 
composition/content of specific PL classes is an interesting and important area for 
future studies on clinical nutrition in fish. 
Immediately prior to challenge, genes related with the different pathways of the 
innate and adaptive immune response were generally expressed at lower levels in fish 
consuming the functional feeds. As this was pre-challenge, this effect must be entirely 
due to the dietary modulation. Broadly similar effects on gene expression were reported 
previously in a trial investigating substitution of dietary FO with VO in salmon (Morais 
et al., 2011). In that trial, expression levels of immune-related genes in liver of fish fed 
a FO diet, with a fatty acid composition similar to the functional feeds, were generally 
lower than in fish fed a VO diet, with a similar composition to the present REF diet.  
However, in the earlier study, genes related with the T-cell response were expressed at a 
lower level in fish fed the VO diet (Morais et al., 2011).  This contradictory result may 
be explained by the higher levels of EPA present in the functional feeds used in the 
present study compared with the FO diet used in the earlier study, as the considerable 
influence of EPA in controlling T-cell signalling pathways has been documented 
previously (Shaik and Edidin, 2006; Calder, 2008). Expression of genes related with 
non-specific immune responses were also higher in fish fed a diet with a blend of VO 
and FO compared with fish fed FO in a study in grouper (Epinephelus malabaricus) 
(Lin & Shiau, 2007). So it appears that, even without any apparent infection, inclusion 
of FO could dampen both innate and adaptive immune responses in humans and fish. 
Although no lesions in the heart were recorded before the PMCV challenge, the 
increased immune status of the fish fed with the REF diet could thus be a factor in the 
earlier development of the immune response and heart lesions associated with CMS in 
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these fish compared with the fish fed the functional feeds. Put another way, the 
functional feeds lowered the immune status prior to viral challenge and, in doing so, 
delayed and dampened the inflammatory/immune response to the infection. Whether 
this could generally improve resistance and/or outcome to this kind of viral infection in 
salmon requires further investigation. 
Before challenge there were also dietary-induced differences in the expression of 
several genes related with other metabolic pathways. Thus, genes related with fatty acid 
oxidation such as carnitine O-octanoyltransferase, and peroxisomal 2, 4-dienoyl-CoA 
reductase showed higher expression in fish fed the REF diet. This was consistent with 
the higher lipid content of the REF diet compared to the functional feeds, and was in 
agreement with a previous study where increased expression of genes related with 
peroxisomal fatty acid oxidation was found in salmon fed diets including VO (Leaver et 
al., 2008b). Perhaps in contrast, some genes associated with lipid transport showed 
higher expression in fish fed the functional feeds, especially the CMS2 diet. However, 
this result was entirely consistent with data from a previous study in rainbow trout 
(Oncorhynchus mykiss) fed a low energy diet (Kolditz et al., 2008). 
Genes related with fatty acid biosynthesis including delta-6 fatty acyl desaturase and 
fatty acyl-CoA hydrolase showed increased expression in fish fed the CMS1 diet 
compared to the REF diet, although the expression of both was unexpectedly lower in 
the fish fed the CMS2 diet. In a previous study with functional feeding and ASRV 
infection in salmon (Chapter 3) and the above study in trout (Kolditz et al. 2008a), these 
genes were up-regulated in fish fed lower energy diets. This is in agreement with the 
data for the CMS1 diet, but the contradictory result in fish fed CMS2 could be related 
with the higher LC-PUFA content, especially EPA, of the CMS2 diet compared with 
the diets used in the aforementioned earlier studies. However, as EPA levels were 
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similar in both functional feeds, interaction between supplementation with histidine and 
the LC-PUFA biosynthesis pathway requires further investigation. 
The heart histology data obtained in the present trial were in agreement with 
previous studies describing the development of heart pathology in CMS (Timmerhaus 
et al., 2011; Haughland et al., 2011). Thus, ventricle and atrium were severely affected 
by the viral infection with the lesions characterised by inflammation, degeneration and 
necrosis. Similarly, there was correlation between the expression of genes related with 
the immune response and the lesions in the heart tissue in agreement with Timmerhaus 
et al. (2011). Importantly, however, the temporary differences in the expression of the 
immune genes observed between the different dietary treatments in the present study 
considerably strengthened this correlation. Thus, overall, the changes associated with 
the progress of CMS heart pathology, previously described by Timmerhaus et al. 
(2011), were temporally similar with the development of the infection in fish fed the 
REF diet. In addition, the present data show a clear delay in the appearance of these 
histological changes in fish fed both functional feeds, and slightly improved 
performance of fish fed the CMS2 diet. This could be associated with a lower up-
regulation of expression of genes associated with the innate immune response in fish 
fed CMS2 compared with the other dietary groups. 
Enrichment analysis of transcriptomic data is commonly used to identify genes 
significantly relevant in selected gene lists (Liu et al., 2007).  In the present study, 
enrichment analysis was particularly effective in elucidating how different signalling 
pathways, especially protein serine-threonine kinase at the peak of the inflammatory 
process, PI at later stages, and genes related with the T-cell receptor signalling 
pathways, were significantly modulated by diet over the course of the infection. At 6-
wpc, gene expression and heart tissue histopathology of fish fed the REF diet were in 
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agreement with those reported by Timmerhaus et al. (2011). Thus, atrium was clearly 
affected by the infection at 6-wpc with histoscores higher in the fish fed the REF diet 
compared to fish fed the functional feeds, whereas ventricle was only slightly affected. 
According to the aforementioned study of Timmerhaus et al. (2011), a peak in the 
expression of genes related with the complement response, B and T-cell responses and 
apoptosis, was expected at this time post-infection. Furthermore, most of the genes 
related with these pathways showed lower expression in fish fed the functional feeds 
compared to fish fed the REF diet. In addition, genes related with antiviral and 
interferon responses showed similar or higher expression in fish fed the functional 
feeds, especially CMS1, compared with fish fed the REF diet. The peak in the 
expression of the latter genes was reported to be at 2-4 wpc in the earlier study 
(Timmerhaus et al., 2011), so this also supported the conclusion that there was a 
delayed response in fish fed the functional feeds. A delayed response to viral infection 
was also observed after ASRV infection in a previous study on HSMI in salmon 
(Martinez-Rubio et al., 2012a; Chapter 2). In the HSMI study, the peak in expression of 
genes related with activation of the immune response was delayed by around two weeks 
in fish fed similar functional feeds compared to fish fed a standard commercial diet. 
As the CMS disease progressed the extent of lesions in the heart increased in both 
atrium and ventricle with the differences between the fish fed the functional feeds and 
fish fed the REF diet being most pronounced at 8-wpc. At this time-point, the fish fed 
the functional feeds, especially CMS2, presented significantly lower histoscores in both 
atrium and ventricle compared with fish fed the REF diet. These differences could be a 
consequence of the striking up-regulation of genes related with the host immune 
response observed at 6-wpc in fish fed the REF diet.  Again, this result was in 
agreement with the previous study by Timmerhaus et al. (2011). At 8-wpc, following 
211 
 
the hypothesis of delayed development of CMS in fish fed the functional feeds, higher 
expression of genes involved in antiviral and innate immune pathways could have been 
expected in these fish compared with fish fed the REF diet but, in contrast, these groups 
showed a lower activation of these pathways. Dietary modulation of the inflammatory 
response has, of course, been described previously in fish. Higher incorporation of n-3 
LC-PUFA in biological membranes of immune cells led to a lower expression of pro-
inflammatory cytokines in gilthead sea bream (Sparus aurata) (Montero et al., 2010b), 
decreased antibody production and macrophage killing activity in rainbow trout (Kiron 
et al., 1995), and lower production of pro-inflammatory eicosanoids in Atlantic salmon 
(Bell et al., 1996). Furthermore, dietary EPA suppressed production and release of 
tumor necrosis factor (TNF), interleukins and IFN in humans (Das, 2003). Dietary EPA 
also suppressed key components of the antiviral response in gilthead sea bream, and 
dietary VO inclusion modulated the expression of Mx proteins, interferon-induced 
mediators of innate resistance to RNA virus (Montero et al., 2008b). The increased 
proportions of dietary n-3 LC-PUFA, especially EPA, in the functional feeds used in 
the present study could, according to these previous studies, be a major factor in 
preventing an uncontrolled immune response that could be more harmful to the fish.  
As expected, according to the description of gene expression related with the 
immune response 8-wpc reported by Timmerhaus et al. (2011), most of the genes 
related with the T-cell response showed lower expression in fish fed the functional 
feeds compared with fish fed the REF diet. However, genes involved in protein 
serine/threonine kinase activity, a group of enzymes crucially controlling transcriptional 
and metabolic pathways determining T-cell function (Finlay and Cantrell, 2011), 
showed higher expression in fish fed the functional feeds, suggesting possible initiation 
of the T-cell response in these fish at 8-wpc. 
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Although gene expression was not assessed at 10- and 12-wpc, increased 
transcription of genes involved in virus clearance may be predicted according to the 
histopathological analysis of lesions in the atrium and ventricle at these time-points. By 
14-wpc, there was a clear remission in the lesions in both parts of the heart in all three 
dietary groups. Although the histopathology of the lesions was not significantly 
different between dietary groups, there was slightly better recovery in fish consuming 
the functional feeds, especially CMS2. As the expression of many of the genes related 
with the immune response was not significantly different between the three dietary 
groups, it is difficult to determine the precise mechanism whereby functional feeds 
could regulate the immune response towards a faster resolution of the inflammatory 
process associated with CMS. Nonetheless, some of the pathways represented in the list 
of genes significantly differentially expressed at 14-wpc in fish fed the different diets 
could be key to that regulation. Thus, important markers of the T-cell response such as 
T cell receptor alpha, CD8 beta and alpha and CD82 antigen showed lower expression 
in fish fed the functional feeds, but genes related with the PI signalling system were 
higher expressed in those fish compared with fish fed the REF diet. As previously 
mentioned, the signalling pathway mediated by PI is highly involved in the regulation 
of the T-cell response (Stulnig and Zeyda, 2004), and dependent on the levels of 
membrane PL classes and their fatty acid compositions. As the lesions in heart tissue in 
CMS were mainly associated with the action of CD8+ cytotoxic T-cells (Timmerhaus et 
al., 2011), any factor controlling this response, such as the anti-inflammatory n-3 LC-
PUFA present in the functional feeds used in the present study, could be key to the 
better performance observed in the fish fed these feeds. Furthermore, results from the 
previous study evaluating the use of functional feeds in salmon suffering HSMI were in 
agreement with this hypothesis.  Thus, milder expression of genes related with 
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inflammatory response and virus clearance, including those related with T-cell 
response, were reported in salmon consuming the functional feeds leading to a better 
performance of those fish over the course of the HSMI infection (Martinez-Rubio et al., 
2012a; Chapter 1). 
Histidine supplementation may be a promising alternative therapy in chronic heart 
failure patients (Kalantar-Zadeh et al., 2008), and a protector of the myocardial function 
after ischemia in humans (Koch et al., 2009). In addition, oxidative stress has been 
associated with viral infections (Hasnain et al., 2003). These studies led us to 
hypothesise that dietary histidine supplementation could be beneficial in modulating the 
level and extent of heart lesions associated with CMS. Although this amino acid has 
been reported to be crucial preventing cataract formation in adult salmonids in periods 
of increased risk (Waagbø et al., 2010), the present study showed that, in general, the 
addition of histidine did not improve the performance of the fish as the level of heart 
lesions and the expression of genes related with the immune response were not further 
reduced in fish fed the histidine supplemented diet. Further investigation is therefore 
required using different doses of histidine and evaluating possible interactions with 
other components of the diet. 
Conclusion 
The present study is the first to describe the effects of functional feeds on the 
expression of genes related with the immune response after infection with PMCV in 
Atlantic salmon. Significant differences in immune and inflammatory responses and 
pathology in heart tissue were found in fish fed the different dietary treatments over the 
course of the infection, highlighting the immune modulatory role of dietary lipid 
content and fatty acid composition in viral infections in Atlantic salmon. A previous 
study (Martinez-Rubio et al. 2012a), clearly associated reduced dietary lipid content 
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and increased EPA with a milder and delayed inflammatory response and, 
consequently, less severity of heart lesions after infection with ASRV. In the present 
study with PMCV infection, the same strategy was also effective albeit slightly less 
than in the previous HSMI study, with this difference possibly associated with the lower 
EPA/ARA ratio in the functional feeds used in the present trial. 
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Chapter 6 
General Discussion 
 
The primary overriding objective of the present thesis was to evaluate the effects 
of functional feeds as an alternative therapy to mitigate chronic inflammatory 
processes associated with two emerging viral diseases in Atlantic salmon 
aquaculture, namely heart and skeletal muscle inflammation (HSMI) and 
cardiomyopathy syndrome (CMS). Experimental challenges with the casual agents of 
both diseases, along with the use of oligoarray technology to determine global gene 
expression, identified the immunomodulatory roles of the functional feeds, 
confirmed their beneficial advantages in viral infection, and opened a new line of 
research for the implementation of clinical nutrition in aquaculture. 
As the work in this thesis was in collaboration with, and partly sponsored by, an 
industrial partner, the major international aquafeed company, EWOS, through their 
research arm EWOS Innovation AS, experimental feeds were based on practical 
formulations and the trials were carefully designed to specifically deliver answers to 
important existing commercial problems. Thus, overall, the study closely linked 
modern, cutting-edge transcriptomic techniques that delivered detailed mechanistic 
data at a molecular level with traditional diagnostic histological data to deliver 
results that had the potential to have immediate commercial application. This short 
pathway to impact is one of the great benefits of a strong academic/industrial 
partnership. Therefore, all of the feed formulations investigated in this study were 
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designed to be suitable for future commercialization, enabling results from this thesis 
to be highly applicable and rapidly applied in the salmon industry.  
Furthermore, the compositions of the reference diets used in the trials were 
closely based on commercial formulations currently in use within the industry. At the 
outset of this study, it was speculated that the increasing prevalence and severity of 
both diseases, HSMI and CMS, may be associated with changes in feed formulations 
that had been taking place over the same timescale. Thus, one hypothesis was that 
the trends for increasing dietary energy/lipid content along with increasing presence 
of plant raw materials as replacements for FM and FO including n-6 PUFA-rich VO 
in the feeds were possible important factors in the increasing importance of these 
diseases probably through disturbances in lipid and fatty acid metabolism affecting 
severity and regulation of the inflammatory responses. Consistent with this 
contention, the timings and incidence of lesions in the heart tissue of fish fed the 
standard, reference feeds were very similar to that previously described in the 
literature for natural outbreaks in fish fed commercial feeds (Ferguson et al., 1990; 
Kongtorp et al., 2004, 2006; Fritsvold et al., 2009). Therefore, changes in lipid 
mobilization and incorporation of dietary fatty acids related with the immune 
response supported by gene expression in fish fed the reference diets likely reflected 
general metabolic changes that farmed salmon are experiencing in response to 
changing dietary formulations and as observed in natural disease outbreaks. This fact 
strongly supported the rationale on which the formulations of the functional feeds 
were based and lent weight to the beneficial effects that were observed in fish fed the 
functional feeds in the different experiments conducted in this study. 
The long duration of the two main experimental trials, continuing for up to 16 
weeks post-challenge, and the evaluation of the changes at several points during the 
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clinical phases of both viral diseases enabled a detailed description and appreciation 
of the dietary modulation of the immune and inflammatory responses during the time 
course of the viral infections. Studies of this duration have no precedents in the 
literature as previous trials evaluating transcriptomic responses after different viral 
infections in Atlantic salmon lasted few days (Jørgensen et al., 2007; Miller et al., 
2007; LeBlanc et al., 2010), 7 weeks (Jørgensen et al., 2008) and a maximum of 12 
weeks (Timmerhaus et al., 2011). Moreover, the use of functional feeding as an 
alternative therapy for viral diseases, has also not been previously reported, being 
just only one study evaluating mortality and gene expression in Atlantic salmon 
suffering HSMI which included RT-qPCR expression of a few genes related with 
cardiac transcription and inflammation after supplementation of tetradecylthioacetic 
acid (Alne et al., 2009; Grammes et al., 2012). 
The use of oligoarray technology to identify effects on gene expression in the 
present study helped to simultaneously identify the interactions between the altered 
lipid and fatty acid compositions of the diets and the main players in the immune and 
inflammatory responses that developed following infection with ASRV and PCMV. 
This was also a new approach for the evaluation of the influence of diet on the 
immune response in aquaculture as previous studies, in general, focused on the 
production of certain specific metabolites such as cytokines and eicosanoids, or the 
expression of a limited set of genes mostly related with the innate immune response 
(Bell et al., 1993, 1996; Tocher et al., 1997; Lin and Shiau, 2007; Montero et al., 
2010b). Transcriptomic results from the oligoarray analyses conducted during both 
viral challenge studies in the present thesis pointed to a dietary influence beyond the 
traditional inflammatory pathways mentioned above. Thus, dietary influences on the 
adaptive immune response through several pathways such as T-cell signaling 
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pathways and antigen presentation, as well as the innate immune response, showed 
that expression of genes related with antiviral responses was particularly affected 
between the dietary treatments. The interactions between dietary LC-PUFA and their 
metabolism and important pathways related with viral clearance were previously 
described in humans (Stulnig and Zeyda, 2004; Shaik and Eidin, 2006), but, to the 
best of our knowledge, little was known about these relationships in fish.  
There was a strong and clear effect that was consistent in both challenges with the 
salmon fed the functional feeds showing delayed immune/inflammatory responses in 
comparison to fish fed the reference feeds. These delays in the development of 
inflammatory responses were also clearly correlated with the histopathology results 
in both challenges, and also the viral load in the case of the ASRV infection. The 
precise mechanism underpinning the overall delayed response is not entirely clear 
but is probably related in some way with an initial repression of the replication of the 
virus. Whether this could ultimately increase disease resistance is also not clear and 
it is difficult to accurately predict the consequences of this delayed immune and 
inflammatory response in a natural outbreak. Therefore, this is very clearly 
something that would be particularly interesting to study in future investigations. 
In general, the expression of the different pathways of the immune response, 
especially those related with the innate response, including antiviral and apoptotic 
pathways, were lower in salmon fed the functional feeds at time points at which the 
viral load was similar across all treatments. This was the case in both challenges, but 
was most evident in fish fed the FF1 diet in the experimental challenge with ASRV, 
the causal agent of HSMI. Therefore, selection of supplements and raw materials for 
the formulation of functional feeds designed for these types of viral disease should 
focus on the inclusion of potential inflammatory response modulators, which could 
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attenuate the lesions associated with the more uncontrolled response that occurs in 
fish fed with standard commercial feeds. The main strategy used in the design of the 
functional feeds tested in the present thesis was focused on lipid and fatty acid 
content and composition, with a combination of EPA supplementation along with a 
reduced lipid content, achieved through the use of different raw materials. In the 
HSMI trial, improved performance was observed in salmon fed the diet which 
contained both krill oil and krill meal (FF2), compared with the fish fed the reference 
feed. This was probably because krill products are not only particularly rich in the 
anti-inflammatory fatty acid EPA, but also it is largely in the form of phospholipid, 
which can facilitate the enrichment of EPA in the phospholipid membranes of cells. 
However, the salmon fed the FF1 diet, which contained krill meal but a blend of fish 
oil and rapeseed oil rather than krill oil, actually showed the best performance and 
the largest impact on both the level of heart lesions and expression of genes of the 
immune response. This possibly reflected the fact that the FF1 feed, although not the 
highest dietary EPA level, had the highest EPA/ARA ratio. In light of the data from 
the ASRV challenge, the formulations of the functional feeds in the subsequent 
PCMV trial were modified to include an even higher supplementation of EPA (more 
than 3-fold greater than in the REF feed, compared to a 2-fold uplift in the ASRV 
trial), which was achieved by using a Southern hemisphere fish oil. The EPA/ARA 
ratios were also higher in the functional feeds in the PCMV trial compared to the 
EPA/ARA ratios in the FF1 and FF2 diets in the previous ASRV trial. However, 
salmon fed both functional feeds following PCMV infection did not show as clear a 
performance benefit as was observed with fish fed the FF1 feed in the earlier ASRV 
trial. Although the viral infections were of course different, we can possibly also 
hypothesize that the difference between the performance of fish in the two trials may, 
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in fact, be due to the different levels of ARA in the feeds in the two trials. Although 
the dietary levels of ARA are relatively low, the high biological activity on this fatty 
acid in inflammatory pathways makes its level crucial. Therefore, an important 
consequence of using Southern hemisphere FO, in addition to increased EPA, is the 
higher level of ARA that they contain. In addition, the dietary ARA level in the REF 
feed in the PCMV trial was lower than in the STD feed in the ASRV trial. 
Consequently, the difference in the EPA/ARA ratio between the STD diet and the 
FF1 diet in the ASRV trial was greater than the difference between the REF diet and 
both functional feeds in the PCMV trial. As EPA/ARA ratio appeared to be 
particularly important in discriminating between the FF1 and FF2 feeds in the ASRV 
trial it is possible that the higher EPA/ARA ratio (due to lower ARA) in the REF 
feed meant that the difference between the diets in EPA/ARA ratio were not as 
pronounced in the PCMV trial. Thus, the increased level of ARA in the functional 
feeds (CMS1 and CMS2) along with the lower ARA level of the REF diet impacted 
the EPA/ARA ratios and lessened the impact of EPA supplementation in 
immunomodulation, confirming the importance of the EPA/ARA ratio in influencing 
the production of lipid mediators of the inflammatory response. Nevertheless, the 
results may also suggest interactions between different components or raw materials 
used, not necessarily related to lipid composition. Therefore, further analysis of the 
different macro- and micronutrients of the diets would be a relevant area for future 
research in this field. 
Interactions between dietary fatty acid composition and lipid and fatty acid 
metabolism after infection with the causal agent of HSMI, ASRV, were evaluated in 
depth in Chapters 3 and 4. Mobilization of LC-PUFA precursors of eicosanoids was 
clearly observed in membrane phospholipids of both heart tissue and head kidney at 
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the time of peak expression of the genes specifically related to the inflammatory 
response. As far as the author is aware this is the first study analyzing the expression 
of genes involved in the major steps in the production of eicosanoids, from the 
release of the LC-PUFA precursors via the expression of different phospholipases, to 
the actual biosynthetic steps in the formation of leukotrienes and prostaglandins from 
LC-PUFA via the analysis of the expression of COX2, ALOX5 and FLAP genes. 
Although the expression of most of the genes was individually not significantly 
different between fish fed the dietary treatments, there was a clear trend across all the 
genes of lower expression in the fish showing improved performance. In 
combination therefore, the overall gene expression pattern added weight to the 
impression that there were biologically significant effects of diet on the eicosanoid 
pathways. The lack of more conclusive results in terms of gene expression in this 
pathway is very likely associated with the fact that both pro- and anti-inflammatory 
eicosanoids are produced through the action of the same enzymes. This makes it 
difficult to directly correlate the expression of the genes involved in this pathway 
with the actual production of either pro- or anti-inflammatory eicosanoids. However, 
the differences in expression of, say, phospholipase observed between the initial and 
latter stages of the infection were significant, pointing to an actively regulated release 
of LC-PUFA from the membrane phospholipids at the beginning of the infection. 
Nevertheless, higher production of the final products of this pathway was observed at 
the end of the trial when the inflammatory response was more active. Thus, the 
eicosanoid pathway is one of the key links between dietary fatty acid composition 
and cellular fatty acid metabolism, through membrane fatty acid compositions, and 
the inflammatory response. Consequently, the role of eicosanoids in these viral 
diseases, associated with a chronic inflammatory process, could be crucial in the 
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evaluation of the physiological and clinical effects of functional feeds. Closer 
monitoring of the changes in the composition of tissue membrane phospholipids, and 
the identification and quantification of the eicosanoids, particularly the balance 
between ARA- and EPA-derived derivatives, produced at different stages of the viral 
disease, may lead to a better understanding of this important link between nutrition 
and the inflammatory response.  
Dietary-induced effects on the phospholipid class compositions and the fatty acid 
compositions of the individual phospholipids in tissue cell membranes changed both 
the expression of genes involved in the eicosanoid pathway and also expression of 
key transcription factors related with the immune response, such as PPARs. These 
effects were more pronounced in the head kidney, a major immune tissue in fish, 
compared with the heart tissue, the main organ affected by the disease, over the time 
course of the infection highlighting the important role of this immune tissue in 
mediating the effects of diet on immunomodulation. This reflects the fact that head 
kidney is the primary source of macrophages in fish and so these immune cells, 
which are associated with the production of eicosanoids (Balfry and Higgs, 2001), 
are produced in the head kidney and travel to the sites of infection, such as heart in 
the case of the viral infections in the present study.  
Dietary modulation of eicosanoid production by tissue at the main organ site of 
the infection can also be hypothesized based on the different levels of the LC-PUFA 
related to inflammatory response in the phospholipids of the heart tissue and the 
different expression of the genes involved in the biosynthesis of the eicosanoids over 
the course of the infection. As these inflammatory mediators have a short half-life 
and so can only be effective in the local vicinity of their production, in situ tissue 
production of eicosanoids could be important in mounting a more effective response. 
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Thus, increased bioavailability of the anti-inflammatory fatty acids such as EPA in 
the heart tissue itself, as well as in macrophages migrating there, could also be an 
important factor to consider in future functional feeding studies in viral diseases 
affecting heart tissue. 
Evaluation of the LC-PUFA biosynthesis pathway was also performed to evaluate 
possible interactions with viral infection and/or dietary fatty acid composition that 
could lead to increased bioavailability of anti-inflammatory fatty acids in fish fed the 
functional feeds. The initial hypothesis, based on the existing literature, was that 
there would be higher expression of the genes related with the LC-PUFA 
biosynthesis pathway in fish fed the reference diet (STD), as the fatty acid 
composition of this diet had lower levels of the LC-PUFA products of this pathway 
and higher levels of C18 PUFA precursors (Leaver et al., 2008; Morais et al., 2009, 
2011). However, the expression of both fatty acyl desaturases, key regulatory 
enzymes in the LC-PUFA biosynthesis pathway were higher in fish fed the 
functional feeds. As this was an unexpected result, a further trial was conducted 
(Chapter 4) in order to determine if the other major difference in lipid composition 
between the reference feed and the functional feeds, dietary digestible energy (lipid 
content), was a factor influencing the LC-PUFA biosynthetic pathway. Dietary lipid 
content was identified as a possible factor influencing the expression of these genes 
as similar effects were previously described in rainbow trout fed diets with differing 
energy levels (Kolditz et al., 2008). Another possible option was that previous 
studies in humans had suggested some depression of the activity of the LC-PUFA 
biosynthesis enzymes after viral infections (Horrobin, 1990), and so the study 
conducted in Chapter 4 was performed in fish without viral challenge. This trial was 
therefore designed to clarify whether dietary lipid content and/or viral infection, 
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which resulted in liver lesions associated with the infection, were the primary cause 
of the unexpected lower expression of the LC-PUFA biosynthesis genes. The results 
obtained in this chapter clearly confirmed that the increased expression of the genes 
of LC-PUFA biosynthesis were not only dependent on the fatty acid composition of 
the diet, but also on the lipid content of the diet. The use of diets with similar 
proportions of both precursors and products of the LC-PUFA biosynthesis pathway 
in all the diets strengthens the result that dietary lipid content was the main factor 
responsible for the increased expression of genes in this pathway. This was the first 
direct demonstration of the effect of dietary lipid content on the expression and likely 
activity of the LC-PUFA pathway in salmon (Zheng et al., 2004; 2005). There was 
no evidence of an association or relationship between the viral infection and the 
expression of desaturase genes and thus LC-PUFA biosynthesis pathway. Whether 
the effect of reduced dietary lipid content in increasing the expression of desaturase 
genes and thus increasing the active synthesis of LC-PUFA could be beneficial in 
maintaining the proportions of the LC-PUFA involved in the immune response 
during the infection requires further investigation. Therefore, this should be included 
in future studies in order to elucidate the important links between the metabolic and 
physiological effects of reduced dietary lipid content in functional feeds and their 
association with inflammatory and immune responses and improved performance of 
fish undergoing viral challenge. 
The overall conclusion of this thesis is that there is a strong influence of lipid 
content and fatty acid composition of the diet on the pathways of immune and 
inflammatory responses in Atlantic salmon after a viral infection. Furthermore, the 
results also demonstrate that great insight into the possible metabolic and 
physiological mechanisms involved can be effectively revealed by the use of oligo 
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microarrays that provide near genome-wide appreciation of the effects on gene 
expression. In summary, the thesis has shown that the concept of clinical nutrition 
could be a powerful alternative therapy against viral diseases in salmon and, likely, 
all fish species. This is particularly the case where a major consequence of the viral 
infection is a chronic inflammatory response as functional feeds could not only 
potentially mitigate the overall immune and inflammatory processes, but also offer 
an opportunity to reduce the use of traditional pharmacological treatments that are 
causing increasing concern in relation to their environmental impact.   
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